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Summary of each chapter 
This report, written following European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) 
guidelines1 is an overview of new developments and trends in the drugs area in Ireland for 2013 and, 
in some cases, for the first six months of 2014. These are covered under the following headings: 
1. Drug policy: legislation, strategies and economic analysis 
2. Drug use in the general population and specific targeted-groups 
3. Prevention 
4. High risk drug use 
5. Drug-related treatment: treatment demand and treatment availability 
6. Health correlates and consequences 
7. Responses to health correlates and consequences 
8. Social correlates and social reintegration 
9. Drug-related crime, prevention of drug-related crime and prison 
10. Drug Markets 
 
 
Main points from Part A 
1. Drug policy: legislation, strategies and economic analysis 
New legislative and regulatory measures include: the Health Identifiers Act 2014, which provides the 
legal basis for individual health identifiers for health service users and unique identifiers for health 
service providers, the Road Traffic (No.2) Act 2014, which provides for non-technology-based 
cognitive tests for driver intoxication; and regulations allowing aapproved medicines containing the 
active ingredients of cannabis to be prescribed in Ireland.  A journal article has examined how 
legislative and law enforcement responses to the emergence of new psychoactive substances (NPS) 
and so-called ‘head shops’ in recent years in Ireland have adversely impacted on academic research 
on NPS. Future legislative approaches in this area should recognise the potential for academics and 
forensic service providers to work together. The Criminal Justice Act 1999 created a new offence of 
possessing controlled drugs having a value of £10,000 (€13,000) or more for sale or supply, which 
attracted a presumptive sentence of 10 years’ imprisonment.  A sentencing court may, however, 
impose a lower sentence where there are mitigating factors that amount to ‘exceptional and specific 
circumstances’.  A recent study found that, in addition to consideration of the quantity or value of 
drugs, other factors influencing sentences under this legislation included the type of controlled drug or 
drugs, the role of the offender, and the condition of the offender. 
 
To progress the integration of drug and alcohol policies, in October 2013 the government approved an 
extensive package of measures to deal with alcohol misuse, to be incorporated in a Public Health 
(Alcohol) Bill. In January 2014 the Department of Health hosted a half-day conference for those 
working in the drugs and alcohol field to (1) assess how the partnership approach to the delivery of 
the NDS could be maintained and strengthened, and (2) provide a forum for participants to give their 
views on how drug and alcohol task forces could integrate alcohol into their work. At the conference, 
details of a new policy coordination mechanism were announced. Between the Oversight Forum on 
Drugs (OFD) and the local and regional drugs task forces (LDTFs and RDTFs), a National 
Coordinating Committee (NCC) for drug and alcohol task forces has been established. It is chaired by 
a senior official in the Department of Health and comprises representatives of relevant organisations 
in the statutory, voluntary and community sectors. Replacing the Drugs Advisory Committee, the NCC 
drives implementation of the NDS at local and regional level. It is responsible for making 
recommendations to the Minister in relation to the implementation of the NDS.  
 
 
2. Drug use in the general population and specific sub-groups 
In 2014 the All-Ireland general population survey 2010/2011 reported detailed information on cocaine 
use. More people than ever before had tried cocaine (including crack) at least once in their lifetime, 
with the rate at 7% for the adult population in 2010/11, compared to 3% in the 2002/03 survey.  
However, the proportion of adults who reported using cocaine in the last year (recent use) remained 
                                               
1
 The EMCDDA guidelines require each Focal Point to write its National Report in a prescribed format using standard headings and covering 
each topic using a check list of items. This helps to ensure comparability of reporting across the EU.  www.emcdda.europa.eu/ . 
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stable between 2006/7 and 2010/11 at just under 2%.  Half of all cocaine users commenced use 
before they were 21 years old. 
 
In 2014 the All-Ireland general population survey 2010/2011 also reported detailed information on 
polydrug use.  Polydrug use was defined as concurrent substance use, where a person uses at least 
two substances within a one-month period.  Twenty per cent of all adults had not used any substance 
within the last month.  Women were more likely than men not to have used any substance (23% vs 
19%).  The most common combination of substances used was alcohol and tobacco (16%), followed 
by alcohol and other legal drugs (7%), alcohol, tobacco and other legal drugs (2%), and alcohol, 
tobacco and any illegal drug (2%).  Association between use of alcohol and tobacco was high. Users 
of cannabis, amphetamine-type stimulants (ATS) and cocaine were highly likely to have used other 
legal and illegal substances. 
 
The Health Behaviour in School-age Children (HBSC) 2010 research programme reported on trends 
between 1998 and 2010.  There was a statistically significant decrease between 1998 and 2010 in the 
number of young people aged 15 to 17 who reported ever having been drunk.  However, gender 
differences were evident, with an increase in the number of girls reporting ever having been drunk 
from 24% in 1998 to 26.6% in 2010.  There was also a statistically significant decrease between 1998 
and 2010 in the percentage of young people aged 15–17 who reported cannabis use in the last 12 
months. 
 
 
3. Prevention 
Among the main developments in environmental prevention, a Public Health (Alcohol) Bill is being 
drafted, which will include measures to restrict alcohol advertising and introduce minimum pricing for 
the sale of alcohol. In 2013 the government published a Tobacco Free Ireland policy document, which 
sets out a framework to protect children and de-normalise smoking and sets a smoking prevalence 
target of less than 5% by 2025. The government is also drafting legislation to ban the smoking of 
tobacco in vehicles when any child under 18 years is present.  
 
In school-based substance use prevention, the working group set up to examine substance use 
education in post-primary schools concluded that multi-element programmes which have whole-
school, parent and community support strands, coupled with a harm reduction approach, appear to 
offer considerable advantages as regards effective substance use education programmes for young 
people. This is the first time that a harm reduction component has been formally endorsed in school-
based substance use education in Ireland. In recognition of the reality that a proportion of students 
are using legal and illegal substances, the working group recommended that teaching and learning 
resources used in schools and centres for education aim at reducing, postponing and/or eliminating 
substance use. 
 
Eighty-eight per cent of primary schools and 93% of post-primary schools that responded to a survey 
reported having a substance use policy in place. An inspection report on the delivery of Social, 
Personal and Health Education (SPHE) in post-primary schools noted that the module on substance 
use is frequently delivered as part of SPHE. When students were surveyed as part of the inspection 
process, they reported high levels of satisfaction with their learning from the module on substance 
use, with the vast majority reporting that they learned about reasons for substance use/misuse, and 
the effects on individuals, families and society.  
 
Published in 2014, a new national policy framework for children and young people sets out five 
outcomes for children and young people up to the age of 24to be achieved  by 2020: (1) be active and 
healthy and have physical and mental wellbeing, (2) achieve full potential in all areas of learning and 
development, (3) feel safe and protected from harm, (4) have economic security and opportunity, and 
(5) feel connected, respected and contributing to their world.  
 
 
4. High risk drug use  
In April 2014 the Health Research Board published figures on treated problem alcohol use in Ireland 
between 2008 and 2012.  The total number of cases treated for problem alcohol use increased from 
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7,940 in 2008 to 8,604 in 2011, decreasing to 8,336 in 2012.  Of those treated in 2012, 17% reported 
using at least one other drug, a similar proportion to that observed in previous years.   
 
A study on non-medical use of psychotropic prescription drugs among adolescents (aged 13 to 18 
years) in substance use treatment, published in 2013, reported that 68% of the 85 adolescents 
surveyed reported life-time non-medical use of any of the seven classes of prescription drugs. The 
most common medication used without a prescription (i.e. diverted use) was sedative/ anxiolytics 
(62%), followed by sleeping (hypnotic) medication (43%).  The paper concluded that non-medical use 
of prescription drugs is commonplace among adolescents who abuse illicit drugs and that they 
typically use these prescription drugs for hedonic reasons.   
 
Merchants Quay Ireland (MQI), a national voluntary agency providing services for homeless people 
and for drug users, reported that in 2012 there were 22,475 visits to its Drug Services and 20,847 
needle exchanges, with 3,639 individuals using the services, 558 of whom were new clients.  
 
A study of drug use in Irish prisons published in 2014 reported that the drugs most commonly used 
by the prison population were cannabis, cocaine powder and benzodiazepines.  Oral fluid testing for 
drug use in the previous 24 to 72 hours showed that 4% had used cannabis, 13% methadone and 
11% benzodiazepines.  Two-hundred-and-twenty-six prisoners said they were ‘doing heroin now’. 
Among these current heroin users, 75% reported smoking (or chasing the dragon) as their only 
method of choice, with 13% reporting injecting and 1% snorting as their only method.   
 
 
5. Drug-related treatment: treatment demand and treatment availability 
The key priorities for the HSE’s national service plan expected to have an impact on addiction 
services in 2014 included, inter alia,  improving health outcomes for persons with addiction issues, 
implementing recommendations from the HSE Opioid Treatment Protocol, implementing 
recommendations with regard to Tier 4 in the residential addiction services report, and finalising the 
implementation plan for the National Overdose Prevention Strategy. 
 
A review of the pharmacist-patient structured methadone detoxification programme (SDD) in Mountjoy 
prison between June 2010 and May 2014 showed that, of the 805 prisoners on methadone 
maintenance treatment, over half were able to reduce their methadone dose significantly using SDD.  
 
TDI data showed that in 2013, 8,684 cases entered treatment, an increase of 981 cases compared to 
2012. The majority were male (72.9%) and the mean age was 29 years, similar trends to 2012. As in 
previous years, opiates (mainly heroin) were the most common main problem drug reported by cases 
entering treatment (51.3%). The reduction in the proportion and number of cases treated for cocaine 
as a main problem substance continued, whereas the number of cases entering treatment for 
cannabis as their main problem substance continued to increase. There were 9,640 clients registered 
for methadone treatment (including those receiving methadone in prison), again only a very small 
increase since 2012. The proportion of clients receiving treatment from GPs has increased slightly, 
from 35% in 2009 to 40% in 2013. The number of cases among the Traveller community seeking 
treatment for problem drug and alcohol use increased by 163% between 2007 and 2010. However, 
this number is likely to be under-estimated. Alcohol was the most common problem substance, while 
the number seeking treatment for opiates increased by 291%. Traveller women reported high rates of 
problem opiate use and injecting behaviours. The findings present a major cultural issue and 
challenge to Traveller health services and, given the high level of sharing, this has implications for the 
delivery of needle exchange services.  
 
6. Health correlates and consequences 
In 2013, 18 new diagnoses of HIV were injecting drug users (IDUs).  This was similar to the number 
diagnosed in the previous four years (ranging from 13 to 23 cases since 2010).  Among the IDUs 
newly diagnosed with HIV infection, 83% were co‐infected with hepatitis C (HCV). 
 
There was an 18% decrease in hepatitis B (HBV) notifications in Ireland in 2013 compared to 2012, 
with only one new acute cases of HBV infection among IDUs.  There was also an 18% decrease in 
HCV notifications in Ireland in 2013 compared to 2012. The decreasing HCV notifications and 
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increasing median age is indicative of a reduced incidence of HCV in the population. Injecting was the 
predominant risk factor for 372 of the new cases and the average age was 38 years.  
 
The annual report from the Rotunda Maternity Hospital for 2012 showed a total of 89 deliveries to 
mothers attending the drug liaison midwife, of whom 76 were HBV positive, 70 were HCV positive, 31 
HIV positive and 18 tested positive for syphilis.  Fourteen babies were admitted to the neonatal unit 
with neonatal abstinence syndrome.   
 
A study on drug use in Irish prisons published in 2014 reported a prevalence of HCV of 13% among 
the general prison population and 42% among IDUs.  The prevalence of HBV among the prison 
population was 0.3%, and 19% among IDUs; the prevalence of HIV among the prison population was 
2%, and 6% among IDUs. 
 
Other reports described in Chapter Six include studies of opiate-induced neonatal abstinence 
syndrome; non-fatal overdoses and drug-related emergencies admitted to Irish hospitals; admissions 
to Irish psychiatric units and hospitals of cases with a drug disorder (ICD-10 Code F11–19, F55); 
mephedrone-induced uvulitis; and methaemoglobinaemia secondary to amyl nitrate use. 
 
In 2012, there were 181 deaths owing to poisoning recorded in Ireland by the National Drug-Related 
Deaths Index (NDRDI). This represents a decrease compared to 2011, when 232 such deaths were 
recorded. 
 
 
7. Responses to health correlates and consequences 
It was reported that a pharmacy-based needle exchange programme, rolled out in 2011 in 42 
pharmacies and extended to 71 pharmacies by the end of 2012, had provided pharmacy-based 
needle exchanges to an average of 360 individuals each month in 2012.  As a consequence, the 
number of individual drug users using sterile injecting equipment had increased by 188%, from 199 in 
January 2012 to 573 in December 2012.  In total, 10,601 needle exchange transactions were 
completed in 2012. 
 
A qualitative study of youth mental health and substance misuse disorders in two deprived urban 
areas, published in 2014, highlighted the progressively deteriorating symptoms experienced by young 
people as their addiction became a full-time occupation. It outlined the need for interventions which 
enhance early identification and treatment of mental health and substance use disorders in young 
people living in deprived urban areas.   
 
A report outlining a holistic approach to supporting families with complex challenges is also described.  
 
 
8. Social correlates and social reintegration 
The proportion of early school-leavers in treatment increased slightly in 2012, compared to 2011; 
there was also an increase in the proportion of new cases. The proportion of both all cases in 
treatment and new cases entering treatment who reported being in employment is reducing. Drug use 
was reported in research among socially-excluded groups, including early school-leavers, people in 
prison, female prisoners, homeless people, the traveller community and among people living in 
disadvantaged communities.  
 
A pilot study to assess the implementation of a framework to support the rehabilitation and 
reintegration of recovering drug users reported that, overall, the 14 service users interviewed felt 
supported; they highlighted  the positive role of care planning in helping them to set recovery goals. 
The views of service providers highlighted the need for better access to services for clients, including 
housing, education and employment, and for improved inter-agency working. Recent major shifts in 
homelessness policy will, if implemented, address the needs of homeless drug users and people in 
recovery who are experiencing difficulty in accessing accommodation. 
 
There are approximately 47 dedicated drugs rehabilitation community employment (CE) schemes for 
recovering drug users, which include 1,000 ring-fenced places. The objective of these CE schemes is 
to provide vocational training and personal development to clients to assist them to access further 
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education and/or employment. The number of clients referred to the schemes increased during 2013, 
but just over one fifth of the 1,000 places were unfilled. Eleven participants in a recent study identified 
the main benefits of participating as  the stability, structure and routine that the projects provided, the 
supports provided by key workers and peers which helped to increase coping skills and develop 
team-working abilities, and an improvement in their self-esteem and confidence. In addition, the 
transformative and empowering effect of education was noted both by participants and by referral and 
state agencies. Two recent reports have called for a reorientation of services for drug users towards a 
recovery-focused paradigm, prioritising the building and maintenance of recovery capital.  
 
 
9. Drug-related crime, prevention of drug-related crime and prison 
Data from the Irish Prison Service for 2013 shows that the number of persons in custody for controlled 
drug offences comprised 17% of the total prison population. The majority of drug offenders were 
serving sentences of 5 to 10 years. The Probation Service published the findings of the first large-
scale, nationwide survey of drug and alcohol misuse among young offenders (aged 20 years or 
under) who were on probation supervision. With regard to the link between substance misuse and 
crime, in more than 80% of cases substance misuse was linked, in the opinion of the probation officer, 
to current offending. Alcohol was the substance most frequently linked to offending, with drug misuse 
on its own being linked to a relatively small amount of offending. 
 
The issue of drug-related intimidation, much of it related to drug debt, has emerged as a major 
concern for many communities in Ireland. A recent report has investigated the causal factors 
underlying intimidation with a view to informing possible interventions and responses by partner 
agencies and the wider community. The CityWide Drugs Crisis Campaign, in association with the 
Health Research Board, is currently conducting a national audit of drug-related intimidation and 
community violence in drugs and alcohol task force areas throughout the state. A recent journal article 
provides an Irish perspective on drug-facilitated sexual assault (DFSA). It discusses the various ways 
in which DFSA is defined, the limitations associated with establishing its prevalence in Irish society, 
the various substances that have been found to be associated with it in other jurisdictions, and the 
complex evidential issues that can arise in trying to establish its basis in law. 
 
A position paper by the Irish Penal Reform Trust has called for a non-custodial approach to be 
adopted for women offenders and, in the few cases where prison is necessary, for the negative 
impact of imprisonment on women, and those they care for, to be minimised. A report on the Dóchas 
Centre (a female prison) by the Inspector of Prisons has highlighted the serious problems associated 
with drugs in the Centre. The Dublin City Business Association has called for the establishment of a 
community court as a means of addressing low-level crimes such as vandalism, theft, anti-social 
behaviour, drug use and drug dealing in the capital. The National Advisory Committee on Drugs and 
Alcohol has published the findings of a study it commissioned to estimate the prevalence of drug use, 
including intravenous drug use, among the prisoner population in Ireland in order to determine the 
need for drug treatment and harm reduction (including needle exchange) services in Irish prisons.  
The authors have made a series of recommendations for drug treatment services in prison. 
 
 
10. Drug markets 
Forced labour in the production of cannabis is the subject of a research report by the Migrant Rights 
Centre Ireland (MRCI). According to MRCI, this phenomenon involves human trafficking for the 
purpose of criminal exploitation. The study examined trafficking for cannabis production, specifically 
focusing on cases and reports where Vietnamese and Chinese nationals were involved. 
 
The illegal street sale of prescription drugs has emerged as an important issue in the Irish drug scene 
in recent years. Data produced by the Forensic Science Laboratory shows trends for some of the 
main prescription drugs, primarily benzodiazepines and Z-hypnotics, seized by An Garda Síochána. 
There has been a significant increase in the seizures of alprazolam and diazepam since 2009, while 
seizures of zopiclone have trebled since 2009.  
 
As part of a recent Flash Eurobarometer survey on young people and drugs, respondents were asked 
about the perceived availability of drugs. Around a quarter of respondents believed it would be easy to 
obtain cocaine, new substances that imitate the effects of illicit drugs, and ecstasy; over half believed 
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it would be easy to obtain cannabis. The proportion of Irish respondents who responded that it was 
‘very easy’ to obtain certain substances was above the proportion across all EU member states for all 
substances, except tobacco.   
 
An analysis of heroin and cocaine seizures submitted to the Forensic Science Laboratory (FSL) 
between April 2010 and March 2012 sought to assess the current status of these particular drug 
markets, in order to track changes in the markets, and for comparison to reported European data. The 
study revealed ‘a general decline of diamorphine [heroin]  purity over the time period, with the 2012 
average being nearly half the average purity obtained for 2010’ (p. 2). As part of the study, the Garda 
National Drugs Unit provided price data for 144 street-level heroin cases submitted to the FSL 
between 2010 and 2011. There was a correlation between pack sizes and prices, leading the authors 
to conclude that ‘the driving factor for diamorphine prices may not be perceived quality, but perhaps 
the quantity of drug sold, or customer demand in times of limited diamorphine supply’ (p. 3). Purity 
was determined for 217 cocaine cases over the 2010–2012 period, with the average purity remaining 
fairly stable, at 15% for 2010, 19% for 2011 and 17% for the first three months of 2012. Price data 
were obtained from the GNDU for 17 cocaine seizures for which purity was determined during the 
study period but no correlation was found between price and purity. 
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Part A: New Developments and Trends 
1. Drug policy: legislation, strategies and economic analysis 
1.1 Introduction 
The classification of drugs and precursors in Ireland is made in accordance with the three United 
Nations conventions of 1961, 1971 and 1988. Irish legislation defines as criminal offences the 
importation, manufacture, trade in and possession, other than by prescription, of most psychoactive 
substances. The principal criminal legislative framework is laid out in the Misuse of Drugs Acts 
(MDA) 1977 and 1984, and the Misuse of Drugs Regulations 1988. The offences of drug possession 
(s.3 MDA) and possession for the purpose of supply (s.15 MDA) are the principal forms of criminal 
charge used in the prosecution of drug offences in Ireland. The Misuse of Drugs Regulations 1988 list 
under five schedules the various substances to which the laws apply. 
 
The National Drugs Strategy (interim) 2009–2016 (NDS) provides the implementation framework 
for illicit drugs policy in Ireland (Department of Community 2009). The Strategy has an overall 
strategic objective, ‘To continue to tackle the harm caused to individuals and society by the misuse of 
drugs through a concerted focus on the five pillars of supply reduction, prevention, treatment, 
rehabilitation and research’. Implementation is based on a ‘partnership’ approach, whereby over 20 
statutory agencies, multiple service providers and community and voluntary groups work together in a 
nationwide network of regional and local drugs and alcohol task forces (DATFs) to deliver the 
Strategy, with the statutory agencies critical in terms of core service provision. The Minister for Health 
has overall responsibility for the NDS, and an Oversight Forum on Drugs (OFD), chaired by the 
Minister for Health, and comprising senior representatives of the various statutory agencies involved 
in delivering on the Strategy, and representatives from the community and voluntary sectors, meets 
every quarter to monitor progress and address any operational issues. The National Co-ordinating 
Committee for Drug and Alcohol Task Forces (NCC) drives implementation of the NDS at the local 
and regional level. It is responsible for making recommendations to the Minister in relation to the 
implementation of the Strategy. The committee is chaired by a senior official in the Department of 
Health with a membership comprising two representatives of each of the four networks – the LDTF 
Chairs, the LDTF Coordinators, the RDTF Chairs and the RDTF Coordinators; representatives of the 
key Departments and agencies involved in the implementation of the NDS; and two community sector 
representatives and two voluntary sector representatives.  
 
Priorities for public expenditure on the drugs issue are set out in the NDS. Public funds are 
allocated by way of the annual parliamentary Estimates process, which allocates funds to 
departmental Votes. Funding for regional or local initiatives may be either directly from government 
agencies and funds such as the Young People’s Facilities and Services Fund (YPFSF), administered 
by the Department of Children and Youth Affairs (DCYA), or via the regional and local DATFs. 
Funding by DATFs proceeds from ‘initial’ to ‘mainstreamed’ funding as follows: 
- Initial funding: DATF projects are set up as pilot projects with funding provided through the Drugs 
Initiative, administered by the Department of Health. The relevant government department or 
agency acts as the channel of funding to the project during this pilot phase.  
- Mainstreamed funding: after the pilot phase, each project is evaluated and a decision taken with 
regard to mainstreaming it in the appropriate government department or agency.  Once 
mainstreamed, responsibility for funding the project transfers to that department or agency and the 
Department of Health is no longer involved. DATFs continue to have a monitoring role in relation to 
mainstreamed projects. 
 
 
1.2 Legal framework 
 
This update covers drug-related Acts and Bills of the Oireachtas introduced or progressed during the 
reporting year. It also identifies new substances brought under control within the terms of the Misuse 
of Drugs legislation. Subject to the obligations of European Union (EU) membership as provided in 
the Constitution of Ireland, the sole and exclusive power of making laws for the State is vested in the 
Oireachtas. The Oireachtas consists of the President and two Houses, Dáil Éireann (House of 
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Representatives) and Seanad Éireann (Senate). Bills are proposals for new laws. They are usually 
approved by a Minister or another member of the government. Occasionally, a private member’s bill is 
proposed by a member of the opposition. Such bills, because they have not originated in government, 
are less likely than government-sponsored bills to become law. To become law, a bill must first be 
approved by both the Dáil and the Seanad, although the Dáil can override a Seanad refusal to pass a 
bill. Joint committees are groups of members of Parliament, including both government members and 
members of the opposition, which discuss proposed legislation and make recommendations for 
amendments to the Minister. Bills can be introduced in either the Dáil or Seanad and there are five 
stages in considering a bill. The second and third stages are considered the most important as they 
offer the fullest opportunities to members to discuss and amend the contents of the bill. Once the bill 
has been passed by the Oireachtas, the Taoiseach (Prime Minister) presents it to the President to 
sign into law, and then it becomes an Act. 
 
Acts do not come into operation until a commencement order is issued in the form of a statutory 
instrument. There are five main types of statutory instrument: orders, regulations, rules, bye-laws and 
schemes. Statutory instruments have a wide variety of functions. They are not enacted by the 
Oireachtas but allow persons or bodies to whom legislative power has been delegated by statute to 
legislate in relation to detailed day-to-day matters arising from the operation of the relevant primary 
legislation. Statutory instruments are used, for example, to implement European Council Directives 
and to delegate the powers of ministers. Specified government ministers and other agencies and 
bodies are authorised to make statutory instruments and several hundred instruments are made 
annually. Notice of the making of the commencement order is published in the Oireachtas newsletter 
Iris Oifigiúil. 
 
Also considered below where available are relevant debates in the Oireachtas in relation drug-related 
legislation, court decisions where the judiciary have provided specific interpretations of legislation, 
and academic and/or research findings in relation to drug-related legislation. 
 
1.2.1 Laws, regulations, directives or guidelines in the field of drug issues  
This update covers drug-related Acts and Bills of the Oireachtas introduced or progressed between 
August 2013 and July 2014. It also identifies any new substances brought under control within the 
terms of the Misuse of Drugs legislation. 
 
The Health Identifiers Act 2014 provides the legal basis for individual health identifiers for health 
service users and unique identifiers for health service providers. It provides, inter alia, for the 
assignment of a unique number to an individual to whom a health service is being, has been or may 
be provided and makes provision for the establishment and maintenance of registers in respect of 
such numbers and other particulars of the individuals to whom the numbers are assigned. It also 
makes provision for the basis on which such registers may be accessed and the personal data 
contained therein may be processed. This will progress action 52 of the NDS, which aims to put in 
place such a unique identifier to facilitate the development of reporting systems (Department of 
Community 2009). The absence of such an identifier has been regarded as a key constraint in 
implementing the NDS. It is anticipated that the new legal provisions will allow the reporting system to 
‘track individual histories and permit the calculation of numbers treated for specific drugs in the 
population’ (p.70).  
 
The Fines (Payment and Recovery) Act 2014 provides for the introduction of attachment of 
earnings as a means of recovering unpaid fines with the intention of reducing substantially the 
numbers of people committed to prison for the non-payment of fines. Where a person fails to pay a 
fine by the due date for payment (including by instalments where the person has chosen to pay by 
instalments) the court will make either a recovery order or an attachment order. If neither of these is 
considered appropriate (for example, where the person is not in employment and has no realisable 
assets), the court will consider imposing a community service order. The court may commit a person 
to prison if it is not possible to make any of the three orders. Community service is also an option, as 
an alternative to imprisonment, where a recovery order or an attachment order has been imposed, 
but where the fine or a portion of the fine remains outstanding. 
 
The Road Traffic (No.2) Act 2014 provides, inter alia, new measures to test for driver intoxication. 
Members of An Garda Síochána will be empowered to require people driving or attempting to drive a 
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mechanically propelled vehicle in a public place, to undertake intoxication impairment testing. This 
involves non technology-based cognitive tests (e.g. walking a straight line, tipping one’s nose, 
counting while standing on one leg). The results of these tests may be used in evidence in support of 
the Garda forming an opinion that the person is intoxicated. Under the new provisions, the Minister 
will be empowered to prescribe in regulations the nature of the tests and their manner of 
administration, as well as a form for recording the observations made during the tests. It will also be 
an offence to fail to comply with a requirement to undergo intoxication impairment testing. Section 12 
amends the Road Traffic Act 2010 to allow for the taking, subject to medical approval, of a specimen 
of blood from an incapacitated (e.g. unconscious) person following a road traffic collision involving 
death or injury. 
 
1.2.2 Laws implementation 
Medicinal cannabis 
Approved medicines containing the active ingredients of cannabis can now be prescribed in Ireland, 
after outgoing Minister of State at the Department of Health Alex White signed regulations legalising 
their use in mid-July 2014. The move means sufferers of multiple sclerosis (MS) will soon be able to 
legally use Sativex, an oral spray containing cannabis extracts, which has proven to help some MS 
patients with spasticity symptoms.  
The Health Products Regulatory Authority (HPRA),2 formerly the Irish Medicines Board, 
recommended the approval of the product for use here in 2012. However, its use remained against 
the law, because of the banning of all types of cannabis under misuse of drugs legislation. The 
changes enable such products to be prescribed, while at the same time maintaining tight controls on 
cannabis availability. Sativex will only be available on prescription from doctors, once it comes to 
market. The National Centre for Pharmacoeconomics (NCPE) will have to assess the likely costs of 
the product, before deciding whether it will be available to medical card holders.3 
 
Legislation on new psychoactive substances 
A journal article by Kavanagh and Power examines the impact of legislative and law enforcement 
responses to the emergence of new psychoactive substances (NPS) and so-called ‘head shops’ in 
recent years in Ireland (Kavanagh and Power 2014). In particular, the article considers how controls in 
this area have adversely impacted on academic research on NPS.  
 
In relation to the ‘legal highs’ phenomenon, on 11 May 2010 the government made the Misuse of 
Drugs Act 1977 (Controlled Drugs) (Declaration) Order 2010 (S.I. 199 of 2010), declaring a range of 
‘legal highs’ to be controlled drugs. To give effect to this decision, on the same day the Minister for 
Health and Children signed the Misuse of Drugs (Amendment) Regulations 2010 (S.I. 200 of 2010), 
the Misuse of Drugs (Designation) (Amendment) Order 2010 (S.I. 201 of 2010), and the Misuse of 
Drugs (Exemption) (Amendment) Order 2010 (S.I. 202 of 2010). Under these statutory instruments, 
approximately 200 individual ‘legal high’ substances, which had been on sale in ‘head shops’ and 
which included the vast majority of products of public health concern, were declared to be controlled 
drugs. Following on from this, the Criminal Justice (Psychoactive Substances) Act 2010 (PSA) was 
implemented in response to the ‘head shops’ selling ‘legal highs’ (Irish Focal Point (Reitox) 2010) 
(Chapter 1.2.1). 
 
Following the implementation of the various statutory instruments referred to above, the Forensic 
Science Laboratory (FSL), which analysed a number of head shop products obtained by means of 
test purchases, found that in the case of cathinone derivatives, ‘following the initial control of a 
selected range of compounds, the contents of retail products were quickly changed to alternative 
compounds not yet controlled’ (p.2). Consequently, the authors suggest that the head shops had 
managed to remain open, something that was contrary to the political intention behind these 
amendments to the misuse of drugs legislation. The PSA, however, did succeed in significantly 
reducing the number of head shops during its first year in operation (Irish Focal Point (Reitox) 2011). 
The authors provide an interesting perspective on why this may have occurred: 
 
There was considerable societal concern about head shops and the owners, being ‘business 
people’ who saw the potential to make a quick profit, in general, complied with retail and 
                                               
2
 http://www.hpra.net  
3
 http://www.ncpe.ie/ 
  15 
legitimate business rules, paid taxes and preferred to operate in a licit rather than an illicit 
marketplace. The introduction of the PSA and public protests at legal high retail units caused 
unease amongst these shop operators and, along with media pressure, many shops 
voluntarily closed and surrendered their products for destruction. (p. 2) 
 
The authors also refer to a reduction between 2010 and 2012 in post-mortem blood samples testing 
positive for cathinone derivatives, based on toxicological analysis conducted by the State Laboratory 
for the Coroners Service. Furthermore, the Drug Treatment Centre Board (DTCB), which screens 
methadone programme patients, reported a 25% decrease in the presence of cathinone derivatives in 
urine samples between 2010 and 2011. 
 
With regard to the impact on the research community, the authors suggest that in the midst of these 
various legal changes, academics involved in NPS research had to ensure that they had the 
appropriate licence for any substance they were investigating. As a consequence, they suggest, 
‘Some researchers preferred to avoid projects involving, or that might involve controlled substances’ 
(p.1). A potentially negative consequence of the approach to NPS is, they suggest, that ‘with little or 
nothing known about their actual harm potential, numerous compounds became controlled drugs, 
thus discouraging academia from pursuing research due to licensing requirements’ (p. 4). In 
hindsight, they suggest that ‘it may have been prudent…to allow researchers to study such 
compounds by allowing them to hold small amounts (i.e. quantities smaller than typical single doses 
as reported anecdotally) in their university based laboratories’ (p. 4). 
 
Future legislative approaches in this area should, according to the authors, recognise the potential for 
academics and forensic service providers to work together, something that would need to be 
facilitated through primary legislation. For example, with regard to the testing of suspected drug 
seizures, ‘forensic drug chemists are primarily interested in uniquely identifying controlled substances 
in case samples rather than impurity or by-product profiling. However, the latter is an important 
intelligence-gathering tool, which can be used to link batches of drugs and provide a valuable insight 
into manufacturing and supply trends’ (p. 6). Work of this type is more research oriented and, as the 
authors observe, ‘academics have more freedom and time to think outside the box and are not 
shackled by accreditation protocols or the seemingly ever-increasing workloads that forensic service 
providers continually face’ (p. 6). 
 
In conclusion, they call for a review of the current legislative framework so that it can accommodate 
an academic input and allow for more targeted research. And although it is acknowledged that any 
relationship between academics and forensic science is rendered more challenging by virtue of the 
fact that some of the work might involve case samples that are sub judice, legislation should, they 
argue, ‘provide better mechanism for academia and forensic service providers to work together and 
share data so that more informed policy decisions can be made’ (p. 6).  
 
Organised crime – use of emergency legislation 
The Criminal Justice Act 2006 and the Criminal Justice (Amendment) Act 2009 created, for the first 
time, the offence of participation in a criminal organisation and made provision to enable all organised 
crime offences to be declared scheduled offences for the purpose of trial in the Special Criminal 
Court, which operates with three judges and without a jury (Alcohol and Drug Research Unit 2007). In 
a Seanad debate a resolution to provide for the continuation in operation of section 8 of the Criminal 
Justice (Amendment) Act 2009 for a 12-month period beginning on 30 June 2014 was supported 
(Conway 2014, 19 June). The Act provides for a limited number of specific organised crime offences 
to be prosecuted in the Special Criminal Court. The proposal to use the Special Criminal Court for 
such offences removes the possibility of jury-tampering or the intimidation of jurors. Addressing the 
debate, Minister of State John Perry TD stated:   
 
The purpose of section 8 is to ensure organised criminal gangs cannot interfere with the 
criminal process to determine the outcome of cases. To this end the section declares that the 
ordinary courts are inadequate to secure the effective administration of justice and the 
preservation of public peace and order in regard to certain offences. The offences in question 
are the organised crime offences under Part 7 of the Criminal Justice Act 2006. In brief, they 
concern the following: directing the activities of a criminal organisation – section 71A of the 
Criminal Justice Act 2006; participating in or contributing to certain activities of a criminal 
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organisation – section 72; committing a serious offence for a criminal organisation – section 
73; and liability for offences committed by a body corporate – section 76.  Section 8 of the 
Criminal Justice (Amendment) Act 2009 makes these scheduled offences for the purposes of 
Part V of the Offences against the State Act 1939. While this means that the Special Criminal 
Court will hear prosecutions for the offences in question, the Director of Public Prosecutions 
may still exercise her power to direct that the offences should be tried in the ordinary courts. 
 
Sentencing in drug cases 
A recent study conducted by the Irish Sentencing Information System (ISIS)4 examined the 
sentencing practice of the courts in relation to the offences of possession or importation of controlled 
drugs for the purpose of sale or supply (Mackey 2014). There are four such offences which were 
covered by the study: 
 possession of controlled drugs for unlawful sale or supply (s.15 of the Misuse of Drugs Act 1977, 
as amended); 
 possession of controlled drugs (valued at €13,000 or more) for unlawful sale or supply (s.15A of 
the Misuse of Drugs Act 1977, as amended); 
 importation of controlled drugs for unlawful sale or supply (several provisions found in the 
Customs Acts, Misuse of Drugs Acts 1979–1984, as amended, and the Misuse of Drugs 
Regulations 1988); and 
 importation of controlled drugs (valued at €13,000 or more) for unlawful sale or supply (s.15B of 
the Misuse of Drugs Act 1977, as amended). 
 
Convictions under s.15A or s.15B attract a ‘basic presumptive sentence’ of 10 years or more (for 
discussion of legislation, see (Irish Focal Point (Reitox) 2011), Chapter 1.2.2). A sentencing court 
may, however, impose a lower sentence where there are mitigating factors that amount to 
‘exceptional and specific circumstances’, which would render the imposition of a sentence of 10 years 
or more ‘unjust in all the circumstances’.  Part I of the report analysed the legislative basis for these 
drug trafficking offences and the reserved judgments of the superior courts. Part II examined the 
application of sentencing principles in relation to the ‘basic presumptive sentence’ provided for in 
sections 15A and 15B above. Part III examined 79 judicial decisions involving 81 offenders before the 
Court of Criminal Appeal from 2009 to 2012. Twenty of these judgements related to ordinary offences 
and 59 to offences carrying the presumptive sentence. 
 
The case law analysed showed that ‘in the majority of s.15A and s.15B sentences (67% of those 
surveyed) the presumptive minimum sentence of 10 years imprisonment or more is not imposed by 
the courts despite the fact that this sentence is popularly described as a “mandatory minimum” ’ (p. 6). 
However, this did not mean that the courts were disregarding the presumptive minimum sentencing 
provisions. As the author explained, ‘the Court of Criminal Appeal has repeatedly emphasised that the 
upper parameters of these offences are properly defined by reference to the maximum penalty of life 
imprisonment and not, as is often the case, to the presumptive mandatory minimum of 10 years’ (p. 
6).  
 
This was the case with regard to possession for supply offences. Regarding importation offences, the 
analysis concluded that the statutory framework ‘is less coherent’. This was due to the fact that the 
ordinary offence existed under legislative provisions which provided different maximum penalties, ‘one 
of which carries a maximum penalty of 14 years imprisonment and the other carries a maximum 
sentence of life imprisonment’. 
 
This anomaly existed primarily for historical reasons that could be traced back to the emergence of 
the heroin epidemic in Dublin in the mid-1980s. Prior to the introduction of the maximum sentence of 
life imprisonment in 1984, the upper limit of 14 years applied to importation and possession for sale 
and supply offences. Such a maximum sentence was imposed in The People (Director of Public 
Prosecutions) v. L.D., i.e. Larry Dunne, a leading member of the family largely credited with 
introducing heroin to Dublin at this time ((Flynn and Yeats 1985)). In the period between the 
commission of the offence and the date of sentencing, the legislature had increased the maximum 
penalty. In passing sentence, McMahon J. stated that the major players involved in drug trafficking 
could in future expect life imprisonment. As the ISIS report showed, however, up to the time of the 
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 http://www.irishsentencing.ie/  
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study no convicted person had received the maximum sentence of life imprisonment. As a 
consequence, as the author pointed out, ‘It is sometimes therefore popularly espoused that custodial 
sentences imposed are too short or that disparity exists from one sentence to the next.’ (p. 7).Such 
disparity was demonstrated in the following cases examined by the report: 
 
... one offender found with €300,500 of cannabis and cocaine was sentenced to the 
presumptive minimum of 10 years while another found with €329,301 of cocaine received a 
wholly suspended sentence; a man found with €43,000 of cocaine received a 1.5 year 
custodial sentence while another man found with €287,050 of cannabis received 4 years. (p. 
7) 
 
The report found that in supply offences involving drugs valued at €13,000 or more, the value was the 
most important factor in the determination of the appropriate sentence. However, this was not the only 
factor considered as sentences differed relative to the circumstances of individual cases and 
individual offenders. This approach was regarded as consistent with general sentencing principles. 
The analysis of cases provided in this report led to the conclusion that there were four primary factors 
that featured most prominently in the construction of sentences for drug trafficking offences: 
 the quantity or value of the controlled drug or drugs, 
 the type of the controlled drug or drugs, 
 the role of the offender, and 
 the condition of the offender. 
 
The Law Reform Commission (LRC) 5 recently recommended that the presumptive sentencing regime 
for drug offences be repealed (Irish Focal Point (Reitox) 2011) (Chapter 1.2.2). 
 
1.3  National action plan, strategy, evaluation and co-ordination 
1.3.1 National action plan and/or strategy 
Combining drugs and alcohol 
Regarding progress on the incorporation of drug and alcohol policies in the one national substance 
misuse strategy, in October 2013 the government approved an extensive package of measures to 
deal with alcohol misuse, to be incorporated in a Public Health (Alcohol) Bill, the general Scheme of 
which was published in 2014 (Martin 2014). The main measures include: 
 minimum unit pricing for retailing of alcohol products, 
 regulation of marketing and advertising of alcohol, 
 structural separation of alcohol from other products in miked trading outlets, 
 enforcement powers to be given to Environmental Health Officers, and 
 health labelling to include warnings and advice. 
 
A working group is due to report in 2015 on the issues surrounding the regulation of sports 
sponsorship. 
 
National Drugs Strategy Conference 
On 16 January 2014 the Department of Health hosted a half-day conference for those in the 
government, statutory, community and voluntary sectors working in the drugs and alcohol field. The 
objectives of the conference were to assess how the partnership approach to the delivery of the NDS 
could be maintained and strengthened, and to provide a forum for participants to give their views on 
how drug and alcohol task forces could integrate alcohol into their work. For details on the second 
objective regarding alcohol, see Section 1.3.2 below. 
 
Reaffirming the primacy of the NDS and the five ‘pillars’, Tánaiste (Deputy Prime Minister) Eamon 
Gilmore TD stressed the importance of maintaining the partnership approach in face of emerging 
challenges, including prescription drugs and grow houses. Minister Alex White TD, then Minister of 
State at the Department of Health with responsibility for Primary Care and the NDS, outlined the 
extensive review of the drugs task forces and the series of bilateral meetings with other government 
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 The LRC is an independent statutory body established to keep the law under review and to make proposals for reform. 
http://www.lawreform.ie  
  18 
ministers, state agencies and the community and voluntary sectors on drugs and alcohol issues, 
which had just concluded (see Section 1.3.4 below for detail on the outcomes of the review and 
bilateral meetings). He highlighted the evidence that had emerged from these engagements of an 
absolute commitment to realising the core objectives across the five pillars of the NDS. 
 
In her presentation, Susan Scally of the Drugs Policy Unit in the Department of Health, expanded on 
the bilateral meetings that Minister White had held with government departments, statutory agencies, 
and representatives of the community and voluntary sectors and the regional and local drugs task 
forces. The meetings indicated that a significant level of progress had been achieved across the five 
pillars. However, some key strategic issues, needing to be addressed, had emerged: 
 the challenge of new psychoactive substances, 
 the needs of children living with parental substance misuse, 
 support for children and young people at risk in high-support settings, and 
 the importance of rolling out the National Drugs Rehabilitation Framework. 
 
Speaking on behalf of the community sector and reflecting on the last twenty or so years of drug 
policy implementation in Ireland, Fergus McCabe listed five things necessary to ensure effective 
policy implementation: 
 political commitment with a special focus on disadvantage, 
 effective cross-cutting and co-ordinating structures, 
 equitable distribution of adequate resources, 
 timely and relevant research and evaluation, and 
 processes for real engagement involving all sectors. 
 
Tony Duffin of the Ana Liffey Drug Project (ALDP) spoke on behalf of the National Voluntary Drug 
Sector (NVDS), a representative body of voluntary drug services across the state which engages with 
the drugs task force structures and processes. The NVDS had identified four key issues regarding the 
implementation of the NDS: 
 Lack of a national representative body to oversee implementation: in principle, the newly 
established National Co-ordinating Committee will meet this need but to be effective it must be a 
real decision-making forum. 
 Role of drugs task forces needs to be refocused and reconstituted: the recent review addresses 
this need and a timeframe for implementing the recommendations needs to be put in place. 
Speaking from his own experience in ALDP, Duffin stressed the need for task forces to take an 
evidence-based approach to selecting services. 
 Alcohol: what existing budget is there for alcohol and what budget will be transferred for the 
implementation of the combined drug and alcohol strategy? Duffin pointed out that the health 
costs of alcohol use far exceed tax receipts from the drinks industry. Also, what role is envisaged 
for the voluntary sector with regard to alcohol? Duffin pointed out that merging drug and alcohol 
policies will mean treatment options, including residential services, will have to be enhanced to 
ensure polydrug users are not excluded. 
 Funding: the cuts since 2008 have resulted in services being cut and this has had a real impact on 
service users. At ALDP much of the progress made over the last 15 years is being lost and the 
service is ‘moving backwards’. 
 
Cabinet reshuffle 
On 11 July 2014, following a cabinet reshuffle, responsibility for the NDS and for alcohol policy 
passed to the Minister for Health, Leo Varadkar TD. Responsibility for drug and alcohol policy now 
rests with a senior government minister with a seat at the cabinet table. Prior to this reshuffle, 
responsibility for both policy domains was held by a junior minister without a seat a cabinet, Alex 
White TD, Minister of State in the Department of Health with responsibility for Primary Care. 
 
1.3.2 Implementation and evaluation of national action plan and/or strategy 
Integrating drugs and alcohol at operational level  
The National Drugs Strategy Conference held in January 2014 and described above in Section 1.3.1 
provided a forum for participants to give their views on how drugs and alcohol task forces could 
integrate alcohol in their work. The conference heard four presentations on incorporating alcohol in 
prevention work. 
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Promoting community engagement in addressing alcohol issues 
Community action seeks to change collective rather than individual behaviour. Because it impacts on 
the environment, it is a universal intervention. Mobilising a community to action on alcohol effectively 
anchors and maximises the work by actively involving local groups and exploiting existing networks. 
Anne Timoney of Community Action on Alcohol outlined the process, from introducing the concept to 
developing the action plan, implementing and evaluating. www.alcoholforum.org 
 
Ballymun community alcohol strategy 
A road to change: Ballymun Community Alcohol Strategy 2010–2016 (Ballymun Local Drugs Task 
Force and Safer Balymun 2010) aims to use a public health approach to reduce alcohol-related risk to 
the Ballymun community’s health, safety and well-being. Hugh Greaves, co-ordinator of the Ballymun 
LDATF, outlined the process whereby the strategy was developed, the principles underpinning the 
approach, and the contents – 41 actions across six pillars: 
1. Supply reduction, availability and enforcement 
2. Community awareness 
3. Treatment and rehabilitation 
4. Prevention and education 
5. Harm reduction 
6. Policy and research  
 
Galway City alcohol strategy 
The Galway City strategy to prevent and reduce alcohol-related harm 2013–2017 (Galway alcohol 
strategy 2013) focuses on four key areas – prevention; supply, access and availability; screening, 
treatment and support services; and research, monitoring and evaluation – and includes 40 
associated actions. An annual action plan is developed, including commitments from a range of 
partners, groups and organisations for each proposed action, and, at the end of the year, a progress 
report is compiled. Among the achievements to date, Evelyn Fanning of HSE West highlighted 
increased public awareness of the issues, improved information and understanding of alcohol 
availability and advertising, and patterns of alcohol-related harm, and responses that have begun to 
have an effect on the level of alcohol-related problems.  
 
Hello Sunday Morning (HSM) initiative 
HSM is a blogging website that encourages people to undertake a period of sobriety and reflect on 
the role alcohol plays in their life. Bloggers or ‘HSMers’ come from several countries but are 
predominantly Australians. They write blog posts, make videos and take pictures of their experiences 
as part of their participation. Ian Power of Spunout.ie described a study that aimed to conceptualise 
and evaluate the social impact of HSM. Analysis of the blog posts of 1,768 HSMers showed that over 
time they changed from being very self-focused, considering their own drinking and the views of 
peers, to reflecting on the role of alcohol in their lives, to finally taking a broader view of the role of 
alcohol in society and ways to help and support others in their personal HSM 
experiences. www.hellosundaymorning.org 
 
Paul Barron, Assistant Secretary, Department of Health, then chaired a workshop session on how 
drug and alcohol task forces could have an impact on changing positively Ireland’s relationship with 
alcohol. Conference participants identified 10 key points relating to three questions: 
 
 What are the key objectives that should guide our response to the misuse of alcohol in the 
community? 
1. identify needs/gaps and specific local issues through assessing/measuring the extent of the 
problem, e.g. local prevalence surveys, public order offences, public health issues (pregnancy 
etc.), density of alcohol-related outlets, opening hours of pubs/off-licences, rural issues (isolation 
of individuals and home drinking), effects on family; 
2. raise public awareness of alcohol-related harms (including long-term effects), laws, own drinking 
habits, cultural norms, pressures on young people to drink and treatment options; 
3. tackle vested interests and challenging situations which can promote a drinking  culture or 
facilitate harmful drinking, e.g. Halloween celebrations, sporting events, music festivals; 
4. provide early interventions for children so they understand the health effects of alcohol misuse; 
5. develop a detailed strategy which considers needs of under-18’s and over 18’s separately; 
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6. extend membership of task forces, e.g. by including homeless services (wet hostels) and 
representation from Vintners or linkages with those involved in the promotion of  events which 
have association with alcohol; 
7. develop a response to alcohol as part of poly-drug use that is different from that appropriate for 
people who have alcohol-only problems;  
8. offer alternative activities to encourage positive healthy behaviours, in conjunction  with youth 
sector;  
9. target women, young people and poly-drug users using alcohol; and 
10. provide brief intervention training (e.g. the SAOR model) to GPs, pharmacies,  teachers etc. 
 
What skills, insight and experience can the drugs task forces bring to this work? 
1. extensive drugs task force infrastructure, networks and connections and understanding that drugs 
task forces cannot work alone; 
2. experience of planning and developing multi-agency strategies and partnerships which promote 
collective action; 
3. knowledge, experience and skills in relation to the issue of addiction; 
4. local knowledge and intelligence; 
5. understanding the issue of stigma which can be a barrier to engaging in addiction services; 
6. capacity to champion and/or facilitate local initiatives and to evaluate them; 
7. capacity to mobilise and build support in communities and to promote attitudinal/cultural changes, 
in particular, where there is ambivalence in relation to  alcohol, which is still not considered a drug; 
8. well-placed to identify gaps in services and developing initiatives or advocating for resources to 
bridge those gaps; 
9. role in raising awareness and developing education programmes; and 
10. experience in making referrals and linking clients to services. 
 
What are the outcomes that you would like to see for your community from this work? 
1. a cultural shift in attitudes towards alcohol in Ireland, 
2. reduction of overall consumption of alcohol, 
3. reduction in alcohol-related harm to individuals, families and communities, 
4. reduction in alcohol-related public order problems, 
5. reduction in alcohol outlets., 
6. healthier society, improved health and well-being, and improved mental health, 
7. better quality of life, e.g. Hello Sunday Morning initiative (parents in playgrounds not in 
hangovers), 
8. appropriate interventions for different people according to their needs, 
9. better treatment facilities and proper funding for treatment for people with addiction problems, and 
10. comprehensive response to alcohol without losing focus on disadvantage. 
 
Concluding the session, Minister of State Alex White said it was his firm intention that the drugs task 
forces should become drug and alcohol taskforces, but did not wish to be overly prescriptive in 
relation to how this would be done. He acknowledged that a different approach was likely to be 
needed in relation to alcohol. He suggested that the approach should build on the experience people 
had had in relation to addressing the drug  problem, but might involve working together with other 
agencies and groups on a broader canvas, along the lines of the Galway City Strategy, or it might 
feature an initiative-based approach, such as the ‘Hello Sunday Morning’ initiative. He looked forward 
to the drugs task forces elaborating their plans and ideas as to how they can integrate into their work 
the alcohol agenda.  
 
Department of Health progress report on implementing the NDS, 2013 
Early in 2014 the Department of Health published its annual report on progress in implementing the 
NDS in 2013 (Department of Health 2014). The new initiatives implemented in 2013 in line with 17 
actions in the NDS are noted below in Table 1.3.2.1. Progress in implementing other initiatives in line 
with the other 46 actions in the NDS may be found in the Department of Health report or elsewhere 
this report in the relevant chapter. 
 
 
Table 1.3.2.1 New initiatives implemented in line with actions in the NDS, 2013 
Action 
 
New initiatives 
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Action 
 
New initiatives 
 
Supply Reduction (Actions 2–18) 
 
2. Establish Local Policing Fora (LPF) 
in all LDTF areas and other areas 
experiencing serious and concentrated 
problems of drug misuse. 
Guidelines for the operation of LPF were circulated to the 
relevant Local Authorities/Joint Policing Committees, An Garda 
Síochána and LDTFs for implementation. 
5. Develop a framework to provide an 
appropriate response to the issue of 
drug-related intimidation in the 
community. 
A framework has been developed, and under it, a ‘Drug-
Related Intimidation Programme’ has been established by the 
GNDU in conjunction with the community-based national FSN, 
with the support of the HSE’s Social Inclusion Unit. The 
purpose of the programme is to respond to the needs of drug 
users, their family members and/or friends who experience 
drug-related intimidation to repay drug debts. As part of this 
framework, an Inspector has been nominated in every Garda 
Division nationwide. The GNDU in conjunction with the FSN 
has developed an on-line campaign, which was launched in 
July 2013. More information about the programme is available 
at www.garda.ie  www.fsn.ie and www.drugs.ie  
7. Develop an initiative to target adults 
involved in the drugs trade who are 
using young children (some under 
the legal age of culpability) to engage in 
illegal activities associated with the 
drug trade. 
A framework has been developed and is now in place on a 
national level, whereby an Inspector has been nominated in 
every Garda Division nationwide to ensure that there is an 
appropriate Garda response to target adults involved in the 
drugs trade who use children to engage in illegal activities 
associated with the drugs trade. All information will be dealt 
with at local level and will be acted upon in a way that does not 
put any child or their family at risk or further risk of harm from 
criminal adults who have used children to assist in the illicit 
trade. 
10. Engage in appropriate enforcement 
strategies to ensure compliance with 
the prohibition of the sale of alcohol 
to persons under 18 years of age. 
The Departments of Justice & Equality and Health have agreed 
a three-step approach to provide for the structural separation of 
alcohol from other products in mixed trading outlets. This 
involves replacing the current voluntary code with a statutory 
code under Section 17 of the Civil Law (Miscellaneous 
Provisions) Act 2011. After two years both Departments will 
review its effectiveness in achieving the policy objectives of 
Section 9 of the Intoxicating Liquor Act 2008. 
 
Prevention (Actions 19–32) 
 
20 & 21. Improve the delivery of Social 
and Personal Health Education 
(SPHE) in primary and post-primary 
schools through the implementation of 
the recommendations of the SPHE 
evaluation in post-primary schools. 
The report on the SPHE evaluation in post-primary schools 
was published in September 2013.  
 
See detailed account of the evaluation in Chapter 3.3.1 later in 
this report. 
23. Implement SPHE in Youthreach 
Centres of Education and in Youth 
Encounter Projects and ensure that 
substance misuse policies are in place 
in these recognised Centres for 
Education. 
As part of a major reform programme, 16 Education and 
Training Boards (ETBs) have been established with effect from 
July 2013, replacing the existing 33 VECs. In October 2013, 
the legislation establishing SOLAS was enacted and FÁS was 
dissolved. SOLAS will be responsible for the coordination and 
funding of Further Education and Training and will play a 
complementary role to the new ETBs in the development of 
appropriate further education and training programmes and 
curricula. 
24. Co-ordinate the activities and 
funding of youth interventions in out-
of-school settings (including the non-
formal youth sector) to optimise their 
impact through targeting risk factors, 
while developing protective factors for 
youth at risk. 
Throughout 2013 the Department of Children and Youth Affairs 
developed a National Children's and Young People's Policy 
Framework. A Youth Strategy specific to those aged 12–25 
years is now being developed to support implementation of the 
policy framework.   
 
See account of the policy framework in Chapter 3.2.3 later in 
this report.  
28. Develop a sustained range of 
awareness campaigns. 
Following the announcement of the government’s measures to 
deal with alcohol misuse on 24 October 2013, a Steering 
Group was re-established to set out the strategic direction for 
the Awareness Campaign. During 2013 the HSE’s National 
Social Inclusion Office actively supported the ‘Let’s Talk About 
Drugs’ National Media Awards. 
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Action 
 
New initiatives 
For more detail, see Chapter 3.6 later in this report. 
29. Develop a series of prevention 
measures that focus on the family. 
The HSE established a National Hidden Harm Project 
Management Group in June 2013.The Hidden Harm project 
operates as an interagency response to ‘hidden harm’ led by 
the National Social Inclusion Office and the Child and Family 
Agency. The overarching aim of the project is to ingrain 
awareness of hidden harm into the overarching framework 
within substance misuse and childcare systems nationally; in 
order to bridge the gulf between substance misuse and 
childcare systems; and to ultimately improve outcomes for 
children. 
 
For more detail, see Chapter 3.3.2 later in this report.  
31. Maintain the focus of existing 
programmes targeting early-school-
leaving and the retention of students in 
schools. 
The Educational Research Centre’s  most recent report, 
launched on 16 December 2013, Changes in pupil 
achievement in urban primary schools between 2007 and 
2013, has found that test scores in DEIS primary schools at all 
grade levels have increased significantly. Levels of pupil 
absence have also fallen from 10.8% in 2007 to 7.1% in 2013.  
A Key Performance Indicator (KPI) in the NDS is to reduce the 
early-school-leaving figures for those within the age range 18 
to 24, from 11.5% in 2007 to 10% by 2012. This KPI has been 
achieved: the figure for 2012 is 9.7%, below the EU average of 
12.8%. 
32: Develop a comprehensive 
integrated national treatment and 
rehabilitation service for all substance 
users using a 4-tier model approach. 
The National Drugs Rehabilitation Framework (NDRF) was 
developed by the National Drugs Rehabilitation Implementation 
Committee (NDRIC) to improve the quality and quantity of 
interagency referrals between drugs services (community, 
voluntary and statutory) and the range of services that a person 
may need to access in their recovery. The framework was 
piloted in 10 sites across the country and in November 2013, a 
process evaluation was concluded. The evaluation found that 
within the pilot sites there was almost universal enthusiasm 
about the framework and what it is attempting to do, and quite 
a degree of optimism that the considerable shift in focus that is 
required will take place. NDRIC is developing an 
implementation plan for national rollout of the framework, 
building on key areas identified in the evaluation.  
 
See Chapter 8.3 later in this report for a full discussion of the 
evaluation. 
 
Treatment and Rehabilitation (Actions 33–48 
 
33. Maximise operational synergies 
between drug addiction services, 
alcohol treatment and rehabilitation 
services, general and emergency 
hospital services and mental health 
services. Within this context, there 
should be a focus on addressing the 
needs of dual diagnosis clients. 
The HSE’s National Addiction Training Programme (NATP) 
undertook to provide an introduction to dual diagnosis (DD) as 
an awareness raising exercise. (1) An outline for an 
introduction to awareness of DD was developed for initial 
presentation to staff of addiction and allied health and social 
care services in Bridge House, Cherry Orchard Hospital, in 
May 2013. (2) A conference on DD was held in June 2013. 
Two members of NATP addressed the conference. The main 
theme of the day was the lack of access to mental health 
services by clients with substance misuse disorders and the 
lack of agreed protocols in the management of clients with 
coexisting disorders. (3) A conference on DD was organised by 
HSE South-East Substance Misuse Services in November 
2013. This module was replicated and delivered in Waterford, 
and later in Donegal and Limerick (January 2014). 
39. Maintain and develop treatment 
services dealing with blood-borne 
viruses (BBVs), with particular 
emphasis on hepatitis C treatment 
services. 
The HSE National Hepatitis C Strategy Implementation 
Committee was established in April 2013 and held three 
meetings during 2013. Three sub-groups have been 
established to progress the recommendations of the strategy: 
Treatment, Surveillance and Screening and Education, 
Prevention and Communication. 
 
Research and Information (Actions 49–56) 
 
52. Seek to put in place a unique 
identifier to facilitate the development 
The Health Identifiers Act 2014 was enacted on 8 July 2014. 
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Action 
 
New initiatives 
of reporting systems in the health area 
while respecting the privacy rights of 
the individuals concerned. 
See detailed account in Section 1.2.1 earlier in this chapter. 
54. Consider the further development of 
systems monitoring changing drug 
trends in line with the EU Early 
Warning System. 
The Early Warning and Emerging Trends Sub-Group of the 
National Advisory Committee on Drugs and Alcohol (NACDA)  
has recommenced with the re-constitution of the NACDA and 
its subcommittees and is supporting Ireland’s full participation 
in the EU early warning system. 
 
Co-ordination (Actions 57–63) 
 
62. Review and renew the participation 
and commitment of members of the 
drugs task forces. 
A series of measures arising from the review of the drugs task 
forces (Department of Health 2012) were announced on 18 
December 2012. The reforms are intended to better equip the 
task forces to respond to the current pattern of drug and 
alcohol misuse. A National Coordinating Committee (NCC) to 
guide the work of the task forces and drive the implementation 
of the NDS. Its inaugural meeting was held on 23 January 
2014.  
 
See Section 1.3.4 later in this chapter for more details. 
Source: (Department of Health 2014) 
 
1.3.3 Other drug policy developments  
Parliamentary debate on cannabis 
On 5–6 November 2013 Irish politicians held a full debate in Dáil Éireann (Irish Parliament) on the 
drugs issue, specifically on a private member’s motion to regulate the cultivation, sale and possession 
of cannabis products (Flanagan 2013, 5–6 November). They voted 112 to 8 in favour of a government 
amendment that recognised the health risks associated with cannabis and its role as a ‘gateway’ 
drug, recognised that leniency in cannabis control could endanger overall international efforts against 
drugs, to which Ireland is signed up under the 1961 and 1971 UN drug conventions, and endorsed 
current government policy ‘to maintain strict legal controls on cannabis and cannabis products in 
Ireland’. Individual deputies contributing to the debate raised three different options – prohibition, 
decriminalisation or regulation. The arguments made in favour of the various options were as follows: 
 
Prohibition 
- The current system of strict controls and regulation of cannabis should continue because of the 
health and social risks associated with cannabis use. 
- Cannabis is a ‘gateway’ drug. 
- The balance of the greater good for society lies in continuing prohibition. 
- The current economic situation would preclude putting in place the measures to deal with the 
‘excesses’ that would ensue if cannabis were legalised. 
- The benefits of legalisation would not exceed the costs. 
- Ireland would become an even bigger channel for the importation of illegal drugs to Europe. 
- Why reduce controls on drugs when controls on tobacco and alcohol are being strengthened? 
 
Decriminalisation 
- Need to stop using prison as a means to tackle the drug issue. Most drug users do not commit 
crimes except the crime of possession. 
- Users found with small amounts of cannabis should not be criminalised or jailed, should not have 
convictions. 
- In Portugal decriminalisation has led to a reduction in drug-related deaths, with no increase in 
drug prevalence. 
- Decriminalising cannabis is a minimum step and a first step along the road in this debate. 
- If cannabis were to be legalised, there is as yet no assurance that the drug gangs will be tackled 
or that enough treatment centres, mental health services and other supports needed will be 
provided. 
 
Regulation 
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- Given that cannabis is freely available in Ireland and its use is normalised (over 7% of the 
population regularly use cannabis), the situation should be regulated so that cannabis users are 
not criminalised and criminals do not profit from the market in cannabis. 
- Public opinion supports regulation of the cannabis market. 
- The health risks associated with cannabis have not been conclusively proven. 
- Regulation of recreational and medicinal cannabis use is happening elsewhere in the world.  
 
Decriminalisation of drug use 
In November 2013 CityWide Drugs Crisis Campaign published Decriminalisation: a new direction for 
drugs policy (CityWide Drug Crisis Campaign 2013). The publication of the leaflet followed on from a 
conference organised by CityWide earlier in the year, when a number of speakers addressed the 
topic ‘Criminalising addiction: is there another way?’ For an account of this conference, see Chapter 
1.3.3 in the 2013 National Report (Health Research Board 2013)).  At the conference, according to 
the leaflet, ‘the most frequent comment from attendees was that they had not fully understood the 
difference between decriminalisation and legalisation and that they were unaware of the way 
decriminalisation has worked in other countries’. The purpose of the leaflet was to provide basic 
information and sources of further information to inform the debate.  
 
The leaflet begins by distinguishing between decriminalisation and legalisation. Legalisation is 
described as a process whereby the importation, sale, purchase and use of drugs are regulated by 
the state in the same way as alcohol and tobacco. With decriminalisation, drugs would remain illegal, 
but a person found in possession of drugs for personal use would not receive a criminal sanction. 
Instead, ‘depending on the circumstances, they could be given a warning, a fine or be directed to drug 
awareness classes or to drug treatment’. The importation of drugs, drug trafficking and the 
commission of crimes to fund drug use would still be prosecuted under the criminal law. 
 
The leaflet identified a number of reasons why Ireland should consider the decriminalisation of drugs 
for personal use. Criminalisation ‘does not act as a deterrent when someone decides to use drugs but 
it does cause significant harm to an individual’s future prospects as the requirement to disclose 
previous convictions never lapses’. Furthermore, decriminalisation, by directing problematic drug 
users into treatment programmes rather than the criminal justice system would reduce criminal costs 
and allow money to be redirected towards tackling organised crime. The leaflet highlighted the model 
introduced in Portugal in 2001, where ‘addiction and drug use are treated as public health issues 
rather than criminal justice issues’. Noting the emphasis on evidence-based policy in the NDS, 
CityWide asserted that ‘there is now a significant evidence base on the impact of criminalisation of 
drugs for personal use and on the experience of decriminalisation’. This information should, according 
to CityWide, inform Ireland’s contribution to UNGASS 2016. 
 
Children and young people and drugs 
On 1 February 2014 the Irish Bishops Drugs Initiative (IBDI) held a national conference in Dublin 
with the theme ‘Quenching the thirst: spirituality and addiction’. The IBDI addressed the pastoral 
response to substance abuse throughout Ireland, aiming to foster a community and pastoral response 
to the problem of addiction. Addressing the conference, Archbishop Martin said: 
 
Many young people today are attracted into the world of drinking because they are told that it 
will help them to socialize.  For some, alcohol and drug use sadly open for them a path which 
is the opposite of socializing: a path of isolation and marginalization from society and 
community.  The Irish Bishops’ Drugs initiative stresses that healing must come from 
community.  Community must become the place where broken lives are welcomed back into a 
place of integration and healing.... 
 
The Church must become the place where broken lives encounter the restoring of love of God 
through the life and witness of the Christian community.   I congratulate all those associated 
with the Irish Bishops’ Drugs Initiative.  I encourage especially those young people who are 
part of this initiative to witness through the way they life to that message of moderation and 
simple and healthy life style, and to be ready to sustain their friends who fail on the path and to 
help them refind the way of hope.’ (Martin 2014) 
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On 24 June 2014 a Flash Eurobarometer survey of young people and drugs across the 28 EU 
member states was released (TNS Political and Social 2014). The last such survey was conducted in 
2011 (The Gallup Organization 2011). Commissioned by the Directorate-General for Justice in the 
European Commission, the telephone poll was conducted between 3 and 23 June 2014. Thirteen 
thousand EU citizens aged between 15 and 24, including 500 in Ireland, were contacted by telephone 
and asked 12 questions.6 The responses of Irish young people to questions about their views on 
drugs and drug policy are noted here. See Chapter 10.4.1 for an account of their responses with 
regard to accessing illicit substances. 
 
Questions 1, 2 and 6: Becoming better informed about illicit drugs and drug use?  
Irish young people have the same order of preferences regarding how to obtain information on illicit 
drugs and drug use as their EU peers – the Internet, asking a friend, consulting a health professional, 
talking to parents, approaching someone at school or work, or using the media. However, they are 
half as likely as their EU peers to consult a specialised drug counsellor/centre (10% vs 21%), or the 
police (5% vs 13%). While the perceived role of media campaigns and school prevention programmes 
in informing young people about illicit drugs has declined sharply since 2011 (down 12% and 9% 
respectively), in Ireland these types of interventions are still perceived to play a role. Moreover, while 
16% of young people across the EU volunteered that they ‘had not been informed at all’ about illicit 
drugs’, only 7% of Irish respondents made this assertion.  
 
Question 7: Perceived health risks of using drugs?  
Respondents were asked about the health risks associated with individual substances, using a 5-point 
scale (high, medium, low, no risk and don’t know). Irish young people were the least likely in the EU to 
regard regular cannabis use as high risk (46% vs 63% across the EU), and only young people in the 
Czech Republic and the Netherlands were less likely than Irish young people to regard occasional 
use (once or twice) as high risk (11% in Ireland vs 21% across the EU). Regarding alcohol, while 
broadly in line with their EU peers, Irish young people tended to play down the health risks. Regular 
alcohol use was regarded by 87% of young Irish people as a high or medium risk (92% across the 
EU), while 84% of young Irish people regarded drinking alcohol only once or twice as low or no risk 
(77% across the EU).  
 
Question 8: How should society’s drug problems be tackled?  
Young Irish people’s views on how society’s drug problems should be tackled are broadly in line with 
those of young people across the EU. However, there are differences in emphasis. A greater 
proportion of young people in Ireland than across the EU were in favour of: 
- offering more sport, entertainment and cultural activities to young people (44% vs 36%), 
- treatment and rehabilitation of drug users (34% vs 33%),  
- reducing poverty and unemployment (28% vs 22%), and  
- making drugs legal (21% vs 18%). 
 
A smaller percentage of young people in Ireland than across the EU favour: 
- tough measures against drug dealers and traffickers (49% vs 57%), 
- information and prevention campaigns (37% vs 43%), and  
- tough measures against drug users (22% vs 25%). 
 
Questions 9 and 10: To ban or regulate illicit drugs and new substances that imitate the effects of illicit 
drugs? 
Fifty-six per cent of Irish respondents believed the cannabis market should be regulated, while 43% 
believed it should remain illegal. Conversely, across the EU, 45% of young people believed the 
cannabis market should be regulated and 53% believed it should continue to be banned.  Ireland and 
Italy have the joint second highest percentage in favour of regulation, behind the Czech Republic on 
71%. Regarding new psychoactive substances, 53% of young Irish people thought they should be 
banned only if they pose a risk to health, 29% thought they should be banned under any 
circumstance, and 17% thought they should be regulated. Regarding alcohol and tobacco, 97% of 
Irish young people thought alcohol use should be regulated and 77% thought tobacco use should be 
regulated. 
                                               
6
 The basic sample design in all states was multi-stage random (probability). Substances investigated in the survey included 
cannabis, ecstasy, cocaine, heroin, new psychoactive substances (defined as ‘substances that imitate the effects of illicit 
drugs and that are sold as legal substances’), alcohol and tobacco. 
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1.3.4 Co-ordination arrangements 
On 16 January 2014 the Department of Health hosted a half-day conference on the NDS for those in 
the government, statutory, community and voluntary sectors working in the drugs and alcohol field. 
The objective of the conference was to assess how the partnership approach to the delivery of the 
NDS could be maintained and strengthened, and to provide a forum for participants to give their views 
on how drug and alcohol task forces could integrate alcohol into their work. 
 
In Sections 1.3.1 and 1.3.2 earlier in this chapter the contributions to the conference of government 
ministers and representatives from the voluntary and community sectors are given. Here the 
presentation of Susan Scally of the Drugs Policy Unit in the Department of Health is described. She 
focused on the local effort to tackle the drugs problem. She said that government recognised that 
there is a need for DTFs to foster interagency and community-based responses to the drugs problem 
at the local level. However, the challenge is to ensure that DTFs continue to remain relevant, effective 
and fit for purpose. Ms Scally stated that it was within this context that government carried out a 
review of DTFs in 2011 (Department of Health 2012). The review recommended the establishment of 
a new National Coordinating Committee (NCC) for drug and alcohol task forces, which would replace 
the Drugs Advisory Group; new terms of reference for task forces; and strengthened accountability 
and feedback mechanisms between local and national structures. Details of the revised co-ordinating 
structures presented here have been taken from the website of the Department of Health on 31 July 
2014.7  
 
At a national level, an Oversight Forum on Drugs (OFD), chaired by the responsible Minister, meets 
quarterly to oversee progress in relation to the actions of the NDS and address any emerging issues. 
The Forum reports to the Cabinet Committee on Social Policy, as required. The terms of reference of 
the OFD are to: 
 examine the progress of the NDS 2009-2016 across the five pillars of supply reduction, 
prevention, treatment, rehabilitation and research in the context of the aims, priorities, actions and 
key performance indicators set out therein; 
 address operational difficulties and blockages in implementing the NDS and agree on appropriate 
ways forward to overcome these difficulties; 
 monitor progress on associated mainline services with a view to influencing outcomes; 
 provide any reports on existing actions and details/rationale of future plans sought by the Minister 
of State, as chairperson of the Forum; 
 consider developments in drugs policies, and in dealing with problem drug use generally, at EU 
and international level; and 
 discuss and agree, as far as possible, on the approach to drugs issues at the Cabinet Committee 
on Social Policy. 
The OFD comprises representatives from the key statutory Departments and agencies involved in the 
implementation of the Strategy, the National Advisory Committee on Drugs and Alcohol, the 
community and voluntary sectors and representatives of the Chairs of the Local and Regional DTFs. 
The National Co-ordinating Committee for Drug and Alcohol Task Forces (NCC) drives 
implementation of the NDS at the local and regional level. It is responsible for making 
recommendations to the Minister in relation to the implementation of the Strategy. The terms of 
reference of the NCC are to: 
 drive implementation of the NDS at local and regional level, 
 oversee, monitor and support the work of the task forces and to ensure that policy on drugs is 
informed by their work, 
 monitor implementation of NDS actions specific to drug and alcohol task forces, 
 monitor the expenditure and activities of the task forces and of drugs projects in their areas, and 
 make recommendations to the minister in relation to the implementation of the NDS and effective 
co-ordination of service delivery at local and regional level. 
 
The committee is chaired by a senior official in the Department of Health with a membership 
comprising two representatives of each of the four networks – the LDTF Chairs, the LDTF 
                                               
7
 http://health.gov.ie/healthy-ireland/national-drugs-strategy/  
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Coordinators, the RDTF Chairs and the RDTF Coordinators; representatives of the key Departments 
and agencies involved in the implementation of the NDS; and two community sector representatives 
and two voluntary sector representatives. 
 
Local and Regional Drugs and Alcohol Task Forces (DATFs) play a key role in assessing the 
extent and nature of the drug problem in their areas and coordinating action at local level so that  
there is a targeted response to the drug problem in local communities. They implemented the NDS in 
the context of the needs of their region or local area through action plans which have identified 
existing and emerging gaps in the following areas – Supply reduction, Prevention, Treatment, 
Rehabilitation and Research. 
 
DATFs comprise representatives from a range of relevant agencies, such as the HSE, the Gardaí, the 
Probation Service, education and raining boards, local authorities, the Youth Service, as well as 
elected public representatives and voluntary and community sector representatives. LDATFs were 
originally set up in areas with the highest levels of drug misuse. Following the establishment of 
RDATFs under the first NDS (2001–2008), all areas of the country are covered by a DTF. There are 
14 LDATFs and 10 RDATFs. Funding from the Drugs Initiative supports local projects set up by 
DATFs in the areas of curbing local supply, prevention and awareness and research.  
 
1.4 Economic analysis 
1.4.1 Public expenditures 
Direct public expenditure on the drugs issue in 2013 shows a 15% decrease (unadjusted) in public 
spending since 2009 (see Table 1.4.1.1). 
 
Table 1.4.1.1  Public expenditure directly attributable to drugs programmes, 2009–2013 
 Public Expenditure €m 
Department/Agency 
 
2009 
 
 
2010 
 
 
2011 
 
2012  2013  
Department of Health 39.377 34.992 32.876 31.475 30.524 
Department of Children and Youth Affairs 28.501 25.740 25.000 22.669 20.310 
Department of Education and Skills 3.643 2.461 0.411 0.815 0.810 
Health Service Executive 104.867 105.400 91.149 90.752 90.392 
Department of Social Protection  18.800 18.000 14.934 11.859 13.434 
Department of Environment, Community and Local 
Government 
0.461 0.461 0.400 0.200 0.00 
Department of Justice and Equality 14.801 14.478 18.681 18.580 18.553 
Irish Prison Service 5.000 5.200 5.200 5.000 4.500 
An Garda Síochána 45.004 44.500 45.014 45.850 44.000 
Revenue’s Customs Service 15.867 15.797 15.470 14.241 14.624 
TOTAL 277.240 267.792 249.839 242.342 237.147 
Source: Drug Policy Unit in the Department of Health, unpublished data 
 
The classification of Ireland’s direct drug-related public expenditure according to COFOG Levels 1 
and 2 for 2013 is shown in Table 1.4.1.2 below. COFOG, a system for the ‘classification of functions 
of government’, was developed by the United Nations as a means of obtaining comparable figures on 
government expenditures across different jurisdictions – by focusing on ‘functions’ rather than 
accounting categories, which can vary across countries. This approach has been adopted by the 
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EMCDDA as a means of seeking comparable data on drug-related public expenditures across EU 
member states (European Monitoring Centre for Drugs and Drug Addiction 2008). 
 
Table 1.4.1.2  Direct drug-related public expenditure, by COFOG functions (Level 1) and groups (Level 2), 2013  
Agency/Service Purpose of the Expenditure COFOG – 
1
st
 & 2
nd
 
Levels 
Expenditure 
€m 
Department of Health  – Total Expenditure €30.524m 
 
Health Research Board (HRB) 
 
Research and reports in relation to drug services 
and drug-related deaths  
gf07.05 0.294 
Health Research Board (HRB) 
 
National Documentation Centre gf07.05 0.663 
National Advisory Committee on 
Drugs and Alcohol (NACDA) 
Research and advisory function of the NACDA gf07.05 0.089 
Local Drugs and Alcohol Task 
Forces 
 
Treatment and rehabilitation services provided to 
drug users 
gf07.02 19.110 
Regional Drugs and Alcohol Task 
Forces 
 
Treatment and rehabilitation services provided to 
drug users 
gf07.02 8.935 
Homeless projects 
 
Homeless focused rehabilitation projects 
gf07.04 0.394 
 
Citywide Drug Crisis Campaign 
National network of community activists and 
community organisations 
gf07.04 0.211 
Family Support Network 
 
Supports the development of family support 
groups throughout the country 
gf07.04 0.201 
 
Dial to Stop Drug Dealing 
 
Freephone service to report drug dealing and 
drug related crime 
 
gf07.04 
 
0.032 
 
Education initiative 
 
UCD co-funded education initiative 
gf07.06 0.035 
 
Community and voluntary 
 
Community and voluntary representation on 
advisory groups 
 
gf07.06 
 
0.121 
Other 
 
Various salaries and other miscellaneous 
activities 
gf07.06 0.294 
 
Capital 
 
Various capital grants gf07.06 0.145 
Department of Children and Youth Affairs  – Total Expenditure €20.310m 
 
Young people's facilities and 
services fund (round 1) 
 
Youth programmes with drug-specific initiatives 
gf08.01 5.905 
 
Young people's facilities and 
services fund (round 2) 
 
Youth programmes with drug-specific initiatives 
gf08.01 13.209 
 
Local drugs task force projects 
Mainstreamed drug projects gf08.01 1.196 
 
Department of Education and Skills – Total Expenditure €0.810m 
 
Local Drugs and Alcohol Task 
Force area projects 
Drug education and prevention projects gf09.05 0.398 
 
Drug Court – education support 
Drug Court - education support gf09.05 0.412 
 
Health Service Executive – Total Expenditure €90.392m 
 
Drug-related health services 
Drug-related health services gf07.04 63.662 
 
National Drug Treatment Service 
Drug-related health services gf07.04 7.462 
 
Primary Care Reimbursement 
Service 
Drug-related health services gf07.04 19.268 
 
Department of Social Protection – Total Expenditure €13.434m 
Community Employment 
Programme 
 
Training and rehabilitation places for drugs 
referred clients on Community Employment    
gf10.05 12.772 
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Agency/Service Purpose of the Expenditure COFOG – 
1
st
 & 2
nd
 
Levels 
Expenditure 
€m 
LDATF mainstream projects 
 
Support for community-based drugs projects  
gf10.07 0.662 
 
Department of Justice and Equality – Total Expenditure €18. 553 
 
Courts Service– Public Order and 
Safety 
Drug Treatment Court gf03.03 0.124 
 
Health Research Board – Health 
Research on drug-related deaths gf07.05 0.100 
Probation Service – Health 
 
Community-based rehabilitation services 
gf07.06 1.595 
Irish Youth Justice Service – 
Education 
Youth crime diversion programmes gf09.06 16.734 
 
Irish Prison Service 
 
Drug treatment services in prisons 
 
gf03.04 
 
4.500 
 
An Garda Síochána  
 
Policing and investigation costs 
 
gf03.01 
 
44.000 
 
Revenue’s Customs Service 
 
Supply reduction – border policing and anti-
smuggling 
gf03.01 14.624 
Source: Drug Policy Unit in the Department of Health, unpublished data 
 
 
1.4.2 Budget 
The budget for directly drug-related public expenditure in 2014 is set out in Table 1.4.2.1 below. It 
shows a small increase in total expenditure compared to 2013. An administrative change has been 
made, with ‘mainstreamed funding’ (€21.570m) in respect of 220 treatment and rehabilitation 
community drugs projects, being channelled via the Health Service Executive rather than the 
Department of Health as in previous years. The funding remaining in the Department of Health Vote 
(€7.381m) supports 100 community drugs prevention projects, the National Advisory Committee on 
Drugs and Alcohol, the National Family Support Network and the Citywide Drugs Crisis Campaign 
 
Table 1.4.2.1  Allocations for directly drug-related public expenditure, 2014 
Agency/Service €m 
Department of Health 8.425 
Department of Children and Youth Affairs 19.548 
Department of Education and Skills 0.810 
Health Service Executive - addiction services 93.207 
Health Service Executive - Drug Task Force projects 21.570 
Department of Social Protection  15.178 
Department of Environment, Community and Local Government 0.000 
Department of Justice and Equality 18.573 
Irish Prison Service 4.200 
An Garda Síochána 44.000 
Revenue's Customs Service 14.624 
TOTAL 240.135 
Source: Drug Policy Unit in the Department of Health, unpublished data 
 
 
  
  30 
2. Drug Use in the General Population and Specific targeted-Groups 
2.1 Introduction 
Drug prevalence surveys of the general and school-child population are important sources of 
information on patterns of drug use, both demographically and geographically, and, when repeated, 
reveal changes over time. In Ireland such surveys are conducted every three to four years. These 
surveys increase understanding of drug use, which, in turn, helps in the formulation and evaluation of 
drug policies. They also enable informed international comparisons, provided countries conduct 
surveys in a comparable manner. The four main data collection tools in Ireland are described below. 
 
An All Ireland Drug Prevalence Survey was initiated in 2002 by the National Advisory Committee 
on Drugs (NACD), now the National Advisory Committee on Drugs and Alcohol (NACDA) in the 
Department of Health, in Ireland, and the Drug and Alcohol Information and Research Unit (DAIRU), 
now the Public Health Information and Research Branch (PHIRB), within the Department of Health, 
Social Services and Public Safety (DHSSPS) in Northern Ireland. The main focus of the survey is to 
obtain prevalence rates for key illegal drugs, such as cannabis, ecstasy, cocaine and heroin, on a 
lifetime (ever used), last year (recent use), and last month (current use) basis. Similar prevalence 
questions are also asked of alcohol, tobacco, and other drugs such as sedatives, tranquillisers and 
anti-depressants. Attitudinal and demographic information is also sought from respondents.  
 
The questionnaire and methodology for this drug prevalence survey are based on best-practice 
guidelines drawn up by the EMCDDA. The questionnaire is administered through face-to-face 
interviews with respondents aged between 15 and 64 normally resident in households in Ireland and 
Northern Ireland. Thus, persons outside this age range, or who do not normally reside in private 
households, have not been included in the survey. This approach is commonly used throughout the 
EU and because of the exclusion of those living in institutions (for example, prisons and hostels) this 
type of prevalence survey is usually known as a general population survey. 
 
The first iteration of this general population drug prevalence survey was undertaken in 2002/3 
(National Advisory Committee on Drugs and Drug and Alcohol Information and Research Unit 2005), 
and a second iteration in 2006/7 (National Advisory Committee on Drugs and Drug and Alcohol 
Information and Research Unit 2008). A series of bulletins reporting the findings of the 2002/3 and 
2006/7 iterations have been published. The most recent (third) survey was conducted in 2010/11 and 
to date, five bulletins on the findings have been published.  
 
As with other European surveys, people over the age of 64 are excluded from this survey, as they 
grew up in an era when both the use and availability of illegal drugs were very limited. Therefore, 
surveys with older people have, to date, shown very low rates of use even on a lifetime basis. This 
situation will change over time as the younger population grows older: lifetime prevalence rates are 
likely to increase for a considerable period of time. When examining the data and comparing results 
over time, last-year use is the best reflection of changes as it refers to recent use. Last-month use is 
valuable insofar as it refers to current use.  
 
The Survey of Lifestyles, Attitudes and Nutrition (SLÁN) is a national survey of the lifestyles, 
attitudes and nutrition of people living in Ireland. To date, three surveys have been completed – in 
1998 (Friel, et al. 1999), 2002 (Kelleher, Cecily, et al. 2003) and 2007 (Morgan, et al. 2008) – and 
have examined the health and social status, and related health service use, of adults aged 18 years 
and older living in private households. SLÁN 1998 and SLÁN 2002 were postal surveys, based on 
samples from the electoral register, and involved 6,539 respondents in 1998 (62% response rate) and 
5,992 in 2002 (53% response rate). SLÁN 2007 interviewed 10,364 respondents face-to-face in their 
homes, based on samples from the GeoDirectory (62% response rate). The SLÁN data are not 
comparable with the results of the 2002/3, 2006/7 and 2010/11 all-Ireland general population drug 
prevalence survey as the SLÁN survey excludes those aged between 15 and 17 years and includes 
those aged over 65 years. 
 
The Health Behaviour in School-aged Children (HBSC) is a cross-national research study 
conducted in collaboration with the WHO (World Health Organization) Regional Office for Europe. 
The study aims to gain insights into, and increase our understanding of, young people's health and 
  31 
well-being, health behaviours and their social context. It collects information on the key indicators of 
health and health-related attitudes and behaviours (including alcohol and cannabis use) among 
young people aged 11, 13 and 15 years. HBSC was initiated in 1982 and is conducted every four 
years. It is a school-based survey with data collected through self-completion questionnaires 
administered by teachers in the classroom.  
 
The Health Promotion Research Centre, National University of Ireland, Galway was invited to join the 
HBSC network in 1994 and conducted the first survey of Irish schoolchildren in 1998 (Friel, et al. 
1999). the survey has been repeated in Ireland in 2002 (Kelleher, Cecily, et al. 2003), 2006 (Nic 
Gabhainn, et al. 2007) and 2010 (Kelly, C, et al. 2012). 
 
The European School Survey Project on Alcohol and Other Drugs (ESPAD) is a collaborative 
effort of independent research teams in about 40 European countries. Data on alcohol and illicit drug 
use among 15–16-year-olds have been collected every four years since 1995, using a standardised 
method and a common questionnaire. The Swedish Council for Information on Alcohol and Other 
Drugs (CAN) initiated the project in 1993. Support has been provided by the Pompidou Group at the 
Council of Europe, the Swedish Ministry of Health and Social Affairs, the Swedish National Institute of 
Public Health and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). The 
data collections in the individual countries are funded by national sources. The rationale for the 
ESPAD surveys is that school students are easily accessible and are at an age when onset of 
substance use is likely to occur. Early school leavers, a group known to be vulnerable to alcohol and 
drug use, are not represented in this survey, so the results do not indicate the extent of alcohol and 
other drug use among all 15–16-year-old children. ESPAD survey information is valuable in planning 
prevention initiatives.   
 
The fourth iteration of the survey was conducted in 35 European countries, including Ireland, in the 
spring of 2007 and the results were published in March 2009 (Hibell, et al. 2009). Data were collected 
for the fifth iteration of ESPAD in 2010/2011 and the survey findings were published in 2012 (Hibell, 
et al. 2012). 
 
2.2 Drug use in the general population (based on probabilistic sample) 
Cocaine use in Ireland: 2010/11 survey results 
The NACDA recently published Bulletin 4 in its series of reports on the 2010/11 survey on drug use in 
the general population (National Advisory Committee on Drugs and Alcohol 2014b). The bulletin 
focuses on cocaine use in the adult population (15–64 years) and provides a profile of cocaine use. 
The final achieved sample was 5,134 in the Republic of Ireland. This represented a response rate of 
60%.  
 
Table 2.2.1 below summarises the prevalence data for cocaine use (including crack) collected in the 
three iterations of the general population drug use survey. Lifetime cocaine use increased in 2010/11 
when compared to 2006/7 (National Advisory Committee on Drugs and Public Health Information and 
Research Branch 2008).  The proportion of adults who reported using cocaine (including crack) at 
some point in their lives increased from 5% in 2006/7 to 7% in 2010/11. The proportion of young 
adults who reported using cocaine in their lifetime also increased, from 8% in 2006/7 to 9% in 
2010/11. As expected, more men reported using cocaine in their lifetime than women, 10% compared 
to 4%.  However, the proportion of adults who reported using cocaine in the last year (recent use) 
remained stable between 2006/7 and 2010/11 at just under 2%. The proportion of young adults who 
reported using cocaine in the last year also remained stable at 3%. The proportion of adults who 
reported using cocaine in the last month (current use) also remained unchanged between 2006/7 and 
2010/11, at less than 1%. 
 
Table 2.2.1   Prevalence of cocaine use (including crack) in Ireland, 2002/3, 2006/7 and 2010/11 
Cocaine 
use 
Adults 
15–64 years 
% 
Males 
15–64 years 
% 
Females 
15–64 years 
% 
Young adults 
15–34 years 
% 
 2002/3 
 
2006/7 
 
2010 
/11 
2002/3 2006/7 2010 
/11 
2002/3 2006/7 2010 
/11 
2002/3 2006/7 2010 
/11 
Lifetime 3.0 5.3 6.8 4.3 7.0 9.9 1.6 3.5 3.8 4.7 8.2 9.4 
Last 
year 
1.1 1.7 1.5 1.7 2.3 2.3 0.5 1.0 0.7 2.0 3.1 2.8 
  32 
Cocaine 
use 
Adults 
15–64 years 
% 
Males 
15–64 years 
% 
Females 
15–64 years 
% 
Young adults 
15–34 years 
% 
 2002/3 
 
2006/7 
 
2010 
/11 
2002/3 2006/7 2010 
/11 
2002/3 2006/7 2010 
/11 
2002/3 2006/7 2010 
/11 
Last 
month 
0.3 0.5 0.5 0.7 0.8 0.8 0.0 0.2 0.3 0.7 1.0 1.0 
Sources: (National Advisory Committee on Drugs and Public Health Information and Research Branch 2008), (National Advisory Committee 
on Drugs and Alcohol 2014b) 
 
Of the 5,134 survey respondents, 7% had used cocaine powder; crack cocaine use was rarely 
reported (0.6%). Half of all cocaine powder users commenced cocaine use before they were 21 years 
old, while half of all crack users commenced before they were 23 years old. Since 2006/7 there has 
been no change in the median age at which either cocaine powder or crack cocaine use commenced.    
 
Of the 26 current cocaine powder users, 95.5% used cocaine less than once per week, while 4.5% 
used it at least once per week. The majority of the current cocaine powder users (95%) reported 
snorting the drug, while the remaining 5% reported smoking it.  No other form of cocaine use was 
reported.  
 
Of the 76 recent cocaine powder users, only 4% obtained their cocaine from a person who was not 
known to them. Cocaine powder was most commonly obtained at the home of a friend (39%) or at a 
disco, bar or club (37%). The majority (70%) of recent cocaine powder users said that it was easy to 
obtain within a 24-hour period.  
 
Of the 75 self-defined ‘regular’ cocaine powder users, 83% had successfully stopped taking cocaine. 
The most common reasons for discontinuing were: did not want to continue using it (18%), could no 
longer afford it (17%), concerns about its health effects (15%), pros did not outweigh the cons (14%), 
and no longer part of social life (13%). 
 
Trying cocaine once or twice was perceived as a ‘great risk’ by 74% of those surveyed.  This 
perception of risk was particularly marked (at 78%) among those who had never tried cocaine, 
compared to lifetime users at (30%). 
 
Variation in cocaine prevalence was analysed by a number of socio-economic indicators (social class, 
work status and age ceased education), none of which proved statistically significant.  However, 
renting from a private landlord, having a third-level education and co-habiting were all associated with 
a significantly higher prevalence of lifetime cocaine use.   
 
The findings of this survey should be interpreted with care in view of the small number of responses 
on which the patterns of cocaine use are based. The socially excluded population is unlikely to be 
represented in a general population survey of this kind; its members may not live at a fixed address 
or, if listed, may be difficult to locate for interview.  
 
Polydrug use in Ireland: 2010/11 survey results 
The NACDA also published Bulletin 5 in its series of reports on the 2010/11 survey on drug use in the 
general population (National Advisory Committee on Drugs and Alcohol 2014a).  The bulletin focused 
on polydrug use in the adult population (15–64 years). Polydrug use was defined as concurrent 
substance use, where a person uses at least two substances within a one-month period.  The final 
achieved sample was 5,134 in the Republic of Ireland. This represented a response rate of 60%. 
 
Twenty per cent of all adults had not used any substance within the last month.  Women were more 
likely than men not to have used any substance (23% vs 19%).   
 
The most common combination of substances used was alcohol and tobacco (16%), followed by 
alcohol and other legal drugs (7%), alcohol, tobacco and other legal drugs (2%), and alcohol, tobacco 
and any illegal drug (2%).   
Last-month prevalence rates for alcohol, tobacco plus any illegal drug were higher among men (3%) 
than women (0.4%) and among young adults aged 15 to 34 (3%) than among older adults aged 35 to 
64 (1%).  However, older adults were more likely than younger adults to have used a combination of 
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alcohol and anti-depressants. The last-month prevalence of polydrug use including any illegal 
substance was 3%.  
Patterns of association between use of one substance and a range of other substances are outlined 
in Table 2.2.2.  Association between use of alcohol and tobacco was high. Users of cannabis, 
amphetamine-type stimulants (ATS) and cocaine were highly likely to have used other legal and 
illegal substances.  Of those who used cannabis within the last month, 85% used alcohol and 77% 
tobacco.  Of those who used cocaine within the last month, all reported having used alcohol, 77% 
smoked tobacco, 41% used cannabis, 14% used ATS and 12% used anti-depressants. 
 
 
Table 2.2.2 Total number of users of one substance by users of another substance and related percentages, all 
adults (aged 15 to 64), 2006/7 and 2010/11 
 
Last month 
prevalence 
Users of 
Alcohol 
Users of 
Tobacco 
Users of 
Cannabis 
Users 
of ATS 
Users of 
Cocaine 
Users 
of ST 
Users of Anti-
Depressants 
 
06/7 10/11 
06/
7 
10/
11 
06/
7 
10/1
1 06/7 
10/1
1 
06
/7 
10/
11 
06/
7 
10/1
1 
0
6/
7 
10
/1
1 06/7 10/11 
Total 
weighte
d N 4967 5126 
365
3 
362
1 
161
9 
145
1 128 143 19 5 25 26 
1
4
7 
14
2 154 209 
Alcohol 73.4 70.6 
  
81.
2 
78.3
* 
90.0
6 84.5 
10
0 
10
0 
10
0 100 
6
5.
3 
65
.2 62.1 63.5 
Tobacco 32.6 28.3 
36.
1 
31.
4
*
 
  
88.3 
76.7
* 
84
.2 
88.
3 80 77.2 
4
5.
6 
46
.1 50 43.5 
Cannabis 2.6 2.8 3.2 3.3 7 7.6 
  
78
.9 
62.
4 60 40.9 
4.
7 9 5.8 6.1 
ATS 0.4 0.1 0.5 0.1 1 0.3
* 
11.7 2.2
*
 
  
25 14.1 
0.
7 
0.
4 0.6 1.2 
Cocaine 0.5 0.5 0.7 0.7 1.2 1.4 11.7 7.4 
33
.3 
74.
1 
  
0.
7 
2.
1 0 1.5 
ST 3 2.8 2.6 3.7 4.8 6.3 5.5 9 
5.
3 
11.
7 4 11.4 
  
38.3 26.2
* 
Anti-
Depress
ants 3.1 4.1 2.6 3.7
*
 4.8 6.3 7 8.9 
5.
3 
52.
9
* 
0 12.4 
4
0.
1 
38
.5 
  All figures are based on weighted data, are rounded to the nearest decimal place and based on valid responses.  
*
 Denotes a statistically significant change between 2006/7 and 2010/11 
ATS – Amphetamine-type stimulants (Ecstasy and Amphetamines) 
ST – Sedatives or Tranquillisers 
Sources: (National Advisory Committee on Drugs and Drug and Public Health Information and Research Branch 2009),   (National Advisory 
Committee on Drugs and Alcohol 2014a) 
 
Table 2.2.2 shows that since 2006/7 there has been a statistically significant reduction in the 
prevalence of tobacco and ATS use among cannabis users (National Advisory Committee on Drugs 
and Drug and Public Health Information and Research Branch 2009).  There has also been a 
statistically significant reduction in the use of sedatives or tranquillisers among anti-depressant users.  
But there has been a statistically significant increase in the prevalence of anti-depressants among 
alcohol users and ATS users. 
 
2.3 Drug use in the school and youth population (based on probabilistic sample) 
Health behaviour in school children: alcohol and cannabis use (trends over time report) 
The Health Behaviour in School-aged Children (HBSC) survey 2010 was published in 2012 (Kelly, C, 
et al. 2012). Researchers at the National University of Ireland, Galway, conducted the survey of which 
previous iterations had been undertaken in 2006, 2002 and 1998.  A further report on trends in Ireland 
between 1998 and 2010 was published in September 2013 (Gavin, et al. 2013). 
 
A nationally representative sample of primary and post-primary schools in Ireland was randomly 
selected and subsequently, within schools, classes were randomly selected. The HBSC questionnaire 
was developed by the international HBSC research network, administered by teachers and completed 
by the selected students themselves.  Younger children received a shorter questionnaire. Just over 
two-thirds (67%) of invited schools and 85% of students participated in the survey. There was a 
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higher representation from social classes 1 and 2 and lower representation from social classes 3, 4, 5 
and 6 in the 2010 survey than in the 2006 survey.  
 
Overall, there was a statistically significant decrease between 1998 and 2010 in the percentage of 
young people aged 15–17 who reported ever having been drunk, from 29.3% to 28.3%. The pattern 
over time was inconsistent: there was an increase between 1998 and 2002, from 29.3% to 31.2%, 
and again between 2002 and 2006, up to 32.4%, followed by a decrease between 2006 and 2010, 
down to 28.3%.  Gender differences were evident: the number of girls reporting ever having been 
drunk increased from 24% in 1998 to 26.6% in 2010.  However, the percentage reporting ever having 
been drunk remains consistently lower for girls and for boys.   
 
There was a statistically significant decrease between 1998 and 2010 in the percentage of young 
people aged 15–17 who reported cannabis use in the past 12 months, from 10.3% to 8.3%. There 
was an increase between 1998 (10.3%) and 2002 (11.1%), and between 2002 and 2006 (12.4%), but 
these changes were not statistically significant. There was a statistically significant decrease between 
2006 and 2010, from 12.4% to 8.3%. The decrease over time was evident among both boys and girls. 
 
In 2002, 62.1% of young people aged 15–17 reported they had ever tried smoking; the percentages 
were 54.1% in 2006 and 45.7% in 2010. Data on lifetime prevalence were not available for 1998. 
There was a statistically significant decrease in the percentage of young people who reported that 
they currently smoked, from 21.1 % in 1998 to 11.9% in 2010, and also between each of the 
intervening years. There was also a statistically significant decrease between 2002 and 2010 in the 
percentage of young people who reported having their first cigarette at 13 or younger. 
 
2.4 Drug use among targeted groups/settings at national and local level  
For the most recent research, on substance use among third-level students in Limerick, see the 2011 
National Report (Health Research Board 2011). 
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3. Prevention 
3.1 Introduction 
Drug prevention is one of the four pillars in the National Drugs Strategy (interim) 2009–2016 
(NDS) (Department of Community 2009). The NDS states that ‘a tiered or graduated approach to 
prevention and education measures in relation to drugs and alcohol should be developed with a view 
to providing a framework for the future design and development of interventions’ (para. 3.56). It 
identifies three levels in this framework: 
 Universal (primary) prevention programmes, aimed at the general population, such as students in 
schools, to promote overall health of the population and to prevent the onset of drug and alcohol 
misuse.  Measures often associated with this type of programme include awareness campaigns, 
school drug/alcohol education programmes and multi-component community initiatives. 
 Selected (secondary) prevention programmes, aimed at groups at risk, as well as subsets of the 
general population including children of drug users, early school leavers and those involved in 
anti-social behaviour, to reduce the effect of risk factors present in these subgroups by building on 
strengths and developing resilience and protective factors. 
 Targeted (tertiary) prevention programmes, for people who have already started using 
drugs/alcohol, or who are likely/vulnerable to engage in problematic drug/alcohol use (but may not 
necessarily be drug/alcohol dependent), or to prevent relapse. These programmes are aimed at 
individuals or small groups and address specific needs. 
 
This framework combines universal, selected and targeted with the old classificatory framework of 
primary, secondary and tertiary, which is misleading in that it implies that universal prevention is also 
the primary step in prevention. In Ireland young people and their families are the main target groups 
for drug prevention activities, which consist mainly of universal and selected prevention, with little 
focus on targeted prevention. 
 
The NDS identifies as priorities for Prevention, improving the delivery of Social, Personal and Health 
Education (SPHE) in primary and post-primary schools and co-ordinating the activities and funding of 
youth interventions in out-of-school settings to optimise their impacts. Drug prevention interventions in 
schools are delivered through the Walk Tall (primary schools) and the SPHE (post-primary schools) 
programmes. The SPHE programme aims to improve social and personal competencies in students 
so they can understand and counter the many social influences that are seen as contributing to their 
use of drugs and alcohol. In the community, prevention programmes are provided in different settings, 
such as youth clubs and youth cafés, and by means of diversion activities provided by the statutory, 
voluntary and community sectors. 
 
The NDS calls for a continued focus on orienting educational and youth services towards early 
interventions for people and communities most at risk. Actions are to be developed to further 
support the families of drugs users, and community development is acknowledged as an important 
step in building the capacity of local communities to avoid, or respond to and cope with, drug 
problems. Early school leavers are targeted through measures such as the School Completion 
Programme and embedding the government’s DEIS (Delivering Equality of Opportunity in Schools) 
Action Plan, which tackles disadvantage among the school-going population, in schools in LDTF 
areas. The Department of Education and Skills (DES) has also developed a strategy to tackle 
educational disadvantage and early school leaving in the Traveller community.  
 
Stand-alone mass media awareness and information campaigns are regarded as less effective 
than multi-component, multi-level interventions that reflect the complex nature of drug prevention and 
harm reduction. The NDS proposes that preference be given to the development of timely awareness 
campaigns targeted in a way that takes individual social and environmental conditions into account in 
key areas such as third-level institutions, workplaces, sports and other community and voluntary 
organisations. 
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3.2 Environmental prevention  
3.2.1 Alcohol and tobacco policies 
Alcohol 
In October 2013 the government approved a number of measures to be included in a Public Health 
(Alcohol) Bill, including limiting advertising of alcohol, minimum pricing for the sale of alcohol and 
restricting outdoor advertising of alcohol. It is reported that the Bill will also increase the powers of 
Environmental Officers to tackle underage drinking. Work is ongoing on developing the legislative 
framework.  
 
In July 2013 the Joint Committee on Transport and Communications published its report Sponsorship 
of sports by the alcohol drinks industry (Joint Committee on Transport and Communications 2013). 
Based on evidence from the medical profession, sporting organisations, the drinks industry and 
advocacy groups, the committee stated in their foreword to the report that ‘it does not believe that the 
link between sponsorship and alcohol consumption has been proved’ and that ‘before any prohibition 
could be contemplated other identifiable streams of funding, which could adequately replace that 
provided by the alcohol industry, would have to be identified’ (p. 3).  
 
Tobacco 
Budget 2014 increased excise duty on cigarettes by 10 cents per packet of 20, with a pro rata 
increase for other tobacco products. Also announced was an increase in the one-off charge to 
retailers wishing to register to sell tobacco products. This increase is in line with the Tobacco Free 
Ireland policy approved by the government in July 2013 (Tobacco Policy Review Group 2013). The 
Tobacco Free Ireland policy sets a target of a tobacco-free Ireland by 2025, in other words a 
prevalence rate of smokers of less than 5%.There are two key themes in the report: protecting 
children and the de-normalisation of smoking.  
 
In May 2012 a number of senators introduced a private member’s Bill to provide a ban on the smoking 
of tobacco in vehicles when any child under 18 years is present. The Department of Health is now 
working with the Office of the Attorney-General to draft the necessary amendments to the Protection 
of Children’s Health from Tobacco Smoke Bill 2012 to provide for the enactment of this legislation 
(Crown 2012, 9 May). 
 
3.2.2 Other social and normative changes  
 
See Chapter 3.2.1 in the 2012 National Report (Health Research Board 2012) for the most recent 
information. 
 
3.3 Universal prevention 
3.3.1 School 
 
SPHE and substance use education 
The Department of Education and Skills (DES) recently launched the report from the working group 
set up to examine how education on substance use is provided in post-primary schools in the context 
of Social, Personal and Health Education (SPHE) (Working Group on educational materials for use in 
SPHE in post-primary schools and centres for education 2014). This work arose from a commitment in 
the 2011 Programme for Government to ‘update the out-dated drugs awareness programme in 
schools to reflect current attitudes and the reality of recreational drug use among teens’ (Fine Gael 
and the Labour Party 2011). 
 
The working group reviewed a selection of international and national literature and concluded that 
‘…multi-element programmes which have whole-school, parent and community support strands, 
coupled with a harm reduction approach, appear to offer considerable advantages as regards 
effective substance use education programmes for young people…’ (p. 40). In recognising the 
potential benefits of including harm reduction components in school-based substance use education, 
the working group cited evidence from an evaluation by McKay and colleagues of an adapted version 
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of the School Health and Alcohol Harm Reduction Project (SHAHRP), conducted in Belfast (McKay, 
et al. 2012). 
 
McKay and colleagues undertook a controlled non-randomised trial with post-primary school students 
aged 13–16 years: eight schools received SHAHRP delivered by teachers, twelve schools received 
SHAHRP delivered by external alcohol and drug education workers, and nine schools, the control arm 
of the trial, received the standard curriculum on alcohol education. The researchers found that, in 
contrast to participants in the control group,  participants receiving the SHAHRP intervention were 
significantly more likely to report increased levels of knowledge about alcohol and its effects, safer 
alcohol-related attitudes, fewer alcohol-related harms (both personal and from others) and lower 
alcohol consumption. These effects were maintained over the 11-month period in which none of the 
students received any intervention. The researchers concluded that ‘the adapted SHAHRP 
intervention is a promising means to address one of the major health and social challenges facing 
young people [alcohol consumption]’ (p. 118). They also acknowledged that harm reduction 
interventions targeting young people can be controversial; however, as in the case of students 
receiving SHAHRP in Belfast, such interventions do not necessarily promote or produce alcohol-
friendly attitudes and/or behaviours among target groups.  
 
The working group addressed the sometimes contentious nature of the term harm reduction, 
particularly when considered in the context of school-based substance use education. They 
acknowledged that the term may have negative connotations, but they went on to say that ‘taking care 
of oneself or looking after one’s own safety, topics already covered in On My Own Two Feet is 
effectively a harm reduction strategy…’ (p. 44). This interpretation is in line with the aims of the 
education provided in Belfast through the SHAHRP intervention. The key messages included in the 
SHAHRP intervention include advice on staying close to trusted friends when consuming alcohol, 
knowing basic first-aid, organising group transport home, having mobile phones available, not making 
decisions while drunk, being able to identify when friends are getting drunk, being on the alert for 
drink spiking and mixing alcohol with other drugs and avoiding arguments and aggressive behaviour 
by self and others.  
 
After considering the evidence and the arguments for and against harm reduction, the working group 
recommended that ‘…teaching and learning resources used in schools and centres for education be 
aimed at reducing, postponing and/or eliminating substance use, as appropriate, in recognition of the 
reality that a proportion of students are using legal and illegal substances…’ (p. 8.)  
 
The working group also undertook a wide-ranging consultation with academics, researchers, public 
health experts, school management and teacher unions. The group also visited eight schools and 
three Youthreach centres and consulted with staff and students in both settings. Arising from these 
consultations and consideration of relevant documents and literature, the working group concluded 
that ‘…quality substance use education is dependent on the quality of standard of delivery, which is 
supported through the use of relevant educational resources…’ (p. 7).  
 
The working group reached the view that updating the current On My Own Two Feet resource (implicit 
in the 2011 Programme for Government commitment) was not an adequate response. The group set 
out recommendations to assist teaching staff, schools and centres for education to deliver SPHE. 
These included providing continuous personal development (CPD) for SPHE teachers, and adopting 
a whole-school approach to student well-being in which providing SPHE was the central strategy. 
These and a number of other recommendations primarily related to supporting teachers and schools 
and embedding SPHE in the school curriculum. These recommendations and principles underpinning 
them are in line with actions 20–21 in the current NDS, which relate to the implementation of SPHE in 
schools  
 
Finally, the working group noted the large number of textbooks and resource materials for SPHE that 
had become available since the early 1990s. They cautioned that ‘…it is possible that teachers could 
become over-reliant on text-book material and so diminish the experiential, interactive approach, 
which is regarded as an essential part of SPHE delivery…’ (p. 55). There is consensus in the 
evidence base that non-interactive programmes are not effective; such programmes include 
information provision alone, emotional education alone, transmission of values and decision-making 
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alone and DARE-type programmes (delivered didactically by police officers in the United States) 
(Bühler and Kröger 2008).  
 
SPHE in post-primary schools 
The Department of Education and Skills compiled a composite report of the findings from SPHE 
subject inspections undertaken in 63 post-primary schools during the 2010/2011 academic year 
(Department of Education and Skills 2013a). Inspectors observed over 300 SPHE lessons in the 
classroom, with 47 (15%) of the lessons observed relating to the substance use module (see Table 
3.3.1.1). The inspectors also used questionnaires and focus group interviews to gather the views of 
students regarding their experience of SPHE.  Discussions with teachers, SPHE personnel and 
school management were also held to elicit views on the SPHE programme.  
 
Table 3.3.1.1 Number of lessons observed in each module of Junior Cycle SPHE, 2010/2011 
Modules in SPHE Number of lessons observed from each module 
Relationship and sexuality education (RSE) 58 
Emotional health  48 
Substance use 47 
Physical health 37 
Self-management 26 
Influences and decisions 23 
Friendship 21 
Communication skills 19 
Belonging and integrating 14 
Personal safety 13 
Source: (Department of Education and Skills 2013a) 
 
All schools are required to timetable SPHE in the Junior Cycle as a discrete subject for at least one 
period per week. All schools visited complied with this requirement, with the vast majority considered 
to have ‘fully appropriate’ provision; in 13% of schools availability was deemed ‘less appropriate’. The 
deployment of staff to deliver SPHE was considered ‘good’ or ‘very good’ in over 80% of schools 
visited. Schools are encouraged to promote a whole-school approach to the provision of SPHE, i.e. 
personal and social development of students is supported through an integrated and structured set of 
initiatives such as anti-bullying and positive mental health interventions. The inspectors reported that 
in 90% of the schools visited the quality of the whole-school approach was ‘good’ or ‘very good’. 
Almost all the schools visited (98%) had a policy on substance use in place. External facilitators were 
used by 35% of schools to deliver the substance use module of SPHE.  
 
Student and parent involvement in reflective practice and self-evaluation of SPHE was practised less 
in schools, with teachers being the main actors in this process. According to the report, ‘…the 
experimental or active learning cycle is recognised as a very appropriate strategy for use in SPHE 
lessons…[it]…allows students to actively participate in their own learning and consists of four stages: 
experiencing: processing: generalising and applying…’ (pp 20–21). 
 
When third-level students were surveyed regarding their experience of teaching methods and 
resources used to deliver SPHE, over 90% responded that discussion and group or pair work were 
widely used and the vast majority either ‘agreed’ or ‘strongly agreed’ that these methods were 
effective in supporting their learning in SPHE. Survey responses also showed that students reported 
high levels of satisfaction with their learning from the module on substance use, with the vast majority 
reporting that they learned about reasons for substance use/misuse, and the effects on individuals, 
families and society. According to the report, ‘…these findings suggest that SPHE lessons are very 
effective in enabling students to acquire knowledge but are less effective in supporting the 
development of some skills…’ (p. 27).  
 
The inspectors voiced concerns about the quality of assessment in SPHE. In 80% of schools visited, 
SPHE departments had not agreed or implemented a common assessment policy. This meant that 
measuring student participation and progress was generally overlooked. This relative lack of 
emphasis on assessment of student progress in SPHE had implications for how the subject was 
experienced and perceived, as the report stated: ‘In most of the schools visited, students…did not 
demonstrate an awareness of how their progress in SPHE was assessed and were often unaware of 
the purpose, relevance or value of assessment in SPHE…’ (p. 29). However, the report also noted 
that in over half the schools visited, students were encouraged to engage in self-assessment and self-
reflection during SPHE lessons. The inspectors endorsed this strategy, citing an extract from a school 
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report ‘…this technique [self-assessment] illustrates the great value of assessment at the time of 
learning and provides good evidence of students’ learning and should be further developed by all 
teachers…’ (p. 31).  
 
SPHE in primary schools 
The most recent data available on SPHE in primary schools derives from a report documenting 
findings from the Chief Inspector’s Report (Department of Education and Skills 2013b). The report 
included a summary of the key findings on the quality of teaching and learning of SPHE in primary 
schools during 2010–2012. The findings were based on an analysis of data from 117 whole-school 
evaluations (WSEs), which included an inspection of SPHE, and the incidental inspection of 164 
SPHE lessons in primary schools during 2010–2012. The findings regarding SPHE in primary schools 
were generally positive. However, aspects of SPHE provision needing more focused attention by a 
considerable number of teachers included preparation for the lessons, the provision of opportunities 
for pupils to work collaboratively, and assessment practices.   
 
Preparation by teachers for 24% of the lessons evaluated through incidental inspection was found to 
be less than satisfactory. For 16% of the lessons, the teachers did not have written plans for SPHE. 
 
The overall quality of teaching and learning in SPHE was found to be ‘good’ or ‘very good’ in 93% of 
the primary schools inspected. Incidental inspections of SPHE lessons found that learning outcomes 
were ‘satisfactory’ in 86% of lessons; appropriate teaching approaches, effective use of resources 
and consolidation of learning were evident in 88% of lessons; pupils were engaged appropriately in 
their learning in 90% of lessons; and talk and discussion were well used in 91% of lessons.  Teachers 
displayed satisfactory classroom management skills in almost all (97%) lessons, while pupils engaged 
in collaborative learning in just 65% of lessons.  WSE reports frequently commented on the positive 
atmosphere evident in classrooms (the school climate and atmosphere being one of the key ways in 
which the SPHE curriculum is delivered in primary schools). The majority of parents (96%) agreed 
that the school helped their child’s social and personal development although a sizeable proportion 
(24%) did not know how the school dealt with bullying. 
 
As in the findings reported in relation to SPHE in post-primary schools, in over a third of the SPHE 
lessons evaluated through incidental inspection in primary schools, assessment practices were found 
to be less than satisfactory.  
 
Drug prevention policies and programmes in schools 
A report on the results of a life-skills survey, undertaken in 2012 in both primary and post-primary 
schools, included data on the implementation of drug prevention policies and programmes 
(Department of Education and Skills 2014). The report stated that 88% of primary schools that 
responded to the survey (n=2,089) reported having a substance use policy in place, an increase of 
1% since the first life-skills survey in 2009. Approximately 94% of respondent primary schools 
(n=2,035) reported using the Walk Tall programme, an increase of 2% since 2009. 
 
Respondent primary schools reported providing information, through the curriculum, on the health 
risks associated with smoking (94%, n=2,041), promoting awareness of and combating alcohol abuse 
(90%, n=2,030), and promoting awareness of and how to combat drug abuse (90%, n=2,019). 
Primary schools reported that they provided this information to students to enable them to make 
sound decisions in relation to these substances and to resist inappropriate peer pressure. Some 
primary schools (n=771) provided information on their use of external agencies to provide information 
to students on substance use, 54% using the services of An Garda Síochána. 
 
In relation to post-primary schools, 93% of respondent schools (n=313) reported having a substance 
use policy in place, a drop of 3% since 2009. Use of the On My Own Two Feet resource, which was 
developed specifically to facilitate drug prevention in post-primary schools, was reported by 83% 
(n=271) of respondent post-primary schools, an increase of 11% since 2009. The vast majority of 
respondent post-primary schools reported providing information to students on harmful substances 
(n=292), on the dangers of smoking (n=292), on alcohol abuse (n=292), and on how to combat 
substance abuse (n=293). The vast majority of respondent schools also reported providing training in 
life skills to enable students to identify influences on their decision-making (n=291), and to withstand 
inappropriate peer pressure (n=291).  
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3.3.2 Family 
Action 29 of the NDS aims to develop a series of prevention measures that focus on the family under 
three programme headings – supports for families experiencing difficulties owing to drug/alcohol use; 
parenting skills; and targeted measures focusing on the children of problem drug and/or alcohol users 
– aimed at breaking the cycle and safeguarding the next generation. The progress report on 
implementing the NDS in 2013 (Department of Health 2014) reported that a broad mix of measures 
are being provided to support families, including individual counselling, family therapy and, in some 
regions, the Strengthening Families programme and the Community Reinforcement Approach. 
However, no data are presented profiling the families using these services or indicating the outcomes 
for families and their children. According to the progress report, the HSE established a National 
Hidden Harm Project Management Group in June 2013. The Hidden Harm project operates as an 
interagency response to hidden harm and is led by the National Social Inclusion Office and the Child 
and Family Agency. The aim of the project is to ensure a response to possible hidden harms is 
included in the overarching national substance misuse and childcare systems, thereby bridging the 
gulf between substance misuse and childcare systems, and ultimately improving outcomes for 
children. 
 
3.2.3 Community 
In 2014 the Department of Children and Youth Affairs (DCYA) published the long-awaited national 
policy framework for children and young people (Department of Children and Youth Affairs 2014). The 
framework sets out an ambitious plan to achieve five outcomes for children and young people up to 
the age of 24 by 2020:  
1. Be active and healthy and have physical and mental wellbeing 
2. Achieving full potential in all areas of learning and development 
3. To feel safe and protected from harm 
4. To have economic security and opportunity 
5. To feel connected, respected and contributing to their world 
 
To support children and young people to achieve these outcomes, the framework includes a 
commitment to transform existing policies, services and resources to be more effective, and sets out 
six aims to realise this transformation: 
1. Support parents in the important task of parenting  
2. Provide earlier interventions and prevention efforts 
3. Build a culture that listens and involve children and young people in key decisions affecting their 
lives  
4. Ensure quality services that are outcome-driven, effective, efficient and trusted 
5. Enable effective transitions at key developmental stages and between child and adult services 
6. Improve cross-government and interagency collaboration and coordination 
 
The framework includes a small number of key indicators, which will be used to measure progress in 
several areas; a more extensive set of indicators will be developed in the course of 2014. Table 
3.2.3.1 lists the indicators relating to substance use among young people and closely related 
correlates of substance use that will be used to assess progress towards achieving outcome 1, which 
relates to the health and wellbeing of children and young people. 
 
Table 3.2.3.1 Indicators relating to substance use, to be used to measure progress towards health and well-being of 
children and young people, National Policy Framework for Children and Young People, 2014–2020  
Key indicator Current baseline in 
Ireland 
Current international 
average 
Data source 
% of 15–16 year olds who 
have ever used cannabis 
18% 17% European School Survey 
Project on Alcohol and 
Other Drugs (ESPAD) 
Cigarette use in past 30 
days  
21% 28% ESPAD 
Alcohol (cl of pure alcohol) 
consumed last drinking day 
among alcohol consumers 
aged 15–16 
6.7cl 5.1cl ESPAD 
% of 15-year-olds who 
report being drunk once in 
26.4% 24.1% Health Behaviour in School-
Aged Children study 
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Key indicator Current baseline in 
Ireland 
Current international 
average 
Data source 
last 30 days (HBSC) 
Early school leaving rate 9.7% 12.7% Eurostat 
% of 15–24-year-olds not in 
education, employment or 
training  
18.7% 13.2% Eurostat 
Source: (Department of Children and Youth Affairs 2014) 
 
The framework adopts both a universal (general population of children and young people) and a 
targeted (children and young people with elevated risk factors) approach. Given that children and 
young people make up 34% of the overall population of Ireland, it is important that policy makers both 
respond to the specific needs of over a third of the national population with investment in evidence-
based policies, and also recognise that a significant minority of young people are at an elevated risk 
of poorer outcomes compared to the general population of young people and respond with 
approaches targeting this minority. 
 
3.4 Selective prevention in at-risk groups and settings 
3.4.1 At-risk groups  
Kelleher and colleagues undertook a review of national and international literature on the participation 
of ‘seldom heard young people’ ’(Kelleher, Cathy, et al. 2014). The purpose of the review was to 
identify best practice around participation, i.e. overcoming barriers, and to identify approaches to 
improve the inclusion and experience of seldom heard young people.  
 
There is general consensus in the literature that ‘seldom heard young people’ are groups of people 
who do not have a collective voice and are often under-represented in consultation or participation 
activities; they are, as the reviewers suggested, ‘…young people whose voices are not heard in 
decisions that affect them...’ (p. 1). These groups rarely form a homogeneous collective and, 
according to the reviewers, ‘…the heterogeneity of the seldom heard population requires diverse 
responses to meet their needs within the participative process…’ (p. 28). The key for practitioners is 
to understand why the voices of certain groups are not heard in the decision-making that affects them 
and to make available and accessible ways of including their voice.  
 
The reviewers defined participation as ‘…the process by which young people have active involvement 
and real influence in decision-making on matters affecting their lives, both directly and indirectly…’ (p. 
29). They also acknowledged that formal participation structures, e.g. Dáil na nÓg (youth parliament) 
and school/student councils, may not be accessible to disadvantaged and/or socially excluded young 
people. The review signalled that there appears to be a reinforcing loop of exclusion between the 
adults who operate these formal participative structures and the groups of seldom heard young 
people: the adults assume that the seldom heard young people such as homeless youth are so 
chaotic as to be incapable of articulating a rational and strategic view; the young people internalise 
this adult view, and their exclusion is reinforced. Another barrier identified in the literature is that the 
issues that concern seldom heard young people are particularly challenging for formal participatory 
structures. Thus, issues such as poverty, social exclusion and stigma are primarily driven by systemic 
and structural forces and forums such as youth parliaments and school councils may be unable or 
unwilling to accommodate such issues on their agenda.  
 
Meaningful participation must extend beyond ‘having a voice’ to ‘making a difference’. This is the 
message given by the reviewers. They summarised the views of marginalised young people who want 
the focus of participation to be relevant to their everyday lives and for participation to be an 
opportunity where they can make a difference by giving something back to their communities. 
According to the reviewers,  ‘…for participation to be meaningful, it should reflect the most salient 
issues for young people at that time, and not the agendas of the organisations and services involved’ 
(p. 43). This observation led to consideration of different levels of participation and the type of 
influence seldom heard young people can bring to the decision-making process. The reviewers 
highlighted one model with three levels of participation, distinguishing between consultative and active 
participation: 
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1. Consultative participation: An adult-led activity where information is exchanged, and/or the views 
of youth are sought on specific issues but are not necessarily incorporated into decisions and 
subsequent actions.  
2. Collaborative participation: Youth share responsibility to varying degrees with adults at any or all 
stages of decision-making and can influence both process and outcome.  
3. Children/youth led participation: Youth are supported to pursue their own agendas and make 
decisions autonomously. Adults may provide information and support.  
 
The reviewers distinguished between the ‘youth development’ and ‘youth involvement’ approaches 
documented in the literature. The first approach helps young people to effect personal change, 
whereas the second empowers young people to be active in social change: ‘…the emphasis in a 
youth involvement approach extends beyond individual change in young people themselves and 
argues that through participation young people are able to change policy-making, organisations and 
society…’ (p. 44). The reviewers pointed out that youth involvement approaches offer the best 
opportunity to provide effective opportunities for seldom heard young people to participate 
meaningfully in formal decision-making structures that affect their lives. Reflecting the heterogeneity 
of seldom heard young people, the reviewers suggested that methods to engage these youth must be 
related to their needs and preferences and, in parallel, practitioners need to reflect on current 
methods of engagement which may exclude rather than include young people.  
 
Reflecting the view expressed in the literature, the authors contended that ‘…overall, it is important to 
highlight that young people are seldom heard, not as a consequence of an inherent characteristic that 
precludes them from participating, but rather due to the absence of appropriate participation 
structures and supports to facilitate their voices being heard…’ (pp. 53–54). They recommended that 
organisations wishing to include seldom heard young people in the decision-making process could 
begin by examining four key components of their work: 
1. Structure: Does the organisation have an adequate level of planning, development and resourcing 
for participation? 
2. Culture: Is the organisational ethos committed to participation? 
3. Practice: Does the organisation have the skills and knowledge to engage young people? 
4. Review: Does the organisation have a system to monitor and evaluate participation activity?  
 
These four components, when combined, comprise what is termed in the literature a whole-systems 
approach. It is essential that they are implemented together to enable organisations to provide 
meaningful opportunities for participation. According to the reviewers, in organisations that do not 
implement these components ‘…the likelihood of creating opportunities for effective and meaningful 
participation [for seldom heard young people] are greatly reduced…’ (p. 65). 
 
3.4.2 At-risk families 
Barnardos is a registered children’s charity that works with vulnerable children and their families 
through 40 services across the country. It recently compiled a report examining different ways to 
support parents experiencing difficulties and to improve outcomes for their children (Barnardos 2014). 
The report was based on desk research and discussion with parents, carers, mental health experts 
and professionals. The report and the recommendations were grounded in the day-to-day work that 
Barnardos staff do with at-risk families. For example, since the onset of austerity measures, some 
families have been finding it difficult to make their declining incomes and support cover their needs. 
According to the report, ‘…the combination of cutbacks to services and reductions in social welfare 
support compound the sense of hopelessness among families…’ (p. 10).  
 
In tandem with the impact of austerity, the report noted that parents using Barnardos’ services have 
been reporting a decline in their mental health and well-being. Barnardos have also observed that 
large numbers of parents using their services are using prescribed medication, various types of 
benzodiazepines, to alleviate their anxiety and stress. Once prescribed, parents often secure repeat 
prescriptions and their use of and reliance on benzodiazepines endures. According to the report, 
‘…they are frequently taken in tandem with other drugs such as non-prescription painkillers, 
methadone or alcohol’ (p. 11).  
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The report made five recommendations to improve the response to parents with mental health 
problems and improve outcomes for children affected by their parents’ poor mental health (see Table 
3.4.2.1). 
 
Table 3.4.2.1 Recommendations to improve mental health outcomes for parents experiencing difficulties and 
outcomes for their children 
Recommendation Rationale 
Challenge mental health prejudice and discrimination Parents often are reluctant to access appropriate support 
due to the entrenched prejudice in society towards people 
with mental health difficulties.  
Adopt a family model approach Due to the dominance of the current medical model on 
treatment and recovery in mental health, rarely is the 
individual parent seen in their family context but too often 
seen only as a patient in isolation. 
Talk with children Children living with a parent experiencing mental health 
issues need to be informed and reassured about their 
parent’s mental health, in an age appropriate manner.  
Expedite the roll out of community based 
services 
Implement the multi-disciplinary team model to provide 
holistic support in the community setting.  
Consult with parents affected by poor mental 
health 
Build a support response for parents with mental 
difficulties around what services and supports they identify 
as necessary for them and their children.  
Source (Barnardos 2014) 
 
See Chapter 7.4 later in this report for more detail from this Barnardos study regarding the effects on 
children living in families experiencing mental health difficulties.  
 
3.4.3 Recreational settings (incl. reduction of drug and alcohol related harm) 
See Chapter 3.4.3 of 2008 National Report (Alcohol and Drug Research Unit 2008) for most recent 
information. 
 
3.5 Indicated prevention  
3.5.1 Children at risk with individually attributable risk factors  
Child and Adolescent Mental Health Service (CAMHS) teams are the first line of specialist mental 
health services for children and young people. The multi-disciplinary teams include psychiatrists, 
psychologists, nurses, social workers, speech and language therapists and occupational therapists. 
The latest CAMHS annual report states that 66 such teams are currently in place, an increase of three 
since 2012    (Health Service Executive 2014c). 
 
The report shows that from October 2012 to September 2013 a total of 12,022 referrals were 
accepted by the service, a 21% increase on the previous 12 months. A total of 9,616 new cases were 
seen by Community teams in the same period, compared with 8,671 for the previous 12 months, an 
increase of 11%.  
 
The report describes the findings of the fifth annual clinical audit carried out by the 60 Community 
CAMHS teams, in November 2012. This audit recorded information on a total of 8,577 cases seen in 
the course of the month. For the purpose of the audit, only one disorder / problem was entered for 
each case. The audit found that: 
– ADHD / hyperkinetic category was the most frequently recorded primary presentation (31.6%), 
followed by the anxiety category (18.3%).  
– Psychotic disorders/problems (including schizophrenia, manic depressive disorder, or drug-
induced psychosis) accounted for 1.5% (n=125) of primary presentations.  
- Deliberate self-harm (including lacerations, drug/medication and alcohol overdose) 
accounted for 5.1% (n=440) of primary presentations.  
– Street drugs were involved in 12% of male and just 1% of female intentional drug overdose acts. 
- Substance abuse referred to drug and alcohol misuse accounted for 0.5% (n=40) of 
primary presentations.  
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3.5 National and local media campaigns 
Action 27 of the NDS seeks to further develop a national website on substance-use-related issues to 
provide fully integrated information, and access to a national helpline; action 28 seeks to develop a 
sustained range of awareness campaigns on substance-use-related items. The progress report on 
implementing the NDS in 2013 (Department of Health 2014) reported that drugs.ie, the national 
website on substance-use-related materials contains information on relevant drug/alcohol campaigns, 
over 50 on-line videos relating to drugs and alcohol in Ireland and an interactive support/chat services 
for people looking for support with drug/alcohol issues. Two specific developments planned are (1) an 
update of the national directory of drug and alcohol services and (2) an online self-assessment tool 
and brief intervention video for people with alcohol problems. It is estimated that the drugs.ie website 
received 114,000 unique visits in 2011, the year in which the site began building its social media 
presence through Facebook and Twitter, which is now used to disseminate information and video 
content on substance-use-related issues. 
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4. High Risk Drug Use (HRDU) 
4.1 Introduction 
This chapter provides an overview of developments and trends in the prevalence and characteristics 
of high-risk drug users (HRDUs) in Ireland.  HRDU is defined as ‘recurrent drug use that is causing 
actual harms (negative consequences) to the person (including dependence, but also other health, 
psychological or social problems), or is placing the person at a high probability/risk of suffering such 
harms’. 
 
A national 3-source capture-recapture (CRC) study, to provide statistically valid estimates of the 
prevalence of opiate drug use in the national population, was commissioned by the National Advisory 
Committee on Drugs (NACD) and undertaken in 2001 and 2006 (Kelly, Alan, et al. 2003), (Kelly, Alan, 
et al. 2009).  The second study indicated that use had increased since the previous survey. There 
were 11,807 known opiate users in 2006. The major expansion of the national methadone treatment 
programme between 2001 and 2006 is the main reason for the inflation of the figures. There is some 
doubt over the estimate produced of a possible further 8,983 opiate users who had not come into 
contact with any of the drug treatment services, hospital in-patient services or the Gardaí. The 
following are among the trends (2001–2006) seen in the study results: 
- the rate of opiate use among females and males aged 15–24 decreased, indicating a significant 
reduction in the number of young people commencing opiate use,  
- an increase in opiate use outside Dublin, and 
- a higher proportion of opiate users in treatment in Dublin than elsewhere, reflecting the more 
recent spread of opiate use outside Dublin and the later development of treatment services.  
 
Other sources of data regarding HRDU cited in this chapter are as follows. 
 
Merchants Quay Ireland (MQI) is a national voluntary agency providing services for homeless 
people and for drug users. Its needle exchange health promotion unit provides drug users with 
information about risks associated with drug use and the means to minimise such risks.  It also 
provides drug users a pathway into treatment and the possibility of living life without drugs.   
 
The National Drug Treatment Reporting System (NDTRS) is an epidemiological database on 
treated problem drug and alcohol use collected at treatment centres throughout Ireland.  Episodes of 
treatment, rather than the number of persons treated each year are recorded which means that 
individuals may appear more than once if they attended more than one treatment service in a year 
and may reappear in the subsequent years. 
 
 
4.2 Prevalence of and trends in HRDU 
4.2.1 Estimates of high risk drug use prevalence 
Findings on cocaine use (Bulletin 4) and polydrug use (Bulletin 5) from the 2010/11 survey on drug 
use in the general population were recently published by the NACDA and are outlined in Chapter 2.2. 
 
4.2.2 Other sources of information on prevalence of high risk drug use  
Treated problem alcohol use in Ireland, 2008–2012  
In April 2014 the HRB published figures from the NDTRS on treated problem alcohol use in Ireland, 
for the period 2008 to 2012 (Health Research Board 2014b).  
 
The total number of cases treated for problem alcohol use increased from 7,940 in 2008 to a peak of 
8,604 in 2011, decreasing to 8,336 in 2012. The number of new cases treated rose by 17.9%, from 
3,833 in 2008 to 4,520 in 2011, but dropped to 4,028 in 2012. The number of previously treated cases 
increased by 16.8%, from 3,606 cases in 2008 to 4,212 in 2012. The treatment status of 96 cases in 
2012 was recorded as ‘unknown’.   
 
Incidence and prevalence  
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The incidence of treated problem alcohol use among the adult population (age 15 to 64 years) living 
in Ireland, expressed per 100,000 of the population, increased from 119.7 in 2008 to 141.2 in 2011 
and subsequently decreased to 125.1 in 2012.  The prevalence of treated problem alcohol use among 
15–64-year-olds living in Ireland, expressed per 100,000 of the population, increased from 248.2 in 
2008 to 269.8 in 2011 and subsequently decreased to 261.5 in 2012. Fluctuations in prevalence and 
incidence may be attributed to changes in patterns of problem alcohol use in the population, levels of 
participation and reporting to the NDTRS, or a combination of both.  
 
Poly-drug use  
Of those treated for problem alcohol use in 2012, a total of 1429 (17.5%) reported using at least one 
other drug, a similar proportion to that observed in previous years. Cannabis (12%), cocaine (5%), 
benzodiazepines (4%) and ecstasy (3%) were the four most common additional problem drugs 
reported (see Figure 4.2.2.1). This reflects a minor change since 2008, when opiates were the fourth 
most common additional drug.  In 82.5% of cases where additional problem drug use was reported, 
only one substance other than alcohol was reported and in 10% of cases two additional substances 
were reported.  These figures are similar to previous years.  
 
 
Figure 4.2.2.1 Number of cases, additional problem substances associated with alcohol as a main problem 
substance, 2008–2012 
Source: (Health Research Board 2014b) 
 
Socio-demographic characteristics  
Of the problem alcohol use cases treated for the first time in 2012, 63% were men 5% were under 18 
years old and 3% were homeless.  The median age was 38, similar to previous years.  The proportion 
of new cases (aged 16 to 65) in employment decreased from 37% in 2008 to 24% in 2012. For those 
cases of problem alcohol use combined with one or more other problem drug, the median age at 
which any drug (excluding alcohol) was started was 16 years.   
 
Problem alcohol use combined with other substances over the period 2008–2012 
Of those new cases of problem alcohol use combined with other substances over the period 2008 to 
2012, 75% were male, 21% in employment, 13% aged 17 years or under and 4.5% in unstable 
accommodation (Figure 4.2.2.2).   
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Figure: 4.2.2.2: Characteristics of new cases, by alcohol only used only and alcohol used with other drugs, 2008–
2012 
Source: Published data NDTRS (Health Research Board 2014b).  
 
 
Treatment 
Of all problem alcohol use cases treated in 2012, 54% (4,508) were outpatient treatments, 40% 
(3,309) inpatient and 6% (519) provided with low threshold services only.  These figures are 
consistent with previous years.  Over half (51%) received one initial treatment intervention only.  A 
further 23% received two interventions, 11% three interventions, 4% received four and 6% received 
five interventions. The NDTRS records the treatment intervention(s) provided when the client is first 
admitted to a treatment service. Counselling was the most common initial treatment intervention, 
being recorded in 52% of cases, followed by brief intervention (42%), group counselling (27%), 
education (25%), alcohol detoxification (24%) and medication-free therapy (19%).    
 
Non-medical use of psychotropic prescription drugs among adolescents in substance use 
treatment 
A recent paper outlined a study conducted with adolescents (aged 13 to 18 years) attending for 
treatment of substance-use disorders at the largest, outpatient treatment programme in Ireland 
between April and June 2011 (Apantaku-Olajide and Smyth 2013). The aim of the study was to 
examine the prevalence of non-medical use of seven classes of psychoactive prescription drugs 
(opioid analgesic, ADHD stimulant, sedative/anxiolytic, sleeping, antipsychotic, antidepressant, and 
anabolic steroid medication) and the sourcing activities among substance-abusing adolescents.  A 
self-reported anonymous questionnaire was administered to participants. 
 
All 85 adolescents attending the programme were invited to participate.  Of these, 63 (74%) agreed, 
seven refused and in 15 cases the clinician failed to ask the young person to participate. The majority 
of the participants were male (76%) and the mean age was 16.3 (SD=1.3, range 13 to 18).  Cannabis 
was the main substance of abuse for the majority (75%) of respondents, followed by alcohol (14%), 
cocaine (10%) and heroin (1%).   
 
Overall, 43 (68%) of the sample reported life-time non-medical use of any of the seven classes of 
prescription drugs.  The mean number of prescription drugs used non-medically was 2.3 (SD=1.1, 
range 1 to 5).  The frequency of non-medical use of prescription drugs among the sample population 
is outlined in Table 4.2.2.1.  Of those on prescribed medication, the most commonly used for non-
prescribed purposes were hypnotics (100%) and sedatives/ anxiolytics (73%).  The most common 
medication used without a prescription (i.e. diverted use) was sedative/ anxiolytics (62%) followed by 
sleeping (hypnotic) medication (43%).  The study did not have sufficient power to analyse differences 
by gender. 
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Table 4.2.2.1 Frequency of lifetime use of prescription drugs among adolescents with substance use disorder 
(n=63), April–June 2011 
Prescription drug  
Non-use 
Medical use   
Of which non-prescribed 
use* 
Diverted use** 
 n (%) n (%) n (%) n (%) 
Opioid analgesics 31 (49) 27 (43) 7 (26) 12 (19) 
Hypnotics 36 (57) 11 (17) 11 (100) 27 (43) 
Sedatives/ anxiolytics 21 (33) 11 (17) 8 (73) 39 (62) 
Stimulants 41 (65) 17 (27) 0 (0) 5 (8) 
Antipsychotics 51 (81) 6 (9) 2 (33) 8 (13) 
Antidepressants 46 (73) 15 (24) 5 (33) 7 (11) 
Anabolic steroids 61 (96) 1 (2) 0 (0) 1 (2) 
*Non-prescribed use: those prescribed the prescription medication and reported use of the same class medication for non-prescribed 
reasons. 
**Diverted use: used without a healthcare professional prescription.  
Source: (Apantaku-Olajide and Smyth 2013) 
 
The most common reasons given for non-medical use were ‘getting a high or buzz’ (79%); ‘having a 
good time’ (63%); ‘relief of boredom’ (56%); ‘help sleep better’ (49%); and ‘fit into group’ (9%).  All of 
the lifetime non-medical users gave more than one readily available source.  Of the 43 non-medical 
users, 33 (76%) reported friends as sources, 17 (40%) street-level drug markets, seven (17%) thefts, 
and seven (17%) family members. 
 
The paper concluded that non-medical use of prescription drugs is commonplace among adolescents 
who abuse illicit drugs and that they typically use these prescription drugs for hedonic reasons.  The 
author suggested that prescribers should be aware of the potential abuse of antidepressant and anti-
psychotic class drugs and that assessment of adolescents with substance use disorder should include 
exploration of abuse of prescribed medication.  
 
 
4.2.3 Trends in this area 
Data on trends in cocaine and polydrug use among the general population in Ireland (aged 15–64 
years) between 2006/7 and 2010/11 were published in 2014 and are summarised here. (For a full 
account of the two bulletins reporting the results of the 2010/11 general population drug prevalence 
survey in relation to cocaine use (National Advisory Committee on Drugs and Alcohol 2014b) and 
polydrug use (National Advisory Committee on Drugs and Alcohol 2014a), see Chapter 2.2 earlier in 
this report.) 
 
Lifetime cocaine use increased in 2010/11 when compared to 2006/7 (National Advisory Committee 
on Drugs and Public Health Information and Research Branch 2008).  The proportion of adults who 
reported using cocaine (including crack) at some point in their lives increased from 5% in 2006/7 to 
7% in 2010/11. The proportion of young adults who reported using cocaine in their lifetime also 
increased, from 8% in 2006/7 to 9% in 2010/11. However, the proportion of adults who reported using 
cocaine in the last year (recent use) remained stable between 2006/7 and 2010/11 at just under 2%. 
The proportion of young adults who reported using cocaine in the last year also remained stable at 
3%. The proportion of adults who reported using cocaine in the last month (current use) also 
remained unchanged between 2006/7 and 2010/11, at less than 1%. 
 
Since 2006/7 there has been a statistically significant reduction in the prevalence of tobacco and ATS 
use among cannabis users and (National Advisory Committee on Drugs and Drug and Public Health 
Information and Research Branch 2009).  There has also been a statistically significant reduction in 
the use of sedatives or tranquillisers among anti-depressant users.  But there has been a statistically 
significant increase in the prevalence of anti-depressants among alcohol users and ATS users. 
 
For trends in treated problem alcohol use in Ireland between 2008 and 2012, see Section 4.2.2 
above.  
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4.3 Characteristics of high risk drug users 
4.3.1 Main patterns of polydrug use among the main groups of high risk drug users 
No information available. 
 
4.3.2 Data and studies of characteristics of high risk drug users  
Merchants Quay Ireland (MQI) Review 2012  
In September 2013 MQI published its annual review for 2012 (Merchants Quay Ireland 2013). It 
reported that there were 22,475 visits to Drug Services and 20,847 needle exchanges, a 10% 
increase from 2011.  In total, 3,639 individuals used the service, of whom 558 were new clients. A 
total of 1,332 safer injecting workshops were undertaken with injecting drug users. 
 
MQI, in association with the Midland Regional Drugs and Alcohol Task Force and the HSE, 
administers the Midlands Family Support and Community Harm Reduction Service, providing 
outreach and working with families of those actively using drugs in that task force region. The harm 
reduction service worked with on average 130 clients per month, with 1,079 interventions in the 
busiest month.  An average of 289 needle exchanges were provided each month during the year. 
 
Drug use in Irish prisons, 2011 
The NACDA has published the results of a survey estimating the extent of drug use and the 
prevalence of blood-borne viruses among the prison population in Ireland (Drummond, et al. 2014). 
The survey questionnaire was completed by a random sample of prisoners between February and 
April 2011. Oral fluid samples were obtained to assess use of specific drugs (cannabinoids, opiates, 
methadone, cocaine and benzodiazepines) in the 24 to 72 hours preceding the survey and to detect 
the presence of hepatitis B, hepatitis C and HIV infections.  Flexibility was required in different prisons 
to accommodate prison schedules, security arrangements and prisoner availability.  
 
Invitations to participate in the study were issued to 1,666 randomly selected prisoners. Of the invited 
prisoners, 886 (53%) attended an information session, and of these 62 (7%) declined to participate in 
the study, leaving 824 (49.5%) to take part in the study. This response rate is much lower than that 
achieved in previous Irish prison studies (Allwright, et al. 2000) (Long, et al. 2000) (Hannon, et al. 
2000) and lower than that required for a robust prevalence estimate. Oral fluid analysis were available 
for 46% (771/1,666) of the invited participants. Field workers reported that the reasons given by the 
780 (47%) invited prisoners who did not attend the information session included unavailability, 
attendance at the gym, school or workshop, mistrust, suspicion, cynicism, apathy, and concerns 
regarding mandatory drug testing and DNA sample collecting.  
 
Most respondents were male (95%) and Irish (92%). The average age was 31 years, and 50% were 
aged 28 years or younger.  Almost one-in-four respondents (23%, 186) had received no schooling or 
primary education only compared to one-in-five of the general population in Ireland and only 13% 
(105) reported having had some, or completed, third-level education compared to 31% in the general 
population. Fifty nine per cent (483) had been in custody for more than one year, and 51% (419) had 
spent more than three of the past ten years in prison.  More than one in ten had been homeless for 
more than seven days in the year before the survey. More women (46%) than men (22%) reported 
that they had been homeless in the 12 months prior to the survey.  
 
Lifetime prevalence (ever used) 
The drugs most commonly used among the prison population were cannabis (87%), cocaine powder 
(74%) and benzodiazepines (68%) (Table 4.3.2.1). There was no difference between men’s and 
women’s lifetime use of cannabis, cocaine or benzodiazepines (Tables 4.3.2.2–5). Lifetime heroin use 
was high at 43% (Table 4.3.2.4). Women were significantly more likely than men to have used heroin 
(64%), methadone (60%) and crack cocaine (59%) at some point in their life (Tables 4.3.2.2–5). It is 
important to note that some of the methadone and benzodiazepine use was prescribed, and most of 
the illicit drug use occurred outside the prison environment. 
Last-year prevalence (recent use) 
Cannabis, at 69%, was the drug most commonly used in the year prior to the survey, followed by 
benzodiazepines, at 55% (Table 4.3.2.1). The 25–34-year-olds were significantly more likely to have 
  50 
used heroin (36%), compared to the older (20%) or younger (30%) age groups (Table 4.3.2.4). Of 
those who had used a drug in the last year, a majority in each case had used the drug while in prison: 
88% had used cannabis; 85% benzodiazepines; 87% other sedatives or tranquillisers; 87% 
methadone; 84% heroin; 66% other opiates; and 52% crack cocaine. 
 
Last-month prevalence (current use)  
Cannabis (43%) was the drug most commonly used in the past month, followed by benzodiazepines 
(29%) (Table 4.3.2.1). One-hundred-and-three prisoners (13%) tested positive for methadone in the 
24 to 72 hours prior to the survey and 106 reported being prescribed methadone daily in the last 
month. Eighteen per cent of those who tested positive for methadone were in the 25–34-year age 
group. Women were significantly more likely to test positive for methadone than men (33% vs 12%).  
 
Use in previous 24–72 hours 
Oral fluid sample testing for drug use in the previous 24–72 hours showed that proportionally more 
women than men were on daily methadone maintenance (Table 4.3.2.1). Four per cent (31), all men, 
had used cannabis in the 24–72 hours before the survey, and 10% (83) had used benzodiazepines. 
Women (20%) were two times more likely to test positive for benzodiazepine use than men (10%).   
 
Table 4.3.2.1   Prevalence of drug use among Irish prisoners, inside or outside prison, 2011 
 Cannabis Cocaine 
powder 
Crack 
cocaine 
Heroin Methadone Benzo- 
diazepines 
Other 
sedatives or 
tranquilisers 
Lifetime use  708 (86.9%) 600 (74.2%) 284 (35.6%) 348 (43.3%) 262 (32.6%) 547 (67.8%) 466 (58.2%) 
Last-year use 554 (68.6%) 226 (28.6%) 92 (11.7%) 233 (29.5%) 167 (20.9%) 434 (54.6%) 367 (46.3%) 
Last-month use 349 (43.4%) 41 (5.3%) 15 (1.9%) 87 (11.1%) 106 (13.3%) 229 (29.0%)  367 (46.3%) 
Past 24–72 hour use 31 (4.0%) Not 
available 
Not 
available 
2* (0.3%) 103 (13.3%) 83 (10.7%) Not available 
*Opiates  
Source: (Drummond, et al. 2014)  
 
Table 4.3.2.2   Prevalence of cannabis use among Irish prisoners, inside or outside prison, by age and gender, 2011 
Cannabis use All Male Female 18–24 years 25–34years 35–64 years 
Lifetime use  708 (86.9%) 670 (87.0%) 38 (84.4%) 241 (94.9%) 297 (92.5%) 162 (70.4%) 
Last-year use 554 (68.6%) 523 (68.6%) 31 (68.9%) 210 (84%) 231 (72.6%) 105 (45.7%) 
Last-month use 349 (43.4%) 332 (43.7%) 17 (38.6%) 128 (51.2%) 148 (46.8%) 67 (29.4%) 
Past 24–72 hour use  31 (4.0%) 31 (4.2%) 0 9 (3.8%) 14 (4.5%) 8 (3.8%) 
Source: (Drummond, et al. 2014) 
 
Table 4.3.2.3   Prevalence of cocaine use among Irish prisoners, inside or outside prison, by age and gender, 2011 
Cocaine use All Male Female 18–24 years 25–34  years 35–64 years 
Lifetime use  600 (74.2%) 571 (74.6%) 29 (65.9%) 210 (83.7%) 262 (81.9%) 121 (53.1%) 
Last-year use 226 (28.6%) 208 (27.8%) 18 (41.9%) 96 (38.9%) 101 (32.3%) 26 (11.8%) 
Last-month use 41 (5.3%) 40 (5.4%) 1 (2.4%) 11 (4.6%) 19 (6.1%) 10 (4.6%) 
Past 24–72 hour use  1 1 Not available Not available 1 Not available 
 
Table 4.3.2.4   Prevalence of heroin use among Irish prisoners, inside or outside prison, by age and gender, 2011 
Heroin use All Male Female 18–24 years 25–34years 35–64 years 
Lifetime use 348 (43.3%) 319 (42.1%) 29 (64.4%) 94 (37.8%) 159 (50.2%) 90 (39.7%) 
Last-year use 233 (29.5%) 212 (28.4%) 21 (46.7%) 74 (29.7%) 112 (36.0%) 45 (20.4%) 
Last-month use 87 (11.1%) 81 (11.0%) 6 (13.3%) 27 (10.9%) 40 (12.9%) 19 (8.8%) 
Past 24–72 hour use  2* (0.3%) 2* (0.3%) 0 0 1* (0.3%) 0 
*Opiates 
Source: (Drummond, et al. 2014) 
 
Table 4.3.2.5   Prevalence of benzodiazepine use among Irish prisoners, inside or outside prison, by age and 
gender, 2011 
Benzodiazepine use All Male Female 18–24 years 25–34 years 35–64 years 
Lifetime use  547 (67.8%) 516 (67.7%) 31 (68.9%) 203 (80.2%) 229 (71.8%) 109 (48.4%) 
Last-year use 434 (54.6%) 406 (54.1%) 28 (62.2%) 174 (69.3%) 188 (59.9%) 68 (30.9%) 
Last-month use 229 (29.0%) 211 (28.3%) 18 (40.0%) 79 (31.5%) 106 (34.0%) 43 (19.7%) 
  51 
Benzodiazepine use All Male Female 18–24 years 25–34 years 35–64 years 
Past 24–72 hour use  83 (10.7%) 74 (10.1%) 9 (20.0%) 25 (10.4%) 40 (12.9%) 18 (8.5%) 
Source: (Drummond, et al. 2014) 
 
Methods of heroin use  
Two-hundred-and-twenty-six prisoners said they were ‘doing heroin now’. Among these current heroin 
users, 75% reported smoking (or chasing the dragon) as their only method of choice, with 13% 
reporting injecting and 1% snorting as their only method. Only a very small proportion (1.3%) currently 
used all three methods of administration. The proportion of those who smoked and snorted was 1.3%, 
whereas 9% both smoked and injected.  
Prescription drug use in prison  
High usage of benzodiazepines, other sedatives or tranquillisers, methadone and other opiates was 
reported by participants. The vast majority (85%) of prisoners who reported taking methadone in 
prison in the month prior to the survey had taken it on prescription. A minority had taken 
benzodiazepines (14%) or other sedatives (22%) under medical supervision (or on prescription).  A 
large proportion reported having taken unprescribed benzodiazepines in prison in the previous month.   
 
Lifetime prevalence of injecting drug use – ever injected 
Over 26% reported having ever injected drugs, with women (44%) more likely to have a lifetime 
history of injecting drug use than men (24%). Thirty-four per cent of the 25–34-year age group were 
more likely to have injected than their older (35–64 years, 22%) or younger (18–24 years, 18%) 
counterparts. The most commonly injected drug was heroin (19%), followed by cocaine powder 
(13%). Women were more likely than men to have ever injected heroin (43% vs 18%), cocaine 
powder (32% vs 12%), mephedrone (16% vs 4%), methylone (11% vs 2%) and any other drug (14% 
vs 4%).   
 
Last-year prevalence of injecting drug use – recent injectors 
The most commonly injected drug in the last year was heroin (7%), followed by cocaine powder (3%), 
benzodiazepines (3%) and steroids (2%). More women than men  had recently injected heroin (21% 
vs 6%), cocaine powder (14% vs 3%), mephedrone (13% vs 2%), methylone (7% vs 1%), 
amphetamines (7% vs 1%) and benzodiazepines (11% vs 2%), with no significant differences across 
age groups. 
 
Last-month prevalence of injecting drug use – current injectors 
The numbers reporting injecting in the last month were low (1 to 8 people injecting each drug). 
Cocaine powder was injected by eight respondents (1%), heroin by seven (0.9%), benzodiazepines 
by four (0.5%) and steroids by four (0.5%).   
 
Age at first use of drugs 
Fifty per cent of cannabis users had used it by their 14th birthday. Half of all benzodiazepines users 
had used it by their 17th birthday. The median age for first use of cocaine powder was 18 years, and 
of heroin, 19 years. Among heroin injectors, the average length of time between moving from smoking 
to injecting was 2.8 years. The median age for commencing injecting head shop drugs such as 
methylone and mephedrone was 24 years, and for injecting steroid 22 years.  
 
First use and first injection  
Of those who reported having ever used heroin (smoking or injecting), 146 (43%) said they had taken 
it for the first time in prison and these were more likely to be men (46%) than women (17%). Twenty-
one per cent of women and 6% of men (8% overall) who had ever injected heroin reported having 
injected it for the first time in prison. Of the 69 who had started injecting in prison, 16 (24%) injected 
steroids while 12 injected heroin. 
 
Of injectors who had injected in the past year, 13 of the 19 recent steroid injectors had injected in 
prison, 9 of 56 recent heroin injectors had done likewise, as had 7 of 23 recent benzodiazepine 
injectors and 7 of 25 recent cocaine injectors.  
 
Overdose history  
While over a quarter (27%) of all prisoners reported ever overdosing, the proportion among injecting 
drug users was much higher (58%). There were significant differences between genders, as women 
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were more likely than men to report a history of overdose (44% vs 26%). This difference was even 
more apparent for injecting drug users (80% vs 55%). There were no significant differences between 
age groups.    
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5. Drug-related treatment: treatment demand and treatment availability  
5.1 Introduction 
Two broad philosophies underlie the approach to drug-related treatment in Ireland: medication-free 
therapy and medication-assisted treatment. Medication-free therapy uses models such as therapeutic 
communities and the Minnesota Model, though some services have adapted these models to suit 
their particular clients’ needs. Medication-assisted treatment includes opiate detoxification and 
substitution therapies, alcohol and benzodiazepine detoxification, and psychiatric treatment. Various 
types of counselling are provided through both philosophies of treatment and independent of either 
type of treatment. Alternative therapies, such as acupuncture, are provided through some community 
projects.  
 
Data on drug treatment in Ireland are collected through two national data collection tools – the Central 
Treatment List and the National Drug Treatment Reporting System. 
 
The Central Treatment List (CTL) was established under Statutory Instrument No 225 following the 
Report of the Methadone Treatment Services Review Group 1998 (Methadone Treatment Services 
Review Group 1998). This list is administered by the Drug Treatment Centre Board on behalf of the 
HSE and is a complete register of all patients receiving methadone (for treatment of opiate misuse) in 
Ireland and provides all data on methadone treatment nationally. 
 
The National Drug Treatment Reporting System (NDTRS) is a national epidemiological database 
which provides data on treated drug and alcohol misuse in Ireland. The NDTRS collects data from 
both public and private outpatient services, inpatient specialised residential centres and low-threshold 
services.  For the purposes of the NDTRS, treatment is broadly defined as ‘any activity which aims to 
ameliorate the psychological, medical or social state of individuals who seek help for their substance 
misuse problems’.  The NDTRS is a case-based, anonymised database. The NDTRS is co-ordinated 
by staff at the Health Research Board (HRB) on behalf of the Department of Health and Children. The 
number of drug treatment services participating in the NDTRS continues to increase (Standard Table 
TDI 34).  Although treatment is provided within the Irish Prison Service, it was only in 2009 that 
counsellors working in the prison service began to return information to the NDTRS.   
 
Other entities mentioned in this chapter are as follows: 
 
The Health Service Executive (HSE), which manages Ireland’s public health sector, provides an 
addiction service, including both illicit drugs and alcohol, delivered through Social Inclusion Services, 
which is part of its Integrated Services Directorate.  Addiction treatment services are provided through 
a network of statutory and non-statutory agencies. Some of the principal non-statutory agencies 
include: 
 
In 1998 a Methadone Treatment Protocol (MTP) was introduced, to ensure that treatment for opiate 
misuse could be provided wherever the demand exists. New regulations pertaining to the prescribing 
and dispensing of methadone were introduced, and a joint Health Board/Irish College of General 
Practitioners (ICGP) committee was formed to provide training, ongoing education and regular audit 
for general practitioners (GPs) taking part in the programme. Under this protocol, any GP wishing to 
take part in the provision of treatment services to drug users, must undertake training as provided by 
the ICGP.  Under the MTP, GPs are contracted to provide methadone treatment at one of two levels – 
Level 1 or Level 2.   Level 1 GPs are permitted to maintain methadone treatment for misusers who 
have already been stabilised on a methadone maintenance programme. Each GP qualified at this 
level is permitted to treat up to 15 stabilised misusers. Level 2 GPs are allowed to both initiate and 
maintain methadone treatment. Each GP qualified at this level may treat up to 35 misusers. Practices 
where two Level 2 GPs are practising are permitted to treat up to 50 misusers. Locally-based 
methadone treatment for opiate misusers is now provided through drug treatment clinics, satellite 
clinics or through GPs in the community.  
 
The National Drug Rehabilitation Implementation Committee (NDRIC) is responsible for 
overseeing and monitoring the implementation of the recommendations contained in the report of the 
Working Group on Drugs Rehabilitation, the development of protocols, service level agreements and 
  54 
a quality standards framework, and ensuring appropriate training is instigated. Chaired by the HSE, 
the NDRIC comprises representatives of the HSE, government departments, agencies and 
community and voluntary sector organisations, the National Advisory Committee on Drugs, service 
professionals, problem drug users and families of problem drug users. 
 
QuADS (Quality in Alcohol and Drug Services) is a quality standards framework developed in the 
UK by Alcohol Concern and SCODA in 1999. QuADS has been contextualised for Irish drug and 
alcohol services and has been adopted as the national quality standards for addiction services in 
Ireland. 
 
The Youth Drug and Alcohol Service (YoDA) is a specialised adolescent outpatient drug treatment 
service in Dublin and is the largest service of its kind in Ireland. 
 
 
5.2 General description, availability and quality assurance 
5.2.1 Strategy/policy 
HSE National Service Plan 2014 
Approved by the Minister for Health on 17 December 2013, the HSE’s National Service Plan 2014 set 
out the type and volume of services the HSE would provide in 2014 (Health Service Executive 2013). 
With the health services budget for the year reflecting cost reductions of €619 million, and against a 
backdrop of a reduction in overall health service funding of almost €4 billion since 2008 and staff 
reductions of over 10,000 in that time, the HSE’s top priority in 2014 was to protect the volume, quality 
and safety of frontline services.   
 
 ‘Addiction issues’ were addressed by Social Inclusion Services in the Primary Care Division of the 
HSE. Social Inclusion Services support equity of access to services and provide targeted 
interventions to improve the health outcomes of minority groups, including Irish Travellers, Roma, and 
other members of diverse ethnic and cultural groups, such as asylum seekers, refugees and migrants, 
lesbian, gay, bisexual and transgender service users. Specific interventions are provided to address 
addiction issues, homelessness and medical complexities.  
 
The key priorities for 2014 expected to have an impact on addiction services were set out on p.37 of 
the plan:  
- achieve improved health outcomes for persons with addiction issues; 
- deliver on the national policy objectives of the national drugs strategy 2009–2016 (Department of 
Community 2009), with specific reference to progressing implementation of relevant actions on 
early intervention, treatment and rehabilitation; 
- implement recommendations from HSE Opioid Treatment Protocol (see Section 5.2.2.1 later in 
this chapter); 
- implement recommendations with regard to Tier 4 in the residential addiction services report 
(Corrigan and O'Gorman 2007) within the context of available resources; 
- finalise the implementation plan for the National Overdose Prevention Strategy (see Chapter 7.4 
later in this report); and 
- prioritise and implement HSE actions in the report on a national substance misuse strategy 
(Steering Group on a national substance misuse strategy 2012). 
 
Table 5.2.1.1 Key performance indicators for HSE’s Addiction Services, 2014 
Key Performance Indicators  
 
Expected 
Activity / 
Target 2014 
Opioid Substitute Treatment 
No. of clients in opioid substitute treatment (outside prisons) 
 
9,100 
Substance Misuse 
No. and % of substance misusers (over 18 years) for whom treatment has commenced within 
one calendar month following assessment  
 
No. and % of substance misusers (under 18 years) for whom treatment has commenced within 
one week following assessment 
 
1,260 (100%) 
 
 
105 (100%) 
Source: (Health Service Executive 2013), p. 38 
 
  55 
HSE National Performance Assurance Report, December 2013 
The HSE National Performance Assurance Report published data on key performance areas for 2013 
(Health Service Executive 2014b) (Health Service Executive 2014a).  It gave a snapshot of how 
Addiction Services, located within Social Inclusion Services, were performing in December 2013.  A 
summary of the report is given below: 
- 9,100 clients (excluding clients in prisons) were on methadone maintenance treatment, of whom  
42% were being treated by GPs in the community.  The report states that this was 5% above the 
expected level of activity.   
- 327 GPs, 73 HSE clinics and 10 prison-based clinics were providing treatment. 
- 60 new patients started methadone treatment, mostly in HSE clinics. 
- 93% (977) of all clients over the age of 18 who were assessed and required treatment, 
commenced treatment within one calendar month. 
- This varied by HSE region: lowest (Dublin Mid Leinster – 81%); highest (Dublin North East – 
100%). 
- All 51 clients aged 17 years or younger started treatment within one week following assessment.  
 
Evaluation of the National Drug Rehabilitation Framework 
An external evaluation of the National Drug Rehabilitation Framework has been published (Barry and 
Ivers 2014).  The framework, developed out of the work of NDRIC, comprises an integrated model of 
rehabilitation, care planning, case management, standardised assessments, protocols and quality 
standards (Doyle and Ivanovic 2010).  According to the authors, of the ten pilot sites chosen to 
implement the framework, only six had commenced.  While many challenges were encountered in the 
pilot, the authors felt that there was ‘near universal’ support for the project and the evaluation 
provided valuable lessons for improving the project.  For a detailed analysis of the evaluation, see 
Chapter 8.3 later in this report. 
 
5.2.2 Treatment systems 
5.2.2.1 Organisation and quality assurance 
Review of Dublin North City and County addiction service 
A recent high-level review of addiction treatment services in the Dublin North City and County area 
concluded that a substantial reconfiguration of services was needed to effectively respond to 
population needs and to emerging national policy (Pilling, et al. 2013). The report contained 14 
recommendations, eight calling for a reconfiguration services and six for a reconfiguration of 
operational elements (Table 5.2.2.1.1).  
 
Table 5.2.2.1.1   Dublin North City and County addiction service, recommendations for changes  
Service recommendations Operational recommendations 
Deliver addiction services around clinical care pathways 
for drugs and alcohol, with a focus on recovery.  
 
All service users should have agreed care plans which 
should be reviewed and updated regularly. 
Organise addiction services to treat all addictions 
(including alcohol and stimulants) in multi-disciplinary 
teams which are locality based. 
 
Locality teams should provide support to individuals with 
drug and alcohol problems who are treated by primary 
care services. 
Develop specialist resources and services around dual 
diagnosis, pregnancy, hepatitis C, assisted withdrawal for 
individuals with complex needs, and children, young 
people and families. 
 
All interventions should be evidence based and service 
providers should have appropriate training and supervision 
to ensure effective delivery. 
Appoint a clinical director who should jointly chair the 
senior management team, and a designated clinical lead 
for each locality team and specialist services. 
 
Assisted withdrawal (detoxification) services and 
rehabilitation services should be developed as a part of all 
care pathways. 
Appoint a service manager who should jointly chair the 
senior management team; all staff should have clear lines 
of accountability. 
 
Provide formal structures to enable service users to 
contribute to the design and evaluation of care. 
 
Have in place a routine outcome monitoring programme; 
outcomes should link to agreed clinical and service 
performance measures. 
 
Appoint a designated implementation manager and 
establish a steering group to implement the 
recommendations in this report.  
 
Develop a clinical governance structure to support the 
work of all clinicians in the addiction service. 
 
  56 
Service recommendations Operational recommendations 
 
Assessment of need and regular reviews of identified need 
should be central to the delivery of addiction services. 
 
Source: (Pilling, et al. 2013), pp. 6–7  
 
The review team drew heavily on consultations with representatives from a range of staff groups, 
including psychiatrists, pharmacists, voluntary sector representatives, service users and outreach 
workers. In summarising the main issues to emerge from these consultations, the authors 
acknowledged that while many elements of the service worked well:  
  
The current service configuration is sub-optimal, meaning that it is not always possible 
for staff to deliver care in line with an evidence-tiered approach…. The service 
currently consists of a number of professional/staff groups, some of whom appear to 
have limited formal interaction with one another…. There are also a number of ad-hoc 
arrangements in place, with staff providing good services but again these are often not 
properly integrated within the wider service system…. Services have typically evolved, 
often without an overall strategic direction, responding to specific issues or 
opportunities. (p. 20) 
 
The authors identified a lack of integration between the different elements of service provision. They 
also pointed out that, in the main, the primary functions of addiction treatment services across the 
area were to assess opioid dependence and dispense methadone. They saw the scope of service 
provision as needing expansion to prioritise responses to alcohol misuse, co-morbid mental health 
disorders, non-opiate drug misuse and the physical healthcare of service users. They also stated that 
a detailed and comprehensive needs assessment was required to document the nature and level of 
services required by people across the area with addiction-related needs.  
 
Finally, the authors recommended that ‘in line with international opinion, the principle of recovery 
should underpin all treatment from the point of first contact’ (p. 20). They gave the following definition 
of recovery: ‘an individual, ‘person-centred journey, enabling people to gain a sense of control over 
their own problems, the services they receive, and their lives and providing opportunities to participate 
in wider society’ (p. 22).  
 
Quality Standards Support Project 
With the support of the HSE and the North Inner City Local Drugs and Alcohol Task Force at a local 
level, the Quality Standards Support Project continues to work to support projects to develop their 
services in line with good practice and QuADS. It provides training for ‘champions’, i.e. a key person 
in an organisation, a policy template library and links to useful resources (drugs.ie). 
 
Development of clinical guidelines for opiate treatment  
In April 2014 a draft of the clinical guidelines for opiate treatment was distributed to a wider group for 
consultation; the results of this consultation are still awaited (personal communication Suzi Lyons, 
Health Research Board). See Chapter 5.2.2.1 of the 2013 National Report (Health Research Board 
2013) for a brief outline of the expected contents of the guidelines. 
 
 
5..2.2.2 Availability and diversification of treatment 
Pharmacist–patient structured methadone detoxification in prison 
Drug treatment pharmacists were introduced in Mountjoy Prison in 2008, primarily to ensure the safe, 
accurate and efficient dispensing of methadone (Cronin, et al. 2014). The pharmacists currently 
dispense in 13 different locations in the Mountjoy complex.  While the safe dispensing of methadone 
remains the priority, since 2010 pharmacists have also been supervising and managing pharmacist–
patient structured methadone detoxification, otherwise known as self-directed detoxification (SDD). 
 
Unlike other detoxification regimes, which are prescribed and have a fixed regime, SDD allows 
prisoners to opt to detoxify at times when they feel they are ready for and capable of change.  The 
pharmacists offer SDD in 12 locations within the Mountjoy Prison Complex (excluding Dochas 
Women’s Prison). All SDDs must be requested 24 hours in advance by the prisoner in order to 
eliminate impulsive decisions. SDD may be undertaken if it is deemed clinically appropriate and if it is 
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provided within certain parameters, i.e. up to a maximum amount, which reduces each week, and is 
communicated to the addiction specialist doctor.  The addiction specialist writes up the prescription 
weekly. If, at a later date, the prisoner chooses to return to their previous dose (i.e. increase their 
consumption), they must see the addiction specialist. The prisoner is supervised on a daily basis by 
the pharmacist so that any changes in demeanour and behaviour can be easily observed by a 
professional familiar with them and interventions can be made where appropriate. 
 
Anecdotally this system has proved successful. However, it was decided to conduct a review in order 
to determine the exact number of prisoners involved in SDD and assess the outcomes. The outcomes 
of all pharmacist–patient structured methadone detoxifications in Mountjoy Prison in Dublin between 
June 2010 and May 2014 were reviewed. The results of the review are reported here for the first time.  
 
Methods 
Three different cohorts of prisoners were chosen for the purposes of the review:   
1. Those on methadone maintenance therapy (MMT) who reduced their maintenance dose by over 
20mls (or 50% of their dose) between their committal to Mountjoy and their final movement out of 
Mountjoy. This cohort included those who returned to the community or were transferred to 
another prison.  
2. Those on MMT who detoxified completely and came off methadone while in custody in Mountjoy. 
For the purposes of the review, a prisoner on MMT was considered detoxified when sequentially 
reduced to a prescribed dose of 7mls or less.  At this dosage, a prisoner will often stop their 
methadone completely but get prescribed lofexidine or another drug to aid with any symptoms of 
withdrawal.   
3. Those on lofexidine therapy as an adjunct to SDD.  
 
The review excluded two cohorts of prisoners: 
1. Prisoners who were in receipt of MMT but who were in custody in Mountjoy for only a short period 
of time (less than 60 days consecutive days).  
2. Prisoners who were prescribed a ‘21-day standard detoxification’.  This group were not in receipt 
of any MMT prescription but tested positive for opiates and/or methadone and did not have an 
MMT clinic place externally. The prison can only offer a ‘21-day standard detoxification’ until a 
clinic place is confirmed for when they are released to continue their care. This regime consists of 
20mls methadone for two days, 30mls for four days, and then a 5mls dose reduction every three 
days to zero. As such their dose reductions cannot be considered SDD. 
 
Data pertaining to all methadone and lofexidine prescriptions in Mountjoy Prison during the period 
June 2010 to May 2014 were examined. The number of prisoners eligible for inclusion in the study 
were as follows: 
 
Methadone – 13,698 prescriptions, of which: 
- 572 prescriptions were for ‘21-day standard detoxifications’.  This equated to 390 prisoners who 
were excluded from the review. 
- 13,126 prescriptions were for 1,207 prisoners on MMT. Of these, 405 were excluded as they had 
not been in custody in Mountjoy for 60 or more consecutive days.  
- In total, 805 prisoners were included in the review. 
Lofexidine – 138 prescriptions.  
 
Results 
Of the 805 prisoners on MMT included in the review, 416 (52%) chose to undertake SDD. Of these, 
202 (49%) reduced their MMT dose by a significant amount of 20mls or more, and 214 (51%) 
detoxified off MMT completely while in Mountjoy. Of the 214 who detoxified off methadone 
completely:  
- 134 (63%) used lofexidine to complete their SDD.  Four prisoners had two courses of lofexidine 
but also completed SDD successfully.  
- 80 (37%) did not use lofexidine to complete their detoxification but completed the programme with 
the support of the pharmacists. 
- 27 (13%) either relapsed temporarily or went back on MMT.   
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Conclusions 
1. The practice of SDD through the pharmacists is routine in Mountjoy Prison.  
2. Over half of all prisoners prescribed methadone (for 60 or more consecutive days) in Mountjoy 
were able to reduce their methadone dose significantly using SDD.  
3. Half the prisoners who undertook SDD were able to detoxify completely off methadone while in 
Mountjoy.  
4. Lofexidine as an adjunct to MMT, to treat withdrawal symptoms, was used by 63% of those who 
chose to undertake SDD to complete their detoxification.  
5. Over a third of those who undertook SDD chose to complete their detoxification without lofexidine 
and completed it in the main prison with the support of the drug treatment pharmacists.  
6. At least 13% of prisoners who underwent SDD and detoxified completely relapsed, some only 
temporarily.  
7. Information on what happened to the prisoners on release from Mountjoy is not known, e.g. did 
they relapse or return to treatment? It would be important to investigate this in order to gauge the 
overall success of the programme.  This would require a further study using the HSE’s Central 
Treatment List (CTL). 
 
Treating problem alcohol use among drug users in primary care 
Problem alcohol use among drug users can negatively affect outcomes of drug treatment and hinder 
recovery.  A body of work has been undertaken to address the issue in the primary care setting.  Drug 
users accessing primary health care highlighted the importance of the patient–GP relationship and 
also felt that GPs should be more proactive in managing their problem alcohol use (Field, et al. 2013). 
Two further publications have outlined the development of clinical guidelines (Klimas, et al. 2014a), 
and an education programme for GPs to identify and manage problem alcohol use in this group 
(Klimas, et al. 2014b). 
 
The clinical guidelines were developed in three stages (Klimas, et al. 2014a): (1) identification of a 
wide range key stakeholders in the addiction, public health and primary care fields; (2) development 
of evidence-based draft guidelines; and (3) consensus on document reached through a modified 
Delphi-facilitated technique. Some of the key differences in the clinical guidelines for treating problem 
alcohol use among drug users, compared to problem alcohol use among those who do not have 
problem drug use, are: 
- screening and treatment need to be more systematic and proactive; 
- lower thresholds required for identification of problem use, treatment and referral; and 
- need for GPs to have specialist skills to manage relapse/dependence. 
 
 
5.3 Access to treatment 
 
For a report on access to treatment in 2013, see ‘HSE National Performance Assurance Report, 
December 2013’ in Section 5.2.1 above. 
 
Need for drug treatment in prison 
As part of the NACDA’s survey estimating the extent of drug use and the prevalence of blood-borne 
viruses among the prison population in Ireland, participants were asked about their need for drug 
treatment (Drummond, et al. 2014).  Participants were asked if they ever needed different types of 
drug treatment while in prison. They were also asked whether those services were available to them 
(within a reasonable time frame) and, if available, whether they used those services.  The different 
types of service were analysed by overall prison population, then by prison drug use category and by 
injecting drug use. To establish appropriate prison drug use categories, the authors used a post-hoc 
hierarchical clustering model to categorise prisons based on prisoners’ self-reported use in the 
previous 12 months of the six drugs included in the EMCDDA ‘problem drug use’ definition. By this 
method they identified four prison clusters based on levels of drug use, which they categorised  as 
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‘low’, ‘medium’, ‘high’  and ‘very high’.8 Some of the main results in relation to need for treatment are 
summarised below. 
 
Overall need 
The greatest proportion of respondents expressed a need for addiction counselling (44%), followed by 
drug-free wing or landing (41%) and  drug-free treatment programme (33%), while the smallest 
proportion expressed a need for alcohol detoxification (14%). Nineteen per cent expressed a need for 
benzodiazepine detox, and the same proportion expressed a need for opiate detox. 
 
The availability of specific drug treatments in relation to the number of participants expressing a need 
for them varied widely, from a low of benzodiazepine detoxification availability for only 22% of those 
expressing a need for it, to a high of methadone maintenance treatment (MMT) availability for 73% of 
those expressing a need. Overall, a high proportion of participants who needed a drug treatment 
service, and for whom it was available in prison, used the service, ranging from 95% for MMT to 78% 
for alcohol detoxification.  The authors noted that availability also varied across prisons (see below).   
 
Need by prison drug use category 
The need for services varied by prison drug-use category.  As might be expected, the expressed need 
was highest in the ‘very high’ drug-use category prisons. The highest need in all prison categories 
was for addiction counselling, ranging from 56% in the ‘very high’ drug-use category prisons to 38% in 
the ‘low’ drug-use category prisons. The need for a more specific intervention, MMT, ranged from 6% 
in the ‘low’ drug-use category prisons to 46% in the ‘very high’ drug-use category prisons. 
 
An analysis of the reported availability of services (among those who needed them) by prison drug-
use category was also done. This showed a wide range of availability across categories. For example, 
in ‘very high’ drug-use category prisons, 88% reported that MMT was available, compared to 49% in 
‘medium’ drug-use category prisons. In the ‘very high’ drug-use category prisons, availability of drug-
free wings or landings (28%) or drug-free programmes (32%) was reported as low. Where these 
services were available there was high uptake, particularly in the ‘high’ and ‘very high’ drug-use 
category prisons.  
 
A sub-group of participants comprising those who had ever injected was analysed by prison drug-use 
category. The expressed need for services was higher across all categories of prison drug-use. The 
need was particularly high for addiction counselling (ranging from 62% to 82%) and for drug-free 
treatment programmes (ranging from 53% to 74%). The authors stated that the results with regard to 
the availability of services and the high uptake of services for this group were similar to those in the 
general prison population as reported above.  
 
Recommendations for drug treatment in prison include: 
- Prisoners on MMT should be placed on an HSE clinic list or GP list to ensure that there is 
continuity of treatment on release from prison.  This would reduce the risk of overdose or early 
relapse. 
- If a prisoner is engaging with counselling, where possible there should be continuity of this 
treatment on release in order to support transition out of prison and into the community. 
- A full range of drug treatment options, encompassing an integrated clinical and psychological 
approach, should be available in all closed prisons. 
- There is a need for drug-free wings and drug-free areas not only for prisoners who do not use 
drugs but for those who wish to avoid relapse. 
- As the women’s prison was included in the ‘very high’ drug-use prison category, it is 
recommended that there be a specific strategy for the needs of women in order to improve their 
outcomes.  
 
See Chapter 4.3.2 earlier in this report for an account of the findings of this NACDA prison study with 
regard to prevalence and patterns of drug use among prisoners, and Chapter 6.2.1 for an account of 
the findings with regard to the prevalence of blood-borne viruses among the prison population. 
                                               
8
 For a detailed description of the method used, see Drummond, A., Codd, M., Donnelly, N., McCausland, D., Mehegan, J., Daly, L. et al. 
(2014). Study on the prevalence of drug use,including intravenous drug use, and blood-borne viruses among the Irish prisoner population. 
National Advisory Committee on Drugs and Alcohol, Dublin. Available at http://www.drugsandalcohol.ie/21750/ pp. 38–41 
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5.3.1 Characteristics of treated clients (TDI data included) 
 
TDI data 
A summary of the Treatment Demand Indicator (TDI) (see also TDI data), as provided by the NDTRS, 
shows that 8,684 cases entered treatment in 2013, an increase of 981 cases since 2012.9  In 2013, 
3,470 (40.0%) cases were new entrants, an increase of 200 cases compared to 2012. In 2013, as in 
previous years, the majority of cases attended outpatient services (5,745, 66.1%). The majority were 
male (6,328, 72.9%) and the mean age was 29 years, similar trends to 2012.  
 
As in previous years, opiates (mainly heroin) were the most common main problem drug reported by 
cases entering treatment in 2013 (4,451, 51.3%). This represents a decrease compared to 2012, 
when 4,971 cases entered treatment for problem opiate use. This decrease is not seen in the CTL 
data (see next section on ‘Clients registered for MMT’ and Standard Table 24). The reduction in the 
proportion of cases treated for cocaine as a main problem substance continued in 2013, decreasing 
from 8.5% in 2012 to 7.8% in 2013.  
 
The number of cases entering treatment for cannabis as their main problem substance has continued 
to increase. In 2013, 2,511 (28.9%) cases entered treatment for problem cannabis use compared to 
2,216 in 2012 and 2,086 cases in 2011. This is not surprising as the most recent general population 
survey showed a significant increase in the proportion of adults in Ireland who have ever used 
cannabis (National Advisory Committee on Drugs and Alcohol 2013). However, it may also reflect 
participation of services in the NDTRS or availability of treatment in the country. 
 
Clients registered for methadone maintenance treatment (MMT) 
The number of clients registered for MMT on 31 December each year is reported by the CTL (see 
Standard Table 24). On 31 December 2013, 9,640 clients were registered for MMT (including those 
receiving methadone in prison) (personal communication, Caroline Comar, CTL). This is a slight 
increase on the previous year (2%). While the number of clients registered has increased from 3,689 
in 1998 to 9,640 in 2013, since 2008 the rate of increase has been less than 4% annually.  This may 
reflect a change in patterns of drug use, but analysis of other sources, including treatment data and 
numbers of problem drug users, is necessary to explore this further. Of the 9,640 clients in 2013, the 
majority were male (69%) and the largest proportion (29%) were aged between 35 and 39 years, the 
same as in 2012.  
 
MMT is provided by specialised clinics, specialist GPs and in prison. In 2013, 55% of patients were 
receiving treatment in specialist outpatient clinics, 40% from GPs and 5% in prison. The proportion of 
clients receiving treatment from GPs has increased slightly, from 35% in 2009 to 40% in 2013.  The 
proportion of clients receiving treatment in specialist outpatient clinics has decreased slightly, from 
58% in 2009 to 55% in 2013.   
 
Travellers accessing addiction services in Ireland 
Since 2007 the NDTRS has recorded ethnic identifiers comparable with those used by the Central 
Statistics Office in the national population census. The inclusion of an ethnic identifier question in 
routine data collection allows the recording of useful information on ethnicity for planning health 
services.  These data formed the basis of a peer-reviewed paper which described individuals from the 
Traveller community who were assessed or treated for problem drug or alcohol use between 2007 
and 2010 (Carew, et al. 2013). The study provided an insight into the needs of Travellers with 
problem substance use and will be useful in informing and developing policies and strategies to tackle 
barriers and issues faced by the Traveller community. 
 
Numbers seeking treatment 
In the period 2007–2010, 68,748 cases sought treatment for problem substance use and were 
reported to the NDTRS. Ethnicity was recorded for 68,329 cases (99.4%), of whom 1,098 (1.6%) 
identified themselves as Irish Travellers. The number of such cases increased by 163% in the four-
year period, from 162 in 2007 to 427 in 2010. However, the authors noted that the number of Traveller 
cases recorded in the routine national drug treatment data is likely to be under-estimated.  
                                               
9
 It should be noted that the selection of NDTRS data for national analysis differs slightly to the selection of data for TDI. Therefore there are 
some differences between what is reported in TDI and what is published in HRB Trend papers and web updates.    
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The incidence of treated problem substance use among the Traveller community was three times that 
among the general population in 2010 (523 per 100,000 vs 173 per 100,000).   
 
Main problem substance 
- Alcohol was the most common problem substance for which cases from both the Traveller 
community (42.3%) and the general population (52.7%) sought treatment. 
- The number of Travellers seeking treatment for opiates (heroin, methadone and other opiates) 
increased by 291% (from 43 cases in 2007 to 168 in 2010), comprising 36.0% of Traveller cases 
in the four-year period, compared to 28.7% of cases from the general population.   
- Although the numbers were small, there was a 240% increase in the number of cases of 
Travellers reporting benzodiazepines as their main problem substance (from 5 in 2007 to 17 in 
2010), and a 200% increase in cases of Travellers reporting cannabis as their main problem 
substance, from 16 in 2007 to 48 in 2010. A similar upward trend, if less pronounced, was 
observed in cases from the general population: benzodiazepines (a 147% increase, from 177 to 
435 cases) and cannabis (a 118% increase, from 1,065 to 2,326 cases). 
- Opiates (heroin and other types) were the most commonly reported problem substance among 
Traveller women, while alcohol was the most commonly reported problem substance among 
women from the general population.  
- Albeit small in number, the proportion of Traveller women treated for benzodiazepines as a main 
problem substance (9, 4.0%) was higher than that in women from the general population (328, 
1.9%). 
 
Additional problem substances 
- The proportion reporting problem use of more than one substance (poly-substance use) was 
higher among Traveller cases (523, 53.2%) than among cases from the general population 
(24,826, 42.1%).  The proportion reporting problem use of more than one substance was higher 
among Traveller men (425, 56.1%) than Traveller women (98, 43.4%).  
- Cannabis was the most commonly reported additional problem substance among both Traveller 
cases and cases from the general population. Alcohol, cocaine, and benzodiazepines were the 
next most frequently reported additional problem substances for both groups.   
Age first used drugs 
- Traveller men who had used drugs commenced their drug use at a younger age (median, 14 
years) than either Traveller women (median, 16 years) or their male counterparts from the general 
population (median, 16 years).  
- Traveller women who had used drugs commenced their drug use at an older age than women 
from the general population (median, 15 years). The median period of time between commencing 
alcohol or drug use and seeking treatment was shorter for Traveller women compared with 
women in the general population. 
 
Injecting risk 
A slightly lower proportion of Travellers reported ever injecting drugs compared to the general 
population (15.3% vs 18.1%), and injecting status differed for men and women.  
 
The proportions of Traveller men who reported ever injecting or ever having shared injecting 
equipment were lower than those in the general population. Traveller men reported starting to inject at 
an older median age than men in the general population (22 vs 19 years). 
 
A higher proportion of Traveller women reported ever having injected compared with women from the 
general population (24.3% vs 16.3%), and also started injecting at a younger median age than women 
from the general population (19 vs 20 years). The proportions of Traveller women who were injecting 
at the time of entry to treatment and who reported having shared injecting equipment were greater 
than those among women from the general population.  
 
Gender differences 
Traveller women reported high rates of problem opiate use and injecting behaviours, contrary to the 
perception that problem substance use in the Traveller community is a predominantly male issue. The 
findings present a major cultural issue and challenge to Traveller health services and, given the high 
level of sharing, this has implications for the delivery of needle exchange services.  
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The paper highlighted the fact that problem drug and alcohol use was a serious issue, presenting 
‘complex and multiple challenges for health services providing treatment’, and the specific needs and 
vulnerabilities of Travellers must be considered in order to provide targeted, appropriate and effective 
addiction services.  
 
Characteristics of adolescents in drug treatment 
Three studies of adolescents attending the Youth Drug and Alcohol Service (YoDA) have been 
published recently (Apantaku-Olajide, et al. 2014) (Apantaku-Olajide and Smyth 2013) (Keane, Lisa, 
et al. 2014).  
 
While the aims and methodologies of the three studies varied, there are many commonalities about 
the characteristics of the different study groups which can be ascertained from the different papers.  
The majority of clients were male.  The main problem drugs reported were cannabis, alcohol, cocaine, 
heroin and benzodiazepines. It was common among this group to report mental health problems.  
Where there was a pre-existing comorbid diagnosis, it was most commonly attention deficit 
hyperactive disorder (ADHD).   Polydrug use was very prevalent, including problem use of both illicit 
and prescription drugs.  Overall, this group had complex needs requiring multi-disciplinary teams with 
appropriate training and good interagency collaboration in order to improve outcomes.  The individual 
studies are described below. 
 
Psychological characteristics (Keane, Lisa, et al. 2014) 
The aims of this study were to (1) examine the psychological characteristics of adolescents, and (2) 
compare two different groups – those who were heroin dependent and those who were non-opioid-
substance dependent. The study focused on the period 2005–2010. Cases during this period for 
whom the Beck Youth Inventories second edition (BYI-11) had been completed were eligible to be 
included in the study.  The BYI-11 measures self-reported levels of depression, anxiety, anger, 
disruptive behaviour and self-concept (how someone thinks about or perceives themself).   
 
Fifty-three heroin-dependent adolescents were recruited for the study. Of these, 21 (40%) were girls.  
The mean age was 17.1 years.  Most reported polydrug use: cannabis (54%), benzodiazepines 
(52%), and cocaine (24%).   The majority of this group received opiate substitution treatment: 
methadone (37, 70%) and buprenorphine (10, 19%).  Six (11%) received psychological interventions 
only.  
 
Almost a quarter (17, 24%) of the 71 adolescents in the non-opioid-substance dependent group were 
girls.  The mean age of this group was 16.1 years.  Seventy-six per cent of this group used more than 
one drug.  The main problem drugs reported were alcohol (96%), cannabis (72%), cocaine (15%), 
ecstasy (13%) and benzodiazepines (6%).  
 
Many of the adolescents attending the specialised service regardless of type of problem drug use 
reported mental health problems (as per the BYI-11 scores).  However, comparison of the scores 
showed significant differences between the heroin-dependent group and the non-opioid-dependent 
group for the domains of self-concept, anxiety, disruptive behaviour and depression, but not for anger.  
Girls in the heroin-dependent group had significantly different scores for self-concept and disruptive 
behaviour compared to boys in this group.   The authors stressed the need for appropriately trained 
staff and care for mental health issues when working with adolescent problem drug users, particularly 
those who use heroin.  
 
Educational attainment and drug use (Apantaku-Olajide, et al. 2014)  
This study looked at the effect of three different issues on educational attainment: (1) severity of drug 
use and psychological problems, (2) a disruptive family environment, and (3) pre-existing psychiatric 
comorbidity.  Data were collected between October 2005 and March 2009.  In total, 193 of the 215 
cases eligible were included in the study.  
 
Of those included, 76% (147) were boys. The mean age was 16.1 years (SD 1.5, range 9 to 19 
years). The majority were living with their families (163, 85%) but 7% were living in residential care, 
6% were living in foster care and 2% in homeless accommodation.  Polydrug use was common but 
the main problem drugs reported were cannabis (40%), alcohol (35%), heroin (11%) and cocaine 
(5%).  Age first used drugs ranged from 12 to 15 years.  Age first used alcohol ranged from 11.5 to 15 
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years.  The majority (113, 65%) of cases had had some contact with the criminal justice system.  Just 
over a third of cases (67, 35%) had a pre-existing psychiatric disorder. Of those 67, 40% (27) had 
ADHD, followed by conduct disorder (17, 25%) and depression (10, 15%).   
 
Educational attainment was categorised into three groups: still in main stream education (84, 44%), 
engaged in alternative education (46, 24%) and school dropouts10 (63, 33%).  
 
The study found significant differences between the three educational groups, with the school dropout 
group showing the greatest problems.  They had higher levels of drug use, notably heroin and 
polydrug use, commenced alcohol use earlier, and reported higher levels of psychiatric comorbidity 
and higher levels of parental drug use.  The authors concluded that the study demonstrated the 
complex needs of this vulnerable group and especially those adolescents who drop out of school 
early.  There was the need for good interagency work involving not only the treatment services but 
also justice, mental health and education to improve the outcomes for these children.  
 
Non-medical use of psychotropic prescription drugs (Apantaku-Olajide and Smyth 2013) 
This final study looked at the non-medical use of seven different psychotropic medications (opiate 
analgesia, ADHD stimulant, sedatives/anxiolytic, hypnotics (sleeping), antipsychotics, antidepressant 
and anabolic steroids) among adolescents attending YoDA. The data were collected between April 
and June 2011, and 63 out of the 85 cases eligible participated in the study. The cases were 
categorised into three groups: (1) medical use (prescribed any of the medication), (2) non-prescribed 
use (i.e. prescribed any of the medication but also had non-medical use), and (3) diverted use (i.e. 
use of any of the medication without a prescription).   
 
The majority were boys (76%).  Cannabis (75%) was reported as the main problem drug, followed by 
alcohol (14%), cocaine (10%) and heroin (1%).  Over two thirds (43, 68%) reported non-medical use 
of prescription drugs and many took more than one (mean number of drugs 2.3, SD = 1.1, range 1 to 
5).  The most common category of prescription drugs misused were sedative/anxiolytics followed by 
hypnotics (sleeping).  The most frequent reasons cited for misusing these drugs were ‘seek high or 
buzz’ (34, 79%); ‘to have a good time’ (27, 63%); and ‘relief from boredom’ (24, 56%). The most 
common sources for the drugs were friends.  The authors concluded that prescribers must be more 
aware of the potential for abuse and diversion of prescription medication and that interventions are 
required to reduce availability and diversion of these medications.  
 
5.3.2 Trends in treated population and treatment provision (incl. numbers) 
For most recent information, see Chapter 5.3.2 in the 2013 National Report (Health Research Board 
2013). 
  
                                               
10
 School dropout was defined as ‘case whose highest level of education attained is lower secondary or below and who have not received 
education (either formal or informal) in the four weeks prior to the assessment’.  
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6. Health Correlates and Consequences 
6.1 Introduction 
Problematic drug use can be associated with a number of other health conditions or lead to a range of 
health consequences, including drug-related infectious diseases, drug-related overdoses, a range of 
chronic illnesses and acute conditions, and psychiatric comorbidity. Information on these various 
health correlates and consequences is collected in a variety of information systems, which are 
described below. 
 
The Health Protection Surveillance Centre (HPSC) is Ireland’s specialist agency for the 
surveillance of communicable diseases.  Part of the Health Service Executive (HSE), and originally 
known as the National Disease Surveillance Centre, the HPSC endeavours to protect and improve 
the health of the Irish population by collating, interpreting and disseminating data to provide the best 
possible information on infectious disease. The HPSC has recorded new cases among injecting drug 
users of HIV since 1982, hepatitis B (HBV) since 2004, and hepatitis C (HCV) since 2006.  
 
The HIPE (Hospital In-Patient Enquiry) is a computer-based health information system, managed 
by the Economic and Social Research Institute (ESRI) in association with the Department of Health 
and the HSE. It collects demographic, medical and administrative data on all admissions, discharges 
and deaths from acute general hospitals in Ireland. It was started on a pilot basis in 1969 and then 
expanded and developed as a national database of coded discharge summaries from the 1970s 
onwards. Each HIPE discharge record represents one episode of care; each discharge of a patient, 
whether from the same or a different hospital, or with the same or a different diagnosis, gives rise to a 
separate HIPE record.  The scheme, therefore, facilitates analyses of hospital activity rather than of 
the incidence of disease. HIPE does not record information on individuals who attend accident and 
emergency units but are not admitted as inpatients.  
 
The National Psychiatric In-Patient Reporting System (NPIRS), administered by the Health 
Research Board (HRB), is a national psychiatric database that provides detailed information on all 
admissions to and discharges from 56 inpatient psychiatric services in Ireland. It records data on 
cases receiving inpatient treatment for problem drug and alcohol use. NPIRS does not collect data on 
the prevalence of psychiatric comorbidity in Ireland. The HRB publishes an annual report on the data 
collected in NPIRS, entitled Activities of Irish psychiatric units and hospitals. 
 
The National Registry of Deliberate Self-Harm is a national system of population monitoring for the 
occurrence of deliberate self-harm, established at the request of the Department of Health and 
Children by the National Suicide Research Foundation (National Parasuicide Registry Ireland 2004). 
Since 2006/07 the Registry has achieved complete national coverage of hospital-treated deliberate 
self-harm. The Registry defines deliberate self-harm as ‘an act with non-fatal outcome in which an 
individual deliberately initiates a non-habitual behaviour, that without intervention from others will 
cause self-harm, or deliberately ingests a substance in excess of the prescribed or generally 
recognised therapeutic dosage, and which is aimed at realising changes that the person desires via 
the actual or expected physical consequences’. All methods of deliberate self-harm are recorded in 
the Registry, including drug overdoses and alcohol overdoses, where it is clear that the self-harm was 
intentionally inflicted. All individuals who are alive on admission to hospital following a deliberate act 
of self-harm are included. Not considered deliberate self-harm are accidental overdoses, e.g. an 
individual who takes additional medication in the case of illness, without any intention to self -harm; 
alcohol overdoses alone, where the intention was not to self-harm; accidental overdoses of street 
drugs (drugs used for recreational purposes), without the intention to self-harm; and individuals who 
are dead on arrival at hospital as a result of suicide. 
 
The National Suicide Research Foundation (NSRF) is an independent, multi-disciplinary research 
unit which investigates the causes of suicide and deliberate self-harm in Ireland. 
 
Problematic drug use can also lead to premature death. Death can occur as a result of overdose 
(either intentional or unintentional), actions taken under the influence of drugs, medical consequences 
or incidental causes. Although illicit drugs are involved in many cases of drug-related death, licit 
(including prescribed) drugs are also frequently involved, either alone or in conjunction with an illicit 
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drug. Alcohol has been reported as the third greatest risk factor for ill health and premature death in 
Europe.  
 
Established in 2005, the National Drug-Related Death Index (NDRDI), which is maintained by the 
HRB, is an epidemiological database which records cases of death by drugs poisoning, and deaths 
among drug users in Ireland, extending back to 1998. The NDRDI also records data on alcohol-
related poisoning deaths, deaths among those who are alcohol dependent, extending back to 2004. 
 
The Central Statistics Office (CSO), acting on behalf of the Department of Health, compiles 
quarterly and annual statistical reports on deaths in the Irish population. These reports are based on 
administrative data supplied by the General Register Office. The principal variables collected include 
date of death, address of residence of deceased, place of death, underlying cause of death, 
occupation, age, sex, and marital status. Since 1 January 2007 the underlying cause of death has 
been coded according to ICD10. 
 
 
6.2 Drug-related infectious diseases 
6.2.1 HIV/AIDS and viral hepatitis 
HIV surveillance, 2013 
Voluntary linked testing for antibodies to HIV has been available in Ireland since 1982. Figure 6.2.1.1 
presents the number of new cases of HIV among injecting drug users (IDUs) reported in Ireland, by 
year of diagnosis; data from 1982 to 1985 are excluded as these four years were combined in the 
source records. According to the most recent report of the HPSC, at the end of 2013, 344 people 
were newly diagnosed with HIV in Ireland (crude notification rate of 7.5 per 100,000 population). 
Since 2010, the annual rate of new HIV diagnoses has been relatively stable, ranging from 7.0 to 7.5 
per 100,000 population (Health Service Executive and Health Protection Surveillance Centre 2014).   
 
In 2013, 5% (18) of newly-diagnosed HIV cases were IDUs. This is similar to the number diagnosed in 
the last four years (ranging between 13 and 23 cases since 2010). Of the 18 newly-diagnosed cases 
who were IDUs, 12 were men and six were women and the median age was 33.5 years (range 23 to 
56 years). Ten cases were born in Ireland, three in Central and Eastern Europe and one in Western 
Europe. Country of birth was unknown for four. Where CD4 count was reported, 56% of IDUs in 2013 
were diagnosed late, including 19% who were severely immuno‐compromised. The proportion 
diagnosed late in 2013 was lower than in 2012 (63%) and 2011 (85%). One of the 18 IDUs was also 
diagnosed with an AIDS-defining illness at the time of their HIV diagnosis. Among the IDUs newly 
diagnosed with HIV infection, 83% were co‐infected with HCV.  
 
 
 
Figure 6.2.1.1 Number and rolling average number of new cases of HIV among IDUs, by year of diagnosis, reported 
in Ireland, 1986–2013 
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Source: Unpublished data reported to Department of Health by National Disease Surveillance Centre and HPSC, 2014 
 
Hepatitis B (HBV) notifications, 2013 
There were 431 notifications of HBV in 2013 compared to 581 in 2012, an 18% decrease (Table 
6.2.1.1). Of the cases notified, 58% (248) were male, 41% (178) were female and in a further five 
cases the gender was unknown. The majority, 71% (306), were aged between 25 and 44 years.  The 
number of acute cases remained low at 31, showing a small decrease since 2012 when there were 37 
acute cases.  Among acute cases of HBV in 2013, one was an IDU. 
 
Table 6.2.1.1   Acute and chronic hepatitis B cases reported to the HPSC, by risk factor status, 2012-13 
 2012 2013 
Hepatitis B status Acute Chronic Unknown Acute Chronic Unknown 
 
N (%) N (%) N (%) N (%) N (%) N (%) 
Total number of cases 37 521 23 31 386 14 
% of cases by status (6.4) (89.6) (4) (7.2) (89.6) (3.2) 
Cases with reported risk factor data 36 243 5 30 230 6 
% of cases with risk factor data (97) (47) (22) (97) (59.6) (42.9) 
of which       
Injecting drug users 0 (0%) 5 (1%) 0 (0%) 1 (3.3%) 6 (2.6%) 0 (0%) 
Cases without reported risk factor data 1 278 18 1 156 8 
% of cases without risk factor data (3) (53) (78) (3) (40.4) (57.1) 
Total 581 431 
Source: Unpublished data reported to Department of Health by National Disease Surveillance Centre and HPSC, 2014 
 
Hepatitis C (HCV) notifications, 2013 
There were 847 HCV notifications in 2013 (Table 6.2.1.2), a decrease of 18% on 2012 when there 
were 1,036 notifications. The notification rate for 2013 was 18.5 per 100,000 population. The 
notification rate has continued to decrease from a peak of 36.5 per 100,000 population in 2007.  The 
median age at notification has increased steadily over the 10 years since notification began in 2004, 
from 32 to 38 years in males and from 29 to 36 years in females.  Decreasing HCV notifications and 
increasing median age are indicative of a reduced incidence of HCV in the population.  Demographic 
data in 2013 remained similar to previous years, with 68% (576) of cases being male and 87% (739) 
aged between 25 and 54 years.    
 
Table 6.2.1.2 Hepatitis C cases and notification rates per 100,000 population, 2004–2013 
Year n Notification rate 
2004 1119 26.4 
2005 1403 33.1 
2006 1210 28.6 
2007 1541 36.5 
2008 1511 35.8 
2009 1240 29.3 
2010 1236 29.2 
2011 1257 29.6 
2012 1036 24.4 
2013 847 18.5 
Source: Unpublished data from HPSC, 2014 
 
Risk factor data were available for 540 (64%) of the 2013 cases (Table 6.2.1.3).  For 372 (69%) of 
these cases, injecting was the predominant risk factor.  Among the cases for whom injecting was the 
predominant risk factor, 272 (73%) were men, the mean age was 37.6 years, and 297 (80%) lived in 
Dublin or the adjoining counties of Kildare and Wicklow (Table 6.2.1.4).  
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Table 6.2.1.3: Hepatitis C cases reported to the HPSC, by risk factor status, 2010–2013 
Risk factor status 2010 2011 2012 2013 
  n (%) n (%) n (%) n (%) 
Total number of cases 1236 1257 1036 847 
Cases with reported risk factor data 728 (58.8%) 753 (59.9%) 651 (62.8%) 540 (63.8%) 
Of which: 
    
Injecting drug users 550 (75.5%) 616 (81.8%) 484 (74.3%) 372 (68.9%) 
Recipient blood/blood products 19 (2.6%) 19 (2.5%) 26 (4%) 16 (3%) 
Other risk factors 143 (19.6%) 106 (14.1%) 127 (19.5%) 135 (25%) 
No known risk factor identified 16 (2.2%) 12 (1.1%) 12 (1.8%) 17 (3%) 
Cases without reported risk factor data 511 (41.3%) 504 (40.1%) 385 (37.1%) 307 (36.2%) 
Source: Unpublished data from HPSC, 2014 
 
Table 6.2.1.4: Hepatitis C cases who reported injecting drug use as a risk factor, by age, gender and place of 
residence, 2010–2013 
  2010 2011 2012 2013 
  n (%) n (%) n (%) n (%) 
Total number of known injector cases 550 616 484 372 
Gender 
    
Male 409 (74%) 419 (68%) 348 (72%) 272 (73%) 
Female 140 (25.5%) 196 (31.8%) 136 (28%) 99 (26.6%) 
Gender not known 1 1 0 1 
Age 
    
Mean age 35.8 35.4 36.9 37.6 
Median age 34 34 36 37 
Under 25 years 32 (5.8%) 45 (7.3%) 23 (4.8%) 10 (2.7%) 
25–34 years 247 (44.9%) 269 (43.7%) 178 (36.8%) 137 (36.8%) 
Over 34 years 271 (49.3%) 300 (48.7%) 282 (58.2%) 225 (60.5%) 
Age not known 0 (0%) 2 (0.3%) 1 (0.2%) 0 (0%) 
Place of residence 
    
Dublin, Kildare or Wicklow 466 (84.7%) 538 (87.3%) 399 (82.4%) 297 (79.8%) 
Elsewhere in Ireland 84 (15.3%) 78 (12.7%) 85 (17.6%) 75 (20.2%) 
Source: Unpublished data from HPSC, 2014 
 
Pregnant women with blood-borne infections, 2012  
The DOVE clinic in the Rotunda Maternity Hospital, Dublin, was established to meet the specific 
needs of pregnant women who have or are at risk of blood-borne or sexually-transmitted bacterial or 
viral infections.  Figures from the clinic for 2012 were published in the hospital’s annual report (The 
Rotunda Hospital 2013).  
 
In 2012, a total of 227 women were booked into the DOVE clinic for ante-natal care. Of these: 
- 31% (70) were positive for HBV surface antigen (down from 85 in 2011), 
- 27% (61) were positive for HCV antibody (down from 74 in 2011), 
- 16% (36) were positive for HIV (up from 27 in 2011), 
- 7% (15) were positive for Treponemal serology (down from 16 in 2011), and 
- 33% (73) were known to be on prescribed methadone programmes.  
 
Deliveries to mothers attending the Dove Clinic are outlined in Table 6.2.1.5.  A total of 89 deliveries 
were to mothers attending the drug liaison midwife (DLM), 76 were HBV positive, 70 were HCV 
positive, 31 HIV positive and 18 tested positive for syphilis.  Fourteen babies were admitted to the 
neonatal unit with neonatal abstinence syndrome.   
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Table 6.2.1.5 Deliveries to mothers attending the DOVE Clinic who were positive for HIV, HCV, HBV or syphilis or 
who were attending the DLM, 2012 
Mothers status HIV(+ve) HCV(+ve) HBV(+ve) Syphilis(+ve) DLM 
Total mothers delivered 31 70 76 18 89 
Total mothers delivered <500g (inc 
miscarriage) 
1 2 3 1 8 
Total mothers delivered>500g 30 68 73 17 81 
Live infants 30 
71 (3 sets 
twins) 
73 17 
82 (2 sets 
twins) 
Miscarriage 3 (triplets) 2 3 3 (triplets) 8 
Stillbirth 0 0 0 0 1 
Infants <37 weeks gestation 2 
14 (3 sets 
twins) 
5 0 18 
Caesarean section 18 22 19 6 25 
NICU admission for NAS - - - - 14 
Maternal median age 32 30 28 30.5 - 
Newly diagnosed at ANS 7 12 15 11 - 
NICU = Neonatal intensive care unit 
NAS = Neonatal abstinence syndrome 
ANS = Ante-natal screening 
DLM = Drug liaison midwife 
Source: (The Rotunda Hospital 2013) 
 
Prevalence of blood-borne viruses in Irish prisons, 2011 
The National Advisory Committee on Drugs and Alcohol (NACDA) has published the results of a 
survey estimating the extent of drug use and the prevalence of blood-borne viruses among the prison 
population in Ireland (Drummond, et al. 2014). The survey methodology, and the demographic 
characteristics and prevalence of drug use in the sample population, are outlined in Chapter 4.3.2 
earlier in this report. 
 
Prevalence of blood-borne viral infection among the prison population  
Risk factors for viral infection reported by prisoners were: 
- Sharing injecting paraphernalia: Of those who reported having ever injected drugs and answered 
the questions on sharing equipment, 48.8% (84/172) shared needles, 49% (81/165) syringes and 
52% (84/162) other injecting equipment. A greater proportion of females (78%) reported sharing 
needles and syringes compared to males (46%).  
- Sexual behaviour: Self-reported rates of unprotected sex (having sex without a condom) were 
high both while in prison (62%) and outside prison (51%). Less than 2% of men reported that they 
had ever had sex with other men (1.5% outside prison and 0.9% in prison).  
- Tattooing: More than two-thirds (68%) of participants had borstal or tattoo markings, and 35% had 
had a tattoo done in prison.  
 
Hepatitis C prevalence: oral fluid test 
The overall prevalence of HCV was 12.9% among the prisoners tested, and 41.5% (83/200) among 
those who were IDUs (Figure 6.2.1.2). Prevalence of HCV varied with the type of drug injected: the 
rates of positive test results were 54% (80/149) of heroin injectors, 66% (66/100) of cocaine injectors, 
62% (42/68) of benzodiazepine injectors, and 27% (14/66) of steroid injectors (Figure 6.2.1.3). The 
prevalence rate in the Irish population has been estimated at 0.5-1.2% (Thornton, et al. 2011), much 
lower than the rate experienced by either prisoners or IDUs.   A previous study reported a prevalence 
rate for HCV of 37% among prisoners and 81% among IDUs; however, these were mainly heroin 
injectors (Allwright, et al. 2000). 
 
The concordance analysis revealed that 21 (9%) of those who thought they were negative had a 
positive test result and three (1%) of those who reported being positive had a negative test result. 
Multivariate analysis indicated that five factors were associated with HCV infection: being female, 
being over 25 years old, having a history of injecting drug use, sharing injecting equipment and having 
had tattoos done in prison.  
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HIV prevalence: oral fluid test 
Fifteen participants tested positive for HIV, resulting in a prevalence of 1.9% among prisoners and 
6.0% among IDUs in prison (Figure 6.2.1.2). Figure 6.2.1.3 presents the prevalence of HIV among 
IDUs by type of drug injected and demonstrates that the prevalence of HIV is between 7% and 10% 
among ‘hard’ drug users.  
 
The concordance analysis revealed that three (1.4%) people who thought they were negative were 
positive and one (0.4%) prisoner who thought he was positive was negative. While the numbers who 
tested positive for HIV were small (15/657), four factors were found to be associated with HIV 
infection: being female, having a history of injecting drug use, sharing injecting equipment, and male-
to-male sexual contact.  
 
 
 
 
Figure 6.2.1.2: Prevalence of HCV and HIV among prisoners tested, 2011 
Source: (Drummond, et al. 2014) 
 
 
 
Figure 6.2.1.3    Prevalence of HCV and HIV in IDU prisoners tested, by type of drug injected, 2011 
Source: (Drummond, et al. 2014) 
 
Hepatitis B prevalence: oral fluid test 
The prevalence of HBV was 0.3% among the prisoners tested. A previous prison study found 
prevalence rates for HBV of 9% among prisoners and 18.5% among injectors in prison (Allwright, et 
al. 2000). The introduction of blood-borne viral testing and hepatitis B vaccination by the Irish Prison 
Service in 1995 accounts for the reduction of HBV infection among drug users in prison. 
Hepatitis C HIV
All prisoners tested 12.9% 1.9%
Injecting prisoners tested 41.5% 6.0%
0.0%
5.0%
10.0%
15.0%
20.0%
25.0%
30.0%
35.0%
40.0%
45.0%
Hepatitis C HIV
Heroin 53.7% 7.4%
Cocaine 66.0% 10.0%
Benzodiazepines 61.8% 10.3%
Steroids 21.2% 3.0%
0.0%
10.0%
20.0%
30.0%
40.0%
50.0%
60.0%
70.0%
  70 
The concordance analysis indicated that eight people (3%) thought they had a disease that they did 
not have and one person (0.4%) had a disease that he did not know he had and may not have been 
taking the necessary precautions to prevent spread of infection to others.  
 
Steroid injectors 
Of note, there were 69 self-reported steroid injectors, of whom 16 had started to inject in prison and 
13 had injected in prison in the last year. Fourteen steroid injectors tested positive for HCV and two 
for HIV. This study identified a new cohort of injecting drug users and HCV infection. 
 
Co-infection: oral fluid test 
Fourteen per cent (106/777) of prisoners had serological evidence of blood-borne virus infection. No 
prisoner tested positive for all three viruses, and there was no co-infection with HBV and HIV. 
However, 10 participants (1.3%) were found to be co-infected with HCV and HIV. One (0.1%) was co-
infected with HBV and HCV. The one factor identified as being significantly associated with co-
infection was ever having shared injecting drug equipment.  
 
6.2.2 STI’s and tuberculosis 
 
The 2013 HPSC HIV report found none of the newly diagnosed HIV cases were co-infected with 
either STIs or tuberculosis (Health Service Executive and Health Protection Surveillance Centre 
2014). See Chapter 6.2.2 in 2013 National Report for the most recent information regarding STIs and 
tuberculosis (Health Research Board 2013).   
 
6.2.3 Other infectious morbidity  
 
A case of a 19-year-old male patient who presented at Accident and Emergency with uvulitis six hours 
after inhalation of mephedrone was documented in the journal Anaesthesia (Murphy and Haughey 
2014).  The patient mistook the mephedrone for ecstasy.  Other than tachycardia, his vital signs were 
normal. He was dysphonic, and unable to complete full sentences or swallow his own saliva. On 
examination, the uvula was grossly swollen. Mephedrone ingestion was confirmed by urinary point-of-
care testing. 
 
He was treated with high-flow oxygen via facemask, hydrocortisone and chlorpheniramine 
intravenously, adrenaline intramuscularly and nebulised adrenaline. Over the following hour, his 
symptoms improved. He was admitted to a high-dependency unit for observation, but discharged after 
12 hours symptom-free and with a normal-looking uvula.  The authors concluded that in addition to 
tachycardia, hypertension, palpitations and respiratory difficulties, which are commonly described as 
side-effects of mephedrone, the patient suffered a hypersensitive reaction which responded rapidly to 
anti-allergy medications. 
 
6.3 Other drug-related health correlates and consequences 
6.3.1 Non-fatal overdoses and drug related emergencies 
Data extracted from the Hospital In-Patient Enquiry (HIPE) scheme were analysed to determine 
trends in non-fatal overdoses discharged from Irish hospitals between 2005 and 2012. There were 
4,462 overdose cases in 2012, of which 40 died in hospital.  Only the 4,422 discharged cases are 
included in this analysis.  The number of overdose cases increased by 5% between 2011 and 2012. 
However, trends over time indicate a decrease in overdose cases admitted to Irish hospitals, falling 
from 5,012 in 2005 to 4,422 in 2012, a reduction of 590 cases (Figure 6.3.1.1). 
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Figure 6.3.1.1Non-fatal overdose cases admitted to Irish hospitals, 2005–2012 (N=36,878) 
Source: Unpublished HIPE data, 2014 
 
Gender 
Between 2005 and 2012 there were more overdose cases among women than among men, with 
women accounting for 2,436 (55%) of all non-fatal overdose cases in 2012 (Figure 6.3.1.2). 
 
Figure 6.3.1.2 Non-fatal overdose cases admitted to Irish hospitals, by gender, 2005–2012 (N=36,878) 
Source: Unpublished HIPE data, 2014 
 
Age group 
There was an increase in the number of non-fatal overdose cases in all age groups between 2011 
and 2012, with the exception of those aged 15 to 24 years.  There were 44 fewer overdose cases in 
this age group.  The incidence of overdose peaked in the 15 to 24 age category and thereafter 
decreased with age (Figure 6.3.1.3).  Trends over time showed that in 2005, 40% of cases were aged 
less than 25 years compared to 31% in 2012. 
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Figure 6.3.1.3 Non-fatal overdose cases admitted to Irish hospitals, by age group, 2005–2012 (N=36,878) 
Source: Unpublished HIPE data, 2014 
 
Drugs involved 
Table 6.3.1.1 presents the positive findings per category of drugs and other substances involved in all 
cases of overdose in 2012. Non-opioid analgesics were present in 34% (1,499) of cases. Paracetamol 
is included in this drug category and was present in 1,148 (26%) of cases.  Psychotropic agents were 
taken in 1,028 (23%) and benzodiazepines in 924 (20%) of cases. There was evidence of alcohol 
consumption in 540 (12%) of cases. Cases involving alcohol are included in this analysis only when 
the alcohol was used in conjunction with another substance.  
 
Table 6.3.1.1 Categories of drugs involved in overdose cases admitted to Irish hospitals, 2012 (N=4,422)* 
Drug category Number % 
Non-opioid analgesics 1499 33.9 
Benzodiazepines 924 20.9 
Psychotropic agents 1028 23.2 
Narcotics and hallucinogens 563 12.7 
Alcohol 540 12.2 
Systemic and haematological agents 183 4.1 
Cardiovascular agents 153 3.5 
Autonomic nervous system 140 3.2 
Anaesthetics 117 2.6 
Hormones 117 2.6 
Systemic antibiotics 74 1.7 
Gastrointestinal agents 82 1.9 
Other chemicals and noxious substance 276 6.2 
Diuretics  59 1.3 
Muscle and respiratory agents 35 .8 
Topical agents 40 .9 
Anti-infectives / Anti-parasitics 19 .4 
Other gases and vapours 49 1.1 
Other and unspecified drugs 908 20.5 
*The sum of positive findings is greater than the total number of cases because some cases involved more than one drug or substance. 
Source: Unpublished HIPE data, 2014 
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Narcotic or hallucinogenic drugs were involved in 563 (13%) of overdose cases in 2012. Figure 
6.3.1.4 shows the number of positive findings of narcotics or hallucinogens drugs among the 563 
cases. Opiates were used in 478 (85%) of the cases, cocaine in 71 (13%) and cannabis in 38 (7%) of 
the cases. The sum of positive findings is greater than the total number of cases because some cases 
involved more than one drug from this category.   
 
 
Figure 6.3.1.4 Narcotics and hallucinogens involved in non-fatal overdose cases admitted to Irish hospitals, 2012 
(N=563) 
Source: Unpublished HIPE data, 2014 
 
In 2,921 cases (66%), the overdose was classified as intentional (Figure 6.3.1.5).  For 81 cases, there 
was no classification of intent recorded. These cases were not included in the analysis. 
 
 
Figure 6.3.1.5 Overdose cases admitted to Irish hospitals, by classification, 2012 (N=4,341) 
Source: Unpublished HIPE data, 2014 
 
 
Table 6.3.1.2 presents the positive findings per category of drugs and other substances involved in 
cases of intentional overdose (n=2,921) in 2012. Non-opioid analgesics were involved in 1,205 (41%) 
of cases, benzodiazepines in 706 (24%) and psychotropic agents in 801 (27%). 
 
Table 6.3.1.2 Categories of drugs involved in intentional overdose cases admitted to Irish hospitals, 2012 (N=2,921)* 
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Drug category Number % 
Non-opioid analgesics 1205 41.3 
Benzodiazepines 706 24.2 
Psychotropic 801 27.4 
Alcohol 380 13.0 
Narcotics and hallucinogens 315 10.8 
Cardiovascular 91 3.1 
Systemic and haematological 92 3.1 
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*The sum of positive findings is greater than the total number of cases because some cases involved more than one drug or substance. 
Source: Unpublished HIPE data, 2014 
 
 
Incidence of opiate-induced neonatal abstinence syndrome 
Neonatal abstinence syndrome (NAS) is a clinical condition which occurs among infants withdrawing 
from in-utero substance exposure.  A recent study published in the Irish Medical Journal 
retrospectively identified cases of NAS in Cork city, Ireland, between 2000 and 2011 (Healy, et al. 
2014).  The aim of the review was to establish whether there had been an increase in the number of 
cases in line with evidence of increasing opiate abuse in the city.  
 
In total, 16 cases of NAS were identified.  Two of these occurred prior to 2007; two to three cases per 
year occurred between 2008 and 2010; and seven cases were identified in 2011.  All mothers were 
self-declared multi-drug abusers.  Opiates used included heroin (n=5), tramadol (n=3) and methadone 
(n=10).  The mothers’ age range was from 22 to 34 years (median age 27).  The mean birth weight of 
the babies was 2,802 +/- 576g and the mean gestational age at delivery was 275 +/- 7 days. All 
infants received supportive care.  Five required pharmacotherapy and prolonged hospital stays. 
 
Only neonates who became symptomatic prior to discharge from the maternity hospital were included 
in the study. Therefore it is possible that other infants were admitted to other paediatric facilities with 
later onset of withdrawal symptoms. The article concluded that the incidence of NAS in Cork is 
increasing with implications for primary, secondary and tertiary care. 
 
Methaemoglobinaemia secondary to amyl nitrate use 
Two cases of methaemoglobinaemia secondary to amyl nitrate use were outlined recently in the Irish 
Medical Journal (Nees and Fitzgerald 2014).  Methaemoglobinaemia occurs when red blood cells 
contain more than 1% methaemoglobin. This results in an inability to bind oxygen.  Cyanosis results 
even if oxygen is given. Methaemoglobinaemia may be congenital or acquired.  Acquisition causes 
include drug abuse with nitrates including the street drug ‘poppers’, and local anaesthetic toxicity.   
 
The first case reported involved a 55-year-old male who had collapsed and was brought to a hospital 
emergency department (ED); the cause of the collapse was unknown.  He had a history of abuse of 
amyl nitrate ‘poppers’ and alcohol. He was markedly cyanosed and his oxygen saturation was low.  
He was immediately intubated and ventilated with 100% oxygen.   His blood was noted to be 
chocolate brown in colour.  Tests showed a very elevated Met-Hb level of 76% (normal range 0-3%).   
Following treatment with methylene blue his condition improved rapidly.  
 
The second case was a 22-year-old female brought into ED with fluctuating GCS11 and slate-grey 
cyanosis. She had a known background history of heroin and methadone use, an empty bottle of amyl 
nitrate had been found beside her and she smelt strongly of alcohol.  She was maintaining her own 
airway but intermittently apnoeic. Oxygen saturations were 87%. Met-Hb was 67% on ABG analysis. 
The urinary toxin screen was positive for benzodiazepine and tetrahydrocannabinol.   She was treated 
with methylene blue, naloxone infusion, vasopressors and high-flow O2 via face mask, and recovered 
quickly.  She was kept overnight in the ED but self-discharged the next day.  
                                               
11
 The ‘Glasgow coma scale’ is a neurological scale for assessing the level of consciousness of a person. 
Autonomic nervous system 90 3.1 
Systemic antibiotics 55 1.9 
Hormones 75 2.6 
Gastrointestinal 64 2.2 
Anaesthetics 36 1.2 
Other chemicals and noxious substances 91 3.1 
Anti-infectives/anti-parasitics 9 .3 
Other gases and vapours 4 .1 
Muscle and respiratory 18 .6 
Topical agents 8 .3 
Diuretics  44 1.5 
Other and unspecified drugs 546 18.7 
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The authors concluded that these cases highlight a need for vigilance regarding 
methaemoglobinaemia secondary to amyl nitrate abuse. If methaemoglobinaemia is suspected, it can 
be diagnosed rapidly and it responds immediately to treatment. 
 
 
6.3.2 Other topics of interest e.g. psychiatric and somatic co-morbidity 
 
Trends in drug admissions to psychiatric facilities 
The annual report based on the data collected in the National Psychiatric In-Patient Reporting System 
(NPIRS) in 2012 shows that the total number of admissions to inpatient care has continued to fall 
(Daly and Walsh 2013).  There was a 21% decline in overall psychiatric admissions in the 10 years 
between 2003 and 2012  
 
In 2012, 831 cases were admitted to psychiatric facilities with a drug disorder (ICD-10 code F11-19, 
F55), which is a rate of 7.8 per 100,000 total population.   Of these, 358 (43%) were treated for the 
first time. This is similar to the number of admissions in 2011 when there were 839 cases, of which 
352 were for the first time.  The report does not present data on drug use and psychiatric co-
morbidity, so it is not possible to determine whether or not these admissions were appropriate.  Figure 
6.3.2.1 presents the rates of psychiatric first admission between 1993 and 2012 of cases with a 
diagnosis of drug disorder.  
 
 
Figure 6.3.2.1: Rates of psychiatric first admission of cases with a diagnosis of drug disorder per 100,000 
population in Ireland, 1993–2012 
Source: (Daly and Walsh 2013) 
 
 
Other notable statistics on first admissions for a drug disorder in 2012 included: 
- The majority were to psychiatric units in general hospitals (246, 69%), followed by admissions 
to psychiatric hospitals (63, 20%) and to private hospitals (39, 11%).   
- 14% were involuntary admissions. 
- The rate was higher for men (11.8 per 100,000) than for women (3.9 per 100,000). 
 
The majority of cases hospitalised for a drug disorder stayed just under one week (53%), and most 
were discharged within three months. It should be borne in mind that admissions and discharges 
represent episodes or events, not persons. 
 
Suicide, hospital-treated self-harm and self-harm in the community among Irish adolescents  
Suicide is a major cause of death among adolescents and those who self-harm are at increased risk 
of suicide.  In a recently published study of suicide, hospital-treated self-harm and self-harm in the 
community among Irish adolescents, the ‘iceberg’ analogy was used to illustrate the relative 
incidences of adolescent suicide (highly visible), hospital-treated self-harm (less visible) and self-harm 
in the community (largely hidden) (McMahon, et al. 2014).  
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The study population consisted of adolescents (aged 15 to 17 years) in counties Cork and Kerry.  
Annual suicide rates were calculated using data from the Central Statistics Office (based on figures 
from 1997 to 2011).  Data on hospital-treated self-harm (between 2003 and 2011) were obtained from 
the National Registry of Deliberate Self-Harm.  Data on self-harm in the community were collected as 
part of the Child and Adolescent Self-Harm in Europe (CASE) study through a cross-sectional survey 
of 3,881 adolescents in Cork and Kerry (conducted between 2003 and 2004).       
 
- The annual suicide rate among adolescents aged 15, 16 or 17 in the selected area was 
10/100,000.  The rate among boys was 16.5/100,000, among girls 2.7/100,000.  The incidence 
ratio of male to female was 6:1.   
- The incidence of hospital-treated self-harm cases was 344.4/100,000. For boys the rate was 
256.2/100,000, for girls 438.1/100,000, giving an incidence ratio of male to female of 1:1.7.   
- Of the respondents to the CASE survey, 8.9% of girls and 2.4% of boys reported self-harm within 
the past year.  The rate of self-harm was 5,551/100,000.  The rate among boys was 
2,400/100,000, among girls 8,900/100,000.  The incidence ratio of male to female was 1:3.7.   
 
Based on these incidence rates, the frequency of suicide and self-harm were calculated.  For every 
adolescent suicide there were 34 hospital presentations with self-harm and 555 adolescents reported 
having self-harmed. Among boys, for every suicide there were 16 cases of hospital-treated self-harm 
and 146 self-reports of self-harm.  Among girls, for every suicide there were 162 cases of hospital-
treated self-harm and 3,296 self-reports of self-harm.   
 
Of the 37 suicides among adolescents aged between 15 and 17 years between 1997 and 2011, four 
were by overdose, 31 by hanging, one by drowning and one by other methods.  Of the 775 cases of 
hospital-treated self-harm in the same age group between 2003 and 2011, 509 (66%) were by 
overdose, 146 (18.8%) by self-cutting, 66 (8.5%) by other methods and 27 (3.5%) by overdose 
combined with self-cutting. Of the 207 cases of adolescents reporting self-harm in the community in 
2003/04, 55 (27%) were by overdose, 121 (58.5%) by self-cutting and 20 (7%) by overdose combined 
with self-cutting.     
 
The study concluded that there are large gender differences in the incidence of self-harm and suicide 
among adolescents, with boys who have a history of self-harm being at particular risk of suicide. 
However, the majority of self-harm is unreported.  The need for interventions to promote awareness of 
mental health issues and enhance help-seeking behaviours among adolescents is highlighted. 
 
Factors associated with self-cutting and intentional overdose as methods of deliberate self-
harm 
A recent study published in the European Journal of Public Health used data from the Irish National 
Registry of Deliberate Self-Harm to compare hospital-treated self-cutting patients and those 
presenting with intentional overdose, looking in particular at gender differences, patients’ 
characteristics and the  outcomes associated with each method of deliberate self-harm (Arensman, et 
al. 2014).  The definition of self-harm used was that of the WHO/EURO Multicentre Study, which 
includes all intentionally-initiated drug overdoses, poisoning or self-injurious behaviour regardless of 
suicidal intent. 
 
The study examined data on 42,585 persons who presented to emergency departments in Ireland 
between 1 January 2003 and 31 December 2009 with a first self-harm episode resulting from self-
cutting, intentional overdose or a combination of both.  Of these, 24,775 (58.2%) were women.   The 
highest number of presentations were as a result of overdose only (34,445), followed by self -cutting 
only (6,398) and finally a combination of overdose and self-cutting (1,742). 
 
Gender was significantly associated with method of self-harm: 21% of male presentations were for 
self-cutting compared to 10% of female presentations. Place of residence was significant for both 
males and females, with those living in cities being over-represented among presentations involving 
self-cutting.  Living circumstances were also significant, with those of no fixed abode being over-
represented among self-cutting presentations.  
 
Among those presenting with combined self-cutting and overdose, males and females were evenly 
represented (4.5% vs 3.8%). People living in cities were also over-represented among presentations 
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involving both self-cutting and overdose. Use of alcohol was significantly associated with overdose by 
both males and females.  Presentations for self-cutting combined with overdose were less likely 
between 9am and 5pm, and more likely at weekends than cases of overdose only.  Repetition was 
also significantly more likely among those presenting with self-cutting. 
 
Multinomial logistic regression was used to identify factors independently associated with method of 
self-harm.  When compared with overdose only, factors independently associated with self-cutting 
among both males and females were living in a city, being of no fixed abode or living in an inpatient or 
custodial setting, presenting outside the hours of 9am to 5pm or at weekends, no alcohol involvement 
and repetition within 12 months. In addition, being aged over 45 years for men and 55 years for 
women was significant. Factors independently associated with combined overdose and self-cutting for 
men were being over 35 year of age, living in a city, presenting at the weekend and repeating within 
30 days.  For women, significant factors were being over 45 years of age, residing in a city, alcohol 
involvement and repeating within 12 months. 
 
The article concluded that the demographic and clinical differences between those presenting with 
different methods of self-harm has implications for choice of intervention. In particular, the association 
between self-cutting and repetition means that adequate follow-up and support needs to be put in 
place.  Moreover, services need to be available outside regular working hours. 
 
6.4 Drug-related deaths and mortality of drug users 
6.4.1 Drug-induced deaths (overdoses/poisonings) 
Drug-induced deaths – Selection D 
In 2012, there were 181 deaths owing to poisoning recorded in Ireland by the National Drug-Related 
Deaths Index (NDRDI) as per Selection D. This represents a decrease to 2011, when 232 such 
deaths were recorded (Table 6.4.1.1; see also Standard Tables 5 and 6). It should be noted that 
annual data previously reported have been changed as the database has been updated as new 
information has become available. 
 
Table 6.4.1.1 Poisonings (Selection D) by year, NDRDI, 2002–2011 
 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 
Selection D 105 127 165 189 208 215 216 175 232 181 
Source: Unpublished data, NDRDI 
 
Overall, the mean age of those who died owing to poisoning remained stable compared to previous 
years at 35.5 years (see Standard Table 6). 
 
Opiates continue to be associated with most poisoning deaths (90.0%) in Filter D.  Methadone (alone 
or with another drug) continues to be the opiate most commonly implicated.  In 2012 there were 86 
deaths compared to 119 in 2011. The reason for the trend in the number of deaths where methadone 
was implicated (alone or in conjunction with another drug) is still not clear. However, the same trend 
has been observed in Scotland in the same time period (General Register Office for Scotland 2013, 
National Records of Scotland 2013). 
 
The number of deaths where heroin was implicated continues to drop from a peak in 2009 to 61 
deaths in 2012. There were 24 deaths where cocaine was implicated (alone or with another drug), the 
same as 2011.  
 
The majority of poisoning deaths (71.8%) involved more than one drug. As in previous years, 
benzodiazepines, alcohol, antidepressants, and other over-the-counter medications were among the 
main drugs implicated in poly-substance poisonings. 
 
Drug-induced deaths – national data 
The National Drug-Related Death Index (NDRDI) publishes national figures on drug-related deaths. 
This comprises all deaths owing to poisonings, including both illicit drugs covered by Selection D, and 
also other drugs such as alcohol and prescription medication not reported in Standard Table 6.  
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In the eight-year period 2004 to 2011, a total of 4,606 deaths by drug poisoning and deaths among 
drug users met the criteria for inclusion in the NDRDI database (Table 6.4.1.2)  (Health Research 
Board 2014a). Of these deaths, 2,745 were due to poisoning and 1,861 were deaths among drug 
users (non-poisoning) (see section 6.4.3 below). 
 
Table 6.4.1.2   Number of deaths, by year, NDRDI 2004 to 2011 (N=4,606) 
  2004 2005 2006 2007 2008 2009 2010 2011 
All deaths 431 503 561 630 624 653 597 607 
 
  
 
  
 
  
 
  
 
Poisoning (n=2,745) 267 300 326 389 386 374 338 365 
Non-poisoning (n=1,861) 164 203 235 241 238 279 259 242 
Source  (Health Research Board 2014a) 
 
The annual number of poisoning deaths increased from 338 in 2010 to 365 in 2011.  As in all previous 
years, males accounted for the majority of deaths (72%). The majority were aged between 20 and 44 
years; the median age was 39 years. 
 
Over half (215, 59%) of all poisoning deaths involved more than one drug (polydrug use). This 
represents a 28% increase from the previous year (168) (Table 6.4.1.3).   
 
Table 6.4.1.3   Combinations of drugs involved in poisoning deaths, NDRDI 2004 to 2011 (N=2,745) 
  2004 2005 2006 2007 2008 2009 2010 2011 
All poisoning deaths 267 300 326 389 386 374 338 365 
 
  
 
  
 
  
 
    
Single substances   
 
  
 
  
 
    
Alcohol alone 61 51 54 86 81 61 78 61 
Opiates alone 33 34 53 54 54 60 48 37 
Analgesic (including an analgesic 
containing an opiate compound) 
22 24 16 6 10 10 7 14 
All other specified single substances 36 58 67 66 51 57 37 38 
   
 
  
 
  
 
    
Polysubstances   
 
  
 
  
 
    
Polysubstances (including opiates such 
as heroin, methadone) 
41 64 80 91 120 121 96 128 
Polysubstances (including analgesics 
containing an opiate compound) 
28 31 15 16 11 14 25 32 
Polysubstances (excluding opiates) 35 29 26 58 50 34 33 44 
Psychoactive medication with alcohol 11 9 15 12 9 17 14 11 
Source  (Health Research Board 2014a) 
 
In 2011, alcohol was, once again, the drug most commonly involved in poisoning deaths (37%) (Table 
6.4.1.4).  The number of deaths where prescription drugs were implicated increased sharply 
compared to 2010 figures.  The number of deaths where benzodiazepines were implicated increased 
by 61%, to 166 in 2011 compared to 103 in 2010.  There was also a steep increase in the number of 
deaths where antidepressant drugs were implicated, from 66 in 2010 to 96 in 2011.  
 
Table 6.4.1.4   All drugs involved in poisoning deaths, NDRDI 2004 to 2011 (N=2,745 
  
2004 2005 2006 2007 2008 2009 2010 2011 
% 
Total 
All deaths* 267 300 326 389 386 374 338 365 100 
 
  
 
  
 
  
 
  
 
  
Alcohol 125 116 111 173 155 142 152 136 40.4 
 
  
 
  
 
  
 
     
Heroin 29 47 68 80 91 115 72 60 20.5 
Methadone 40 43 61 55 80 69 60 113 19 
Other opiate
†
 62 69 55 54 47 52 58 78 17.3 
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2004 2005 2006 2007 2008 2009 2010 2011 
% 
Total 
Cocaine 19 36 53 66 60 53 21 23 12.1 
MDMA 13 10 7 19 7 ~ ~ 11 ~ 
 
  
 
  
 
  
 
     
Diazepam 31 41 64 61 66 80 67 129 19.6 
Other benzodiazepine 28 25 29 42 38 30 34 69 10.7 
Flurazepam 18 13 23 21 20 24 27 48 7.1 
 
  
 
  
 
  
 
  
 
  
Other prescription medication
§
 42 37 39 61 62 59 74 85 16.7 
Antidepressant 54 53 43 48 85 67 66 96 18.7 
Non-opiate analgesic 13 23 12 19 18 16 15 19 4.9 
 
  
 
  
 
  
 
     
Other
‡
 9 22 21 26 31 50 37 40 8.6 
Source  (Health Research Board 2014a) 
*This is a multi-response table taking account of illicit use of up to six drugs. Therefore numbers and percentages in columns 
may not add up to totals shown as individual cases may use more than one drug or substance. 
† Includes morphine, codeine, unspecified opiate-type drug, other opiate analgesic. 
§ Includes non-benzodiazepine sedatives, anti-psychotics, cardiac and all other types of over-the-counter medication. 
‡ includes solvents, insecticides, herbicides, other amphetamines, hallucinogens, cannabis, barbiturates, novel psychoactive 
substances and other chemicals. 
~ Less than five cases. 
 
  
Of note, the number of deaths where methadone was implicated increased to 113, compared to 60 in 
2010.  The reasons behind these upward trends are not yet clear and further analysis is needed to 
begin to understand the factors involved.  What is known is that there was no change in the 
methodology used by the NDRDI between 2010 and 2011.  What is also known is that 68% of those 
who died where methadone was implicated were not registered on the Central Treatment List (of 
people receiving methadone substitution treatment) at the time of their death. 
 
The number of poisoning deaths in which heroin was implicated continues to decline, falling by 17% 
to 60 in 2011, compared to 72 in 2010. It is of note that similar trends were observed in Scotland 
during the same time period (General Register Office for Scotland 2013, National Records of Scotland 
2013). 
 
Media reporting of PMA/PMMA deaths 
In the first six months of 2014 there were several media reports of deaths apparently due to PMA 
(para-Methoxyamphetamine) and PMMA (para-Methoxy-N-methylamphetamine) (2014a, 2014b, 
Brady 2014, Mullally 2014).  Although some of these deaths are reported to have occurred in 2013 
(Naughton 2014, 18 July) it is not possible to report on the precise number of deaths and 
characteristics of those who died of these particular drugs as NDRDI data for 2013 deaths are not 
currently available.  In 2012, PMA/PMMA was implicated in less than five deaths recorded in the 
NDRDI however MDMA was implicated in 11 deaths. 
 
 
6.4.2 Mortality and causes of deaths among drug users 
Currently there are no mortality cohort studies under way.  The most recent research on mortality 
among drug users was a 25-year longitudinal study of a cohort of injecting drug users in inner-city 
Dublin published in 2013 (O'Connor, et al. 2013). 
 
 
6.4.3 Specific causes of mortality indirectly related to drug use  
 
Non-poisoning deaths 2011 
In the eight-year period 2004–2011 a total of 1,861 non-poisoning deaths among drug users met the 
criteria for inclusion in the NDRDI database (Table 6.4.1.1). The number of non-poisoning deaths 
recorded among drug users dropped for a second year, to 242, compared to 259 in 2010 (Table 
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6.4.1.2). These deaths are categorised as being due either to trauma or to medical causes (Figure 
6.4.3.1). 
 
Figure 6.4.3.1   Non-poisoning deaths among drug users, NDRDI 2004 to 2011 (N=1,779) 
Source  (Health Research Board 2014a) 
 
Deaths due to trauma 
The number of deaths due to trauma decreased in 2011, to 117 deaths, down from 122 in 2010 
(Figure 6.4.3.1).  The majority (71%) of those who died were aged under 39 years. The median age 
was 29 years. As in previous years, the majority were male (86%).  The most common causes of 
death due to trauma were hanging and road traffic collisions.  Even though there has been a slight 
overall reduction in the number of traumatic deaths, it is notable that there has been a rise in the 
number of deaths due to hanging, from 49 deaths in 2010 to 65 in 2011. 
 
Deaths due to medical causes 
The number of deaths due to medical causes decreased slightly in 2011 (Figure 6.4.3.1). The majority 
(60%) of those who died were aged between 30 and 49 years. The median age was 43 years. Males 
accounted for 76% of those who died. The most common medical causes of death were cardiac 
events and liver diseases. 
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7. Responses to Health Correlates and Consequences 
7.1 Introduction 
This chapter presents new data on the prevention of drug-related mortality, the management of blood-
borne viral infections, and responses to co-morbidity. The public, voluntary and community sector 
institutions that have been engaged in the various initiatives reported in the following sections are 
briefly described here.  
 
Barnardos is a children’s charity. It works with vulnerable children and their families in Ireland and 
campaigns for the rights of all children.  
 
The Elton John AIDS Foundation (EJAF) is an independent AIDS charity. It funds a broad range of 
services for those living with or affected by HIV/AIDS, including education, peer support, medical 
care, income generation, counselling and testing. It funds both UK-based and international projects. 
Particular emphasis is given to the most disadvantaged or high risk groups, both nationally and 
internationally, and to community-driven programmes that place people living with HIV/AIDS at the 
centre of service provision. 
 
The Health Service Executive (HSE) is responsible for managing and delivering health and personal 
social services in Ireland. It supports numerous responses to the health correlates and consequences 
of problematic drug use.  
 
The Irish Pharmacy Union (IPU) is the professional, representative organisation for community 
pharmacists in Ireland. 
 
7.2 Prevention of drug-related emergencies and reduction of drug-related deaths 
For the most recent information, see Chapter 7.2 in 2013 National Report (Health Research Board 
2013). 
 
 
7.3 Prevention and treatment of drug-related infectious diseases.  
Pharmacy needle exchange in Ireland 
In October 2011 the HSE rolled out the national pharmacy needle exchange programme, which was a 
partnership initiative between the Elton John Aids Foundation, the Irish Pharmacy Union and the 
HSE. The programme targeted counties outside of Dublin and ran until September 2014. Once 
pharmacies had signed a service level agreement with the HSE, their contact details were passed on 
to the relevant HSE services so that they could promote access to sterile injecting equipment at the 
participating pharmacies and accept referrals for investigation and treatment.  
 
There were 42 pharmacies providing needle exchange at the end of 2011 and this increased to 71 by 
the end of 2012. There are pharmacies providing needle exchange in each regional drugs and alcohol 
task force area (Table 7.3.1), apart from those covering counties Dublin, Kildare and Wicklow, which 
are served by a mix of static and outreach needle-exchange programmes. The data presented here 
were collected from participating pharmacies by the HSE.  
 
Table 7.3.1   Number of pharmacy needle exchanges, excluding counties Dublin, Kildare and Wicklow, 2011 and 
2012 
Regional drugs and alcohol task force area 2011 2012 
Midland (Longford, Laois, Offaly, Westmeath) 1 414 
Mid West (Clare, Limerick, North Tipperary) 20 2464 
North Eastern (Meath, Louth, Cavan, Monaghan) 101 1377 
North West (Sligo Leitrim, West Cavan, Donegal) 0 4 
Southern (Cork and Kerry) 199 3124 
South East (Carlow, Kilkenny, Waterford, Wexford. South Tipperary) 250 3424 
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Regional drugs and alcohol task force area 2011 2012 
Western (Galway, Mayo, Roscommon) 0 250 
Source: Unpublished data from HSE 2013 
 
An average of 360 individuals attended pharmacy-based needle exchanges each month in 2012. The 
number of individual drug users using sterile injecting equipment increased by 188%, from 199 in 
January 2012 to 573 in December 2012 (Figure 7.3.1). Of the individual attenders, 78% were male, 
and had an average age of 31 years; the average age of female attendees was 29 years.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.3.1: Number of individuals attending needle exchanges, by gender, 2012 
Source: Unpublished data from HSE 2013 
 
The needle exchanges completed 10,601 transactions in 2012, distributing 11,693 packs; each pack 
contained 10 sets of injecting equipment. The number of transactions increased by 132%, from 522 in 
January 2012 to 1,209 in December 2012 and the number of packs distributed followed a similar trend 
(Figure 7.3.2). Each individual user received an average of 2.7 packs (27 needles and syringes) in a 
calendar month in 2012. Thirty-eight per cent of the injecting equipment provided by pharmacies was 
returned for disposal.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Janua
ry
Febru
ary
Marc
h
April May June July
Augu
st
Septe
mber
Octob
er
Nove
mber
Dece
mber
Unique individuals 199 197 264 282 298 382 360 329 494 494 449 573
Male 158 152 185 233 243 296 274 247 380 380 354 459
Female 41 45 54 49 57 86 85 81 117 117 95 110
0
100
200
300
400
500
600
700
Janua
ry
Febru
ary
March April May June July
Augus
t
Septe
mber
Octob
er
Nove
mber
Dece
mber
Number of transactions 522 587 617 687 795 896 838 814 1249 1201 1186 1209
10 packs given out 617 594 770 788 907 986 961 968 1419 1342 1069 1272
10 pack returns 295 265 324 352 345 359 325 318 575 501 376 435
0
200
400
600
800
1000
1200
1400
1600
  83 
Figure 7.3.2:  Number of transactions at needle exchanges, 10-packs distributed, and used 10-packs returned, 2012 
Source: Unpublished data from HSE 
 
The pharmacy needle exchanges provided a link between harm reduction services and drug 
treatment services in 2012 through referring individuals for blood-borne viral testing (253) and 
hepatitis B vaccination (165), and to tier three and tier four services (261).  
 
7.4 Responses to other health correlates among drug users 
National overdose prevention strategy and naloxone demonstration project 
One of the key priorities of the HSE’s National Service Plan 2014 (Health Service Executive 2013) is 
to improve health outcomes for people with addiction issues (see Chapter 5.2.1 earlier in this report 
for an overview of the service plan).  One of the related actions in the plan is the finalisation of the 
implementation plan for the National Overdose Prevention Strategy (not yet published). Investigating 
the possibility of enhanced availability of naloxone, a drug used to counter the effects of opiate 
overdose, is a key element of the HSE’s overdose strategy (personal communication, Joe Doyle, 
national planning specialist, HSE).  
 
The proposals on how to progress the naloxone demonstration project include:12  
- identify stakeholders: to include a wide range of organisations, including  community, families and 
voluntary services; 
- product choice: e.g. pre-filled syringe or nasal formulation; 
- legislative issues: naloxone is a prescription-only medication in Ireland and can only be dispensed 
by a pharmacist to a named person, for their use only, and can only be administered to that 
person by a trained healthcare professional (which includes certain ambulance service 
personnel); and   
- cost and evaluation: to include pharma-economic evaluation, costs of training and supply of 
product. 
 
Youth mental health and substance misuse disorders in deprived urban areas  
A recent qualitative study of the experience of young people living with mental health and substance 
misuse disorders in two deprived urban areas in Ireland highlighted how early intervention in a 
primary care setting may help to prevent the escalation of symptoms (Schaffalitzky, et al. 2014).   
Semi-structured interviews were conducted with 20 young adults (aged 16 to 25 years) attending 
health-care settings in areas of extreme social deprivation in the cities of Limerick and Dublin.  The 
aim of the study was to examine the manifestation and experience of mental health and substance 
misuse disorder from the perspective of the young people. 
 
Young people who participated in the study described initial feelings of anxiety, depression and 
worthlessness which they recognised as problematic but for which they did not seek help. These 
symptoms progressed to a point where they became debilitating.  As symptoms worsened, young 
people developed issues which further exacerbated their problems.   Substance abuse was common, 
with some becoming addicted.  Self-harm was another coping mechanism. 
 
Despite their deteriorating symptoms, the participants described a reluctance to seek help or to 
accept help when it was offered.   This was particularly the case for those dealing with addiction.  
Deteriorating life-circumstances such as homelessness was often the motivating factor in seeking 
treatment. 
 
The young people felt themselves losing control as addiction became a full-time occupation, 
relationships broke down and negative feelings and thoughts became overwhelming.  Nearly half of 
all participants had serious suicidal ideation.  Many felt it would be impossible to get better, 
                                               
12
 The Take Home Naloxone (THN) demonstration project started in Wales in 2009 is one of a number of UK models that have been 
documented Bennett, T. and Holloway, K. (2011). Evaluation of the Take Home Naloxone demonstration project. Welsh Assembly 
Government, Merthyr Tydfil. Available at http://wales.gov.uk/docs/caecd/research/110627naloxonefinalreporten.doc . Its main aim was to 
reduce drug-related deaths in Wales and it incorporated an independent evaluation at the end of the first year. The project continues in 
Wales and has been expanded to different pilot settings. For example, in one major hospital emergency department, staff have been trained 
to give THN to clients at risk of overdose when leaving the hospital. For further information see http://tinyurl.com/nkrxmvy 
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particularly when they had gone for a long time without treatment or support.  They needed to be 
convinced to seek help and to keep living. 
 
Participants described feelings of shame, embarrassment and isolation. The majority had left school 
early and some had legal issues. Many were dependent on social welfare and struggling to engage 
with society.  As a result of living in an area of urban deprivation, troubled families, stressful life 
circumstances and a drug-taking culture had all become the norm. This made it more difficult for the 
young people to cope with their mental health and substance misuse issues.   
 
The findings from this study outlined progressively deteriorating symptoms, social isolation and 
stigmatisation among the participants. It highlighted the need for interventions which enhance early 
identification and treatment of mental health and substance use disorders in young people living in 
deprived urban areas.  These interventions need to be delivered in an environment that is accessible 
and acceptable.  General practice was identified as a less stigmatising environment owing to its 
availability and familiarity with disadvantaged young people and its ability to target young people who 
present with physical problems for support around their mental health and substance misuse issues. 
 
Supporting children in families experiencing mental health difficulties 
In June 2014 Barnardos published a report entitled Patients, parents, people – towards integrated 
supports and services for families experiencing mental health difficulties (Barnardos 2014). It outlined 
the experiences of children of parents with mental health difficulties, reviewed current levels of 
supports and made recommendations for enhancing services.  The report reviewed the relevant 
literature and drew on discussions with parents, carers and professionals in the mental health area. 
 
The report emphasised that parents’ mental health difficulties alone present little risk of harm to 
children but that a lack of appropriate supports can compromise a child’s ability to cope.  However, 
parental mental health difficulties are often associated with other risk factors such as poverty or 
addiction, which can have a huge impact on family life.  As a result, the child’s social, emotional and 
cognitive development can be adversely affected.  Children are affected by their parents’ mood and 
can become anxious and unsettled, particularly if the situation has not been explained to them by a 
supportive adult in an age-appropriate way.  Moreover, many children take on an unrecognised caring 
role in the family. 
 
Entrenched societal attitudes and discrimination mean that parents are often reluctant to ask for help 
as they fear their capacity to parent their children will be questioned.  Moreover, the current, 
predominantly medical, approach to mental health issues leads to a reliance on medication and does 
not adequately address broader family support needs.  As a result, parents and children can feel 
isolated and the root cause of the distress can be overlooked.  Side-effects of medication can further 
compound problems,  with parents who are taking benzodiazepines or other medication experiencing 
drowsiness and slowed reactions which compromise their ability to respond to children’s needs. 
 
The report outlined a need for a holistic approach to supporting families facing complex challenges 
whereby each family member is heard and their needs considered.  Barnardos believe that the 
present family, health and child support systems need to move from a traditional approach of working 
in isolation to an integrated inter-agency working model which recognises patients as parents and 
sees parents and children in a family context.  The introduction of a family model approach is called 
for.  Key recommendations arising from the report are: 
- challenge mental health prejudice and discrimination, 
- adopt a family model approach, 
- talk to children, 
- expedite the roll-out of community-based services, and 
- consult with parents affected by poor mental health. 
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8. Social Correlates and Social Reintegration 
8.1  Introduction 
The links between social exclusion and drug use in Ireland have been well established (Keane, Martin 
2007). Problem drug users in treatment tend to be young and male, have low levels of education and 
are unlikely to be employed. For a small proportion, around 10%, homelessness and insecure 
accommodation are persistent problems.  
 
The aim of social reintegration is to empower individuals to plan and pursue alternative activities to 
those they engaged in when using drugs. This is achieved through providing accommodation, 
education, and training and employment opportunities for recovering drug users.  
 
This chapter presents new data on the social correlates of drug use in Ireland, and describes policy 
and programmes initiated in the past year to support the social reintegration of recovering drug users. 
The broad policy approach and funding to support social reintegration are briefly outlined in this 
section. 
 
The National Drugs Strategy 2009–2016 (NDS) (Department of Community 2009) lists as a priority 
the implementation of the recommendations contained in the report of the working group on drugs 
rehabilitation (Working Group on drugs rehabilitation 2007). It proposes that the recommendations be 
incorporated in a comprehensive integrated national treatment and rehabilitation service, using the 
four-tier model approach.  
 
The Dublin Region Homeless Executive is responsible for providing support and services to the 
Dublin Joint Homelessness Consultative Forum and the Statutory Management Group, both of which 
were established under the Housing (Miscellaneous Provisions) Act 2009. The Act also requires an 
action plan to be in place.  
 
The Community Employment (CE) scheme, operated from the Department of Social Protection, 
includes 1,000 places ring-fenced for recovering drug users. The scheme operates through local 
projects primarily in local drugs and alcohol task force areas, where community and voluntary groups 
are required to sign service agreements that outline the work programme and the target outcomes for 
the individuals placed on the CE schemes. The objective is to prepare participants for entry into the 
labour force, but the outcomes outlined by most projects tend to refer to personal development, 
improved literacy skills and education capital, and support progression to more specialised training 
and education, rather than help the individual to find employment.  
 
Acknowledging the CE scheme for helping recovering drug users to develop their personal and 
employment skills and find a pathway back to work, the NDS suggests that implementation of the 
Individual Learner Plan (ILP) would help to identify participants’ needs and design progression 
routes towards labour market reintegration.  The development of targeted programmes is seen as 
essential and should be an integral part of the NDS in the future.  
 
 
8.2 Social exclusion and drug use 
 
8.2.1 Social exclusion among drug users 
Data provided by the National Drug Treatment Reporting System (NDTRS) show that there is a slight 
increase in the proportion of all cases in treatment in 2012 that were early school leavers compared to 
the previous year; there is also an increase in the proportion of new cases (Table 8.2.2.1). The 
NDTRS does not collect data on unemployment, but the proportion of both all cases in treatment and 
new cases entering treatment who report being in employment is reducing.  
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Table 8.2.1.1 Socio-economic characteristics of cases, by treatment status, NDTRS, 2011–2012  
 2011 2012 
 n (%) n (%) 
All cases 7372 7169 
Early school leaver 1311 (17.8) 1328 (18.5) 
Employed (aged 16–64) 656 (9.1) 572 (8.2) 
New cases 2948 2972 
Early school leaver 361 (12.2) 403 (13.6) 
Employed (aged 16–64) 339 (12.0) 294 (10.5) 
Source: NDTRS unpublished data, 2014  
 
 
8.2.2 Drug use among socially excluded groups 
 
Drug use among early school-leavers 
Apantaku-Olajide and colleagues (Apantaku-Olajide, et al. 2014) analysed data relating to 193 new 
cases aged 19 years or under who were referred to a treatment centre in Dublin for problems with 
substance abuse. Of these, 84 (43.5%) were in mainstream education, 46 (23.8%) were in alternative 
education and 63 (32.7%) had dropped out of school; the 63 young people who were identified as 
school drop-outs were persons whose highest level of education attained was lower secondary and 
who had not received education in the four weeks prior to the assessment.  
 
Lifetime use of cannabis, tranquilisers and amphetamines and use of these substances in the last 30 
days was higher among the school drop-outs compared to young people continuing in mainstream 
education. Lifetime use of cocaine and last month use of heroin was higher among the school drop-
outs compared to those in mainstream education.  
 
The authors pointed to the high levels of poly-substance use, psychological issues, disruptive family 
situations and offending behaviours that characterised the school drop-outs. They went on to say that 
‘…these results support previous findings of greater levels of substance use and related psycho-
social problems among adolescents of school-going ages who had left school without completing 
secondary education, when compared with school-attending students’ (pp. 171–172).  
 
Drug use among people in prison 
The National Advisory Committee on Drugs and Alcohol (NACDA) commissioned a study to estimate 
the extent of drug use and the prevalence of blood-borne viruses among the prison population in 
Ireland (Drummond, et al. 2014). See Chapter 4.3.2 earlier in this report for an account of the findings 
of this study with regard to prevalence and patterns of drug use among prisoners; Chapter 5.3 for an 
account of prisoners’ perceived needs for drug-related treatment; and Chapter 6.2.1 for an account of 
the findings with regard to the prevalence of blood-borne viruses among the prison population.  
 
In relation to services within prisons, the authors noted that there was a demonstrated willingness on 
the part of surveyed prisoners to engage with relevant one-to-one services. Some services, such as 
addiction counselling, whilst needed by 40% of prisoners, were available only 60% of the time and 
had almost universally high uptake when they were available. The authors highlighted that without the 
provision of appropriate services and support both inside and outside prison, prisoners face an uphill 
struggle to achieve sufficient change to help them reintegrate into mainstream society. They 
concluded: 
 
We cannot again assess the directionality of the relationship between being imprisoned and 
having limited life chances but we can be clear that these characteristics of social and lifestyle 
disadvantage certainly limit prospects of rehabilitation and reintegration into mainstream 
society following release and highlight once again the need for step-down facilities, adequate 
training and positive lifestyle health promotion initiatives. The rates of re-offence and re-
incarceration are also problematic for prisoner populations. This reinforces the vicious, cyclical 
circle of the situation. Those who are disadvantaged are more likely to slip into an adverse 
lifestyle including exposure to drugs, in turn are at higher risk of crime and consequent 
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imprisonment, are exposed to the drug culture in prison and face serious challenges in 
achieving rehabilitation afterwards. (p. 104) 
 
Drug use among female prisoners 
Research was undertaken with female prisoners serving short sentences in the Dóchas Centre, the 
women’s prison in Mountjoy Prison in Dublin (McHugh 2013). Data were collected through in-depth 
interviews with 16 women and the main focus of the research was the women’s needs as they 
prepared for release.   
 
The use of drugs by the women was explored and the predominant problem drug was heroin, with 
three quarters of the women who ever had drug problems describing this as their only problem drug 
or one of their problem drugs. The women also reported problems with using prescription drugs, 
street methadone and, to a lesser extent, crack cocaine and cocaine powder. Many of the women 
described having problems with only one drug or a small number of drugs, but  their experience of 
drug use was in most cases substantial and over a long period of time, with many reporting that they 
had tried everything – ‘you name it’. 
 
The prevalence of experiences of homelessness and rough sleeping was extremely high. Fourteen of 
the women had experienced homelessness at some point in their lives, with five experiencing 
homelessness for longer than one year. The prevalence of these women staying either with family 
members or friends at various intervals in their adult lives was also extremely high. Eight of the 
women had spent time in some form of supported accommodation or housing and five women had 
spent time in a psychiatric hospital. Eleven of the women had at some point used emergency 
homeless hostels and nine had slept rough. 
 
The author, in seeking to bring the narratives of these women together, highlighted the degree of 
marginalisation that connected their lives. However, there was also a signal as to what could bring 
these women in from the margins: a home, help with their addiction, and structure to their day. 
McHugh neatly encapsulated these competing parts of their narratives in the following extract:  
 
These women’s stories are, as outlined above, in the majority, stories of women who have 
been marginalised and victimised, who have multiple and complex needs, and who are in 
need of significant support whether in prison or in the community. These women represented 
a resource poor network, with little or poor contact and support even within their immediate 
family circles. Post release needs are thus extensive.… They are looking for accommodation, 
support for substance abuse, something to keep them busy during the day… (p. 32). 
 
Drug use among the homeless 
McGarry House provides temporary supported accommodation for 30 men and women who find 
themselves homeless in Limerick City. McGarry House also provides long-term supported 
accommodation for 37 residents in one-, two- and three-bed apartments. This facility provides 
individuals with a degree of independent living, while offering supports and life-skills programmes 
where required. Dermody undertook in-depth interviews with 15 residents in McGarry House as part 
of a study investigating the problem of overdosing and responses to incidents of overdose (Dermody, 
et al. 2014). Interviewees included 10 males and five females; 12 were under the age of 35; nine had 
been resident for at least six months; and seven were in receipt of prescribed methadone.  
 
When asked to name their primary substance of use (non-prescribed), four reported heroin, four 
benzodiazepine/Z drugs, three alcohol, two cannabis and one ketamine. One interviewee reported 
using prescribed methadone and not using any other substance. Eight interviewees reported using 
benzodiazepines on a daily basis; however, the report did not make clear whether this was prescribed 
or non-prescribed use. All interviewees reported having used alcohol, cannabis, amphetamines and 
cocaine or crack at some point in their lives, and 14 had used benzodiazepines at least once. Eight 
reported injecting drugs frequently.  
 
The study also reviewed documentation relating to the administration of McGarry House. The records 
showed that of the 114 people who resided in the house at some stage during 2012, 27% presented 
with drug use, an increase on the 17% who presented with drug use in 2010. 
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The life histories and experiences of 50 people staying in Cork Simon’s emergency shelter over a 
five-week period in early summer 2013 were analysed (O'Reilly 2013). Three quarters of the people 
included in the analysis were currently using alcohol and / or drugs problematically, and four out of 
five of these people also had a mental health condition. Over three in five had spent time previously in 
a care institution, two out of five had a literacy problem, and almost a third had a learning difficulty. A 
profile of the people is provided below: 
- 92% (46) were unemployed; 
- 80% (40) had experience of the criminal justice system; 
- 78% (39) were early school leavers; 
- 76% (38) were unskilled; 
- 76% (38) were using alcohol and / or drugs to the extent that it was causing problems in their 
lives; 
- 68% (34) had a diagnosed mental health condition; 
- 60% (30) had a diagnosed mental health condition and were using alcohol and / or drugs 
problematically; 
- 56% (28) had spent some time previously in a care institution; 
- 46% (23) require medium or high levels of support with living skills; and 
- 44% (22) had a diagnosed physical health condition. 
 
Drug use in disadvantaged communities 
A study of current patterns of illicit and licit drug use (including alcohol and prescribed drugs) in 
Finglas–Cabra was commissioned to fill an evidence gap regarding current trends, as it was 
perceived that substance use and practices were changing from the days when heroin was the main 
problem drug in the area (O'Gorman, et al. 2013).  
 
Primary data were collected through a series of interviews, conversations and focus groups with 
people living, or working in drug-related fields, in the Finglas and Cabra areas. Over thirteen focus 
groups were held with 120 participants. Over 180 hours of ethnographic fieldwork were undertaken. 
Over 100 contacts were made with drug users. Fieldwork sessions took place at different times and 
days to try and capture a broad-as-possible sense of drug use in the areas, with each session lasting 
approximately three hours. 
 
According to the authors, ‘A key finding from our interviews and fieldwork with the young recreational 
drug users was the absolute abhorrence they had of heroin, crack cocaine, and intravenous drug use. 
As a consequence, they placed a firm boundary around their drug consumptions practices in respect 
to these drugs.’ (p. 44) This was a community that in the early 1990s was designated as having acute 
levels of problematic heroin use; such a designation led to the areas being allocated local drug task 
force status to address the problem.  
 
The authors provided an insight into the shift that had taken place in the consumption of drugs, 
particularly among younger and what may be called ‘recreational’ drug users:  
 
An analysis of key indicator data on drug use, accompanied by evidence from our fieldwork, 
highlighted a number of new and emerging trends. These included a shift in use from cannabis 
resin to herbal cannabis with concomitant concerns about its effects on mental health, and an 
increased diversity in stimulant use which included cocaine, new psychoactive drugs, and 
more recently ecstasy. Additional trends were noted regarding the pervasiveness of polydrug 
use and the widespread availability and affordability of ‘tablets’ which were used, along with 
alcohol, across drug user groups…evidence is clear that a high risk environment – in terms of 
economic disadvantage, unemployment and educational disadvantage – such as that 
inhabited by many residents in the Finglas–Cabra LDTF area, contributes to a high level of 
drug-related harm.’ (p. 52) 
 
Drug use among the Traveller population 
The Irish Penal Reform Trust commissioned research with members of the Traveller community who 
had served a prison sentence (Costello 2014). In-depth interviews were undertaken with 10 Traveller 
ex-prisoners (5 males, 5 females) between September and November 2013. Access to the 
interviewees was facilitated by voluntary organisations working with the Traveller community.  
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Five of the interviewees reported a history of multiple criminal convictions, drug dependence and 
homelessness; the other five interviewees had served one sentence and did not report drug 
dependence or being homeless at any stage. The former group also reported experiencing domestic 
violence in the family home, being placed in care and leaving education at a young age; this group 
also reported being isolated within the Traveller community owing to their drug use and offending 
behaviour. Most of the interviewees who reported drug dependence were introduced to drugs at an 
early age and their use of drugs culminated in using heroin; interviewees reported how they used the 
proceeds from theft to fund their heroin use.  
 
8.3 Social reintegration 
 
Evaluation of the National Drugs Rehabilitation Framework Pilot 
The overarching framework for the social reintegration of drug users is the National Drugs 
Rehabilitation Framework (NDRF). It was piloted in a number of locations and the evaluation of the 
pilot was recently published (Barry and Ivers 2014). The NDRF was developed to provide a 
framework for the implementation of a set of recommendations drawn up by the working group on 
drugs rehabilitation. (Working Group on drugs rehabilitation 2007) These recommendations, which 
include the provision of housing, education and employment supports for recovering drug users, are 
now being implemented under the rehabilitation pillar of the NDS. The evaluation of the NDRF pilots 
provides a lot of detail regarding the extent to which recovering drug users were supported to access 
housing, education or employment supports. It is also useful in highlighting the slow progress in 
implementing the framework. A selection of service providers, service users and key informants were 
interviewed across 10 volunteer pilot sites. Of the 10 sites, six had begun implementing the 
framework and four had not.  
 
Data were collected from 14 service users via a questionnaire and interviews. All 14 service users 
had completed an assessment and all had a key worker; two thirds had a case manager. When asked 
about their experience with their key workers and case managers, service users were generally very 
positive and felt supported in the process. Service users spoke about the benefits of connecting with a 
service and the direct effect that this had on their lives. In terms of the benefits that were more directly 
attributable to the framework, care planning was the most recognisable practice for service users; the 
majority of service users had a clear idea of their goals and aspired to build on the current success. 
Overall, service users reported being satisfied with the service they were receiving.  
 
Data were collected from 48 key workers/case managers and 19 service managers. Three quarters of 
key workers/case managers reported always engaging in care planning, and the remainder 
sometimes; similar levels of engagement in inter-agency meetings were reported. Service managers 
reported some difficulty undertaking comprehensive assessments.  All bar one service manager said 
care planning was being implemented but, of those doing so, all except three reported difficulties. 
Around three quarters of service managers reported some difficulty in implementing confidentiality 
protocols. Service managers reported varying levels of access to support services including addiction 
services, education and employment, housing, justice and law reform services. All service managers 
reported some engagement in inter-agency working but all reported some difficulty implementing 
service level agreements. Both service managers and key workers/case managers reported an 
improvement in communication, sharing of information and referrals following implementation of the 
framework. 
 
As pointed out by the authors in their conclusion, the evaluation was ‘an examination of procedures 
and process rather than outcomes, with input from mostly providers’ (p. 80). This means that we know 
very little about how the majority of service users experienced the practices within the framework and 
we know very little about how effective these work practices were in delivering identified outcomes for 
service users. However, what we can say is that for a small number of service users who were 
engaging with the framework, their experience of care planning seemed beneficial. From the 
perspective of service providers, there were difficulties in implementing the NDRF; in particular, there 
is a need for better access to services for clients including housing, education and employment. There 
is also an identified need for improved inter-agency working within the NDRF.  
 
Review of Dublin North City and County Addiction Service 
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A recent high-level review of addiction treatment services in the Dublin North City and County area 
concluded that a substantial reconfiguration of services is needed to respond effectively to population 
needs and to emerging national policy (Pilling, et al. 2013). The report contains 14 recommendations, 
eight calling for a reconfiguration services and six for a reconfiguration of operational elements. See 
Chapter 5.2.2.1 earlier in this report for a detailed account of the recommendations.   
 
The authors concluded that ‘in line with international opinion, the principle of recovery should underpin 
all treatment from the point of first contact’ (p. 20). They defined recovery as ‘an individual, person-
centred journey, enabling people to gain a sense of control over their own problems, the services they 
receive, and their lives and providing opportunities to participate in wider society’ (p. 22). They pointed 
out that addiction recovery is becoming the guiding principle for substance use treatment in a number 
of jurisdictions, and in the words of the authors: 
 
Implementing the recommendations in this report will not only bring the service in line 
with national policy expectations, but will place it in a strong position to become the 
leader in addiction treatment in Ireland. (p. 34)  
 
Reorienting drug treatment and rehabilitation services towards a recovery-focused paradigm   
A report was recently published by Soilse, the drug rehabilitation service in HSE Dublin North City. 
Entitled Addiction recovery: a contagious paradigm, the report made the case for a recovery-focused 
approach to addiction treatment in Ireland.  
 
The report contained three main sections:  
- a review of the evidence underpinning the principles of recovery, 
- a review of Irish drug policy in relation to recovery/rehabilitation, and  
- the inputs that build policy, and the personal narratives and perspectives of people in recovery.  
 
There are increasing calls in the literature to draw on the experiences of people in recovery as a 
means of building effective policy and practice. This paper drew on the outputs of a symposium on 
recovery held in north inner-city Dublin in the summer of 2012. Over 100 people attended the 
symposium, the vast majority of whom were living with or working in communities deeply stigmatised 
by opiate addiction. The report also contained the detailed narratives of four people in recovery, plus 
a number of vignettes from Soilse participants speaking about their recovery journeys. One Soilse 
graduate talked about how having allies in recovery helped him reconnect with society: 
 
In recovery I began to feel a part of something. For the first time in life I moved around with 
people who were happy. Felt comfortable and safe and wanted to hold onto it. I got structure 
into my life for the first time. Up to then had lost job, no prospects, drinking in house, no light in 
the tunnel, no way out. 
 
The report set out the case for the reorientation of drug treatment and rehabilitation policy and 
practice towards a recovery-focused paradigm. The authors argued that that such a shift could be 
achieved by placing the framework of recovery capital at the centre of policy and grounding practice in 
the principles of recovery. Table 8.3.1 captures the essence of recovery capital: a framework that 
contains the properties of what initiates and sustains addiction recovery. Recovery capital was 
referred to in the report as an ‘assets-based model’, i.e. a way of recognising and prioritising the 
assets that people bring to their recovery and the attributes they need to develop to sustain their 
journey. This model differs from the ‘deficits-based’ model which seeks to emphasise the reduction of 
risks and problems such as drug use and crime. The report contained a detailed exploration of this 
debate.  
 
Table 8.3.1:  Four dimensions of recovery capital 
1. Social capital The sum of resources that each person has as a result of their relationships with, support from and 
obligations to groups to which they belong.  
2. Physical capital Tangible assets such as property and money that may increase recovery options.   
3. Human capital Personal skills and education, positive health, aspirations and hopes.  
4. Cultural capital Values, beliefs and attitudes that link the individual to social attachment and the ability to fit into 
mainstream social behaviour.  
Source: (Cloud and Granfield 2009)  
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Table 8.3.2 lists the principles of recovery that are based on robust research and inputs from 
consultations with service users and providers. There is consensus in the literature regarding these 
principles, a consensus echoed in the testimonies of Soilse participants. These principles recognise 
that there are multiple pathways and styles of long-term addiction recovery, and all should be cause 
for celebration. Central to the vision encapsulated in these principles is the recognition that the person 
in recovery is an ‘active agent’ in their own journey and that change for them via an improved quality 
of life is the key outcome to be pursued. The report contained an exploration of the evidence from the 
research to support the transfer of these principles into practice.  
 
Table 8.3.2: Twelve principles of addiction recovery 
1. There are many pathways to recovery. 
2. Recovery is self-directed and empowering. 
3. Recovery involves a personal recognition of the need for change and transformation. 
4. Recovery is holistic. 
5. Recovery has cultural dimensions. 
6. Recovery exists on a continuum of improved health and wellness. 
7. Recovery emerges from hope and gratitude. 
8. Recovery involves a process of healing and self-redefinition. 
9. Recovery involves addressing discrimination and transcending shame and stigma. 
10. Recovery is supported by peers and allies. 
11. Recovery involves (re)joining and (re)building a life in the community. 
12. Recovery is a reality. 
Source: (Sheedy and Whitter 2009) 
 
The report concluded with recommendations on how to promote the reorientation of addiction policy 
and practice towards a recovery-focused paradigm. These included the proposal that recovery 
replace rehabilitation as the fifth pillar in the NDS.  
 
8.3.1 Housing 
 
There is scant information available on measures to provide housing for people affected by substance 
misuse. However, there are major shifts in policy around measures to tackle homelessness among 
the general population, given the increase in the numbers presenting as homeless since the 
economic downturn. These measures, if implemented, will also address the needs of homeless drug 
users and people in recovery who are experiencing difficulty in accessing accommodation.  
 
Progress towards 2016 goals on homelessness 
The first report of the Homelessness Oversight Group was recently released (Kennedy, et al. 2013). 
The Group was established by the then Minister for Housing, Jan O’Sullivan TD, in February 2013. Its 
role, as set out in the policy statement on homelessness launched by the minister on the same day 
(Kennedy, et al. 2013), was to monitor and review progress on the housing-led approach to ending 
long-term homelessness and the need to sleep rough by 2016 This first report, based on 
consultations with representatives from 36 stakeholders, a review of Pathway Accommodation and 
Support System (PASS) data on homelessness in the period ending September 2013, and detailed 
consideration of relevant policy-related material, gave a realistic account of the major obstacles to 
achieving the 2016 goals and a detailed set of recommendations on how these obstacles can be 
overcome. 
 
Trends in homelessness 
The Homelessness Oversight Group acknowledged that changes to the methods of measuring 
homelessness over the last 10 years made it difficult to track precisely what progress had been made 
in reducing either overall homelessness or long-term homelessness. However, the Group suggested 
that the indicators available pointed to progress being slow. In reviewing the available datasets, 
including Counted In, 2008 (Homeless Agency 2008), data from the Census 2011 (Central Statistics 
Office 2012) and the PASS data, the Group signalled that overall ‘it seems likely that no significant 
reduction in long-term homelessness had occurred between 2008 and 2011. Rough sleepers are on 
an upward trend… [and] …little change in the incidence of homelessness seems to have occurred in 
Dublin in recent years’ (pp. 9–10).  
 
Obstacles to progress to securing permanent housing 
The housing-led approach seeks to place homeless people in sustainable rented accommodation as 
a first step, and provides ‘floating supports’ at the request of the person being housed. Such supports 
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may include assistance with social welfare enquiries, developing independent living skills or seeking 
help for addiction problems. The Group’s report was quite explicit in identifying the key obstacle to this 
approach as a structural one, centred on the lack of integration between two social policy and 
implementation areas – care and housing. This lack of integration was neatly encapsulated in the 
following extract from the report: 
  
…housing providers [i.e. local authorities, approved NGOs and the Department of Social 
Protection] have housing responsibilities which go well beyond the homeless and embrace a 
wide range of low-income households. … Their priority targets (such as families with children 
and elderly households) do not include the single adult males who make up the majority of the 
long-term homeless. Homeless agencies, by contrast, are more narrowly focused on provision 
of shelter, social supports and related health services to the homeless but also require access 
to long-term housing in order to meet what is the core need of their clientele – the need for a 
permanent home. … they depend on housing providers since they themselves have little role in 
housing but they struggle to make successful claims for access in the light of the low priority 
accorded to their clientele in the wider system of housing allocations. (p.10) 
 
Recommendations to overcome blockages 
The Group’s core recommendation was that a high-level team be set up and given responsibility for 
achieving the 2016 goals. This homelessness policy implementation team would be part of the 
general housing policy section of the Department of the Environment, and supported by an 
implementation unit. It is proposed that the team would enter into service level agreements with 
approved housing bodies capable of accessing capital funding from the Housing Finance Agency in 
order to supply permanent housing units, and with agencies providing care and support for the 
homeless people when they are housed. 
 
Are the 2016 goals attainable?  
The Group set out four grounds on which the 2016 goals could be realised:  
1. The scale of homelessness is not insurmountable. An estimated 1,500–2,000 permanent 
housing units being made available over the next three years is not an unrealistic target, given 
that the state currently provides an estimated 250,000 state-supported housing units. 
2. There are many under-used housing units and related financial resources which could be used 
to tackle and reduce long-term homelessness. 
3. Current expenditure on expensive short-term accommodation and shelter will be freed-up as 
the long-term homeless make the transition to permanent housing. 
4. Services provided to meet the health and social care needs of homeless people have 
improved greatly since the early 2000s, providing a platform on which to build an infrastructure 
of care and support to sustain long-term tenancies when the supply of permanent housing is 
increased.  
 
Recent research has found that the views of stakeholders in Ireland are in broad agreement with the 
international consensus that responses to homelessness involve more than just providing housing in 
the form of ‘bricks and mortar’ (Pleace, et al. 2013). Effective responses need to include housing 
alongside appropriate support, especially for people with high support needs. The Homelessness 
Oversight Group’s report concurred with these findings, stating: ‘As the long-term homeless are 
moved into permanent housing between now and 2016…services will need to follow them and 
provide necessary supports in new ways and in new contexts’ (p. 4). 
 
In direct response to the first report of the Homelessness Oversight Group, on 25 February 2014 the 
government approved the establishment of a Homelessness Policy Implementation Team and a 
Central Implementation Unit to implement the recommendations contained in the Group’s report. In 
addition, the government published a detailed plan to assist in implementing the recommendations 
and to make the transition from a shelter-led to a sustainable housing-led response to homelessness 
(Department of Environment and Local Government 2014). The plan contains 80 actions with 
responsible agents for each action. Three actions, when implemented, will benefit both people 
engaged in active drug use and people in recovery from drug use (see Table 8.3.1.1). 
 
Table 8.3.1.1: Three actions from the government’s plan on homelessness targeting people with drug and housing 
problems  
Action 1 Action 2 Action 37 
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Action 1 Action 2 Action 37 
We will provide accommodation for 
rough sleepers as quickly as possible 
pending the tendering and delivery of 
the Housing First service in Dublin. 
We will support the planned 
establishment of a Housing First 
service in Dublin for the rough sleeping 
cohort with a view to delivering a 
minimum of 100 households to 
independent living with support over 
the period to 2016. This service, 
expected to be in place before the end 
of 2014, will target persons in Dublin 
who experience enduring and habitual 
rough sleeping and who manifest 
chronic mental ill health and/or 
substance misuse and addiction. 
We will continue to ensure that the 
recommendations of the Working 
Group Report on Rehabilitation on 
housing for recovering drug misusers, 
including homeless drug misusers are 
implemented appropriately 
Source: (Department of Environment and Local Government 2014) 
 
Youth homelessness 
The Department of Children and Youth Affairs commissioned and has published a high-level review of 
the 2001 Youth Homelessness Strategy (Denyer, et al. 2013). The objective of the review was to 
establish the extent to which the Strategy had been successful, identify blockages and challenges to 
its implementation and make recommendations. The review reported that the number of children 
considered homeless – or at risk of homelessness – had decreased since the introduction of the 
Youth Homelessness Strategy. It also reported that instances of children sleeping rough were rare, 
and that there had been an increase in the range of accommodation options available to children who 
presented as homeless, including residential beds and emergency accommodation. The review 
recommended that the use of Garda stations as a means of accessing emergency accommodation for 
the first time should be avoided and emergency accommodation in Dublin should remain open to 
children during the day. 
 
 
8.3.2 Education, training 
The Department of Social Protection (DSP) supports the objectives of the NDS for the re-integration 
of people recovering from substance misuse into the labour market (Department of Social Protection 
2013). Central to this support is funding provided by the DSP for 1,000 drug rehabilitation places on 
both dedicated and mainstream Community Employment (CE) schemes; currently, funding for these 
1,000 places is ring-fenced, which provides a certain degree of continuity. The overwhelming majority 
of these places are taken up through dedicated CE schemes, which the DSP defined as follows: ‘A 
dedicated drugs rehabilitation scheme is a scheme where participants are referred to the scheme by a 
recognised drug rehabilitation service or agency. The focus of the scheme is on rehabilitation and 
training and development; and multi-agency co-operation is important for the achievement for 
successful outcomes of participants…’ (p. 3).  
 
There are approximately 47 dedicated drugs rehabilitation schemes, 35 in the Dublin region, and 
participants on these schemes are in recovery from substance misuse. There are also mainstream 
CE schemes that include drug rehabilitation places; these are schemes which cater predominantly for 
people not referred by a recognised drug service. The number of clients referred to the dedicated 
drug rehabilitation CE schemes increased during 2013, the most recent year for which data on 
referrals is available (see Table 8.3.2.1). When support workers who do not need to be in recovery 
but who must comply with CE eligibility conditions are excluded from the numbers, just over a fifth of 
the 1,000 places remain unfilled. There are a number of factors causing this shortfall and these are 
discussed below in connection with a recent report by the CityWide Drugs Crisis Campaign examining 
the current operation of dedicated drugs rehabilitation projects/schemes (Citywide 2014).  
 
Table 8.3.2.1: Ring-fenced drug rehabilitation places on CE scheme, 2013 
Month Referred clients Support workers Total 
January 662 168 830 
February 664 159 823 
March 676 159 835 
April 700 149 849 
May 723 157 880 
June 737 158 895 
July 737 155 892 
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August 735 151 886 
September 733 160 893 
October 735 169 904 
November 759 163 922 
December 790 161 951 
Source: (Burton 2013 June 9) 
 
The ultimate aim of using CE schemes as a labour-market activation intervention is to reinforce or 
replace the skill sets of people experiencing unemployment in order to assist them into employment. 
However, for people in recovery from substance misuse who are referred to drug rehabilitation places 
as part of CE schemes, the medium and long-term outcomes can be different owing to the multiple 
disadvantages that characterise the lives of people in recovery from substance misuse.  
 
According to the Department of Social Protection, ‘…many schemes with drug rehabilitation places 
operate in communities where significant social problems add to the realities of chronic 
unemployment…’((Department of Social Protection 2013), p. 9). For example, the majority of 
participants who take up drug rehabilitation places on these schemes have experienced educational 
disadvantage prior to engaging with this service; 58% of people referred to these schemes in 2012 
only reached Junior Certificate level or lower in their formal education (see Table 8.3.2.2).  
 
Table 8.3.2.2: Ring-fenced drug rehabilitation places on Community Employment schemes, by education level and 
gender, 2012  
Education level Male Female Total Percentage 
Primary/no education 126 82 208 25.2 
Junior Certificate or 
equivalent 
183 92 275 33.4 
Leaving Certificate or 
equivalent 
66 79 145 17.6 
3
rd
-level education 52 53 105 12.7 
Unknown 39 52 91 11.0 
Total 466 358 824 100.0 
Source: (Department of Social Protection 2013) 
 
In 2014 CityWide Drugs Crisis Campaign published a report examining the current operation of 
dedicated drugs rehabilitation projects/schemes against the recent background of fiscal austerity 
measures and changes to labour market activation policies and to legislation governing welfare 
provision (Citywide 2014).  
 
The report highlighted the barriers to social participation that often ensue from experiencing multiple 
disadvantages. According to CityWide, ‘…these existing barriers to participation are primarily linked to 
disadvantage and drug use and include low self-esteem, low levels of literacy or modest educational 
achievements, poor health, insecure housing, weak social networks, poor family relationships and 
limited access to childcare…’ (p. 13). Participants with this type of profile who are referred to drug 
rehabilitation places on CE schemes participate in a different way from those enrolled in mainstream 
CE schemes and the outcomes are also different. The vast majority of drug rehabilitation places are 
taken up via drug rehabilitation projects which operate in highly disadvantaged communities. By way 
of addressing the multiple barriers to social participation that participants experience, these projects 
provide a range of services including personal development and elements of education and training. 
According to CityWide, this range of services ‘…aims to provide participants with stability in their lives 
so that they can address their drug use and reintegrate into the lives of their families and 
communities…’ (p. 9). Although the long-term goal of finding employment may be not be realisable for 
some people in drugs rehabilitation places, at least for some time during the initial stages of their 
recovery, their willingness to engage and accrue some medium-term benefits needs to be 
acknowledged.  
 
As part of their consultation with relevant stakeholders in the sector, CityWide interviewed 11 
participants who were currently participating in drug rehabilitation places on CE schemes. Participants 
identified the main benefits as the stability, structure and routine that the projects provided, the 
supports provided by key workers and peers which helped to increase coping skills and develop 
team-working abilities, and an improvement in their self-esteem and confidence. Education was 
highlighted as a particularly useful mechanism to deliver a range of benefits to participants. For 
example, according to CityWide, ‘A key confidence building measure was the availability of education 
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for participants. The transformative and empowering effect of education was noted both by 
participants and by referral and state agencies. Drug rehabilitation places enabled participants to gain 
formal qualifications and develop new skills as many participants had little formal education…their 
involvement in [projects] enabled them to set goals for the first time in many years. Most of these 
goals involved further education, accessing employment, or working with young people…’ (p. 15). 
 
These reported medium-term benefits for participants suggest that the work undertaken with them by 
the projects in their local communities was beneficial to them, their families and their communities. In 
particular, the role of education was noted, and CityWide noted the following benefits to families, 
‘…participation in education enhanced the confidence of participants who could then take a greater 
role in their own children’s education, for example, by supporting them with their school work…’ (p. 
15). 
 
As already reported in this section, participants referred to drugs rehabilitation places on CE schemes 
have experienced multiple disadvantages and faced numerous personal and structural barriers to 
social participation. They have also experienced stigma and prejudice. CityWide noted the efforts of 
the local projects that provide drug rehabilitation places and the achievements of participants that 
goes some way to reversing this stigma: ‘…state and referring agencies…referred to events that had 
been held to mark participants’ graduation from education programmes…. such events have had a 
positive impact on the community in that they can mitigate the negative attitudes towards drug users. 
Moreover, they highlight that recovery, change and rehabilitation is possible’ (p. 16). 
 
Despite the many benefits reported by this small number of participants on drug rehabilitation 
schemes and endorsed by service providers, there remain major concerns regarding the current 
operation of these schemes against the background of recent fiscal austerity measures and legislative 
changes to the provision of state welfare provision. The report concluded that changes introduced to 
the CE scheme in order to increase its focus on labour market activation have not taken into account 
the distinct nature of drug rehabilitation projects, which tend to emphasise working with recovering 
drug users to initiate and sustain their recovery while providing some elements of education and 
training to improve their employability. In particular, CityWide pointed out that recent budgetary 
changes have led to a change in the profile of those applying for places on the projects: there have 
been increases in applications for places on drug rehabilitation projects from people who are on a 
One-Parent Family or a Disability benefit and also from people who are on a Job Seekers benefit. 
They also provided a financial incentive for people parenting alone and for those in receipt of disability 
payments to address their addiction problems. Budget 2012, the report concluded, ‘wiped out’ this 
incentive. The majority of projects have seen a decrease in the number of women joining projects and 
‘a spike in applications from younger men over the past two years; this younger cohort may never 
have used heroin, but use a cocktail of illegal drugs, tablets and alcohol. This provides a more 
challenging environment in which to deliver rehabilitation programmes’ (p. 30). 
 
Working with women affected by prostitution to achieve social reintegration 
Ruhama is a non-governmental organisation that works on a nationwide basis with women affected 
by prostitution. It provides support and assistance to women who are active in prostitution, have a 
history of prostitution, or are victims of sex trafficking.  Ruhama’s latest annual report shows that in 
2012 the service worked with 258 women of 32 different nationalities (Ruhama 2013).  
 
Street outreach  
The Ruhama street outreach service, comprising 30 outreach workers (including paid staff and 
volunteers), worked 108 nights during 2012 and supported 72 women, some on multiple occasions; 
10 of the women also engaged with Ruhama ’s casework service. The outreach service uses a 
purposely adapted vehicle which is referred to as ‘the van’ by service users throughout the report. The 
report documents the issues that women involved in street prostitution present with, including 
addiction, debt, homelessness, poor health, suicidal ideation and violence. Ruhama is particularly 
conscious of the negative role that addiction plays in the lives of women engaged in prostitution. 
According to the report:  
 
A majority of women involved in street prostitution who accessed Ruhama 
services via the Outreach Van in 2012 led chaotic lives due to their drug misuse. 
Ruhama has noted that this particular cohort of women may not access the full 
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services offered, particularly those available in education and development. 
Ruhama has proactively engaged with low threshold drugs services to ascertain 
what kind of interaction with education best suits the client needs, and with this in 
mind is developing a number of once-off workshops that women could access 
without having to sign up for regular classes. (p. 15) 
 
Casework 
In 2012, there were 170 women engaged with caseworkers; 45 were new cases in general casework 
and 18 were new cases in victims of trafficking casework. The other 107 women had been in 
casework from before the start of 2012. Casework involves the woman working individually with a 
caseworker to identify goals and address pertinent issues and needs in a planned way; the woman 
may also receive emotional support through counselling. Women who are deeply traumatised are also 
offered psychotherapy and some may benefit from art therapy. It usually takes approximately two 
years for a woman affected by prostitution to work through a care plan.  
 
Education and development 
Providing education and development services is a cornerstone of Ruhama’s work. In 2012, 88 
women engaged with Ruhama‘s education and development programme, an increase of 14% on 
2011. Table 8.3.2.3 provides a breakdown of the numbers of women and the activities they engaged 
with.  
 
Table 8.3.2.3   Development and education activities offered by Ruhama, and number of participants, 2012 
Activity Participants Activity Participants 
Developed a career path plan 47 
 
Engaged in group classes 33 
One-to-one tuition 33 Engaged in external group classes 20 
One-to-one study skills 10 Worked on developing CVs 50 
IT training 9 Learned English as second 
language 
22 
Started FETAC courses 11 Applied for third-level/further 
education or training 
52 
Completed FETAC courses 7 Received financial support to 
access education  
45 
Source: (Ruhama 2013) 
 
Resettlement support service  
Ruhama employs a worker specifically to assist women to access suitable housing and 
accommodation; this service also assists women to access social welfare benefits and entitlements. 
In 2012, 33 women availed of Ruhama‘s resettlement support service.  
Conclusion 
Ruhama’s mission is to support women to (re)gain their independence and eventually exit the 
services provided by Ruhama: assisting and supporting women to exit prostitution and to deal with the 
emotional and material experience of prostitution are key objectives. The annual report shows that, in 
the course of 2012, Ruhama had been able to close the case files on 49 clients, meaning that the 
women had worked through their care plans and were no longer reliant on the services. However, 
work of this kind with vulnerable and marginalised people can rarely be captured by reference to 
numbers and categories. In the words of the chairperson:  
 
In this report we read many statistics, and behind each one is an individual woman’s 
story, a personal experience, where she has been trafficked, coerced or otherwise 
socialised into a life which she now wishes to leave, but where her escape may be 
threatened by danger, fear and absence of options. (p. 3)  
 
 
8.3.3 Employment 
See Section 8.3.3 in 2013 National Report (Health Research Board 2013) for the most recent 
information. 
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9. Drug-related crime, prevention of drug-related crime and prison 
9.1 Introduction 
This chapter presents the most recent statistical data on drug-related crime in Ireland, including drug 
law offences and offences committed as a consequence of a drug addiction. It also describes policies 
and programmes initiated in the past year to prevent drug-related crime both in the community and in 
prisons as well as research studies on drug-related crime, prevention and prison. In this section the 
data sources and types of drug-related crimes in Ireland are described, and the approaches to 
preventing drug-related crime, both in the community and in prisons, are also briefly outlined. 
 
Since 2006 reporting crime statistics has been the responsibility of the Central Statistics Office 
(CSO). The CSO data are derived from the Garda Síochána computerised PULSE system (Police 
Using Leading Systems Effectively). The vast majority of drug offences reported come under one 
of three sections in the Misuse of Drugs Act (MDA) 1977: section 3 – possession of any controlled 
drug without due authorisation (simple possession); section 15 – possession of a controlled drug for 
the purpose of unlawful sale or supply (possession for sale or supply); and section 21 – obstructing 
the lawful exercise of a power conferred by the Act (obstruction). Other MDA offences regularly 
recorded relate to the importation of drugs (section 5), cultivation of cannabis plants (section 17) and 
the use of forged prescriptions (section 18). 
 
Driving under the influence of drugs (DUID) has been a statutory offence in Ireland since the 
introduction of the 1961 Road Traffic Act. The principal legislation in this area is contained in the Road 
Traffic Acts 1961 to 2002. Section 10 of the Road Traffic Act 1994 prohibits driving in a public place 
while a person is under the influence of an intoxicant to such an extent as to be incapable of having 
proper control of the vehicle. Intoxicants are defined as alcohol or drugs and any combination of drugs 
or of drugs and alcohol. Although penalties for driving under the influence of alcohol are graded 
according to the concentration of alcohol detected, the law does not set prohibited concentrations for 
drugs. Neither does it distinguish between legal and illegal drugs. Tests to identify the level of 
impairment can only take place where there is a reasonable suspicion that an offence is being 
committed. The Road Traffic (No.2) Act 2014 provides, inter alia, new measures to test for driver 
intoxication. Members of An Garda Síochána will be empowered to require people driving or 
attempting to drive a mechanically propelled vehicle in a public place, to undertake intoxication 
impairment testing. This involves non technology-based cognitive tests (e.g. walking a straight line, 
tipping one’s nose, counting while standing on one leg). The results of these tests may be used in 
evidence in support of the Garda forming an opinion that the person is intoxicated. It will also be an 
offence to fail to comply with a requirement to undergo intoxication impairment testing. Section 12 
amends the Road Traffic Act 2010 to allow for the taking, subject to medical approval, of a specimen 
of blood from an incapacitated (e.g. unconscious) person following a road traffic collision involving 
death or injury. 
 
In reading the tables in this chapter, please note that ‘relevant proceedings’ refer to the legal 
proceedings, such as prosecution, taken in relation to an offence as it was originally recorded in the 
Garda Síochána IT system, PULSE (Police Using Leading Systems Effectively). 
 
Over and above the ‘inherent’ drug crimes, that is crimes under the Misuse of Drugs Acts or the Road 
Traffic Acts, ‘non-inherent’ drug crimes are also recorded in Ireland, for example acquisitive crime 
to pay for drugs, crimes of intimidation and violence inflicted by drug gangs, money laundering, 
smuggling or other finance-related crimes, or public nuisance. Official crime statistics do not allow one 
to identify where offences were drug-related. These connections can only be made through specific 
research in the area. This is reported in this chapter when available.  
Crime prevention in Ireland proceeds on several fronts. Tackling community disadvantage is one 
important approach. Disadvantage in communities is recognised as a risk factor in contributing to, 
among other things, the spread of drug-related crime. A wide range of national initiatives exist to 
tackle disadvantage and its consequences, including a Local and Community Development 
Programme, which aims to tackle poverty and social exclusion through partnership and constructive 
engagement between government and its agencies and people in disadvantaged communities; a 
Youth Capital Programme, which funds youth cafés; and the Dormant Accounts Fund, which is used 
to target economic and social disadvantage and educational disadvantage and to provide support for 
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persons with disability.13 In relation to the drug problem, in 1998 local drugs task forces were 
established in areas identified as having the highest concentrations of drug misuse; without exception, 
these areas were all also experiencing high levels of socio-economic disadvantage. Recast as local 
drugs and alcohol task forces (LDATFs) in 2014, their purpose is to co-ordinate local action plans in 
relation to curbing local supply as well as treatment, rehabilitation, education and prevention.  A 
central feature of the LDATFs is that as well as co-ordinating the provision of services locally, they 
also allow local communities and voluntary organisations to participate in the planning, design and 
delivery of services.  
 
Diversion is another important means of seeking to prevent crime including drug-related crime – both 
before, and after, a crime has been committed. Garda Youth Diversion Projects are local 
community activities which work with children. These projects aim to help children move away from 
behaving in a way that might get them or their friends into trouble with the law.  In 2005 the Irish 
Youth Justice Service (IYJS) was established to develop a co-ordinated partnership approach among 
agencies working in the youth justice system, to improve service delivery in the system through 
diversion, restorative justice, rehabilitation and detention as a last resort. Garda (Irish police force) 
statistics show that the types of offence committed by children under the age of 18 years are primarily 
theft, alcohol-related offences, criminal damage, assault, traffic offences, drugs possession, public 
order offences and burglary. In addition to the Garda Youth Diversion Projects, the Garda Juvenile 
Diversion Programme (GJDP) provides an opportunity to divert juvenile offenders from criminal 
activity. It operates on a nationwide basis under the supervision and direction of the Garda National 
Juvenile Office. The GJDP provides that, in certain circumstances, a young person under 18 years of 
age who freely accepts responsibility for a criminal incident be cautioned as an alternative to 
prosecution. The GJDP employs such strategies and initiatives as formal and informal cautioning, 
supervision, restorative cautioning and conferencing, community policing and referral to the Garda 
Youth Diversion Projects (which operate outside the GJDP but in concert with it). First established on 
a pilot basis in 2001 the Drug Treatment Court is a specialised District Court, which offers long-term 
court-monitored treatment, including career and education support, to offenders with drug addictions 
as an alternative to a prison sentence. The idea is that by dealing with the addiction, the need to 
offend is no longer present.  
 
Finally, individuals and communities are encouraged to participate in helping to prevent and/or detect 
crime. For example, the Customs Drugs Watch Programme, first launched in 1994, encourages 
those living in coastal communities, maritime personnel and people living near airfields to report 
unusual occurrences to Customs. Under the Garda Síochána Act 2005, Joint Policing Committees 
(JPCs) have been established in local authority areas to bring together public representatives, 
representatives of local authorities, the Garda Síochána and representatives of the voluntary and 
community sectors to assess levels of crime and anti-social behaviour, including that related to 
alcohol use and illicit drug use, and to make recommendations as to how to prevent and address such 
problems. The JPCs are empowered to establish local policing fora (LPF), to deal specifically with 
drugs and associated issues such as estate management and anti-social behaviour. Another initiative 
recently established is a joint initiative of the Family Support Network and the Garda Síochána to 
assist individuals and families in responding to drug-related intimidation, the incidence of which has 
increased in recent years, as reported in National Reports. 
 
The presence of drugs in prisons led the Irish Prison Service (IPS) to develop a policy based on 
three underlying principles (Irish Prison Service 2006): 
 the presence of drugs in prison will not be tolerated; 
 prisoners will be encouraged and supported to develop a responsible attitude to drugs, both while 
in prison and following release, through a range of measures including education and counselling; 
and 
 prisoners who are addicted to drugs or have other medical problems caused by the misuse of 
drugs will be offered every reasonable care and assistance. 
 
In the accompanying strategy the IPS lists two aims in relation to illicit drugs in prisons: (1) to 
eliminate the supply of drugs into prisons, and (2) to provide prisoners with a range of opportunities 
which encourage them to adopt a drug-free lifestyle, before and after release, thereby reducing 
                                               
13
 These programmes are all administered by Pobal, a not-for-profit company with charitable status that manages programmes on behalf of 
the Irish Government and the EU. For further information, see www.pobal.ie  
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demand for drugs.The Probation Service works in partnership with communities, local services and 
voluntary organisations to reduce offending and to make communities safer. It funds and supports 
organisations and projects providing drug treatment to offenders, as well as other important services 
such as employment placement, accommodation, education and training, restorative justice initiatives. 
Probation Service staff in the community and in prisons may refer clients to these community-based 
projects, to enhance their re-integration and resettlement as positive, contributing members of their 
communities. 
 
 
9.2 Drug-related crime 
The link between drugs and crime in Ireland exists simply by virtue of prevailing legislation which 
defines as criminal offences the importation, manufacture, trade in and possession, other than by 
prescription, of most psychoactive substances. Apart from such official statistical indicators, it is eight 
years since any research and analysis on the connection between illicit drugs and other types of 
crime such as theft from the person, burglary, larceny and prostitution was published in Ireland 
(Connolly 2006). Data on drug law offences is presented in Section 9.3 below, and information on 
other drug-related crime is presented in Section 9.4. 
 
9.3 Drug law offences 
Court outcomes for drug offences 
The Courts Service Annual Report for 2013 provided statistics on the outcomes of prosecutions for 
drug offences between January and December 2012 (Courts Service 2014). Table 9.3.1 shows the 
outcomes of trials for 14,008 drug offence cases, involving 9,297 defendants, prosecuted in the 
District Court, the lowest court in the system where most drug offences are dealt with. This total 
represented a 21% decrease on the number of cases prosecuted in 2011 (n=17,715). The most 
common outcome in 2013 was for cases to be struck out (n=2,784). There were 2,339 offences that 
resulted in fines. Just 7.7% (n=1,083) cases resulted in imprisonment or detention while 1,803 cases 
were dealt with by way of community service or probation. 
 
Table 9.3.1 Sentences for drug offences in the District Court, 2012 
Sentences Imprisonment Fines Community 
service/ 
probation 
Struck 
out 
Dismissed Taken into 
consideration* 
Other Peace 
bond 
Total  
Number of 
offences 
1083 2339 1803 2784 225 2317 3323 120 14008 
* Taken into consideration: The Criminal Justice Act, 1951, s8, provides that where a person, on being convicted of an offence, admits him- 
or herself guilty of any other offence and asks to have it taken into consideration in awarding punishment, the Court may take it into 
consideration accordingly. If the Court takes an offence into consideration, a note of that fact is made and filed with the record of the 
sentence, and the accused cannot be prosecuted for that offence, unless her/ his conviction is reversed on appeal.  
Source: (Courts Service 2014) 
 
The Courts Service reported that 1,029 drug offences were tried in the Circuit Criminal Court. The 
Circuit Court has a higher jurisdiction than the District Court and can thus impose a more severe 
sentence. Of the prosecutions in the Circuit Criminal Court, 420 led to guilty pleas. Of the 36 cases 
that went to trial, 17 resulted in convictions and 19 in acquittals.  In relation to the penalties imposed 
on conviction by offence, it was reported that 10 led to community service; 196, suspended 
sentences; 171, imprisonment; 651, other (including community bond, taken into consideration, struck 
out, forfeiture of goods/money/drugs/weapons, disqualification from driving) (Courts Service 2014). 
 
Prison committals for drug offences 
The Irish Prison Service (IPS) annual report for 2013 provided statistics on the number of persons in 
custody under sentence (i.e. not on remand) on a given day in the year (30 November) and also on 
the number of committals under sentence by sentence length (Irish Prison Service 2014). Table 9.3.2 
shows that the number of persons in custody for controlled drug offences comprised 17% (n=589) of 
the total prison population, which was 3,474. The majority of drug offenders (n=308) were serving 
sentences of 5 to 10 years (n=207), with 101 serving more than 10 years. Just 19 prisoners were 
reported to be serving less than 12 months in prison. 
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Table 9.3.2 Persons in custody on 30 November 2013 for controlled drug offences by sentence length 
Months Years Life Total 
drug 
offenders 
 
589 
Total 
prison 
population 
 
3474 
Drug 
offenders 
% 
 
17% 
<3 3 to 
<6 
6 to 
<12 
1 to 
<2 
2 to  
< 3 
3 to  
< 5 
5 to 
< 10 
 
10+ 
- 6 13 26 64 172 207 101 - 
Source: (Irish Prison Service 2014)  
 
Table 9.3.3 shows the number of committals under sentence for the whole of 2013 for drug offences, 
by sentence length. When compared with Table 9.3.2, it can be seen that just more than 50% of 
committals were for a period of less than three months (n=429), while more than 70% of committals 
were for less than a year (n=594). It should be noted that some of the committals for less than three 
months could have related to the same persons being imprisoned more than once during the year.  
 
Table 9.3.3 Committals under sentence for controlled drug offences, by sentence length, 2013 
Months Years Life Total 
drug 
offenders  
 
846 
Total 
committals 
 
 
12489 
Drug 
offenders 
% 
 
6.7% 
<3 3 to  
<6 
6 to  
<12 
1 to  
<2 
2 to  
< 3 
3 to  
< 5 
5 to  
< 10 
 
10+ 
429 84 87 36 59 98 41 12 - 
Source: (Irish Prison Service 2014)  
 
9.4 Other drug related crime 
Probation Service study on drug and alcohol use among young offenders  
In 2012, the Probation Service published the findings of the first large-scale, nationwide survey of 
drug and alcohol misuse among the adult offender population on probation supervision ((Health 
Research Board 2013): Chapter 9.4). This was followed in late 2013 by the report of a similar survey 
of young offenders (aged 20 years or under) who were on probation supervision (Horgan 2013). A 
better understanding of the nature of the connection between drug use and offending has implications 
for drug and crime prevention and for treatment and criminal justice interventions. A major 
impediment in this area in Ireland, however, has been the absence of research and data from within 
the criminal justice system. Although, as shown in Section 9.3 above, annual data have been 
available from the CSO and the Courts Service on the number of drug offences (infringements of drug 
laws such as possession and supply) that are committed, and from the IPS on the number of prison 
committals for drug offences, data have not been routinely available on the number of drug-related 
offences committed as a consequence of substance misuse, such as thefts by dependent drug users 
to feed their drug habit. The development of a knowledge base of this kind requires further analysis of 
the data compiled within agencies of the criminal justice system.  
 
The objectives of the young offenders’ survey were to:  
- determine the number of young offenders under probation supervision who had misused 
drugs and/or alcohol, 
- investigate the nature and frequency of drug and alcohol misuse, 
- examine the context within which drug and alcohol misuse occurred, 
- ascertain whether a relationship exists between drug misuse and offending behaviour and 
alcohol misuse and offending behaviour, and 
- identify the range and nature of engagement with drug and alcohol treatment services.  
 
The survey population was identified by means of the Probation Service electronic case tracking 
system. Probation officers completed and returned survey questionnaires relating to 721 offenders on 
their casebooks on 3 December 2012, of whom 647 (89.7%) were male and 74 (10.3%) were female. 
Of the 721 cases surveyed, 628 (87%) were identified as having misused drugs, alcohol or a 
combination of both; 12% had misused drugs only, and 12% had misused alcohol only. Male and 
female offenders had relatively similar rates of substance misuse. Alcohol was the substance most 
often misused on a weekly basis (39.8% of males and 43.6% of females), followed by cannabis 
(20.4% of males and 14.5% of females). Females were less likely than males to have misused both 
drugs and alcohol, and significantly less likely to have misused drugs alone (1%). However, females 
were more likely than males to have misused alcohol only (16% vs 12%)’. Twenty-six per cent of 
females were reported to have abstained entirely from either drug or alcohol abuse, compared to 11% 
of males. A higher percentage of females (14.5%) than males (8.9%) misused prescription drugs.  
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The study also explored the ‘gateways and influences’ which surround the misuse of drugs and 
alcohol by young offenders. Alcohol was recorded as the most common substance first misused, 
followed by cannabis. A higher percentage of females than males were reported to have started with 
alcohol (70.9% vs 55.7%), while cannabis as the first substance used was higher for males (35.3% vs 
23.6%). While substance misuse was reported as commencing among individuals as young as nine 
years, the median age was 14 years. Consistent with most other studies in this area, more than 80% 
of offenders first engaged in substance misuse with their peers. Of the 628 offenders who had 
misused a substance, 38.9% had parents with a history of substance misuse, while 55.6% did not. In 
explaining this phenomenon, and citing a UK study, the report stated that ‘alcohol consumption in 
Great Britain and Ireland can only be appreciated in the context of a “wet culture”, whereby young 
people’s drinking is essentially “normal” behaviour, part of a wider socialisation process, reflecting 
adult practices’ (p. 25). 
 
With regard to the link between substance misuse and crime, in more than 80% of cases substance 
misuse was linked, in the opinion of the probation officer, to current offending. Alcohol was the 
substance most frequently linked to offending for 61.7% of females and 43.8% of males. Drug misuse 
on its own was linked to a relatively small amount of offending. Public order was the most common 
offence category linked to offending and ‘in nearly 70% of those cases alcohol was the substance of 
misuse’ (p. 30). In cases of assault, over half the cases identified alcohol as the substance of misuse. 
Again, these findings are consistent with those of earlier Irish research in this area (Institute of 
Criminology 2003). Over half the survey population had attended some form of drug/alcohol 
treatment, the majority when they were aged between 18 and 20 years. 
 
One of the key performance indicators under the research/ information pillar of the National Drugs 
Strategy 2009–2016 (NDS) is comprehensive and timely reporting systems for the ‘progression of 
offenders with drug-related offences through the criminal justice system'.  Action 55 proposes as an 
area of research ‘the impact of alcohol and drugs on the Irish health and justice systems’. This 
initiative by the Probation Service makes an important contribution in this respect. 
 
Drug-related intimidation and community violence 
The issue of drug-related intimidation, much of it related to drug debt, has emerged as a major 
concern for many communities in Ireland in recent years ((Health Research Board 2012): Chapter 
9.4).  It has also been identified as a key issue in the NDS, where Action 5 aims ‘to develop a 
framework to provide an appropriate response to the issue of drug related intimidation in the 
community’. A study of the issue in Blanchardstown, West Dublin, undertaken by the co-ordinator of 
Safer Blanchardstown (the local community policing forum), sought to identify those most likely to 
engage in local intimidation and those most likely to be victimised (Jennings 2013). The research also 
investigated the causal factors underlying intimidation with a view to informing possible interventions 
and responses by partner agencies and the wider community. Primary research involved a series of 
interviews with senior outreach staff from a number of local agencies, including youth projects, 
community drug teams, family support services, social workers, health workers and the local Garda 
drugs unit. These interviews, conducted in late 2011, were supplemented by minutes of local 
residents meetings on community safety and a literature review. 
 
The resulting report highlighted the complex and multi-layered nature of the phenomenon and 
recommended that responses should be systematic, co-ordinated and directed along a continuum of 
different ‘orders’ of intimidation – lower, middle and higher. The report used the metaphor of an 
iceberg to link these different levels of intimidation, as illustrated below.  
 
Lower order intimidation, according to the report, involves: 
 
… young children [aged 8–16] bullying, assaulting, stealing, vandalising and 
spreading fear within the community, often directed to do so by older siblings and 
friends. Children may be directed to intimidate those who are thought to be talking 
to the Gardaí/Local Authority. This intimidation can take the form of breaking of 
windows, property damage, name calling, racial slurs and harassment of [other] 
children in the street. (p.11)  
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Young people at this level, the study found, are sometimes supported in such behaviour by older 
siblings, family and friends, and experience a ‘lack of parental control, boundaries or direction in their 
lives’. In relation to lower-order intimidation the report highlighted the importance of early 
interventions for young people who may be likely to become involved in such behaviour. One local 
initiative currently being piloted is the Interagency Working Agreement Group (IWA) for 
Mulhuddart/Corduff. This group has developed protocols for the sharing of confidential information 
between all agencies working with young children and their families in order to provide them with 
appropriate supports. The report recommended the following: 
 
The principal aim of the IWA should be, through the provision of appropriate 
supports, an increase in educational attainment, the reduction in the number of 
young people with a low school attendance, at risk of suspension/exclusion from 
school or who have come to the attention of Fingal County Council/Gardaí in 
relation to anti-social behaviour harassment or intimidation. (p.14) 
 
The report also noted the potential of problem-oriented policing methods, with ‘Garda problem solving’ 
training currently being rolled out across Blanchardstown, targeting agency staff and residents. This is 
a model of problem solving referred to as SARA (Scanning, Analysis, Response, Assessment) to 
inform multi-agency interventions.14 
 
Middle-order intimidation, involving those aged between 13 and 20, some of whom are dependent 
drug users and dealers, was reported as the level at which ‘most of the drug-related intimidation takes 
place and from which stems the criminal activity that financially supports those caught up in addiction’ 
(p.16). The report recommended the development of a Prolific and Priority Offender (PPO) approach, 
defined as ‘an approach that effectively manages offenders who are identified as committing a 
disproportionate amount of crime and harm in their communities’ (p.17). This approach involves a 
‘catch and convict’ strand which ‘requires that the criminal justice agencies work together to ensure 
effective investigation, charging and prosecution’ of PPOs in as short a timescale as possible. It also 
incorporates a ‘rehabilitate and resettle’ strand, whereby PPOs are provided with a ‘simple choice – 
the opportunity to reform or face a very swift return to court should they re-offend or fail to comply with 
the conditions of court orders’ (p.18). This latter strand, the report stated, must be supported through 
‘locally agreed and implemented rehabilitation plans’.  
 
Higher-order intimidation is described as ‘where the serious players reside’, that is, ‘those gang 
members and leaders who actively defend and try to expand their share of the drugs market’ (p. 20). 
In describing the recreational demand side of the illicit drugs market, the report provided an 
interesting analogy with the local pub: 
 
People who go to the pub daily or on a regular basis enable the landlord to pay the 
rent, heat, light and staff wage bills. It’s at the weekend however; when the casual 
drinkers come out that the publican makes the real money. Likewise with the drug 
suppliers, it’s at the weekend when the casual recreational users order their small bit 
of hash/cocaine etc. that the real money is made and it is this real money that 
attracts the serious violence. (p. 20) 
 
The report also employed the iceberg metaphor to illustrate the local impact of so-called gangland 
murders. When such a murder is committed, ‘as a consequence of the interrelated nature of 
intimidation residents will attribute a relationship between those at the lower orders and those at the 
higher order even where this is not warranted. This fear will be picked up by those in the lower order 
whose swagger and power to intimidate will increase’ (p. 20). This in turn leads to further fear and 
community submission and silence. The report stressed the need to expose the link between casual 
recreational drug use and such violence in communities. 
 
One of the major consequences of drug-related intimidation is that its victims (both direct and indirect) 
refuse to engage with state authorities because of fear of reprisal from those involved in the drug 
trade. The report advocated the establishment of a community information network to gather 
information on intimidation whereby people could provide information to the gardaí and local 
                                               
14
 For further information on such techniques, see the Centre for Problem Oriented Policing at www.popcenter.org 
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authorities without committing to going to court. This would enable the authorities to build a profile of 
those involved and, by encouraging people to talk about the issues, it could enhance initiatives such 
as the support service provided by the National Family Support Network and the Garda National 
Drugs Unit to individuals and families facing intimidation.15 This report is an important local 
contribution to an issue that is not only of increasing national significance but also under-researched. 
The final recommendation highlighted the need for further research ‘in order to better inform workers, 
local communities and wider Irish society on how best to tackle this devastating behaviour’ (p. 25). 
 
Another study on drug-related intimidation was completed by the North Dublin Inner Local Drugs and 
Alcohol Task Force in October 2013 (North Inner City Drugs Task Force 2013). This trends and 
behaviour survey on violence, intimidation and threats involved an online survey of individuals and 
groups engaging with community-based projects in the north inner-city. The survey was issued to 20 
local projects and there was a 70% response rate (14 projects). Of the projects that responded, 11 
worked primarily with adults, one mainly with youth (aged 12 to 23) and their families, and two with 
children and their families. The following were some of the key findings of the survey: 
- There was a significant level of engagement with services about violence, intimidation or 
threats in the area: 18% of service users (501/2,752) of 13 projects expressed concern about 
these issues in the last 12 months. 
- Violence, intimidation or threats were most often directed at the individual reporting the issue 
(32%),  or a family member (54%). 
- Those most commonly affected were between 26 and 35 years of age. 
- The violence, intimidation or threats took place mostly on the street (17%) and at home (17%),  
although 14% took place via the phone and 9% via the internet. 
- The most often cited reason for the violence, intimidation or threats was drug-related (28%). 
- The issues affected individuals in a variety of ways, with financial problems the most significant 
single effect cited (13%). 
- About 50% of those affected sometimes/often/always reported the issue confidentially to An 
Garda Síochána. 
- Two thirds (64%) of respondents said they were concerned at least some of the time about their 
own and a colleague’s safety when supporting individuals/groups with issues relating to violence, 
intimidation or threats. 
- Almost 72% of the projects that responded had a working policy to support staff when dealing with 
issues of violence, intimidation or threats. 
 
The CityWide Drugs Crisis Campaign, in association with the Health Research Board, is currently 
conducting a national audit of drug-related intimidation and community violence in drugs and alcohol 
task force areas throughout the state.16 The purpose of this project is to develop an evidence-base in 
order to establish sustainable locally-based responses to the issue. 
 
Drug-facilitated sexual assault: an Irish perspective  
A recent journal article provides an Irish perspective on drug-facilitated sexual assault (DFSA) 
(McBrierty, et al. 2013). It discusses the various ways in which DFSA is defined, the limitations 
associated with establishing its prevalence in Irish society, the various substances that have been 
found to be associated with it in other jurisdictions, and the complex evidential issues that can arise in 
trying to establish its basis in law. DFSA was defined by the authors as ‘sexual assault that is 
facilitated by alcohol, drugs or other intoxicating agents where consent cannot be obtained due to lack 
of capacity of the victim’ (p. 190). Rape that is facilitated by alcohol, drugs or other intoxicants has 
often been confused with so-called ‘date rape’. However, the authors explained that ‘date rape’ is just 
one specific form of DFSA ‘where the victim is on a date with the perpetrator’ and that there are ‘many 
other situations where drugs and alcohol may be used to facilitate a sexual assault’. The authors 
explained  further that terms such ‘date rape drugs’ have been used to describe drugs that can cause 
specific biological effects that ‘facilitate sexual assault’ (p. 189).  Rape is generally defined in 
legislation as ‘unlawful sexual intercourse or certain sexual activity perpetrated on an individual where 
consent is not present, or where consent is not valid due to a lack of capacity of that individual to 
                                               
15
 For further information about the drug-related intimidation reporting programme, see the National Family Support Network 
at www.fsn.ie 
16
 For further information about CityWide, see www.citywide.ie 
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consent…due to intoxication’. The article identified three separate circumstances where DFSA can 
occur. These are where: 
 (i) there is an involuntary ingestion of an intoxicating substance by the victim, 
 (ii) there is both voluntary and involuntary ingestion of an intoxicating substance by the victim, 
 (iii) there is voluntary ingestion of an intoxicating substance by the victim (p.190) 
 
With regard to the prevalence of DFSA in Ireland, the authors highlighted the general under-reporting 
of rape and sexual assault to An Garda Síochána. In particular, they noted a report of the Rape Crisis 
Centre (RCC) to the effect that less than one in five victims of rape reported the offence to the gardaí. 
Furthermore, from an analysis of 10,155 phone calls to the RCC in 2007, 2.3% related to ‘drug rape’. 
This figure, according to the authors, was misleading and related to a confusion between drug rape,  
date rape and DFSA. As explained above, DFSA is sexual assault facilitated by alcohol, drugs or 
other intoxicating agents. The substance most commonly involved in DFSA is alcohol, and this is not 
included in figures presented for so-called drug rape. In Ireland, according to the study, ‘alcohol is 
involved in about half of all adult sexual assaults’ (p.191). Consequently, the offence of DFSA is 
‘hugely underestimated’ in Ireland. From a brief analysis of UK case law regarding consent in rape 
cases where the complainant/victim is self-intoxicated with alcohol, the courts generally hold that 
‘drunken consent is still considered consent’ (p. 192). 
 
One of the major challenges in legally establishing DFSA, however, is the failure to test for the 
presence of specific substances in victims. In particular, samples need to be taken from victims in a 
timely manner, while the drugs or alcohol are still detectable. This, according to the authors, is 
‘especially relevant with drugs such as GHB and ethanol, which clear rapidly from the body’. The 
study includes a table showing the length of time different drugs generally associated with DFSA 
remain detectable in urine samples, and this can vary from 7 to 12 hours in the case of alcohol, to 30 
days for long-acting benzodiazepines. The authors concluded their analysis by highlighting the under-
reporting of crimes of sexual violence in Ireland. DFSA is, they suggested, an issue that cuts across 
various disciplines including forensic science, medicine and law. Further education of frontline service 
providers, facilitating a greater awareness of the legal and forensics issues involved, might, the 
authors suggested, be a positive step towards addressing the general under-reporting of offences in 
this area. 
 
 
9.5 Prevention of drug-related crime 
The Youth Justice Action Plan 2014-2018 was launched in October 2013 (Irish Youth Justice Service 
2014). It included an analysis of Garda statistics on youth crime and found that alcohol- and public-
order-related offences accounted for 40% of youth crime while simple drugs possession offences 
accounted for 4%, although it was assumed that the latter category of  offending was likely to be more 
prevalent given difficulties in the detection of such offences. In addition, the document suggested that 
‘a small number of young people may be in drugs supply chains, either through choice or coercion’ (p. 
9). The action plan identified five general high-level goals and 15 objectives. An action under high-
level goal 2, which aimed to strengthen and develop the evidence base about youth offending and the 
performance of the youth justice system, was to ‘profile substance misuse among young people 
subject to community sanctions/ probation service supervision’. This profiling would, according to the 
action plan, assist the Probation Service to develop more effective interventions. The action plan also 
sought to promote early intervention and prevention programmes targeting those at risk of offending 
behaviour through the Garda Juvenile Diversion Programme (GJDP) and the Garda Youth Diversion 
Projects (GYDPs.) 
 
The GJDP operates under the Children Act 2001. Published in 2014, the Annual report of the 
committee appointed to monitor the effectiveness of the diversion programme (Committee appointed 
to Monitor the Effectiveness of the Diversion Programme 2013) reported the following outputs of the 
GJDP in 2012: 
- The total number of individual children referred to the GJDP was 12,246, compared to 12,809 in 
2011. 
- 25% of children referred to the GJDP were female, while 75% were male, the same as in 2011. 
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- Public order offences (29%), theft and related offences (24.9%) and damage to property and to 
the environment offences (10.4%) constituted the three main categories of offences for which 
children were referred, similar proportions to 2011. 
- Controlled drug offences accounted for 1,205 or 5% of the total number of referrals. Of these 
offences, 965 (4%) involved simple possession, while 194 (0.8%) involved possession for supply. 
 
 
9.6 Interventions in the criminal justice system 
9.6.1 Alternatives to prison 
Women in prison 
A position paper by the Irish Penal Reform Trust (IPRT),17 Women in the criminal justice system – 
towards a non-custodial approach, called for a non-custodial approach to be adopted for women 
offenders and, in the few cases where prison is necessary, for the negative impact of imprisonment 
on women, and those they care for, to be minimised (Irish Penal Reform Trust 2013).  
 
The position paper began with a review of recent trends in the imprisonment of women in Ireland. In 
the past decade, the number of women imprisoned had doubled while community-based alternatives 
remained under-explored. The number of women imprisoned had increased from 1,459 in 2009, 
representing 11.8% of the prison population, to 2,151 in 2012, representing 15.1% of the prison 
population. Most women were committed to prison for defaulting on fines, with the bulk of the 
remainder imprisoned for non-violent offences against property or for theft or road traffic offences. 
According to the position paper, ‘in 2012, out of 2,071 female committals under sentence, 1,687 were 
for non-payment of court-ordered fines’ (p. 4). As a consequence of the high rate of female 
imprisonment, women’s prisons were overcrowded, and temporary release was being over-used. In 
January 2011, for example, the Dóchas Centre, opened in Dublin in 1999 as a model for women’s 
prisons, was operating at 64% over capacity. A more recent report on the Dóchas Centre by the 
Inspector of Prisons stated: ‘On the 19th June 2013 there were 141 prisoners in the Centre, when the 
maximum should have been 105’ (Reilly Michael 2013) (p. 9). According to the position paper, the 
other female prison in Ireland, based in Limerick, was also overcrowded, ‘with doubling up taking 
place in up to 10 of the 24 cells’ (p. 5), which were designed and only suitable for single occupancy. 
 
The position paper went on to examine the complex needs of many women convicted of offences and 
the excessive use of remand for women offenders. In addition, many women have caring 
responsibilities for children and other dependent relatives. These needs and responsibilities were 
summarised as follows: 
 
Women offenders tend to come from a background of social disadvantage and poverty, and 
often suffer from mental health problems, substance dependency, accommodation problems 
and poor family relationships. These issues can make it difficult for women to adhere to bail 
conditions, which has led to an overuse of remand for women offenders. This in turn has 
negative implications for children of women who are imprisoned on remand and the 
employment prospects of these women. A high proportion of women in prison have children. 
Women also play an important role in caring for dependent relatives. Women who are 
imprisoned can no longer fulfil their caring responsibilities and the consequences of this can 
be significant. This is particularly an issue for mothers with babies, due to the absence of a 
mother and baby unit in either female prison in Ireland. (pp. 11–12) 
 
Problems associated with substance use among women offenders are not just related to drug 
dependency. The Inspector’s report on the Dóchas Centre highlighted the ‘serious problems of drugs 
in the centre’ (Reilly Michael 2013). The position paper outlined a number of challenges faced by 
women leaving prison, particularly related to housing, accommodation and stability, with women ex-
prisoners ‘at high risk of reoffending’.    
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The position paper reviewed some emerging models of good practice in other jurisdictions, focusing in 
particular on community-based approaches to women offenders. It also considered models recently 
developed in Ireland. It concluded with two primary recommendations.  
1. In relation to adopting a non-custodial approach to women offenders, future policy and legislative 
development should be informed by a number of principles, including the following: 
- Where a woman is accused of a minor, non-violent offence, the default position should be that 
she will have a non-custodial sanction imposed…such as community service orders, gender-
specific diversion programmes, and holistic support services in the community. 
- If a person convicted of an offence is the primary carer of young children, an issue that affects 
more female than male offenders, the best interests of the children should always be taken into 
account in determining an appropriate sentence. 
2. The negative effects of imprisonment on ‘the small number of cases where prison is necessary for 
women who have been convicted of an offence’, and their families, should be minimised. 
According to the position paper, achieving this will require a number of reforms including: 
- establishing a truly open prison for women, 
- addressing overcrowding in both female prisons, 
- introducing mother and baby units at Limerick prison, and 
- ensuring visiting facilities are non-threatening, child-friendly and permit physical contact and 
play. 
 
Following on from the position paper, in early 2014 the Probation Service and the Irish Prison Service 
published a joint strategy – An effective response to women who offend 2014-2016 (Probation 
Service and Irish Prison Service 2014). This strategy commited both services to developing a ‘range 
of options which provide an effective alternative to custody, enhance reintegration and reduce re-
offending’ and to promoting ‘awareness and confidence amongst key stakeholders of the significant 
role of community sanctions in the reduction of re-offending by women’ (p. 7). 
 
 
9.6.2 Other interventions in the criminal justice system 
Community courts 
The Dublin City Business Association (DCBA) has called for the establishment of a community court 
as a means of addressing low-level crimes such as vandalism, theft, anti-social behaviour, drug use 
and drug dealing in the capital. Addressing a seminar organised by the DCBA in January 2014, its 
CEO, David Brennan, said:  
 
We seek a system that manages the individual…. We envisage a non-adversarial justice 
system that deals with the underlying causes of the offences and seeks to help the person and 
provide relevant support services to the perpetrators of these low level crimes and reduce 
reoffending. We ask the Government to consider establishing a working committee to 
establish a pilot for Community Courts in the capital. (Dublin City Business Association 2014, 
29 January)   
 
The seminar also heard presentations from Julius Lang of the Centre for Court Innovation in New 
York and from Phil Bowen of its affiliate organisation in the UK.18 After the seminar both speakers 
addressed the Joint Oireachtas Committee on Justice, Defence and Equality, which had convened a 
meeting to discuss the feasibility of introducing such a community court system in Ireland (Lang and 
Bowen 2014, January 29). There are currently more than 60 community courts in operation 
internationally, mostly in the United States where they began, and more recently in South Africa, 
England, Wales, Scotland, Australia and Canada. In a 2007 report making the case for community 
courts in Ireland, the National Crime Council (NCC) recommended the establishment of such a court 
in Dublin’s inner city to deal with ‘quality of life offences committed in the Store Street and Pearse 
Street Garda station catchment areas’ (National Crime Council 2007).  
 
Community courts, sometimes called community justice centres, have a number of characteristics that 
differentiate them from traditional courts. In particular, according to the NCC report, community courts: 
- are designed to help defendants to solve the problems that underlie their criminal behavior, 
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- hold defendants to account for the specific incidents that brought them to court, 
- consult with local stakeholders in setting and accomplishing priorities, 
- are pro-active in preventing crime rather than merely responding when a crime has occurred, 
- bring the criminal justice agencies (courts, prosecutors, defence lawyers and police) into close co-
ordination to address community issues, and 
- strive to create an atmosphere which is conducive to engaging communities.  
 
With regard to the last objective, community courts are normally located in a particular locality and 
their jurisdiction is limited to that neighbourhood. They are presided over by a dedicated judge who 
can, as a consequence, develop an in-depth understanding of the problems in the area and a 
familiarity with local stakeholders, supports and services. The logic behind this approach was 
explained by Julius Lang, in his presentation to the Oireachtas Committee where he referred to the 
setting-up of the first community court in Times Square, New York, in the early 1990s (Lang and 
Bowen 2014, January 29). The crime problem in Times Square was ‘a combination of complex social, 
economic, health and other issues and, as such, it defies easy solutions. … It was a type of crime that 
did its damage through an accumulation of relatively small but constant insults to the social fabric’ (p. 
3). Times Square had become a ‘mecca for the small and ugly, including street prostitution, open-air 
drug dealing, drunken brawling, assaults, shoplifting and illegal street trading’ (p. 4). The model 
adopted in response was described as: 
 
… a court with a geographic focus which would harness the power of the justice system to 
work with the community to solve local problems. …typical punishment consists of a 
combination of a community restitution assignment and mandated social services. These 
responses are delivered quickly, not days or weeks after the fact, often on the same day or 
next day after sentencing. (p. 4) 
 
Evaluations of community courts have provided mixed results (Henry and Kralstein 2011). Philip 
Bowen, in his presentation to the Oireachtas Committee, explained that various evaluations had found 
that community courts can lead to reductions in the use of jail sentences, increased compliance with 
community-based court orders, decreases in crime such as prostitution and illegal street trading, and 
positive cost-benefit outcomes (Lang and Bowen 2014, January 29). On the other hand, the recent 
closure of the North Liverpool Community Justice Centre was prompted by the low caseload coming 
before the court and the finding that the project did not reduce re-offending at a greater rate than the 
UK average. 
 
In advocating the establishment of a community court in Dublin, the NCC recommended that its remit 
should primarily involve responding to public order offences, most of which, the evidence shows, are 
alcohol-related (Institute of Criminology 2003). (See also the report on the Probation Service survey 
on youth offending, described in Section 9.4 above, in which alcohol figured prominently.) In response 
to drug-related offences, a community court could also function as a gateway to treatment services, or 
indeed, to the Drug Treatment Court, which has been operating in Dublin for many years ((Health 
Research Board 2013): Chapter 9.6). Substance-related crime and anti-social behavior in Dublin city 
centre are not new phenomena, but they have attracted a great deal of attention in recent years 
(Strategic Response Group 2012). The establishment of a community court would represent a novel 
approach to this old issue. 
 
In July 2014 the Joint Oireachtas Committee on Justice, Defence and Equality published its report on 
community courts and recommended that a pilot community court be established in central Dublin 
‘under the supervision of a single judge, supported by an implementation group and with the support 
of local community groups and services’ (Joint Committee on Justice Defence and Equality 2014). 
Responding to the recommendation, the Minister for Justice  and Equality, Frances Fitzgerald TD, 
stated her intention to bring forward proposals for the establishment of such a court: ‘I believe that 
appropriate planning is the key to getting an effective court in place and it will also entail significant 
consultation with all stakeholders including the community itself.’ (Department of Justice and Equality 
2014) 
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9.7 Drug use and problem drug use in prison 
Drug use in Irish prisons, 2011 
The NACDA has published the results of a survey estimating the extent of drug use and the 
prevalence of blood-borne viruses among the prison population in Ireland (Drummond, et al. 2014). 
The survey questionnaire was completed by a random sample of prisoners between February and 
April 2011. Oral fluid samples were obtained to assess use of specific drugs (cannabinoids, opiates, 
methadone, cocaine and benzodiazepines) in the 24 to 72 hours preceding the survey and to detect 
the presence of hepatitis B, hepatitis C and HIV infections.  
 
See Chapter 4.3.2 earlier in this report for a detailed account of the methodology, and of the findings 
with regard to prevalence and patterns of drug use among prisoners. Chapter 6.2.1 gives an account 
of the study’s findings with regard to the prevalence of blood-borne viruses among the prison 
population. 
 
 
9.8 Reintegration of drug users after release from prison 
Need for drug treatment in Irish prisons, 2011 
As part of the NACDA’s survey estimating the extent of drug use and the prevalence of blood-borne 
viruses among the prison population in Ireland in 2011 (Drummond, et al. 2014), participants were 
asked about their need for drug treatment. See Chapter 5.3 earlier in this report for an analysis of the 
responses. 
 
Drugs, alcohol and substance use/misuse: policy for children detention schools 
The Irish Youth Justice Service (IYJS) published a document setting out a policy framework within 
which children detention schools should manage issues relating to substance use/misuse (Drugs 
Policy Working Group and Irish Youth Justice Service 2013). The policy was informed by two key 
objectives: (1) to keep children detention centres/schools drug- and alcohol-free and free of 
substance use/misuse, and (2), in respect of young people actively involved in drug and substance 
use/misuse prior to admission or who are dependent on drugs/alcohol, to provide access to 
counselling and medical services. The policy document stated that ‘individual programmes of care for 
each child will actively reflect these two key objectives’ (p. 4). The policy document covered health, 
welfare and rehabilitation, education and training issues in relation to substance use/misuse and also 
provided details on procedures for conducting drug searches and testing. 
 
9.8.1 Drug treatment  
The number of clients registered for methadone maintenance treatment (MMT) in prisons on 31 
December each year is reported by the Central Treatment List (CTL) (see Standard Table 24 and 
Chapter 5.3.1 earlier in this report). On 31 December 2013, 9,640 clients were registered for MMT 
(including those receiving methadone in prison) (personal communication, Caroline Comar, CTL).  Of 
these, 524 (5.4%) received treatment in prisons. The number of clients registered as receiving MMT 
in prison has increased from 345 in 2004 to 524 in 2013.  However, the proportion of clients treated in 
prison has remained relatively stable over the past number of years. In 2013, the vast majority were 
male (94%) and the largest proportion (29%) were aged between 30 and 34 years, the same as in 
2012.  
 
As part of the NACDA’s survey estimating the extent of drug use and the prevalence of blood-borne 
viruses among the prison population in Ireland, participants were asked about their need for drug 
treatment (Drummond, et al. 2014).  They were asked if they ever needed different types of drug 
treatment while in prison, and whether those services were available to them (within a reasonable 
time frame) and, if available, whether they used those services. See Chapter 5.3 earlier in this report 
for an account of the findings. 
 
Drug treatment pharmacists were introduced in Mountjoy Prison in 2008, primarily to ensure the safe, 
accurate and efficient dispensing of methadone. The pharmacists currently dispense in 13 different 
locations in the Mountjoy complex.  While the safe dispensing of methadone remains the priority, 
since 2010 pharmacists have also been supervising and managing pharmacist–patient structured 
methadone detoxification, otherwise known as self-directed detoxification (SDD). Anecdotally this 
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system has proved successful. However, a review of the outcomes of all pharmacist–patient 
structured methadone detoxifications in Mountjoy Prison in Dublin between June 2010 and May 2014 
was undertaken in order to determine the exact number of prisoners involved in SDD and to assess 
the outcomes.  For the results of this review, see Chapter 5.2.2.2 earlier in this report. 
 
9.8.2 Prevention and reduction of drug-related harm 
See Chapter 5.3 earlier in this report for recommendations relating to harm reduction in prisons, 
contained in the recent NACDA survey on the extent of drug use and the prevalence of blood-borne 
viruses among the prison population in Ireland (Drummond, et al. 2014).   
 
Drug-free units 
In October 2013 the Jesuit Centre for Faith and Justice (JCFJ) published a report on the progress 
achieved under the Irish Prison Service’s (IPS) three-year strategic plan 2012–2015 (Jesuit Centre for 
Faith andJustice 2013); ((Health Research Board 2013): Chapter 9.8.1). With regard to drug-free units 
(DFUs), the JCFJ stated that DFUs currently existed in seven closed prisons, with 417 spaces 
available in these units.  Despite a commitment by the IPS to establish DFUs in all prisons by the end 
of 2013, the JCFJ report stated that they were still not available to approximately a quarter of the 
prison population: ‘With no drug-free unit in either prison of the midland complex, which includes 
Ireland’s largest prison, more than 1,000 prisoners do not have access to drug-free accommodation’ 
(p. 19). The report also noted that, according to the Department of Justice, 91% of national drug-free 
accommodation places were filled. The IPS in its annual report for 2013 stated that the establishment 
of DFUs in these prisons was a priority for early 2014 (Irish Prison Service 2014). 
 
 
9.8.3 Prevention, treatment and care of infectious diseases 
In 2014 the National Advisory Committee on Drugs and Alcohol (NACDA) published the findings of a 
study it commissioned to estimate the prevalence of drug use, including intravenous drug use, among 
the prisoner population in Ireland in order to determine the need for drug treatment and harm 
reduction (including needle exchange) services in Irish prisons.  The study was conducted in 2011 
(Drummond, et al. 2014). The findings are reported on in this national report as follows: 
- Chapter 4.3.2: survey methodology, and the demographic characteristics and prevalence of drug 
use in the sample population; 
- Chapter 5.3: survey respondents’ perceptions of their need for drug treatment, and the availability 
of those services; and   
- Chapter 6.2.1: prevalence of blood-borne viruses in Irish prisons. 
 
The authors of the study made the following recommendations for drug treatment services in prison: 
- Prisoners on MMT should be placed on an HSE clinic list or GP list to ensure that there is 
continuity of treatment on release from prison.  This would reduce the risk of overdose or early 
relapse. 
- If a prisoner is engaging with counselling, where possible there should be continuity of this 
treatment on release in order to support transition out of prison and into the community. 
- A full range of drug treatment options, encompassing an integrated clinical and psychological 
approach, should be available in all closed prisons. 
- There is a need for drug-free wings and drug-free areas not only for prisoners who do not use 
drugs but for those who wish to avoid relapse. 
- As the women’s prison was included in the ‘very high’19 drug-use prison category, it is 
recommended that there be a specific strategy for the needs of women in order to improve their 
outcomes.  
 
 
9.8.4 Prevention of overdose-risk upon prison release 
The report by the JCFJ, discussed above in Section 9.8.2, also argued that, despite the IPS strategic 
plan, there was ‘inadequate planning for the continuation of drug treatment on release’ and that this 
‘continues to hamper the effectiveness of drug treatment services in the Irish prison system’. The 
                                               
19
 See Chapter 5.3 earlier in this report for an explanation of ‘very high’ drug-use prison category.  
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report recommended the provision of custodial drug treatment, as provided for in section 28 of the 
Misuse of Drugs Act, 1977: 
 
Custodial drug treatment, as set out in the act, allows the court to order that a person convicted of 
certain drug offences be detained in a custodial drug treatment centre for up to one year, and that on 
successful completion of such a programme, a period of probation or suspended sentence would be 
imposed in lieu of imprisonment. ….the existing provisions in legislation should be considered by the 
courts in the sentencing of drug-related offences. ((Jesuit Centre for Faith andJustice 2013): p.18)  
 
 
9.9 Reintegration of drug users after release from prison 
Research on recidivism 
The IPS, the Probation Service and the CSO have established a partnership to conduct research on 
prisoner recidivism and on re-offending rates among offenders on supervision in the community 
((Health Research Board 2013): Chapter 9.9). Two studies were published by the CSO in December 
2013. The first study, of probationer recidivism, was based on an analysis of individuals who were 
placed on probation orders or community service orders in the year 2008 and their subsequent levels 
of re-offending (Central Statistics Office 2013a). Recidivism, in this context, relates to the 
probationer’s first subsequent conviction. The study found that over 40% of offenders re-offended 
within three years. Re-offending rates differed significantly, however, ‘when considering demographic 
factors, type of probation service supervision and the initial offence’ for which the offender was placed 
on probation. Recidivism was higher among males than females, and  among younger offenders. 
When compared with a recidivism study of a 2007 cohort (Irish Prison Service and Central Statistics 
Office 2013)  and ((Health Research Board 2013): Chapter  9.9), the study showed that the recidivism 
rate among the 2008 cohort fell for most offence groups, including controlled drug offences, where it 
decreased by 3.3%. However, there was a rise in recidivism for fraud, deception and related offences. 
With regard to the type of probation, of those placed on community service orders (n=1,205), 38.4% 
re-offended within three years, while among those issued with probation orders, the rate was 42.3%. 
In terms of offence type, the highest rates of recidivism were for burglary and related offences and 
weapons and explosives offences. 
 
The second study, of prisoner recidivism, found that in 2008, 5,489 individuals were released from the 
custody of the IPS and, of these, 2,802 (51%) re-offended within three years (Central Statistics Office 
2013b). Most of those who re-offended did so within six months of their release. When compared with 
a 2007 cohort of released prisoners, the study found that there was a 4.35 decrease in the recidivism 
rate; the recidivism rate fell among all age groups and most offence groups. However, unlike the 
study of probationer recidivism, the study of prisoner recidivism showed there was a rise in recidivism 
for controlled drug offences between 2007 and 2008, from 43.8% to 49%. 
 
Community return 
The Community Return scheme is a joint Probation Service and IPS initiative whereby selected 
prisoners are granted temporary release on condition they perform unpaid supervised work in the 
community ((Health Research Board 2013): Chapter 9.9). Both services report continued success in 
the development of this scheme in 2013, with 396 structured releases provided, exceeding  the 
annual target of 300 (Irish Prison Service 2014), (Probation Service 2014). 
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10. Drug Markets 
10.1 Introduction 
The first comprehensive study of illicit drug markets in Ireland is due to be published by the National 
Advisory Committee on Drugs and Alcohol (NACDA) and the Health Research Board (HRB) in late 
2014. A detailed summary of the relevant findings from this study were presented in the National 
Report for 2011 (Health Research Board 2011) (Chapter 10).  Most of the data from that study are not 
yet available, however. Data from several other information sources which give indications of the 
nature and size of the illicit drugs market in Ireland are presented here. 
 
Prevalence surveys may ask respondents about their access to illicit drugs and about the availability 
of various drugs. For example, the all-Ireland general population drug prevalence survey, described in 
detail in Chapter 2.1 of this report, asks respondents how they obtained individual substances  (who 
from and under what circumstances), where did they obtain them (in what type of location) and how 
easy were they to obtain. The European School Survey Project on Alcohol and Other Drugs (ESPAD), 
reported in the National Report 2012  (Health Research Board 2012) (Chapter 2.3), contained a 
question, the answer to which indicated the perceived availability of some illicit substances – ‘How 
difficult do you think it would be for you to get each of the following (cannabis, amphetamine, 
ecstasy)?’ 
 
Data on drug seizures by Customs Drug Law Enforcement (CDLE) and the Garda Síochána 
sometimes provide insights into the origins of drugs being brought into Ireland, and the nature of the 
market in terms of supply and availability. However, these data must be treated with caution as the 
number of drug seizures in any given period can be affected by such factors as law enforcement 
resources, strategies and priorities, and by the vulnerability of traffickers to law enforcement activities.  
 
Drug offence data published by the Central Statistics Office (CSO) can assist in understanding 
aspects of the operation of the illicit drug market in Ireland. With regard to the so-called middle market 
level, which involves the importation and internal distribution of drugs, data on drug supply offence 
prosecutions by Garda division are a possible indicator of national drug distribution patterns. While 
these data primarily reflect law enforcement activities and the relative ease of detection of different 
drugs, they may also provide an indicator of national drug distribution trends. These data can be 
compared with other sources such as drug treatment data, for example, to show trends in market 
developments throughout the State. Such data can also indicate trafficking patterns by showing 
whether there is a concentration of prosecutions along specific routes.  
 
For policing purposes Ireland is divided into six regions, each of which is commanded by an Assistant 
Commissioner. Each region is divided into divisions commanded by a Chief Superintendent, and each 
division is then divided into districts commanded by a Superintendent, who is assisted by a number of 
Inspectors. The districts are divided into sub-districts, each normally the responsibility of a Sergeant.  
 
The six regions are: 
 Dublin Metropolitan Region  
 Northern Region  
 Western Region  
 Eastern Region  
 Southern Region  
 South Eastern Region 
 
Each region is divided into divisions commanded by a Chief Superintendent, and each division is then 
divided into districts commanded by a Superintendent, who is assisted by a number of Inspectors. 
The districts are divided into sub-districts, each normally the responsibility of a Sergeant.  
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Map 10.1.1 Irish Garda regions and divisions 
 
The Forensic Science Laboratory (FSL) provides impartial scientific evidence following examination 
of crime scenes, including seizures of drugs. However, not all drugs seized by the law enforcement 
agencies (An Garda Síochána or CDLE) are necessarily analysed and reported on by the FSL. For 
example, if no individual is identified in relation to the drug seizure, and no prosecution takes place, 
the drugs may not be sent for analysis and may be destroyed.  Moreover, drug purity data are not 
collated in a systematic way at different market levels in Ireland. The primary function of the FSL in 
this area relates to supporting the criminal justice system, and not to research. Only a very small 
proportion of drugs seized are tested to ascertain the percentage purity. Occasionally, the FSL 
conduct ad hoc studies on drug seizures and purities and these are reported when available.   
 
Drug prices are not regularly reported on in Ireland. However, An Garda Síochána monitor drug 
markets on a nationwide basis annually and record current drug values. These are also reported 
when available. 
 
10.2 Supply to and within the country 
10.2.1 - Drugs origin: national production versus imported 
See National Report 2013 for most recent information (Health Research Board 2013). 
 
10.2.2 Trafficking patterns, national and international flows, routes,  
modi operandi; and organisation of domestic drug markets 
Forced labour in the production of cannabis is the subject of a research report by the Migrant Rights 
Centre Ireland (MRCI) (Migrant Rights Centre Ireland 2014). According to MRCI, this phenomenon 
involves human trafficking for the purpose of criminal exploitation. The study examined trafficking for 
cannabis production ‘specifically focusing on cases and reports where Vietnamese and Chinese 
nationals were involved’ (p.1). The research is part of a wider European study led by the Anti-Slavery 
International (ASI) Race in Europe project. ASI has identified a trend of victims being trafficked from 
Vietnam to Ireland via the UK in recent years. 
 
In Ireland, human trafficking for criminal exploitation has only recently been criminalised, under the 
Criminal Law (Human Trafficking) (Amendment) Act 2013. Consequently, there is limited available 
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data on the effect of the legislation. The MRCI study involved semi-structured interviews with 
members of the legal profession, the Anti-Human Trafficking Unit (AHTU) of the Department of 
Justice and Equality, which was established in 2008, the Human Trafficking Investigation and Co-
ordination Unit within An Garda Síochána, established in 2009, and the Chaplain Service at Mountjoy 
Prison in Dublin. An analysis of media articles and press releases was also conducted and a number 
of case studies were presented in the MRCI report. 
 
The report highlighted the increase in domestic cannabis cultivation in Ireland in the last five years, 
noting the dismantling of 500 cannabis cultivation sites by the gardaí during 2011. It referred to a 
recent EU drug market study by the EMCDDA and Europol which reported the involvement of 
Vietnamese and Chinese organised crime groups (OCGs) in cannabis cultivation in Ireland (European 
Monitoring Centre for Drugs and Drug Addiction and Europol 2013). (For a review of this study, see 
Chapter 10.2.2 of the 2013 National Report (Health Research Board 2013).) According to the MRCI, 
there were 80 people of Asian origin in Irish prisons in 2013 for drug-related offences, with 50 of these 
in custody for cannabis cultivation. The report referred to numerous newspaper and online media 
articles about cases involving Vietnamese and Chinese nationals, and presented two case studies, of 
which abridged versions are given here: 
– MR W was offered the opportunity to move to Ireland from the UK, where he had been paid below 
the minimum wage for a number of years. He was offered work in a Chinese restaurant as a 
porter. On arrival in Ireland, he was taken to a small house in a rural location. He was told to water 
the plants in the house and that, if he tried to escape, he would be killed by the recruiter’s boss, 
who was Irish. W escaped and contacted An Garda Síochána. He was hospitalised for a number 
of days suffering from exposure. He was then arrested on drugs charges and later imprisoned. 
The courts requested An Garda Síochána to conduct an assessment of human trafficking. 
Trafficking was not identified by the relevant Garda in this case. 
– Mr B, a Vietnamese national, was offered a job in Ireland as a gardener. He was smuggled out of 
Asia and ended up in an industrial estate in rural Ireland. He was locked in a barn and ordered to 
look after hundreds of plants and control the hoses, lights and heaters. He slept on a mattress and 
was brought food once a week. He had no idea what country he was in, but he knew he was 
minding a cannabis factory. When police located the barn, they found Mr B locked inside. Through 
an interpreter he told them he had been kept as a slave, forced to tend to the plants and 
threatened with violence. He told them he had received no money. Mr B was charged with 
possession of the plants and faces a mandatory minimum ten-year prison sentence.  
 
The report stated that, ‘out of all the Vietnamese nationals who have been arrested and charged with 
cannabis cultivation since 2010, no cases of trafficking for forced labour have been identified by An 
Garda Síochána’ (p. 5); as a consequence, ‘potential victims are being prosecuted, convicted and 
imprisoned for crimes they may have been forced to commit – while their traffickers enjoy impunity’ (p. 
5). MRCI argued that the inability of An Garda Síochána to identify victims in such circumstances has 
created the need for such victims to be ‘formally identified’ by an agency such as the Health Service 
Executive, with the co-operation of MRCI, so that victims can receive the care and attention they 
require.  
 
Among the study’s recommendations were the following: 
– All cases of potential trafficking for forced labour in cannabis production should be investigated for 
human trafficking by An Garda Síochána. 
– An independent national rapporteur should be appointed by the government to identify trends in 
human trafficking and address problems of lack of identification and prosecution. 
– Victims should be provided with a reflection and recovery period, safe accommodation, health 
care, counselling and financial supports where they have been identified as a suspected victim of 
human trafficking. 
– Training needs to be provided by ASI and MRCI for investigators, prosecutors, judiciary, and the 
legal profession to equip them with the skills to identify such victims. 
– A non-punishment clause should be included in the Criminal Law (Human Trafficking) Act 2008 to 
ensure victims of trafficking are exempt from prosecution for offences they were forced to commit. 
 
MRCI intends to conduct further research in this area in the future as more information becomes 
available. 
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10.3 Seizures 
The number of drug seizures in any given period can be affected by such factors as law enforcement 
resources, strategies and priorities, and by the vulnerability of traffickers to law enforcement activities. 
However, drug seizures are considered indirect indicators of the supply and availability of drugs (see 
Standard Table 13). 
 
10.3.1 Quantities and numbers of seizures of all illicit drugs 
Cannabis seizures account for the largest proportion of all drugs seized. Figure 10.3.1.1 shows trends 
in cannabis-related seizures and total seizures between 2004 and 2013. The total number of drug 
seizures increased from 5,299 seizures in 2004 to a peak of 10,444 seizures in 2007. Between 2008 
and 2010, the number almost halved, to 5,477. This decrease can be explained primarily by the 
significant decrease in cannabis-type substances seized. Although, as explained in Section 10.1 
above, not all drugs seized by law enforcement are necessarily analysed and reported by the FSL, it 
is difficult to know if the reduction in cannabis-related seizures reflects a decline in cannabis use or a 
reduction in law enforcement activity. Following a slight increase in 2011, cannabis seizures have 
trended downwards slightly. 
 
 
Figure 10.3.1.1 Trends in the total number of drug seizures and cannabis seizures, 2004–2013  
Sources: FSL 2005–2014 unpublished data  
 
The decrease in cannabis seizures between 2008 and 2010 may also be partly explained by a 
change in the nature of cannabis use, with people moving from resin to more potent forms of 
cannabis, such as herbal cannabis. For example, Figure 10.3.1.2 shows that although seizures of 
cannabis resin decreased between 2009 and 2013, seizures of cannabis plants increased steadily 
between 2007 and 2011, with a slight decrease between 2011 and 2013. Herbal cannabis seizures 
almost doubled between 2009 and 2011, from 981 to 1,833, and plateaued in the two subsequent 
years. That there has been a move in consumption away from cannabis resin and towards more 
potent forms of cannabis is supported by the findings of the 2010/11 all-Ireland prevalence survey on 
drug use (National Advisory Committee on Drugs and Alcohol 2013). 
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Figure 10.3.1.2 Trends in the total number of drug seizures by cannabis type, 2007–2013 
Sources: FSL 2008–2014 unpublished data 
 
Other controlled drugs 
The reduction in the total number of reported seizures since 2008 shown in Figure 10.3.1.1 above 
may also be explained by a reduction in the number of seizures of other drugs. Figure 10.3.1.3 shows 
trends in seizures for a selection of drugs, excluding cannabis, between 2007 and 2013. There was a 
significant decline in seizures of cocaine and heroin between 2007 and 2011. Although heroin 
seizures increased slightly in 2012, they decreased again in 2013. Cocaine seizures have continued 
on a downward trend since 2008. Seizures of ecstasy-type substances also decreased significantly 
between 2008 and 2010. However, in 2011, they increased by more than 900%. This upward trend 
continued in the subsequent two years. 
 
 
Figure 10.3.1.3 Trends in the number of seizures of selected drugs, excluding cannabis, 2007–2013 
Sources: FSL 2008–2014 unpublished data 
 
Illicit street-level retail market in prescription drugs 
Another factor that may be impacting on the seizure trends for illicit drugs is the illegal street sale of 
prescription drugs. This has emerged as an important issue in the Irish drug scene in recent years 
(see the 2012 and 2013 National Reports (Health Research Board 2012) (Chapter 1.2), and (Health 
Research Board 2013) (Chapter 10.3). The government is currently reviewing the Misuse of Drugs 
Regulations with a view to introducing additional controls on certain prescription drugs being traded 
illicitly (Health Research Board 2013) Chapter 1.2.2). 
 
Table 10.3.1.1 shows trends for some of the main prescription drugs, primarily benzodiazepines and 
Z-hypnotics, seized by An Garda Síochána and analysed by the FSL in recent years. There has been 
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a significant increase in the seizures of alprazolam and diazepam since 2009, while seizures of 
zopiclone have trebled since 2009.  
 
Table 10.3.1.1 Seizures of a selection of benzodiazepines and z hypnotics 2009-2013 
  
2009 2010 2011 2012 2013 
Alprazolam 42 89 121 111 145 
Diazepam 
 
270 448 479 463 450 
Flurazepam 34 37 46 52 35 
Zopiclone 
 
67 138 155 0 205 
Source: FSL 2010–2014 unpublished data 
 
 
Table 10.3.1.2 All drugs seized that were reported on by the FSL, 1 January–31 December 2013 
Drug Quantity No.Cases 
Alprazolam 155,665 tablets 145 
Amphetamine 22, 735 grams 77 
Buprenorphine 145 tablets 2 
BZP  1,245 tablets, 14.63 grams 7 
Cannabis 1,101,745.625 grams 1770 
Cannabis resin 677,246.359 grams 367 
Cannabis plants* 6,309 plants 427 
Chlorpheniramine 241 tablets 2 
Clonazepam 2,032 tablets 16 
Cocaine 65,975.100 grams 366 
Diamorphine  (Heroin) 60,663.689 grams 690 
Diazepam 96.766 grams 92,049.034 tablets 450 
Dihydrocodeine 281 tablets, 1.5 gram 7 
Ephedrine 226 tablets 3 
Ecstasy MDMA 462,934 tablets 434 
Flephedrone 13.057 grams 1 
Flunitrazepam (Rohypnol) 1,639 tablets 6 
Flurazepam 44 tablets 783 capsules 35 
Fluroamphetamine 317.946 grams 5 
JWH-018 1,042.180 grams 4 
JWH-073 3.150 grams 1 
Ketamine 60.229 grams 19 
LSD 889 squares 10 
MDEA 2,149  tablets 30 
Methandienone** 434 tablets 9 
Methadone 7,062 mls 26 
Methylamphetamine 2,936.019 grams 4 tablets 37 
Methylone 1,347.855 grams 12 
Methyltestosterone 805 tablets 11 
Morphine 409 tablets 2 
Phenacetin 12,763.827 grams 5 
PMA 216 tablets 5 
PVP 22,096.144 grams 81 
Sildenifil** 1116 tablets 19 
Stanozolol** 502 tablets 5 
Temazepam 707 tablets 6 
Triazolam 140 tablets 7 
TFMPP 5,313 tablets 26 
Zolpidem 5,379 tablets 7 
Zopiclone** 16,226 tablets 205 
The list of drugs is a record of main categories of drugs delivered to the FSL and reported on for 2013. There may be some large 
cannabis/cannabis resin cases without a suspect, in relation to which no analysis was conducted and no weight was determined.  
*The number of cannabis plants does not reflect the total number detected as only a sample of the plants is sent for analysis.  
** These drugs were not controlled under the Misuse of Drugs Acts, 1977 and 1984.  
Source: FSL unpublished data 2014 
 
 
10.3.2 Quantities and numbers of seizures of precursor chemicals 
 used in the manufacture of illicit drugs 
See 2010 National Report for most recent information (Irish Focal Point (Reitox) 2010). 
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10.3.3 Number of drug production sites (and related facilities) dismantled; 
 description of methods of production; and precise type of illicit drugs 
 manufactured there 
 
The annual report of An Garda Síochána for 2013 reported that there were 28,851 cannabis plants 
seized from a total of 394 cultivation and/or manufacture incidents as part of ongoing Operation 
Nitrogen. (For a discussion of this operation, see Chapter 10 in the 2013 National Report (Health 
Research Board 2013) and page 4 of the 2013 annual report of An Garda Síochána (An Garda 
Siochana 2014).) The annual report also reported that 157 grow houses were detected during 2013 
(p. 40). 
 
10.4 Availability 
10.4.1 Perceived availability of drugs, exposure, access to drugs 
  e.g. in general population, specific groups/places/settings, problem drug users 
 
As part of a recent Flash Eurobarometer survey on young people and drugs, described in Chapter 
1.3.3 earlier in this report, respondents were asked about the perceived availability of drugs. Around a 
quarter of respondents believed it would be easy to obtain cocaine, new substances that imitate the 
effects of illicit drugs, and ecstasy; over half believed it would be easy to obtain cannabis.  
 
Table 10.4.1.1 presents the responses from Ireland and the UK, of which Ireland is sometimes 
regarded as a sub-market for certain drugs, and the EU average with regard to ease of access. The 
proportion of Irish respondents who responded that it was ‘very easy’ to obtain certain substances 
was above the proportion across all EU member states for all substances, except tobacco.  Of the 
Irish respondents, 40% said cannabis was ‘very easy’ to obtain compared to 29% of respondents 
across all member states.  Ecstasy was regarded as very easy to obtain by 19% of Irish respondents 
compared to 7% across all member states.  Perceived availability of heroin was broadly similar across 
Ireland, the UK and the EU. In Ireland, relative to the UK, perceived availability was higher for all 
substances except for new substances that imitate the effects of illicit drugs. 
 
 
Table 10.4.1.1  Flash Eurobarometer June 2014, number (%) who responded ‘Very easy’ to the question ‘How 
difficult or easy do you think it would be for you personally to obtain the following substances within 24 hours?’ 
Substance EU average United Kingdom Ireland 
Cannabis 3807 (29%) 167 (33%) 202 (40%) 
Alcohol 10561 (81%) 404 (80%) 419 (84%) 
Cocaine 1033 (8%) 68 (14%) 74 (15%) 
Ecstasy 916 (7%) 55 (11%) 96 (19%) 
Tobacco 10439 (79%) 369 (73%) 390 (78%) 
Heroin 503 (4%) 21 (4%) 26 (5%) 
New substances that  imitate the effects of illicit drugs 964 (7%) 66 (13%) 45 (9%) 
Source: (TNS Political and Social 2014) 
 
Table 10.4.1.2 presents the answers to a question about the supply of ‘new substances that imitate 
the effects of illicit drugs’ during the previous 12 months. Most respondents across the EU reported 
receiving them from a friend. The second main supply source was a ‘drug dealer’, with Ireland below 
the EU average (24%/ vs 27%) but the UK, at 39%, was 12 percentage points higher than the EU 
average. Only 3% of respondents reported buying new substances via the internet. In Ireland, the 
proportion was 5%. 
 
Table 10.4.1.2 Flash Eurobarometer June 2014, responses to the question ‘Thinking about your use of new 
substances in the last 12 months, how did you get them?’ by number (%) 
Source:   (TNS Political and Social 2014) 
 
Country EU average United Kingdom Ireland 
Total respondents 508 27 44 
I was given or bought them by a friend 347 (68%) 16 (58%) 27(61%) 
I bought them from a specialised shop 49 (10%) 5(18%) 7(16%) 
I bought them from the internet 15 (3%) 2(6%) 2(5%) 
I bought them from a drug dealer 136 (27%) 10 (39%) 11(24%) 
Other 29 (6%) 1 (2%) 1(2%) 
Don’t know/ no answer 7 (1%) 0 0 
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10.4.2 Price of illicit drugs at retail level and wholesale level 
It was reported in the media that payments made to prostitutes and the money made from illicit drug 
deals are to be included in the official record of the wealth generated by the country each year. This 
story appeared in the printed version of the Irish Examiner on 31 May 2014 (2014c). The CSO, the 
article reported, ‘confirmed that the gross domestic product figures it will release at the end of June 
will be higher as a result of the inclusion of what the EU describes as "production forbidden by law, 
e.g. prostitution and production of drugs".’ The article stated that the ‘move to include illegal trade 
follows new Eurostat guidelines for countries to include all economic transactions in the statistics, so 
that those with differing legislation around drugs and prostitution can compare their total economic 
activity’.  
 
Responding to a Parliamentary Question on the issue, Minister for Finance Michael Noonan TD, 
stated: 
 
Section 13 of the 1993 Statistics Act provides that the Director General of the Central 
Statistics Office (CSO) has sole responsibility for, and is independent in, the exercise of the 
functions of deciding the statistical methodology and professional statistical standards used by 
the Office, as well as the content of statistical releases and publications issued by the Office. 
Regarding the challenge of accurately measuring illicit activities, I am informed by the CSO 
that this is difficult. Statisticians use any available data that can produce a repeatable estimate 
for these activities over time. The illegal nature of these activities makes it particularly difficult 
to estimate their level and value. Consequently, the estimation methods used can only be 
expected to deliver approximations of the actual levels and value of activity. Data are obtained 
from a range of sources, including the Gardaí and organisations involved in the welfare of 
prostitutes or drug addicts. International research in these matters is also reviewed by the 
CSO. The CSO also inform me that there have been no changes to the methodology relating 
to the measurement of illicit activities recently. (Griffin 2014, 10 June) 
 
National accounts are compiled in the EU according to the European System of National and 
Regional Accounts (ESA) framework. All EU member states had to adopt ESA 2010 by September 
2014. In addition to the ESA 2010 changes, extended estimates for illegal economic activities are also 
included. A press release issued by the CSO in June 2014 stated: 
 
There has been a requirement to include illegal activities in the National Accounts since the 
ESA 95 version of the national accounting standards were introduced but a lack of detailed 
and comprehensive data sources for these activities have been the cause of significant 
measurement difficulties for all EU member states. The European statistical agency, Eurostat, 
has agreed recommendations on the estimation and recording of these activities in recent 
years and now requires each member state to include estimates for illegal activities in their 
National Accounts before September 2014. To comply as far as possible with the Eurostat 
requirement, the revised and additional estimates for illegal activities for Ireland are included in 
CSO's Quarterly National Accounts (QNA) in respect of Q1 2014 and the annual National 
Income & Expenditure accounts (NIE) 2013 releases (Central Statistics Office 2014) . 
 
The percentages in respect of illegal activities supplied in Table 10.4.2.1 include estimates of not only 
the smuggling and production of drugs but also fuel and cigarettes and prostitution. It is not possible 
at present to clarify either the proportion of the total that represents earnings derived from illicit drugs 
or how this figure was calculated. 
 
 
Table 10.4.2.1 Ireland’s gross domestic product (GDP) on an ESA 2010 basis at current market prices 
 2010 2011 2012 2013 
GDP €164.9bn €171.0bn €172.8bn €174.8bn 
contribution of:         
Illegal economic activities   0.73% 0.72% 0.70% 0.72% 
Source: (Central Statistics Office 2014) 
 
For the latest information on drug prices, see Chapter 10.4.1 and Table 10.3.1.2 in the 2013 National 
Report (Health Research Board 2013). The only difference from the process reported last year is that 
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the price of GHB/GBL is currently €1 per ml (Garda National Drugs Unit, personal communication, 
July 2014). 
 
 
10.4.3 Purity/potency of illicit drugs 
An analysis of heroin and cocaine seizures submitted to the FSL between April 2010 and March 2012 
sought to assess the current status of these particular drug markets, ‘in order to track changes in the 
markets, and for comparison to reported European data’ (Boyle, et al. 2014). This study also sought 
to establish whether purity plays a role in the pricing of street drugs. This is particularly important in 
the Irish context as, under the terms of Section 15a of the Criminal Justice Act 1999 (as amended), a 
mandatory minimum sentence of 10 years applies where a person is convicted of possession of drugs 
with a market value of €13,000 or more. (For a recent review of this legislation, see Chapter 1.2.2 of 
the 2013 National Report (Health Research Board 2013)). For the purposes of this legislation, the 
market value is interpreted as the maximum value a drug could realistically be expected to obtain at 
street level when purchased by an end user.  
 
Street-level purity data give an indication of the purity of the substance reaching the end user. Unlike 
markets for legitimate goods, in the illicit drug trade the quality of the commodity is not regulated or 
guaranteed and therefore is something than can only be assessed by the user after consumption. As 
a consequence, just like restaurant meals or used cars, illicit drugs are referred to as ‘experience 
goods’, as their quality is only fully knowable after use (Reuter and Caulkins 2004).  A further 
complicating factor is that adulterants are added to drugs not only to bulk them up for sale but also to 
enhance or mimic the effects of the drug for the user. For example, where a user might believe the 
drugs s/he consumes are of a good quality, this does not necessarily mean that they are of a higher 
purity. (For further discussion of the role of adulterants in drug markets, see (Coomber 2006).) 
 
In Boyle’s analysis of FSL data (Boyle, et al. 2014), quantitative analysis to determine drug purity was 
carried out on randomly selected street-level seizures on a monthly basis during the two-year period 
of the study. Data were also collected on the type and frequency of adulterants detected in the 
seizures. Price information for a subset of the cases quantified and also for a number of cases not 
quantified was obtained from An Garda Síochána. Below, the findings of this analysis are compared 
with an analysis by Connolly and O’Donovan of earlier seizure purity data conducted by the FSL as 
part of a national study of illicit drug markets (Connolly and Donovan In press).  
 
Findings in relation to heroin seizures 
Connolly and O’Donovan’s analysis found an average heroin purity of 45% in a sample of 131 heroin 
seizures from four distinct markets in 2008/2009. In the Boyle analysis, in a sample of 239 
diamorphine (heroin) cases, the mean purity was 47% for 2010, 30% for 2011 and 24% for the first 
three months of 2012. The study revealed ‘a general decline of diamorphine purity over the time 
period, with the 2012 average being nearly half the average purity obtained for 2010’ (p. 2). 
 
Of the 239 heroin samples analysed, 81% contained adulterants/dilutants. The frequency of detected 
adulterants increased from 67% of cases in 2010 to 100% in 2012. This may help explain the drop in 
purity during the same period as it was also found that ‘the mean purity of heroin samples with no 
detected adulterants was 58%, whereas the mean purity…containing adulterants was 31%’ (p. 2). 
The main adulterants found were caffeine and paracetamol, usually together.  
 
In a discussion of drug adulteration, Coomber points out that one of the reasons caffeine is commonly 
found with heroin is that, when heroin is smoked or ‘chased’, caffeine has been shown ‘to enable a 
higher amount of the heroin (around 76%) to be recovered (i.e. the amount of heroin left available in 
the ‘smoke’ which is inhaled), after volatization (the heating, melting and then vaporization of the drug 
for inhalation or ‘chasing’) than when compared to pure heroin alone’ (Coomber 2006) (p. 73). Heroin 
is also commonly adulterated  with paracetamol because the latter has approximately the same 
melting point as heroin and also has analgesic (pain-killing) properties.  
 
As part of the Boyle study described above (Boyle, et al. 2014), the Garda National Drugs Unit 
(GNDU) provided price data for 144 street-level heroin cases submitted to the FSL between 2010 and 
2011. The powder weights for these packs ranged from 0.097g to 1.862g, with an average price per 
gram of €116.71. The most frequent street-pack prices were €20, €25 and €50. There was a 
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correlation between pack sizes and prices, leading the authors to conclude that ‘the driving factor for 
diamorphine prices may not be perceived quality, but perhaps the quantity of drug sold, or customer 
demand in times of limited diamorphine supply’ (p. 3). 
 
Findings in relation to cocaine seizures 
In the Connolly and O’Donovan study (Connolly and Donovan In press), a forensic analysis of 93 
samples of cocaine found that purity levels were generally very low, averaging 14% across the four 
local drug markets studied. The Boyle study (Boyle, et al. 2014), in which purity was determined for 
217 cocaine cases over the 2010–2012 period, made a similar finding, with the average purity 
remaining fairly stable, at 15% for 2010, 19% for 2011 and 17% for the first three months of 2012. The 
study also recorded a larger degree of variation in the purities of cocaine samples when compared to 
those for diamorphine. Ninety-nine per cent of samples contained one or more adulterants, with the 
main ones being lignocaine, levamisole, phenacetin, caffeine and benzocaine. Similar findings have 
also been reported from research on the UK drug market, which, given that these are all substances 
that have either analgesic and/or stimulant properties, showed the ‘purposive nature of such cutting’, 
or adulteration (Coomber 2006) (p. 76). As part of the Boyle study described above (Boyle, et al. 
2014), pricing data were obtained from the GNDU for 17 cocaine seizures for which purity was 
determined during the study period but no correlation was found between price and purity.  
 
When the findings of the study for 2010 were compared to similar data compiled by the EMCDDA, it 
was found that Ireland’s mean purity of diamorphine was the second highest after Turkey and that it 
ranked as the third most expensive after Sweden and Latvia. With regard to cocaine data for 2010, it 
was found that the mean purity of cocaine in Ireland was the lowest reported to the EMCDDA, while 
the price per gram was the second highest after Luxembourg. The compilation and reporting of drug 
purity trend data in studies such as this can enhance our understanding of illicit drug markets and also 
the impact of drug law enforcement interventions on the behaviour of such markets. Studies such as 
this also enable us to provide some context to changes in the behaviour of street-level drug markets. 
For example, it is worth speculating whether the decline in heroin purity since 2010 identified in the 
Boyle study may be linked to the heroin drought of that year, and also whether the poor quality of 
heroin may have contributed to the rise in the street sale and use of benzodiazepines by opiate users 
in recent years (see Chapter 1.2 in the 2011 National Report (Health Research Board 2011)).  
 
Comprehensive chemical profiling of drug seizures can also indicate links between seizures in 
different locations, thereby providing intelligence on patterns of drug supply. Information on the types 
of adulterants used to bulk up drugs for street sale and/or to enhance their quality for the end user 
can provide important public health information. At present, however, the purity of drugs in Ireland is 
not routinely tested (quantified) owing to the resource requirements. 
 
 
10.4.4 Composition of illicit drugs and drug tablets 
These data have never been reported in Ireland. 
  
  121 
 
Part C 
 
13. Bibliography 
The National Documentation Centre (NDC) on drug use is Ireland’s national alcohol and drugs library. 
We have a comprehensive collection of drug and alcohol publications which can be accessed at 
www.drugsandalcohol.ie  The NDC staff compile the bibliography of this National Report on behalf of 
the authors and link to full text publications where possible. 
 
13.1 List of references 
(2014a). Ecstasy users in jeopardy as deaths increase. Irish Examiner, 2 June. Retrieved from 
http://www.drugsandalcohol.ie/21990/ 
(2014b). HSE issues new drug warning after death at Donegal party. Irish Examiner, 27 May. 
Retrieved from http://www.drugsandalcohol.ie/21958/ 
(2014c). Drugs money to form part of GDP. Irish Examiner. Retrieved from 
http://www.drugsandalcohol.ie/21989/ 
Alcohol and Drug Research Unit (2007). 2007 National Report (2006 data) to the EMCDDA by the 
Reitox National Focal Point. Ireland: new developments, trends and in-depth 
information on selected issues. Health Research Board, Dublin. Available at 
www.emcdda.europa.eu/attachements.cfm/att_61198_EN_NR2007Ireland.pdf 
Alcohol and Drug Research Unit (2008). 2008 National Report (2007 data) to the EMCDDA by the 
Reitox National Focal Point. Ireland: new developments, trends and in-depth 
information on selected issues. Health Research Board, Dublin. Available at 
http://www.drugsandalcohol.ie/11486/ 
Allwright, S., Bradley, F., Long, J., Barry, J., Thornton, L. and Parry, J. V. (2000). Prevalence of 
antibodies to hepatitis B, hepatitis C and HIV and risk factors in Irish prisoners: results 
of a national cross-sectional survey. British Medical Journal, 321, (7253), 78–82. 
Available at http://www.drugsandalcohol.ie/6741/ 
An Garda Siochana (2014). An Garda Síochana: annual report 2013. An Garda Siochana, Dublin. 
Available at http://www.drugsandalcohol.ie/22370/ 
Apantaku-Olajide, T. and Smyth, B. P. (2013). Non-medical use of psychotropic prescription drugs 
among adolescents in substance use treatment. Journal of psychoactive drugs, 45, (4), 
340-346. Available at http://www.drugsandalcohol.ie/21192/ 
Apantaku-Olajide, T., James, P. and Smyth, B. P. (2014). Association of educational attainment and 
adolescent substance use disorder in a clinical sample. Journal of Child & Adolescent 
Substance Abuse, 23, (3), 169-176. Available at http://www.drugsandalcohol.ie/21868/ 
Arensman, E., Larkin, C., Corcoran, P., Reulbach, U. and Perry, I. J. (2014). Factors associated with 
self-cutting as a method of self-harm: findings from the Irish National Registry of 
Deliberate Self-Harm. European journal of public health, 24, (2), 292-297. Available at 
http://www.drugsandalcohol.ie/21823/ 
Ballymun Local Drugs Task Force and Safer Balymun (2010). A road to change: Ballymun community 
alcohol strategy. Ballymun Local Drugs Task Force,  Available at 
http://www.drugsandalcohol.ie/13265/ 
Barnardos (2014). Patients. parents. people. Towards integrated supports and services for families 
experiencing mental health difficulties. Barnardos, Dublin. Available at 
http://www.drugsandalcohol.ie/22129/ 
Barry, J. and Ivers, J.-H. H. (2014). Evaluation report of the National Drugs Rehabilitation Framework 
pilot. Health Service Executive, Dublin. Available at 
http://www.drugsandalcohol.ie/21600/ 
Bennett, T. and Holloway, K. (2011). Evaluation of the Take Home Naloxone demonstration project. 
Welsh Assembly Government, Merthyr Tydfil. Available at 
http://wales.gov.uk/docs/caecd/research/110627naloxonefinalreporten.doc  
Boyle, M., Carroll, L., Clarke, K., Clarke, P., Coyle, H. J., English, H. et al. (2014). What's the deal? 
Trends in Irish street-level heroin and cocaine 2010-2012. Drug testing and analysis, 
early online. Available at http://www.drugsandalcohol.ie/21608/ 
  122 
Brady, T. (2014). Death toll from lethal ecstasy tablets rises to 11. Irish Independent, 9 June. 
Retrieved from http://www.drugsandalcohol.ie/22048/ 
Bühler, A. and Kröger, C. (2008). Prevention of substance abuse. EMCDDA Insights 7. Office for 
Official Publications of the European Communities, Luxembourg.  
Burton, J. (2013 June 9) Parliamentary Debates Dáil Éireann (Official report: unrevised): Written 
answers.Community Employment Scheme Numbers. Question(s) 85. Available at 
http://www.drugsandalcohol.ie/20289/ 
Carew, A. M., Cafferty, S., Long, J., Bellerose, D. and Lyons, S. (2013). Travellers accessing 
addiction services in Ireland (2007 to 2010). Journal of Ethnicity in Substance Abuse, 
1, (4), 339–355. Available at www.drugsandalcohol.ie/20892 
Central Statistics Office (2012). Homeless persons in Ireland: a special census report. Central 
Statistics Office, Cork. Available at http://www.drugsandalcohol.ie/18334 
Central Statistics Office (2013a). Probation recidivism 2008 cohort. Central Statistics Office, Dublin. 
Available at http://www.drugsandalcohol.ie/21040/ 
Central Statistics Office (2013b). Prison recidivism: 2008 cohort. Central Statistics Office, Cork. 
Available at http://www.drugsandalcohol.ie/21084/ 
Central Statistics Office (2014) Implementing new international standards for national accounts and 
balance of payments statistics. Press release issued by 3 July. Accessed at 
http://www.cso.ie/en/newsandevents/pressreleases/2014pressreleases/implementingn
ewinternationalstandardsfornationalaccountsandbalanceofpaymentsstatistics/ 
Citywide (2014). Barriers or bridges? Drug rehabilitation projects – the road to recovery. Citywide, 
Dublin. Available at http://www.drugsandalcohol.ie/21512/ 
CityWide Drug Crisis Campaign (2013). Decriminalisation: a new direction for drugs policy. CityWide, 
Dublin. Available at www.drugsandalcohol.ie/20698 
Cloud, W. and Granfield, R. (2009). Conceptualising recovery capital: expansion of a theoretical 
construct. Substance Use and Misuse, 42, (12/13), 1971–1986.  
Committee appointed to Monitor the Effectiveness of the Diversion Programme (2013). Annual report 
of the committee appointed to monitor the effectiveness of the diversion programme 
2012. An Garda Siochana, Dublin. Available at http://www.drugsandalcohol.ie/21160/ 
Connolly, J. (2006). Drugs and crime in Ireland. HRB Overview Series 3. Health Research Board, 
Dublin. Available at http://www.drugsandalcohol.ie/6045/ 
Connolly, J. and Donovan, A. M. (In press). The illicit drug market in Ireland (working title) National 
Advisory Committee on Drugs, Health Research Board, Dublin.  
Conway, M. (2014, 19 June) Seanad Debate.Criminal Justice (Amendment) Act 2009: Motion.  
Available at http://www.drugsandalcohol.ie/22139/ 
Coomber, R. (2006). Pusher myths: re-situating the drug dealer. Free Association, London. Available 
at http://www.drugsandalcohol.ie/4031/ 
Corrigan, D. and O'Gorman, A. (2007). Report of the HSE working group on residential treatment & 
rehabilitation (substance users).  pp. 62. Health Service Executive, Dublin. Available at 
www.drugsandalcohol.ie/6382/ 
Costello, L. (2014). Travellers in the Irish prison system: A qualitative study. Irish Penal Reform Trust, 
Dublin. Available at http://www.drugsandalcohol.ie/21915/ 
Courts Service (2014). Courts service annual report 2013. Courts Service, Dublin. Available at 
http://www.drugsandalcohol.ie/22382/ 
Cronin, B., Ryan, G. and Lyons, S. (2014). An review of pharmacist-patient structured methadone 
detoxification in Mountjoy Prison. Drugnet Ireland, (51).  
Crown, J. (2012, 9 May) Seanad Debate.Protection of Children’s Health from Tobacco Smoke Bill 
2012. Second Stage. Vol. 215.  Available at http://www.drugsandalcohol.ie/17584/ 
Daly, A. and Walsh, D. (2013). Activities of Irish psychiatric units and hospitals 2012. Health Research 
Board, Dublin. Available at http://www.drugsandalcohol.ie/20823/ 
Denyer, S., Sheehan, A., Bowser, A., Children, I. D. o. and Affairs, Y. (2013). Every child a home: a 
review of the implementation of the youth homelessness strategy. Stationery Office, 
Dublin. Available at http://www.drugsandalcohol.ie/20203/ 
Department of Children and Youth Affairs (2014). Better outcomes brighter futures. The national 
policy framework for children & young people 2014 - 2020. Stationery Office, Dublin. 
Available at http://www.drugsandalcohol.ie/21773/ 
Department of Community, Rural and Gaeltacht Affairs (2009). National Drugs Strategy (interim) 
2009–2016. Department of Community, Rural and Gaeltacht Affairs, Dublin. Available 
at http://www.drugsandalcohol.ie/12388/ 
  123 
Department of Education and Skills (2013a). Looking at Social, Personal and Health Education. 
Teaching and Learning in Post-Primary Schools. Department of Education and Skills, 
Dublin. Available at http://www.education.ie/en/Publications/Inspection-Reports-
Publications/Evaluation-Reports-Guidelines/Looking-at-Social-Personal-and-Health-
Education-Teaching-and-Learning-in-Post-Primary-Schools.pdf 
Department of Education and Skills (2013b). Chief Inspector’s Report 2010 -2012. Inspectorate of the 
Department of Education and Skills, Dublin.  
Department of Education and Skills (2014). Results of the Department of Education and Skills 
‘lifeskills’ survey, 2012. Department of Education and Skills, Dublin. Available at 
http://www.drugsandalcohol.ie/21391/ 
Department of Environment, C. and Local Government (2014). Implementation plan on the State's 
response to homelessness May 2014 to December 2016. Department of Environment, 
Community and Local Government, Dublin. Available at 
http://www.drugsandalcohol.ie/21933/ 
Department of Health (2012). Report on the review of drugs task forces and the national structures 
under which they operate. Department of Health, Dublin. Available at 
http://www.drugsandalcohol.ie/19054/ 
Department of Health (2014). National Drugs Strategy 2009-2016: progress report to end 2013. 
Department of Health, Dublin. Available at http://www.drugsandalcohol.ie/21621/ 
Department of Justice and Equality (2014) Minister Fitzgerald welcomes reports of Joint Oireachtas 
Committee on Justice, Defence and Equality. Press release issued by Department of 
Justice and Equality. Accessed at http://www.justice.ie/en/JELR/Pages/PR14000188 
Department of Social Protection (2013). Community employment drug rehabilitation places. 
Department of Social Protection, Dublin. Available at 
http://www.drugsandalcohol.ie/22494/ 
Dermody, A., Gardner, C., Quigley, M. and Cullen, W. (2014). Preventing and responding to overdose 
in McGarry House, Novas. Novas Initiatives, Limerick. Available at 
http://www.drugsandalcohol.ie/22183/ 
Doyle, J. and Ivanovic, J. (2010). National drugs rehabilitation framework document. Health Service 
Executive, Dublin. Available at www.drugsandalcohol.ie/13502/ 
Drugs Policy Working Group and Irish Youth Justice Service (2013). Drugs, alcohol & substance 
use/misuse: policy for children detention schools. Irish Youth Justice Service, Dublin. 
Available at http://www.drugsandalcohol.ie/20917/ 
drugs.ie (2014). The quality standards support project. Accessed on  19 May 2014 at 
http://www.drugs.ie/resources/the_quality_standards_support_project/ 
Drummond, A., Codd, M., Donnelly, N., McCausland, D., Mehegan, J., Daly, L. et al. (2014). Study on 
the prevalence of drug use,including intravenous drug use, and blood-borne viruses 
among the Irish prisoner population. National Advisory Committee on Drugs and 
Alcohol, Dublin. Available at http://www.drugsandalcohol.ie/21750/ 
Dublin City Business Association (2014, 29 January) Dublin City Business Association calls for a 
working committee to establish community courts for the capital. Press release issued 
by DCBA at a seminar organised by the DCBA in Dublin. Accessed on 23 April 2014 at 
http://www.dcba.ie/?m=201401 
European Monitoring Centre for Drugs and Drug Addiction (2008). Towards a better understanding of 
drug-related public expenditure in Europe. Selected Issue. Office for Official 
Publications of the European Communities, Lisbon.  
European Monitoring Centre for Drugs and Drug Addiction and Europol (2013). EU drug markets 
report: a strategic analysis. Publications Office of the European Union, Luxembourg. 
Available at http://www.drugsandalcohol.ie/19227 
Field, C.-A., Klimas, J., Barry, J., Bury, G., Keenan, E., Smyth, B. P. et al. (2013). Problem alcohol 
use among problem drug users in primary care: a qualitative study of what patients 
think about screening and treatment. BMC Family Practice, 14, 98. Available at 
http://www.drugsandalcohol.ie/20447/ 
Fine Gael and the Labour Party (2011). Towards recovery: programme for a national government 
2011–2016.  pp. 64. Fine Gael, Labour Party, Dublin. Available at 
www.drugsandalcohol.ie/14795/ 
Flanagan, L. (2013, 5–6 November) Parliamentary Debates Dáil Éireann (Official report: unrevised): 
motion [private members].Cannabis regulation. Vol. 819 Available at 
  124 
http://oireachtasdebates.oireachtas.ie/debates%20authoring/debateswebpack.nsf/take
s/dail2013110500043?opendocument#QQ00100 
Flynn, S. and Yeats, P. (1985). Smack: the criminal drugs racket in Ireland. Gill & Macmillan, Dublin.  
Friel, S., Nic Gabhainn, S. and Kelleher, C. (1999). The national health & lifestyle surveys: survey of 
lifestyle, attitudes and nutrition (SLÁN) & the Irish health behaviour in school-aged 
children survey (HBSC). National University of Ireland, Galway. Available at 
http://www.drugsandalcohol.ie/5035/ 
Galway alcohol strategy, G. h. c. f. (2013). Galway City strategy to prevent and reduce alcohol-related 
harm 2013-2017. Galway alcohol strategy, Galway health cities forum, Galway. 
Available at http://www.drugsandalcohol.ie/19344/ 
Gavin, A., Molcho, M., Kelly, C. and Nic Gabhainn, S. (2013). The HBSC Ireland trends report 1998–
2010: Child health behaviours, outcomes and contexts. Department of Health and 
National University of Ireland, Galway, Dublin. Available at 
http://www.drugsandalcohol.ie/20575/ 
General Register Office for Scotland (2013). Drug-related Deaths in Scotland in 2012. List of Tables 
and Figures. General Register Office for Scotland. Accessed on  22 October 2013 at 
http://www.gro-scotland.gov.uk/statistics/theme/vital-events/deaths/drug-
related/2012/list-of-tables-and-figures.html 
Griffin, B. (2014, 10 June) Parliamentary Debates Dáil Éireann (Official report: unrevised): Written 
answers.Drugs Crime. Question(s) 156. Available at 
http://www.drugsandalcohol.ie/22063/ 
Hannon, F., Kelleher, C., Friel, S., Barry, M., Harrington, J., McKeown, D. et al. (2000). General 
healthcare study of the Irish prison population. Stationery Office, Dublin.  
Health Research Board (2011). 2011 National report (2010 data) to the EMCDDA by the Reitox 
National Focal Point. Ireland: new developments, trends and in-depth information on 
selected issues. Health Research Board, Dublin. Available at 
http://www.drugsandalcohol.ie/16812/ 
Health Research Board (2012). 2012 National Report (2011 data) to the EMCDDA by the Reitox 
National Focal Point. Ireland: new developments, trends and in-depth information on 
selected issues. Health Research Board, Dublin. Available at 
http://www.drugsandalcohol.ie/18808/ 
Health Research Board (2013). 2013 National Report (2012 data) to the EMCDDA by the Reitox 
National Focal Point. Ireland: new developments, trends and in-depth information on 
selected issues. Health Research Board, Dublin. Available at 
http://www.drugsandalcohol.ie/20857/ 
Health Research Board (2014a). Drug-related deaths and deaths among drug users in Ireland: 2011 
figures from the National Drug-Related Deaths Index. Health Research Board, Dublin. 
Available at http://www.drugsandalcohol.ie/21005/ 
Health Research Board (2014b). Treated problem alcohol use in Ireland: figures for 2012 from the 
National Drug Treatment Reporting System. Health Research Board, Dublin. Available 
at http://www.drugsandalcohol.ie/21518/ 
Health Service Executive (2013). Health service: national service plan 2014. Health Service 
Executive, Dublin. Available at http://www.drugsandalcohol.ie/21092 
Health Service Executive (2014a). Health service management data report. November 2013. Health 
Service Executive, Dublin. Available at http://www.drugsandalcohol.ie/21287/ 
Health Service Executive (2014b). Health service performance assurance report. January 2014. 
Health Service Executive, Dublin. Available at http://www.drugsandalcohol.ie/21735/ 
Health Service Executive (2014c). Fifth annual child & adolescent mental health service report 2012 - 
2013. Health Service Executive, Dublin. Available at 
http://www.drugsandalcohol.ie/21387/ 
Health Service Executive and Health Protection Surveillance Centre (2014). HIV in Ireland. 2013 
report. Health Protection Surveillance Centre, Dublin. Available at 
http://www.drugsandalcohol.ie/22099/ 
Healy, D., English, F., Daniels, A. and Ryan, C. (2014). Emergence of opiate-induced neonatal 
abstinence syndrome. Irish Medical Journal, 107, (2), 46. Available at 
http://www.drugsandalcohol.ie/21454/ 
Henry, K. and Kralstein, D. (2011). Community courts: the research literature. A review of findings. US 
Bureau of Justice Assistance, Washington. Available at 
www.courtinnovation.org/research/community-court-research-literature 
  125 
Hibell, B., Guttormsson, U., Ahlström, S., Balakireva, O., Bjarnason, T., Kokkevi, A. et al. (2009). The 
2007 ESPAD report: substance use among students in 35 European countries. The 
Swedish Council for Information on Alcohol and Other Drugs (CAN) and the Pompidou 
Group of the Council of Europe, Stockholm. Available at www.espad.org/espad-reports 
Hibell, B., Guttormsson, U., Ahlström, S., Balakireva, O., Bjarnason, T., Kokkevi, A. et al. (2012). The 
2011 ESPAD report: substance use among students in 36 European countries. The 
Swedish Council for Information on Alcohol and Other Drugs (CAN) and the Pompidou 
Group of the Council of Europe, Stockholm. Available at 
http://www.drugsandalcohol.ie/17644/ 
Homeless Agency (2008). Counted in, 2008: a report on the extent of homelessness in Dublin.  pp. 
108. Homeless Agency Partnership, Dublin. Available at 
www.drugsandalcohol.ie/11718/ 
Horgan, J. J. (2013). Drug and alcohol use among young offenders on probation supervision in 
Ireland. The Probation Service, Navan. Available at www.drugsandalcohol.ie/21333 
Institute of Criminology (2003). Public order offences in Ireland: a report by the Institute of 
Criminology, University College Dublin, for the National Crime Council. Stationery 
Office, Dublin. Available at www.drugsandalcohol.ie/5437 
Irish Focal Point (Reitox) (2010). 2010 National Report (2009 data) to the EMCDDA by the Reitox 
National Focal Point. Ireland: new developments, trends and in-depth information on 
selected issues. Health Research Board, Dublin. Available at 
http://www.drugsandalcohol.ie/14714/  
Irish Focal Point (Reitox) (2011). 2011 National Report (2010 data) to the EMCDDA by the Reitox 
National Focal Point. Ireland: new developments, trends and in-depth information on 
selected issues. Health Research Board, Dublin. Available at 
http://www.drugsandalcohol.ie/16812/ 
Irish Penal Reform Trust (2013). Women in the Criminal Justice System: towards a non-custodial 
approach. Irish Penal Reform Trust, Dublin. Available at 
http://www.drugsandalcohol.ie/21019/ 
Irish Prison Service (2006). Irish Prison Service health care standards. Irish Prison Service, Dublin. 
Available at http://www.drugsandalcohol.ie/5924/ 
Irish Prison Service (2014). Irish prison service annual report 2013. Irish Prison Service, Longford. 
Available at http://www.drugsandalcohol.ie/21497/ 
Irish Prison Service and Central Statistics Office (2013). Irish Prison Service recidivism study 2013. 
Irish Prison Service, Dublin. Available at http://www.drugsandalcohol.ie/19942/ 
Irish Youth Justice Service (2014). Tackling youth crime – youth justice action plan, 2014-2018. 
Department of Justice and Equality, Dublin. Available at 
http://www.drugsandalcohol.ie/21336/ 
Jennings, P. (2013). Melting the iceberg of fear: a collective response. Safer Blanchardstown, Dublin. 
Available at www.drugsandalcohol.ie/20566 
Jesuit Centre for Faith andJustice (2013). Making progress? Examining the first year of the Irish 
Prison Service’s three year strategic plan 2012—2015. Jesuit Centre for Faith and 
Justice, Dublin. Available at http://www.drugsandalcohol.ie/21228/ 
Joint Committee on Justice Defence and Equality (2014). Report on hearings in relations to 
community courts. Houses of the Oireachtas, Dublin. Available at 
http://www.drugsandalcohol.ie/22396/ 
Joint Committee on Transport and Communications (2013). Report on sponsorship of sports by the 
alcohol drinks industry. Houses of the Oireachtas Joint Committee on Transport and 
Communications,  Available at http://www.drugsandalcohol.ie/20134/ 
Kavanagh, P. and Power, J. D. (2014). New psychoactive substances legislation in Ireland – 
Perspectives from academia. Drug testing and analysis, Early online. Available at 
http://www.drugsandalcohol.ie/22211/ 
Keane, L., Ducray, K. and Smyth, B. P. (2014). Psychological characteristics of heroin-dependent and 
non-opioid-substance-dependent adolescents in community drug treatment services. 
Journal of Child & Adolescent Substance Abuse, 23, (4), 205. Available at 
http://www.drugsandalcohol.ie/22368/ 
Keane, M. (2007). Social reintegration as a response to drug use in Ireland. HRB Overview Series 5. 
Health Research Board, Dublin. Available at http://www.drugsandalcohol.ie/6358/ 
Kelleher, C., Seymour, M. and Halpenny, A. M. (2014). Promoting the participation of seldom heard 
young people: a review of the literature on best practice principles. Centre for Social & 
  126 
Educational Research, Dublin Institute of Technology, Dublin. Available at 
http://www.drugsandalcohol.ie/21452/ 
Kelleher, C., Nic Gabhainn, S., Friel, S., Corrigan, H., Nolan, G., Sixsmith, J. et al. (2003). The 
national health & lifestyle surveys: survey of lifestyle, attitudes and nutrition (SLÁN) & 
the Irish health behaviour in school-aged children survey (HBSC). National University 
of Ireland, Galway. Available at http://www.drugsandalcohol.ie/5417/ 
Kelly, A., Carvalho, M. and Teljeur, C. (2003). Prevalence of opiate use in Ireland 2000–2001: a 3-
source capture-recapture study. Stationery Office, Dublin. Available at 
http://www.drugsandalcohol.ie/5942/ 
Kelly, A., Teljeur, C. and Carvalho, M. (2009). Prevalence of opiate use in Ireland 2006: a 3-souce 
capture-recapture study. Stationery Office, Dublin.  
Kelly, C., Molcho, M. and Nic Gabhainn, S. (2012). The Irish Health Behaviour in School-aged 
Children study 2010. National University of Ireland and Department of Health, Galway. 
Available at www.drugsandalcohol.ie/17360 
Kennedy, M., Langford, S. and Fahey, T. (2013). Homelessness oversight group: first report. Dublin 
Region Homeless Executive, Dublin. Available at www.drugsandalcohol.ie/21105 
Klimas, J., Cullen, W. and Field, C.-A. (2014a). Problem alcohol use among problem drug users: 
development and content of clinical guidelines for general practice. Irish Journal of 
Medical Science, 183, (1), 89-101. Available at http://www.drugsandalcohol.ie/20158/ 
Klimas, J., Lally, K., Murphy, L., Crowley, L., Anderson, R., Meagher, D. et al. (2014b). Development 
and process evaluation of an educational intervention to support primary care of 
problem alcohol among drug users. Drugs and Alcohol Today, 14, (2). Available at 
http://www.drugsandalcohol.ie/21886/ 
Lang, J. and Bowen, P. (2014, January 29) Joint Committee on Justice, Defence and Equality debate. 
Community courts system: discussion. . Available at 
http://oireachtasdebates.oireachtas.ie/Debates%20Authoring/DebatesWebPack.nsf/co
mmitteetakes/JUJ2014012900003?opendocument 
Long, J., Allwright, S., Barry, J., Reaper-Reynolds, S., Thornton, L. and Bradley, F. (2000). Hepatitis 
B, hepatitis C and HIV in Irish prisoners, part II: prevalence and risk in committal 
prisoners 1999. Stationery Office, Dublin. Available at 
http://www.drugsandalcohol.ie/5110/ 
Mackey, K. (2014). Analysis of sentencing for possession or importation of drugs for sale or supply. 
Irish Sentencing Information System, Dublin. Available at 
http://www.drugsandalcohol.ie/21866/ 
Martin, D. (2014). Quenching the thirst: spirituality and addiction. Paper presented at: Irish Bishops’ 
Drugs Initiative National Conference, Church of the Holy Child, Whitehall. Available at 
http://www.drugsandalcohol.ie/22625/ 
McBrierty, D., Wilkinson, A. and Tormey, W. P. (2013). A review of drug-facilitated sexual assault 
evidence: an Irish perspective. Journal of Forensic and Legal Medicine, 20, (4), 189-
197. Available at http://www.drugsandalcohol.ie/21237/ 
McHugh, R. (2013). Tracking the needs and service provision for women ex-prisoners. Association for 
Criminal Justice, Dublin. Available at http://www.drugsandalcohol.ie/20354/ 
McKay, M. T., McBride, N. and Sumnall, H. (2012). Reducing the harm from adolescent alcohol 
consumption: results from an adapted version of SHAHRP in Northern Ireland. Journal 
of Substance Use, 17, (2), 98–121. Available at http://www.drugsandalcohol.ie/17020/ 
McMahon, E. M., Keeley, H., Cannon, M., Arensman, E., Perry, I. J., Clarke, M. et al. (2014). The 
iceberg of suicide and self-harm in Irish adolescents: a population-based study. Social 
psychiatry and psychiatric epidemiology, Early online. Available at 
http://www.drugsandalcohol.ie/22193/ 
Merchants Quay Ireland (2013). Annual review 2012. MQI, Dublin. Available at 
http://www.drugsandalcohol.ie/20514/ 
Methadone Treatment Services Review Group (1998). Report of the methadone treatment services 
review group. Department of Health and Children, Dublin. Available at 
http://www.drugsandalcohol.ie/5092/ 
Migrant Rights Centre Ireland (2014). Trafficking for forced labour in cannabis production. Migrant 
Rights Centre Ireland, Dublin. Available at http://www.drugsandalcohol.ie/21642/ 
Morgan, K., McGee, H., Watson, D., Perry, I., Barry, M., Shelley, E. et al. (2008). SLÁN 2007: survey 
of lifestyle, attitudes and nutrition in Ireland: main report. Stationery Office, Dublin. 
Available at http://www.drugsandalcohol.ie/6385/ 
  127 
Mullally, U. (2014). Warning about PMA/PMMA drug after six deaths in Ireland. Irish Times, 14 June. 
Retrieved from http://www.drugsandalcohol.ie/22101/ 
Murphy, A. and Haughey, R. (2014). Mephedrone-induced uvulitis. Anaesthesia, 69, (2), 189-190. 
Available at http://www.drugsandalcohol.ie/21541/ 
National Advisory Committee on Drugs and Alcohol (2013). Drug use in Ireland and Northern Ireland 
2010/11 drug prevalence survey: cannabis results. . Bulletin 3. National Advisory 
Committee on Drugs and Alcohol, Dublin. Available at 
http://www.drugsandalcohol.ie/20139/ 
National Advisory Committee on Drugs and Alcohol (2014a). Drug use in Ireland and Northern Ireland 
2010/11 drug prevalence survey: polydrug use results. Bulletin 5. National Advisory 
Committee on Drugs and Alcohol, Dublin. Available at 
http://www.drugsandalcohol.ie/22171/ 
National Advisory Committee on Drugs and Alcohol (2014b). Drug use in Ireland and Northern Ireland 
2010/11 drug prevalence survey: cocaine results. Bulletin 4. National Advisory 
Committee on Drugs and Alcohol, Dublin. Available at 
http://www.drugsandalcohol.ie/21727/ 
National Advisory Committee on Drugs and Drug and Alcohol Information and Research Unit (2005). 
Drug use in Ireland and Northern Ireland: first results (revised) from the 2002/2003 
drug prevalence survey. Bulletin 1. National Advisory Committee on Drugs, Dublin. 
Available at http://www.drugsandalcohol.ie/5652/ 
National Advisory Committee on Drugs and Drug and Alcohol Information and Research Unit (2008). 
Drug use in Ireland and Northern Ireland: first results from the 2006/2007 drug 
prevalence survey. Bulletin 1. National Advisory Committee on Drugs, Dublin. Available 
at http://www.drugsandalcohol.ie/11529/ 
National Advisory Committee on Drugs and Drug and Public Health Information and Research Branch 
(2009). Drug use in Ireland and Northern Ireland: 2006/2007 drug prevalence survey: 
polydrug use results. Bulletin 5. National Advisory Committee on Drugs, Dublin.  
National Advisory Committee on Drugs and Public Health Information and Research Branch (2008). 
Drug use in Ireland and Northern Ireland. 2006/2007 drug prevalence survey: cocaine 
results. Bulletin 4. National Advisory Committee on Drugs, Dublin. Available at 
http://www.drugsandalcohol.ie/11528/ 
National Crime Council (2007). Problem solving justice: the case for community courts in Ireland. 
Stationery Office, Dublin. Available at www.crimecouncil.gov.ie/index.html 
National Parasuicide Registry Ireland (2004). Annual report 2003. National Suicide Research 
Foundation, Cork. Available at http://www.drugsandalcohol.ie/6157/ 
National Records of Scotland (2013). Drug-related deaths in Scotland in 2012. Statistics of drug-
related deaths in 2012 and earlier years, broken down by age, sex, selected drugs 
reported, underlying cause of death and NHS Board and Council areas Edinburgh. 
Available at http://www.gro-scotland.gov.uk/files2/stats/drug-related-
deaths/2012/drugs-related-deaths-2012.pdf#page=61&zoom=100,0,842 
Naughton, G. (2014, 18 July). Coroner in warning about 'super-ecstasy' following inquests. Irish 
Independent. Retrieved from http://www.drugsandalcohol.ie/22349/ 
Nees, F. and Fitzgerald, M. (2014). Two cases of methaemoglobinaemia secondary to amyl nitrate 
use. Irish Medical Journal, 107, (2). Available at http://www.drugsandalcohol.ie/21434/ 
Nic Gabhainn, S., Kelly, C. and Molcho, M. (2007). The Irish Health Behaviour in School-aged 
Children (HBSC) study 2006. Department of Health and Children, Dublin. Available at 
http://www.drugsandalcohol.ie/6366/ 
North Inner City Drugs Task Force (2013). North Inner City Drugs Task Force trends and behaviours 
online survey . Violence, intimidation and threats. North Inner City Drugs Task Force, 
Dublin. Available at http://www.drugsandalcohol.ie/22405/ 
O'Connor, G., McGinty, T., Yeung, S. J., O'Shea, D., Macken, A., Brazil, E. et al. (2013). Cross-
sectional study of the characteristics, healthcare usage, morbidity and mortality of 
injecting drug users attending an inner city emergency department. Emergency 
Medicine Journal, early online. Available at http://www.drugsandalcohol.ie/20015/ 
O'Gorman, A., Piggott, K., Napier, K., Driscoll, A., Emerson, D., Mooney, R. et al. (2013). An analysis 
of current licit and illicit drug use patterns in the Finglas-Cabra local drugs task force 
area. Finglas/Cabra Local Drugs Task Force, Dublin. Available at 
http://www.drugsandalcohol.ie/20723/ 
  128 
O'Reilly, O. (2013). How did I get here? Cork Simon Community, Cork. Available at 
http://www.drugsandalcohol.ie/20654/ 
Pilling, S., Hardy, R. and Psychological Interventions Research Centre (UCL) review team (2013). 
Review of the Dublin North City and County addiction service. HSE Addiction Services, 
Dublin. Available at www.drugsandalcohol.ie/21143 
Pleace, N., Bretherton, J. and Simon Community (2013). Finding the way home: housing-led 
responses and the homeless strategy in Ireland. Simon Community, Dublin. Available 
at http://www.drugsandalcohol.ie/20183/ 
Probation Service (2014). The Probation Service annual report 2013. Probation Service, Dublin. 
Available at http://www.drugsandalcohol.ie/21506/ 
Probation Service and Irish Prison Service (2014). Joint Probation Service – Irish Prison Service 
strategy 2014 - 2016: an effective response to women who offend. Probation Service 
and Irish Prison Service,  Available at http://www.drugsandalcohol.ie/21496/ 
Reilly Michael (2013). Interim report on the Dóchas Centre by the Inspector of Prisons Judge Michael 
Reilly. Department of Justice and Equality, Dublin. Available at 
http://www.drugsandalcohol.ie/21006/ 
Reuter, P. and Caulkins, J. P. (2004). Illegal ‘lemons’: price dispersion in cocaine and heroin markets. 
Bulletin on Narcotics, LVI, (1 & 2), 141-165. Available at 
http://www.unodc.org/pdf/bulletin/bulletin_2004_01_01_1_Art6.pdf 
Ruhama (2013). Ruhama annual report 2012. Ruhama, Dublin. Available at 
www.drugsandalcohol.ie/20863 
Schaffalitzky, E., Leahy, D., Armstrong, C., Gavin, B., Latham, L., McNicholas, F. et al. (2014). 
'Nobody really gets it': a qualitative exploration of youth mental health in deprived urban 
areas. Early Intervention in Psychiatry, Early online. Available at 
http://www.drugsandalcohol.ie/22191/ 
Sheedy, C. K. and Whitter, M. (2009). Guiding principles and elements of recovery-oriented systems 
of care: what do we know from the research? HHS Publication No. (SMA) 09-4439. pp. 
68. Center for Substance Abuse Treatment, Substance Abuse and Mental Health 
Services Administration, Rockville, MD.  
Steering Group on a national substance misuse strategy (2012). Steering group report on a National 
Substance Misuse Strategy. Department of Health, Dublin. Available at 
http://www.drugsandalcohol.ie/16908 
Strategic Response Group (2012). A better city for all. A partnership approach to address public 
substance misuse and perceived anti-social behaviour in Dublin city centre. Strategic 
Response Group, Dublin. Available at http://www.drugsandalcohol.ie/17769/ 
The Gallup Organization (2011). Youth attitudes on drugs. Flash Eurobarometer 330.  Analytical 
report. European Commission, Luxembourg. Available at 
http://www.drugsandalcohol.ie/15497/ 
The Rotunda Hospital (2013). Rotunda hospital. Clinical report 2012. The Rotunda Hospital, Dublin. 
Available at http://www.drugsandalcohol.ie/21027/ 
Thornton, L., Murphy, N., Jones, L., Connell, J., Dooley, S., Gavin, S. et al. (2011). Determination of 
the burden of hepatitis C virus infection in Ireland. Epidemiology, 140, (8), 1461-1468. 
Available at http://www.drugsandalcohol.ie/15981/  
TNS Political and Social (2014). Flash Eurobarometer 401. Young people and drugs. European 
Commission, Luxembourg. Available at http://www.drugsandalcohol.ie/22196/ 
Tobacco Policy Review Group (2013). Tobacco free Ireland. Department of Health, Dublin. Available 
at www.drugsandalcohol.ie/20655 
Working Group on drugs rehabilitation (2007). National Drugs Strategy 2001-2008: rehabilitation. 
Report of the working group on drugs rehabilitation. Department of Community, Rural 
and Gaeltacht Affairs, Dublin. Available at http://www.drugsandalcohol.ie/6267/ 
Working Group on educational materials for use in SPHE in post-primary schools and centres for 
education (2014). Report of the Working Group on educational materials for use in 
SPHE in post-primary schools and centres for education with particular reference to 
substance use education in the context of SPHE. Department of Education and Skills, 
Dublin. Available at http://www.drugsandalcohol.ie/22264/ 
 
 
  129 
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http://www.drugsandalcohol.ie/  
 
For descriptions of relevant databases not currently available on-line, see introductions to chapters 5, 
6, and 7. 
 
 
13.3 List of relevant internet addresses 
http://aldp.ie  
http://addictionireland.ie  
http://www.alcoholforum.org/ 
http://alcoholireland.ie/  
http://www.barnardos.ie/  
http://www.citywide.ie 
http://www.cso.ie 
http://www.dcya.gov.ie/viewdoc.asp?DocID=120  
http://www.drugsandalcohol.ie/  
http://www.drugs.ie/ 
http://www.emcdda.europa.eu/  
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https://www.hellosundaymorning.org/  
http://www.hpra.net  
http://www.hpsc.ie  
http://www.hrb.ie  
http://www.hse.ie 
http://www.irishsentencing.ie/ 
http://www.lawreform.ie 
http://www.ncpe.ie/ 
http://www.popcenter.org/ 
http://www.sphe.ie/ 
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14.  Annexes 
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Standard Table 24 Access to treatment 
Structured Questionnaire 23/29 Prevention and Reduction of Health-related harm associated with 
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Structured Questionnaire 27P1 Treatment programmes 
Structured Questionnaire 27P2 Interventions Quality assurance 
TDI 34 TDI data 
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14.3 List of figures 
Figure 4.2.2.1 Number of cases, additional problem substances associated with alcohol as a main 
problem substance, 2008–2012 
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Laws 
 
Statutory Instruments 
Misuse of Drugs Act 1977 (Controlled Drugs) (Declaration) Order 2010 (S.I. 199 of 2010) 
Misuse of Drugs (Amendment) Regulations 2010 (S.I. 200 of 2010) 
Misuse of Drugs (Designation) (Amendment) Order 2010 (S.I. 201 of 2010)  
Misuse of Drugs (Exemption) (Amendment) Order 2010 (S.I. 202 of 2010) 
 
Bills 
Public Health (Alcohol) Bill 2014 
 
Acts 
Criminal Justice (Psychoactive Substances) Act 2010 (PSA) 
Criminal Justice Act 2006 
Criminal Justice (Amendment) Act 2009 
Criminal Law (Human Trafficking) (Amendment) Act 2013 
Civil Law (Miscellaneous Provisions) Act 2011 
Fines (Payment and Recovery) Act 2014 
Health Identifiers Act 2014 
Housing (Miscellaneous Provisions) Act 2009 
Misuse of Drugs Acts (MDA) 1977 and 1984 
Misuse of Drugs Regulations 1988 
Road Traffic (No.2) Act 2014 
Road Traffic Act 2002 
Road Traffic Act 1994 
 
14.5 List of abbreviations 
ADHD   Attention-Deficit Hyperactivity Disorder 
AHTU   Anti-Human Trafficking Unit 
AIDS   Acquired Immunodeficiency Syndrome 
ALDP   Ana Liffey Drug Project 
ANS   Ante-natal screening 
ASI   Anti-Slavery International 
ATS   amphetamine-type stimulants 
BBVs   Blood Borne Viruses 
CAMHS  Child and Adolescent Mental Health Service 
CDLE   Customs Drug Law Enforcement 
CE   Community Employment 
COFOG  classification of functions of government 
CRC   capture-recapture   
CSO   Central Statistics Office 
CTL   Central Treatment List 
DAIRU   Drugs and Alcohol Information and Research Unit (DHSSPS, NI) 
DATFs   Drugs and Alcohol Task Forces 
DCBA   Dublin City Business Association 
DCYA   Department of Children and Youth Affairs 
DD   Dual Diagnosis  
DES   Department of Education and Skills (since March 2010) 
DEIS   Delivering Equality of Opportunity in Schools 
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DFSA   drug-facilitated sexual assault 
DFUs   drug-free units 
DHSSPS  Department of Health, Social Services and Public Safety (NI) 
DLM      Drug Liaison Midwife 
DoH   Department of Health 
DSP   Department of Social Protection 
DTCB   Drug Treatment Centre Board 
DTF   Drugs Task Force 
DUID   Driving Under the Influence of Drugs 
ED   Emergency Department 
EJAS   Elton John AIDS Foundation 
EMCDDA  European Monitoring Centre for Drugs and Drug Addiction 
ESA   European System of National and Regional Accounts 
ESPAD  European School Survey Project on Alcohol and Other Drugs 
ETBs   Education and Training Boards 
EU   European Union 
FSL   Forensic Science Laboratory 
FSN   Family Support Network 
GDP   gross domestic product 
GJDP   Garda Juvenile Diversion Programme 
GNDU   Garda National Drugs Unit 
GP   General Practitioner 
HBSC   Health Behaviour in School-aged Children Survey 
HBV   Hepatitis B Virus 
HCV   Hepatitis C Virus 
HIV   Human Immunodeficiency Virus 
HIPE   Hospital In-Patient Enquiry scheme 
HPRA   Health Products Regulatory Authority 
HPSC   Health Protection Surveillance Centre 
HRB   Health Research Board 
HRDU   High Risk Drug Use 
HSE   Health Service Executive 
HSM   Hello Sunday Morning 
IBDI   Irish Bishops Drugs Initiative 
IDUs   Injecting Drug Users 
ILP   Individual Learner Plan 
IPRT   Irish Penal Reform Trust 
IPS   Irish Prison Service 
IPU   Irish Pharmacy Union 
IYJS   Irish Youth Justice Service 
JCFC   Jesuit Centre for Faith and Justice 
JPC   Joint Policing Committee 
KPI   Key Performance Indicator 
LDTF   Local Drugs Task Force 
LDATF   Local Drugs and Alcohol Task Force 
LRC   Law Reform Commission 
LPF   Local Policing Fora 
MDA   Misuse of Drugs Act 
MMT   Methadone Maintenance Programme 
MRCI   Migrant Rights Centre Ireland 
MS   Multiple Sclerosis 
MTP   Methadone Treatment Protocol 
MQI   Merchants Quay Ireland 
NACD   National Advisory Committee on Drugs 
NACDA  National Advisory Committee on Drugs and Alcohol 
NATP   National Addiction Training Programme 
NAS   Neonatal Abstinence Syndrome 
NCC   National Co-Ordinating Committee  
NCC   National Crime Committee 
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NCPE   National Centre for Pharmacoeconomics 
NDRDI   National Drug Related Death Index 
NDRIC   National Drugs Rehabilitation Implementation Committee 
NDS   National Drug Strategy 
NDTRS  National Drug Treatment Reporting System 
NGO   Non-Government Organisation 
NICC   National Co-ordinating Committee for Drug and Alcohol Task Forces 
NICU   Neonatal intensive care unit 
NIE   National Income & Expenditure accounts 
NPIRS   National Psychiatric Inpatient Reporting System 
NSRF   National Suicide Research Foundation 
NVDS   National Voluntary Drug Sector 
OCGs   organised crime groups 
OFD   Oversight Forum on Drugs 
PHIRB   Public Health Information and Research Branch 
PPO   Prolific and Priority Offender 
PQ   Parliamentary Question 
PULSE  Police Using Leading Systems 
PSA   Psychoactive Substances Act 
QNA   Quarterly National Accounts 
QuADS  Quality Standards in Alcohol and Drugs Services 
RCC   Rape Crisis Centre 
RDTF   Regional Drugs Task Force 
RSE   Relationship and sexuality education 
SDD   self-directed detoxification 
SHAHRP  School Health and Alcohol Harm Reduction Project 
SLÁN   Survey of Lifestyle, Attitudes and Nutrition in Ireland 
SPHE   Social, Personal and Health Education 
STI   Sexually Transmitted Infection 
TD   Teachta Dála (Member of Parliament) 
TDI   Treatment Demand Indicator 
THN   Take Home Naloxone 
WHO   World Health Organization 
WSEs   whole-school evaluations 
YoDA   Youth Drug and Alcohol service 
YPFSF  Young People’s Facilities and Services Fund 
 
 
 
